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Preface
Brain injury caused by stroke is a leading cause of disability with a tendency for an 
increasing societal burden of stroke-related disability globally. At the same time, 
our knowledge about effective rehabilitation treatment is rapidly increasing as indi-
cated by the multitude of clinical trials, systematic reviews and meta-analyses being 
published. For the individual health care professionals involved in stroke rehabilita-
tion, it is hardly possible to keep track with the evolution of clinical evidence and 
hence there is a risk for an increasing gap between the state of the art in clinical 
stroke rehabilitation research and clinical practice and decision-making.
Guidelines help to bridge this gap, if systematically evidence-based. Usually 
written for a specific (national) background they are, however, frequently not read-
ily applicable to other health care situations limiting their usefulness elsewhere.
The authors of this book, mainly coming from the various Special Interest 
Groups of the World Federation for NeuroRehabilitation (WFNR) with a multidis-
ciplinary and regionally diverse background, had a different goal: the development 
of international evidence-based stroke practice recommendations that focus on the 
link between evidence and clinical decision-making related to rehabilitation therapy 
rather than issues related to or being dependent on organisational issues.
As a consequence, the evidence-based practice recommendations that had been 
developed with an international perspective can be applied globally for clinical 
decision-making in stroke rehabilitation. In addition, the knowledge provided can 
be used in very different health care situations to further structure and adapt regional 
or local stroke rehabilitation pathways. Last but not least, by providing clinical ori-
entation the practice recommendations can support service development in a way 
that will eventually achieve effective stroke rehabilitation in areas with limited ser-
vices so far.
The international practice recommendations for stroke rehabilitation developed 
by the WFNR are published open access with this book supporting their accessibil-
ity and dissemination. May they help to promote effective stroke rehabilitation for 
those in need.




All authors dedicated their time and effort to collectively provide evidence-based 
guidance for clinical decision-making in stroke rehabilitation. In addition, they pro-
vided peer review for the other chapters of this book as did the feedback panel 
members (for reference see Table 1 in Chap. 2). All these contributions are grate-
fully acknowledged.
The World Federation for NeuroRehabilitation (WFNR) sponsored this book 
project and made it possible to be published as an open access book. This will 
largely facilitate its distribution and availability quite independent of financial 
resources of potential users.
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A stroke occurs somewhere in the world every 2 s adding up to almost 17 million 
people each year (Feigin et al. 2014). Stroke is one of the most common causes of 
disability. Over one million people in the UK are currently living with the conse-
quences of stroke, over one-third of whom are dependent on others for their care. 
Even though stroke mortality is declining (Lackland et  al. 2014), the number of 
people set to live with the consequences of stroke is set to rise over the next 20 years 
(Patel et al. 2017; Crichton et al. 2016) with huge personal, societal and economic 
consequences (Patel et al. 2017). Improvement of recovery and long-term outcomes 
is therefore an urgent clinical and scientific goal, but success is slow to materialize. 
Understanding the underlying neurobiology of stroke recovery could speed up ways 
to help improve outcomes.
Care in the hyperacute and acute period after stroke has improved dramatically 
over the past two decades, but it is widely accepted that our attention must turn to 
treatments that actively promote recovery. The key treatments for promoting behav-
ioural recovery in motor, language and cognitive domains after stroke are them-
selves behavioural treatments (loosely grouped under the headings physiotherapy, 
occupational therapy, speech and language therapy, neuropsychology) that we can 
consider inputs (into the brain). The consequent change in behaviour can be 
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considered an output (from the brain). It is becoming more accepted that the amount 
of input (and probably the quality) affects the output (Lohse et al. 2014). For exam-
ple, significantly higher doses of good quality upper-limb rehabilitation have large 
beneficial effects, even in chronic stroke (McCabe et  al. 2015; Daly et  al. 2019; 
Ward et al. 2019). The input–output relationship can be modulated by brain states, 
and we think of these states as enhancing the potential for experience dependent 
plasticity, and it is these brain states that will be the focus of this review.
The early post-stroke phase has been described as a period of ‘spontaneous 
biological recovery’ (Krakauer et al. 2012). Spontaneous biological recovery is a 
behavioural response to underlying biological events occurring in the first few 
weeks and months after stroke attributable to enhanced post-stroke plasticity 
mechanisms. Recovery is rapid, occurs at the level of impairment and generalizes 
beyond the tasks that are used in post-stroke training, which is different to 
improvements seen in the chronic phase of stroke (Zeiler and Krakauer 2013). 
This leads to the hypothesis that behavioural interventions will have a quantitative 
and qualitatively greater effect if delivered in this period compared to outside of 
this period. This raises two major challenges for the field of stroke rehabilitation. 
The first is to determine what is the correct form of behavioural training (the 
input) to take advantage of this critical period. This is not trivial, as has been dis-
cussed elsewhere (Krakauer and Carmichael 2017). The second challenge is how 
(and importantly, when) to augment the biological mechanisms of post-stroke 
plasticity to enhance or prolong the effects of behavioural training in patients after 
a stroke. It is important to note that although work in preclinical animal models 
has been pivotal in highlighting the biological basis of recovery, few benefits have 
been seen for human stroke patients. This is likely to require the development of 
human biomarkers to move this field of research into the human arena (Ward 
2017). Here, we define biomarkers using the Stroke Recovery and Rehabilitation 
Roundtable criteria—Indicators of disease state that can be used clinically as a 
measure reflecting underlying molecular or cellular processes that might be dif-
ficult to measure directly in humans, and can be used to predict recovery or treat-
ment response (Bernhardt et al. 2016).
One of the first studies providing behavioural evidence of this post-stroke critical 
period for recovery-related training was provided by Biernaskie and colleagues 
(Biernaskie et al. 2004) who found that rats commencing training of the affected 
forelimb starting at 30 days post-stroke exhibited the same level of improvement as 
those who received no training. However, those whose treatment commenced at 
5–14 days post-stroke had better recoveries. This suggests that there is a time lim-
ited effect of the lesion itself on the brain’s potential for plasticity. This was sup-
ported by Zeiler and colleagues (Zeiler et al. 2015) who showed that intensive motor 
training of a mouse commenced 7 days after stroke was not able to promote full 
recovery. However, when the same animal was given a second stroke and training 
was commenced 2  days later then recovery was substantially enhanced. These 
results suggest that focal brain damage results in a series of biological events that, 
when combined with appropriate behavioural training (Krakauer et al. 2012), can 
support recovery.
E. Kane and N. S. Ward
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1  Changes in Structural Plasticity After Stroke
A substantial amount of work has been undertaken in animal models to define the 
molecular and cellular processes that occur after stroke. These studies are well 
described elsewhere (Krakauer and Carmichael 2017; Murphy and Corbett 2009; 
Carmichael 2016; Cramer and Chopp 2000; Wieloch and Nikolich 2006) and by the 
nature of the experimental model concern largely sensorimotor recovery rather than 
other domains that are important in human stroke. Nevertheless, these studies are 
instructive if we are interested in the capacity of the central nervous system to sup-
port recovery. Briefly, focal ischaemic brain damage leads to cell death followed by 
secondary damage, then to the elements important for recovery, namely regenera-
tion and (partial) repair (Krakauer and Carmichael 2017; Wieloch and Nikolich 
2006). The basic elements of neural repair that can be seen in animal models of 
stroke change over time and include axonal sprouting, dendritic branching, synap-
togenesis, neurogenesis and gliogenesis and all can be enhanced in the early post- 
stroke period. These post-stroke changes also have spatial characteristics, seeming 
to occur in brain regions connected to the damaged area, including peri-infarct, 
ipsilesional and contralesional brain and spinal cord networks. Not all these biologi-
cal responses to injury are necessarily beneficial. For example, only axonal sprout-
ing that links functionally related brain areas is consistently associated with 
improved post-stroke outcomes (Carmichael et al. 2016). The precise temporal and 
spatial ordering of the biological events that occur after stroke are likely to be gov-
erned by alterations in gene expression and it is often suggested that the biological 
environment of the post-stroke brain resemble that of the developing brain, and that 
‘recovery recapitulates ontogeny’ (Cramer and Chopp 2000). Recent work however 
points to this being an over simplification and that in reality there is a unique regen-
erative molecular program at work with a clear distinction between regenerative and 
developmental transcriptomes (Li et  al. 2010). Furthermore, expression of the 
regenerative transcriptome is strongly influenced by age at stroke onset, with 
younger animals expressing growth-promoting molecules earlier and growth- 
inhibiting molecules later than older animals (Li and Carmichael 2006). Definitive 
evidence of these restorative processes in humans is scarce, but markers suggestive 
of neurogenesis (Jin et al. 2006), gliogenesis (Sanin et al. 2013) and axonal sprout-
ing (Jin et al. 2006) have been found in human post-stroke perilesional brain tissue. 
Consequently, the occurrence of similar biological responses to brain injury in both 
animals and humans seems probable.
There are a number of approaches to developing pharmacological therapies that 
aim to promote structural plasticity after stroke in order to enhance outcomes. 
Firstly, there is successful preclinical work to block extracellular inhibitory signals 
that counteract regeneration using axonal growth inhibitors (Wahl and Schwab 
2014; Benowitz and Carmichael 2010). For example, myelin-associated proteins 
such as NogoA, myelin-associated glycoprotein (MAG) and myelin-associated oli-
godendrocyte basic protein have been shown to block neuronal regeneration. Anti- 
NogoA strategies have been used in preclinical models both of stroke and of spinal 
cord injury and can lead to improved recovery profiles, probably through both 
Neurobiology of Stroke Recovery
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vascular and neural repair mechanisms (Rust et  al. 2019). In terms of structural 
changes to the central nervous system in response to anti-NogoA, axonal sprouting 
is often seen across the midline, either at the level of brain stem or spinal cord. 
Lindau and colleagues (Lindau et al. 2014) found that in rats undergoing sensorimo-
tor cortex ablation but then treated with anti-NogoA antibody, intact corticospinal 
tract had extensively sprouted across the midline into the denervated spinal hemi-
cord, which led to a somatotopic anatomical and functional side switch in the pro-
jection of adult corticospinal neurons. The safety of anti-NogoA antibodies has 
been tested in patients with spinal cord injury (Wahl and Schwab 2014) and amyo-
trophic lateral sclerosis (Meininger et al. 2014), and anti-MAG has been tested in 
patients with stroke (Cramer et al. 2013). Many of the antibody molecules are large 
and it is not clear how well they cross the blood–brain barrier after stroke (when it 
is damaged). Alternative ways of achieving the same response, through genetic 
manipulation for example (Rust et al. 2019), are being explored.
Other candidate molecules that inhibit the axonal growth cone, e.g. semaphorins 
and ephrins, and so block neuronal regeneration are also being investigated. After 
stroke damage, ephrin-A5 is induced in astrocytes in peri-infarct cortex, which 
leads to inhibition of axonal sprouting. When ephrin-A5 signalling is blocked, 
motor training is more liable to promote recovery (Overman et al. 2012).
Axon growth can also be blocked by perineuronal nets (PNNs), a property medi-
ated by chondroitin sulphate proteoglycans. After ischaemic cortical damage, the 
density of PNNs is reduced in peri-infarct cortex, likely representing one of the 
mechanisms of spontaneous biological recovery (Allred et al. 2005). This biological 
environment can be recreated by the enzyme chondroitinase ABC, which can 
reverse blocking of axonal growth, thereby reinstating critical period plasticity via 
the inactivation of chondroitin sulphate proteoglycans and therefore PNNs 
(Pizzorusso et al. 2002). In a rat model of stroke, chondroitinase ABC helped restore 
motor function after both acute and delayed administration (Gherardini et al. 2015).
Rather than blocking axonal growth inhibitors, the naturally occurring purine 
nucleoside inosine has been reported to enhance axon growth and improve out-
comes in a preclinical model of stroke. Inosine promotes axonal collateral sprouting 
into areas that have lost their normal innervation, such as the corticospinal tract after 
stroke (Zai et al. 2009) or hippocampus after experimental traumatic brain injury 
(Dachir et al. 2014). Furthermore, inosine can augment the effects of anti-NogoA 
antibody to restore skilled forelimb use after stroke (Zai et al. 2011).
In other classes of drugs, phosphodiesterase (PDE) inhibitors can prevent the 
degradation of cyclic nucleotides (cAMP and cGMP) which amongst other things 
promote axonal sprouting. There has been interest in whether drugs such as silde-
nafil (PDE5 inhibitor) or cilostazol (PDE3 inhibitor) can improve outcomes after 
stroke (Munshi and Das 2017), but their translation into use in human stroke remains 
a long way off.
Increasingly, interest has been shown in the use of stem cell therapy to promote 
recovery after stroke (Kalladka and Muir 2016). The two main lines of stem cell 
therapies are endogenous (promoting the production of existing neural stem cells) 
or exogenous (transplanted from another source) (Azad et al. 2016). Over the past 
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few years, research has explored how to reprogram adult human somatic cells to 
induced pluripotent stem cells thereby producing patient-specific cells for autolo-
gous transplantation (Tornero et al. 2013). Rather than restoring lost tissue, stem 
cells could act as stimulants for trophic factors and modulators of immunological 
and inflammatory changes after stroke. Trials of exogenous cells in humans have 
proved safe, and claims have been made for improved clinical outcomes in patients 
with chronic stroke (Steinberg et al. 2016; Kalladka et al. 2016).
The timing of administration of growth-promoting compounds, both in relation 
to the initial stroke damage and to the behavioural training itself, will clearly have a 
major effect on the therapeutic capacity. Whether training is delivered at the same 
time as growth-promoting molecules or sequentially could influence the type of 
sprouting that occurs and, consequently, whether behaviour is helped or hindered 
(Wahl et al. 2014). In addition, the effect that post-stroke behaviour can have on 
regenerative processes themselves is important to understand. For example, early 
compensatory use of the contralesional forelimb impairs recovery of the affected 
limb (Allred et al. 2005), possibly through aberrant synaptogenesis in the perile-
sional cortex (Kim et al. 2015). Any behaviour, if overtrained, will take advantage 
of the increased post-stroke potential for experience-dependent plasticity, and so 
abnormal or compensatory patterns of behaviour can become learned. Once again, 
this finding highlights the need for an appropriate form of behavioural training that 
can take advantage of any spontaneous or therapeutically enhanced potential for 
plasticity.
As well as asking ‘when’ treatment should be administered and ‘where’ is prob-
ably an equally important question. Most of the compounds discussed have been 
administered via intravenous or intrathecal routes, but accurate spatial and temporal 
delivery might both be necessary to achieve the desired outcomes. Advances made 
in the last few years in tissue engineering (Nih et al. 2016; Memanishvili et al. 2016) 
and optogenetics (Pendharkar et al. 2016) provide potential methods for precisely 
delivering regenerative molecules to functionally relevant brain regions. In this 
case, it might then be preferable to take advantage of the possibility of delivering 
brain region–specific stem cell therapies (cells that have cortical or basal ganglia- 
like phenotypes). Given the importance of white matter damage in human stroke 
(white matter constitutes over 50% of brain volume in humans in comparison to less 
than 10% in rodents), it is even possible that replacing lost glia is a more successful 
strategy in some cases, than replacing lost neurons (Tornero et  al. 2013; Kokaia 
et al. 2017).
2  Changes in Functional Plasticity After Stroke
So far, we have concentrated on post-stroke changes in brain structure and how 
these processes may be therapeutically altered. In addition to these structural 
changes, focal brain damage also results in alterations in neuronal excitability 
(Carmichael 2012). Immediately after stroke, signalling by the excitatory neu-
rotransmitter glutamate is excitotoxic and contributes to cell death, whereas 
Neurobiology of Stroke Recovery
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signalling by the inhibitory neurotransmitter GABA can counteract this toxicity 
through cell hyperpolarization (Lai et al. 2014). In the mouse model, the beneficial 
and detrimental effects of GABA and glutamate signalling seem to reverse after 
about 3 days post-stroke (Clarkson et al. 2010). This is of potentially great interest, 
since changes to the cortical excitatory–inhibitory balance have long been known to 
influence the potential for experience-dependent plasticity and can reopen critical 
periods of plasticity in the adult brain (Bavelier et  al. 2010). The link between 
changes in so called ‘functional plasticity’ is that reduced inhibitory tone can lead 
to facilitation of downstream changes in neuronal structure (Chen et al. 2011). One 
possibility then is that the altered levels of neuronal activity that result from a 
change in excitability regulate neurogenesis and the activity of growth factors (such 
as brain derived neurotrophic factor; BDNF) through epigenetic mechanisms 
(Felling and Song 2015). Reduced cortical inhibitory mechanisms can also lead to 
expanded and less specific receptive fields (Alia et al. 2016; Winship and Murphy 
2008), enhanced long-term potentiation (Hagemann et al. 1998) and remapping of 
sensorimotor functions to surviving cortex (Takatsuru et  al. 2009) in both hemi-
spheres (Que et al. 1999), all of which is potentially useful when functional reorga-
nization of residual post-stroke brain structures is important for recovery of normal 
function. Stroke-induced changes in the inhibitory–excitatory balance in surviving 
brain regions (particularly cortex) could, therefore, be a key event that sets other 
restorative mechanisms in motion.
One idea is that attenuation of neuronal activity in brain regions connected to 
the damaged area after stroke might be reversed by a homeostatic increase in neu-
ronal excitability, a process that can last at least several weeks (Murphy and 
Corbett 2009). Levels of neuronal excitability are determined by the balance in 
activity between GABA and glutamate, both of which are known to be altered 
after stroke (Carmichael 2012). For example, enhanced glutamate signalling 
through AMPA receptors, the major excitatory signalling system in the adult 
brain, is associated with improved recovery in stroke models due to downstream 
induction of BDNF (Clarkson et al. 2011). GABAA receptors, on the other hand, 
are dowregulated (Que et al. 1999; Schiene et al. 1996), and the density of a num-
ber of inhibitory interneurons is reduced after focal brain damage (Alia et  al. 
2016; Zeiler et al. 2013), suggesting a reduction in in phasic (synaptic) inhibition 
in the first few weeks after injury (Neumann-Haefelin et al. 1995) to increase the 
likelihood of long-term potentiation (Hagemann et al. 1998). Both increased glu-
tamatergic signalling and reduced phasic GABAergic signalling would be consis-
tent with the idea of a homeostatic restitution of neuronal activity (Murphy and 
Corbett 2009). However, other work has focussed on tonic GABAergic inhibition, 
suggesting that there is a dominant increase in perilesional tonic inhibition, medi-
ated by extrasynaptic GABAA receptors (Clarkson et al. 2010; Lake et al. 2015). 
Reversing this tonic inhibition (using an α5 subunit that contained an extrasynap-
tic GABAA-receptor inverse agonist) improved motor outcomes in both mouse 
(Tornero et al. 2013) and rat (Lai et al. 2014) models of stroke. The increase in 
tonic inhibitory signalling can persist for more than 1 month (Carmichael 2012) 
making this therapeutic window attractive.
E. Kane and N. S. Ward
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The interactions between excitatory pyramidal cells and numerous inhibitory 
interneurons in the cortex are clearly complex and become more complex after 
stroke (Clarkson 2012). In addition, prolonged ischaemia affects different cell types 
unequally (Sakuma et al. 2008) and causes alterations in the distribution of receptor 
subtypes (Kharlamov et al. 2008). Nevertheless, the weight of evidence from animal 
studies to date suggests that spontaneous biological recovery is either augmented by 
a homeostatic restitution of cortical activity secondary to reduced phasic GABAergic 
inhibitory signalling or blocked by excessive tonic GABAergic inhibitory signal-
ling. Beyond the hyperacute period (up to 3 days post-stroke), what follows at a 
cellular level suggests that alterations in cortical inhibitory and excitatory mecha-
nisms are important in determining the potential for plasticity and downstream 
structural changes that support recovery. Consequently, components of these inhibi-
tory and excitatory mechanisms represent exciting and novel therapeutic targets for 
enhancing behavioural training after stroke.
The mechanisms responsible for the alterations in cortical excitatory–inhibitory 
balance that underlie changes in post-stroke functional plasticity are amenable to 
pharmacological and non-pharmacological manipulation. There is much interest in 
the use of selective serotonin reuptake inhibitors (SSRIs) for promoting recovery 
after stroke. SSRIs can influence structural plasticity, but there is compelling evi-
dence to support a plasticity-modifying effect mediated through the GABAergic 
system. Chronic doses of fluoxetine can reinstate critical period plasticity in adult 
rats through a reduction of extracellular levels of GABA and an increase in BDNF 
expression (Maya Vetencourt et al. 2008). Furthermore, in a mouse model of stroke, 
Ng and colleagues (Ng et al. 2015) showed that fluoxetine treatment prolonged (but 
did not reinstate) the critical period of post-stroke plasticity through the reduction 
of inhibitory interneuron expression in intact cortex (Ng et al. 2015). Serotonin can 
have inhibitory (via 5HT1A receptors) or facilitatory (via 5HT2A receptors) effects on 
pyramidal cells, but most fast-spiking inhibitory interneurons are inhibited by sero-
tonin through 5HT1A receptors (Puig et al. 2010). In the cortex, chronic fluoxetine 
administration induces a reduction in layer II–III inhibitory interneuron activity 
which facilitates experience-driven structural dendritic remodelling (Chen et  al. 
2011). A separate study in human primary motor cortex slices demonstrated that 
fluoxetine-induced reduction of inhibitory tone comes about through suppression of 
layer II–III monosynaptic excitatory connections from pyramidal cells to inhibitory 
interneurons, which leaves the monosynaptic output of GABAergic cells unaffected 
(Komlósi et al. 2012). This layer-specific effect of fluoxetine is interesting in the 
context of work that demonstrates that early post-stroke ‘enriched rehabilitation’ is 
more effective than environmental enrichment or reach training alone as a result of 
the enhancement of use-dependent plasticity in peri-infarct layer II–III cortex 
(Clarke et al. 2014). One idea is that fluoxetine (and other pharmacotherapies) might 
influence training effects by replicating the biological effects of enriched 
environments.
Fluoxetine has been well studied in human stroke patients. The fluoxetine for 
motor recovery after acute ischemic stroke (FLAME) study in which 20 mg fluox-
etine daily, started 5–10 days after ischaemic stroke and continued for 3 months, 
Neurobiology of Stroke Recovery
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enhanced upper-limb motor recovery (Chollet et  al. 2011). However, the larger 
FOCUS study did not show that fluoxetine had an effect on the modified Rankin 
Scale (FOCUS Trial Collaboration 2019). However, we know that changing the 
potential for plasticity still requires the appropriate behavioural intervention to take 
advantage of this new brain state. In FOCUS, no attempt was made to control for or 
measure the amount of rehabilitation patients received, which makes the results dif-
ficult to interpret.
Another approach might be to target the proposed increase in perilesional tonic 
inhibition. Tonic inhibition can be reversed by antagonists or inverse agonists of the 
α5-subunit-containing extrasynaptic GABAA receptor, and compounds for use in 
humans are currently available and under investigation. Zolpidem is an interesting 
pharmacological agent that binds with high affinity to α1-containing GABAA recep-
tors through which it mediates sedative and hypnotic effects. However, zolpidem 
can also influence tonic inhibition through α5-containing GABAA receptors in a 
dose-dependent manner, such that low levels of the drug augment tonic inhibition 
and high levels reduce it (Prokic et al. 2015). Zolpidem can improve recovery in a 
mouse model of stroke (Hiu et al. 2015) and has been reported to mediate interest-
ing effects such as the temporary reversal of deficits in language, cognitive and 
motor function in single patient cases with stroke (Cohen et al. 2004; Hall et al. 
2010). However, given the uncertainty over how zolpidem works, the mechanism of 
recovery in these individuals remains unclear.
The most studied therapeutic option for promoting recovery after stroke is likely 
to be non-invasive brain stimulation (NIBS). Several systematic reviews suggest 
that NIBS is able to enhance the effects of behavioural training to a small degree 
(Hsu et al. 2012; Kang et al. 2015). In a mouse model, direct current stimulation to 
the brain appeared to augment synaptic plasticity through BDNF dependent mecha-
nisms (Fritsch et al. 2010). However, in human studies, it is not clear how much or 
how accurately electrical current is delivered to target brain regions, and conse-
quently results are inconsistent and potential mechanisms poorly understood 
(Bonaiuto and Bestmann 2015; de Berker et al. 2013).
3  Conclusion Regarding the Neurobiology 
of Stroke Recovery
The rationale for understanding how to optimize the post-stroke brain environment 
is to maximize the effect of behavioural training—which can take the form of physi-
cal, cognitive or speech therapy. The presence of a critical period of plasticity man-
dates for the delivery of high dose and high intensity behavioural training during 
this window of opportunity to maximize recovery of function by minimizing impair-
ment (Zeiler and Krakauer 2013). Whilst this idea is strongly supported in animal 
models as already discussed (Biernaskie et al. 2004; Zeiler et al. 2015), there is as 
yet no direct evidence of this in human stroke patients. Targeting the mechanisms 
that underlie early spontaneous biological recovery in humans represents the most- 
promising path to dramatically improve patients’ outcomes (Zeiler and Krakauer 
E. Kane and N. S. Ward
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2013) and should be prioritized. The limits of what is possible in stroke recovery 
have not yet been explored, especially if the delivery of high doses of behavioural 
therapy in post-acute or reopened critical periods of plasticity becomes possible.
4  Take Home Message for Clinical Practice 
in Stroke Rehabilitation
This chapter on the neurobiology of stroke recovery portrays the state of the art in 
research on the structural and functional mechanisms of recovery after stroke. It 
provides scientific reasoning on how clinical interventions in stroke rehabilitation 
might work and where potentials for future research in stroke recovery and rehabili-
tation are seen from a neuroscience perspective. It does, however, not provide clini-
cal evidence for stroke rehabilitation, and hence it is not possible to link clinical 
practice recommendations directly to this type of reasoning. This information will 
be given in the remainder of the chapters in this book.
As far as the neuroscience perspective goes, some general take-home messages 
are nevertheless worthwhile to portray on the basis of the overview given.
Alterations of body functions after acquired brain damage such as motor, percep-
tual, language or cognitive dysfunctions are results of network activities that are 
affected by structural brain damage. Complex changes in neural excitability and 
structural changes that occur over an extended period after brain damage will even-
tually determine the extent of functional recovery achieved by an individual. These 
processes can be influenced by rehabilitation treatment most likely if it is based on 
targeted training of high enough intensity and specificity for the affected brain net-
works and hence dysfunctions. In addition, the processes related to functional 
recovery can theoretically be modulated by non-invasive brain stimulation, medica-
tion and stem cell therapy as outlined above. It is important to keep in mind that 
these are not completely independent mechanisms. Rather to consider their (partial) 
contribution and integration into the complex processes of recovery are conceptu-
ally appropriate. Whilst the potential for rehabilitation-mediated recovery seems to 
be biggest early after stroke and needs to be supported by rehabilitation therapy, 
strategies to promote recovery in later stages after stroke also need to be entertained 
as focus on its own.
Declaration The authors declare no competing interests.
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Stroke remains the second leading cause of death and disability and one of the leading 
causes of depression and dementia globally (GBD 2015 Neurological Disorders 
Collaborator Group 2017; Owolabi et al. 2018). While stroke-related mortality stan-
dardized for age decreased over the last decades, the absolute number of new strokes 
(incidence), stroke-related deaths and stroke survivors living in our societies (preva-
lence) dramatically increased. From 1990 to 2010, the worldwide stroke prevalence 
increased by 15% from 435 on average to 502 per 100,000 people (Feigin et al. 2014) 
and then more recently by 21.8% from 2005 to 2015 for ischemic stroke globally and 
years lived with stroke-related disability by 22.0% (GBD 2015 Disease and Injury 
Incidence and Prevalence Collaborators 2016). This “dramatic” increase in stroke-
related burden of disease and disability is foreseen to continue in societies around the 
globe due to ongoing epidemiologic transition and an ageing world population.
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Fortunately, specialized inter-professional stroke care including rehabilitation 
can significantly reduce stroke-related disability and prevent the need to receive 
institutional care among stroke survivors (Stroke Unit Trialists’ Collaboration 
2013). In the Cochrane review, including 21 RCTs with a total of 39,994 partici-
pants, the risk to remain dependent (or die) after stroke could considerably be 
reduced compared to non-specialized care (OR 0.79, 95% CI 0.68 to 0.90; 
P  =  0.0007). Furthermore, there is ample meta-analytic Cochrane evidence that 
specific interventions developed for stroke rehabilitation reduce impairment and 
promote activities, examples are arm robot therapy (Mehrholz et al. 2018), treadmill 
training with partial body-weight support (Mehrholz et  al. 2017a), or electrome-
chanical gait training (Mehrholz et al. 2017b) to name a few. Without proper care, 
stroke survivors are at higher risk to remain dependent on carers, face heavy restric-
tions in their societal participation, and have to leave their homes and become nurs-
ing home residents.
Thus, there is an urgent need to promote, achieve, and sustain multidisci-
plinary stroke rehabilitation to tame the rapidly increasing burden of stroke-
related disability worldwide. This is best performed by a multidisciplinary 
approach involving specialist doctors, nurses, and therapists from various disci-
plines with the best available external evidence being implemented in clinical 
practice.
But how should such teams know the most valid up-to-date evidence and thus 
take their decisions reliably in the best interest of their patient? How can the knowl-
edge from clinical research be translated to everyday clinical practice so that stroke 
survivors regain independence with activities of daily living, participate in social 
life to the best possible degree, and maximize their quality of life?
Clinical pathways can be of great help for this purpose. They are documented 
tools that provide multidisciplinary teams with recommendations for appropriate 
care for a medical condition. When they are based on the best available up-to-date 
and valid evidence, they help to maximize achievement of treatment goals.
2  Clinical Pathways
Clinical pathways (CP) are structured multidisciplinary care plans for a certain con-
dition (Campbell et al. 1998). They declare how in a standardized way multistep 
managed care of a clinical condition is meant to be performed at a given point of 
health care provision, i.e. locally. Based on three sentinel articles (Campbell et al. 
1998; De Bleser et al. 2006; Vanhaecht et al. 2006), a Cochrane review on CPs iden-
tified five characteristic features of CPs: a CP is (1) a structured multidisciplinary 
plan of care, (2) promoting translation of evidence or guideline to local structures, 
(3) detailing steps in the course of treatment for a medical condition, (4) with time 
frames of criteria-based progression, and (5) aiming for standardization of care for 
a clinical condition (Rotter et al. 2010).
As such, they are suitable for the guidance and implementation of evidence- 
based interventions for stroke rehabilitation with the involvement of various health 
care disciplines, for the different clinical target domains (e.g. perception [somato-
sensory, visual], communication, swallowing, arm activities, mobility, cognition, 
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17
and emotion) to be addressed during the time course after stroke, [i.e. the acute (up 
to 7 days), the subacute (first 6 months) and chronic phase], with implications for 
functional recovery and achievement of therapeutic goals (Bernhardt et al. 2017).
3  The Evidence Gap
The inherent challenge for the generation of evidence-based clinical pathways for 
such a complex issue as stroke rehabilitation is the very broad and rapidly expand-
ing evidence base that needs to be taken into account. For any individual or health 
care centre, it is impossible to systematically search and critically appraise the rel-
evant evidence even when one would restrict oneself to only the most relevant and 
valid research, i.e. randomized controlled trials (RCTs) and systematic reviews 
(SR) with meta-analytic data synthesis. Even national societies will hardly be able 
to cover all relevant evidence and perform an explicit critical appraisal when they 
generate their guidelines for stroke rehabilitation.
Anyone responsible for the generation of (local) stroke rehabilitation CPs will 
invariably face the following challenges:
While high-quality SR can provide valid and precise estimate of beneficial thera-
peutic effects, they do so only for a single type of intervention and one target syn-
drome. Hence, their coverage in stroke rehabilitation is rather restricted. Most 
frequently, they give no clue on how to decide between the various available thera-
peutic options when faced with a clinical question. In addition, even for their 
restricted scope they provide evidence, but refrain from giving explicit clinical prac-
tice recommendations. They are meant to provide an evidence synthesis, but do not 
incorporate the methodological structure to systematically deduce practice 
recommendations.
Guidelines, on the other hand, are more comprehensive in their coverage, yet 
have critical limits that may restrict their validity and applicability for CP devel-
opment outside their primary societal context (Platz 2019). In some countries, 
recommendations for stroke rehabilitation were embedded in general stroke care 
guidelines or overall stroke rehabilitation guidelines, yet with a restricted evi-
dence base; this may cause bias by evidence selection. In other countries, guide-
lines were limited to certain target domains within stroke rehabilitation (e.g. 
mobility) and thereby had a chance to be systematically evidence-based; here the 
restriction is their coverage in terms of clinical aspects in stroke rehabilitation. In 
addition, most of the available guidelines were developed in high-income coun-
tries and formulated for their specific national health care systems (Platz 2019). 
As such, they are not necessarily applicable in other nations, especially not in 
low- or middle-income countries with quite different health care context and prac-
tice settings.
Therefore, the development of valid up-to-date systematically evidence-based 
stroke rehabilitation CP is daunting. Nevertheless, two initiatives of the World 
Federation for NeuroRehabilitation (WFNR) might help to better achieve these 
goals in the future, one being a project on research for the provision of systematic 
evidence-to-decision knowledge covering both (a) a systematic best evidence syn-
thesis based on systematic reviews and (b) a systematic multistep approach from the 
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evidence  to  clinical practice recommendations (compare Platz et  al. 2020 as an 
example), and the second being the evidence-based clinical practice recommenda-
tions for major topics in stroke rehabilitation provided in this book.
4  International Provision of Practice Recommendations
The evidence-based clinical practice recommendations, as presented in this book 
and authorized by the WFNR, systematically link best evidence synthesis with spe-
cific clinical practice recommendations for various key clinical problems faced in 
stroke rehabilitation. The recommendations do not go into organizational issues (i.e. 
how to organize the implementation) except for the final chapter. Any organiza-
tional recommendations related to individual clinical problems would likely only be 
valid for a restricted scope of health care systems. Implementation needs to take 
regional context and resources into account and is thus better addressed by local 
clinical pathway development, not international recommendations.
Other aspects integrated in the development of the practice guidelines presented 
in this book are (a) the coverage of individual chapters by international experts in 
the respective field, mostly being members of the corresponding Special Interest 
Groups (SIG) of the WFNR, (b) a multi-professional group of authors, (c) coming 
from different health care settings around the globe, and (d) a structured review 
process for the recommendations involving the panel of all book authors, fur-
ther WFNR experts (non-authors), and stroke survivor representatives.
The rest of this chapter will present the scope, content, and methodology used for 
the generation of these practice recommendations in greater detail.
5  Scope, Content, and Methodology Used 
for the Generation of the Practice Recommendations
5.1  Scope of the Evidence-Based Clinical 
Practice Recommendations
The International Classification of Functioning, Disability, and Health (ICF) (World 
Health Organization 2001) is based on the biopsychosocial approach used to inte-
grate the biological, individual, and social dimensions of health. The ICF distin-
guishes three components: (1) body functions and structures; (2) activity and 
participation; and (3) environmental and personal factors. While the organic brain 
damage causes deficits of body structures (i.e. of the brain) and function (so-called 
“impairments” such as paresis), the resulting activity limitations (e.g. reduced 
mobility) translate into participation restrictions (i.e. handicaps) depending on mul-
tiple individual and environmental factors.
Each chapter of this book addresses the assessment and treatment of the specific 
functional consequences of stroke that are related to breathing, swallowing, 
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consciousness, cognition, emotion, communication, visual perception, motor func-
tions, and activities including arm activities and mobility as well as driving 
after stroke.
Individual stroke survivors might be affected by one or more functional deficits 
with high inter-individual variation of degree of functional deficit and remaining 
functional capacity. Furthermore, these deficits change over time due to spontane-
ous recovery and therapeutic effects. Therefore, stroke rehabilitation treatment 
needs to be highly individualized. Most chapters of this book focus on the evidence 
for treatment effects in a specific dimension of function and provide valuable guid-
ance on treatment decisions. This is to be implemented in the context of an individu-
alized comprehensive rehabilitation care plan.
It is crucial to understand the overall current situation of a stroke survivor, to 
assess any functional strengths and weaknesses as well as individual goals for reha-
bilitation. Individualized treatment decisions across functional domains are then 
taken on that basis. Practice recommendations as provided in this book are not 
meant to be of a recipe-book character. They are rather subjected to the overall indi-
vidualized rehabilitation goals and plan and apply whenever the rehabilitation plan 
addresses the clinical problem covered.
Since stroke rehabilitation works best when team-based (Stroke Unit Trialists’ 
Collaboration 2013) and stroke rehabilitation frequently involves different profes-
sions such as neuropsychologists, occupational therapists, physiotherapists, speech 
and language therapists, sport therapists, nurses, and physicians, an interdisciplin-
ary team is formed whenever possible. Accordingly, goal setting and team approach 
with the ICF used as framework are important in stroke rehabilitation and are 
addressed in Chap. 3.
Stroke rehabilitation starts within acute stroke care and remains a life-long 
endeavor in many cases. It takes place in various health care settings from the inten-
sive care unit, the acute stroke care, and stroke rehabilitation unit, to the outpatient 
clinic, community-based, and domiciliary settings. These issues are discussed in 
Chap. 14 on health care settings in neurorehabilitation.
5.2  Target Users of the Practice Recommendations
Target population of the clinical pathways for stroke rehabilitation are physicians 
treating stroke survivors, especially neurologists and physiatrists, physiothera-
pists, (neuro)psychologists, nurses, occupational therapists, and speech and lan-
guage therapists among other health care professionals involved in stroke 
rehabilitation.
Stroke survivors, their related proxy carer, stroke service providers, and politi-
cians might also benefit from the pathways for their interest and purposes. The 
language necessary to portray the evidence and recommendations specifically might 
however not permit an easy understanding for non-professionals, even though the 
intention was to promote understanding across a broad audience.
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5.3  Stakeholder Involvement
5.3.1  Practice Recommendations Developer Group
The practice recommendation development group includes individuals from the 
various relevant professional groups, i.e. occupational therapists, physicians, phys-
iotherapists, psychologists, and speech and language therapists. In addition, mem-
bers of the group come from different continents and regions with diverse 
socioeconomical backgrounds. By these facts, the broadest representation of stroke 
rehabilitation scenarios by profession, region, and socioeconomical background 
was sought to be achieved.
For each member of the guideline development group, the following information 
is provided (see Table 1):
• name,
• discipline/content expertise (e.g. neurologist, physiotherapist),
• institution (e.g. City hospital),
• geographical location (e.g. Nigeria),
• description of the member’s role in the guideline development group,
• conflict of interest statement
5.3.2  Integration of Views and Preferences 
of the Target Population
We created an feedback panel with all book authors, two neurorehabilitation expert 
clinicians sharing international responsibility within the WFNR who were not 
authors of chapters and who come from different socioeconomic backgrounds (the 
U.S.A. and Mexico), and four representatives of stroke survivor support groups 
from Germany (Stiftung Deutsche Schlaganfall-Hilfe; www.schlaganfall-hilfe.de/) 
and Europe (Stroke Alliance for Europe, SAFE is a non-profit organization that 
represents a range of stroke patient groups from across Europe; www.safestroke.
eu/). They all were invited to provide feedback on individual chapters and their 
recommendations.
Feedback given on individual chapter’s recommendations by the panel of all 
authors, the two independent neurorehabilitation experts, and the representatives of 
stroke survivor support groups through a structured chapter-by-chapter webpage- 
based process was used by chapter authors to revise their chapter before it was 
accepted for publication.
5.4  Methods Used for Evidence Synthesis 
and Recommendation Development
5.4.1  General Remarks
The methods for evidence synthesis described below apply to a truly systematic 
review with critical appraisal of the literature. Given the resource restraints of the 
author groups, this was not possible for most of the chapters; the aspects fulfilled are 
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given in individual chapters. The methods presented here, nevertheless, describe the 
“gold standard”.
In terms of the rules to assess the level of evidence of references, the quality of 
evidence, and the grading of recommendations, the methodology as described 
below was applied in all clinical chapters of this book.
5.4.2  Systematic Search
Details of the strategy used to search for evidence should be provided including 
search terms used, sources consulted, and dates of the literature covered. Sources 
included electronic databases (e.g. MEDLINE, EMBASE, CINAHL) and databases 
of systematic reviews (e.g. the Cochrane Library, DARE) and published conference 
proceedings. Other guidelines (e.g. the US National Guideline Clearinghouse, the 
German Guidelines Clearinghouse) could be used for comparison.
The information provided should include:
• named electronic database(s) or evidence source(s) where the search was per-
formed (e.g. MEDLINE, EMBASE, PsycINFO, CINAHL),
• time periods searched (e.g. January 1, 2008 to April 30, 2018),
• search terms used (e.g. text words, indexing terms, subheadings),
• and may include the full search strategy (e.g. located in supplementary online 
material).
5.4.3  Criteria and Methods for Evidence Selection 
and Data Extraction
Criteria for including/excluding evidence should be provided. For example, some 
chapter authors decided to only include evidence from randomized clinical trials 
and to exclude articles not written in English. A description of the inclusion criteria 
included the target population (patient, public, etc.) characteristics, type of study 
design, intervention(s), comparison(s), outcome(s), language, and context, using an 
extended PICO schema (Lichtenstein et al. 2009).
Two independent assessors should perform evidence selection and data extrac-
tion. A consensus process should be in place to resolve any disagreement.
5.4.4  Critical Appraisal, Level of Evidence, Evidence Synthesis, 
and Grading its Quality
The following steps were taken from search for and critical appraisal of evidence to 
formulation of recommendations (Platz 2017, 2021) and are described in greater 
detail below.
 I. For each source (original paper, systematic review, and meta-analysis)
 1. evaluation of the methodology (internal validity, e.g. study design, risk 
of bias)
 2. classification of evidence level of each source (1a to 5 according to the 
CEBM, for explanation see Table 1) (CEBM 2009)
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 3. summarizing the results and their relevance for clinical practice based on 
individual sources.
 II. For the collated data from all sources for a specific therapeutic intervention 
(original papers, systematic reviews, and meta-analyses)
 4. assessment of the quality of evidence for the sources included, i.e. the result-
ing confidence in the estimate of the therapeutic effect strength (Schünemann 
et al. 2013) and.
 5. formulating and grading of the derived recommendation (Schünemann et al. 
2013; Platz 2017).
Ad (I)
Accordingly, for each reference and the body of literature for a given therapeutic 
intervention, the level of evidence was described (for details see Table 2).
Apart from data extraction and level of evidence classification, various aspects of 
trial validity should be critically appraised as presented in Table 3 for individual 
evaluation studies.
For systematic reviews, questions that are suggested to be addressed are given in 
Table 4. The criteria were adapted from AMSTAR 2 (A Measurement Tool to Assess 
Systematic Reviews) (Shea et al. 2017).
The characteristics of an individual study/systematic review together with the 
results of the critical appraisal, the main study results, and any clinical implications 
of that piece of information should be documented in an evidence table. There, the 
conclusion for individual references should specifically take into consideration the 
clinical relevance of the outcome measure(s), the magnitude and precision of the 
effect documented, the benefit-harm ratio, and the intervention’s acceptability; 
methodological weaknesses/risk of bias; in case of meta-analyses subgroup analy-
ses and heterogeneity; and finally, the relevance of findings for clinical practice.
Ad (II)
For any intervention-related recommendation, the quality of the evidence col-
lated across all studies and systematic reviews included was assessed according to 
Table 2 Level of Evidence Classification




































Levels of evidence for Therapy, Prevention, Aetiology and Harm 1a to 5 according to the “Oxford 
Center for Evidence-Based Medicine—Levels of Evidence”, presented in table is the version from 
March 2009, retrieved from https://www.cebm.net/2009/06/oxford-centre-evidence-based-medi-
cine-levels-evidence-march-2009/) (CEBM 2009). Alternatively, the classification from 2011 may 
be used (https://www.cebm.net/wp-content/uploads/2014/06/CEBM-Levels-of-Evidence-2.1.pdf)
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Table 3 Critical appraisal of individual evaluation studies
1. Clear definition of eligibility criteria.
2. Clear definition and adequate assessment of study outcomes.
3. Reporting of side effects and acceptability.
4. Adequate follow-up assessment (long-term effects).
5. Clear definition and description of experimental and control condition.
6. Were participants randomly allocated (selection bias)?
7. Allocation concealment (selection bias).
8. Comparability of experimental and control groups at baseline (selection bias).
9.  Blinded staff and patients during intervention and comparable treatment of randomized 
groups aside from investigated effects (performance bias).
10.  Blinded outcome assessment (detection bias).
11.  No selective reporting (reporting bias).
12.  (Almost) Complete outcome data (attrition bias).
13.  Intention-to-treat analysis reported.
14.  Do the results sufficiently support the conclusions reported?
Answers can be: yes (y), no (n), or not clear (nc).
Table 4 Critical appraisal of systematic reviews and meta-analyses
1. Were review methods established prior to the conduct of the review (written protocol)?
2.  Were research questions clearly phrased, e.g. did selection criteria for the review include 
the components of PICO, and clinically meaningful?
3. Was the study design selection of included trials adequate for the research question?
4.  Did the review authors use a comprehensive literature search strategy (data bases, key 
words, justify search restrictions [e.g. language])?
5.  Were all processes (screening, selection, assessment risk of bias, data extraction) 
performed in duplicate?
6. Did the review authors describe the included studies in adequate detail (compare PICO)?
7.  Did the review authors use a satisfactory technique for assessing the risk of bias (RoB) in 
individual studies that were included in the review?
8.  If meta-analysis was performed, did the review authors use appropriate methods for 
statistical combination of results, and was it meaningful to combine the studies selected 
for meta-analyses?
9.  Have all clinically relevant effects of the intervention(s) of interest (benefit, including 
long-term effects; harm; acceptability) been addressed?
10.   Did the review authors assess the potential impact of RoB in individual studies and of 
publication bias on the results of the meta-analysis or other evidence synthesis and discuss 
the implications of the findings of their assessment on the estimates of therapeutic effects 
as reported?
11.   Did the review authors provide a satisfactory explanation for and discussion of any 
heterogeneity observed in the results of the review?
12.   Did the review authors report any potential sources of conflict of interest (CoI), including 
any funding they or the authors of included studies received for conducting the review or 
their studies? If a risk that CoI might have influenced the review’s result is not unlikely, 
was its management described (for the review or the trials included) and adequate?
13.  Do the results sufficiently support the conclusions drawn?
Answers can be:
yes (y), partially yes (py) [not all, but “essential features” yes], no (n), not clear (nc), or not 
applicable (na).
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the GRADE approach (Grading of Recommendations, Assessment, Development, 
and Evaluation) (Schünemann et  al. 2013). The quality of evidence reflects the 
extent to which our confidence in an estimate of therapeutic effect is adequate to 
support a particular recommendation. The corresponding quality of evidence cate-
gories are presented in Table 5.
Randomized trials (and meta-analyses based on RCTs) without serious limi-
tations provide high-quality evidence; observational studies without special 
strengths or serious limitations provide low-quality evidence. Limitations (risk 
of bias, inconsistency, indirectness, imprecision, and publication bias) or spe-
cial strengths (e.g. large magnitude of effect or dose-response gradient) can, 
however, modify the quality of the evidence of both randomized trials and 
observational studies. For a more detailed explanation of risk of bias and other 
factors modifying the quality of the evidence, see the GRADE Handbook 
(Schünemann et al. 2013) and the Cochrane Handbook for Systematic Reviews 
of Interventions (Higgins et al. 2019; Schünemann et al. 2019).
5.4.5  Synthesis of Evidence-Based Recommendations
Recommendations were based on evidence for interventions and certain outcomes 
across studies and when available across systematic reviews. A recommendation 
reflects the extent to which the group developing the recommendation is confident 




High We are very confident that the true effect lies 
close to that of the estimate of the effect
Evidence from high-quality 
RCTs or meta-analyses of 
RCTs
Moderate We are moderately confident in the effect 
estimate: The true effect is likely to be close 
to the estimate of the effect, but there is a 
possibility that it is substantially different
Evidence from RCTs or 
meta-analyses of RCTs with 
serious limitations
Evidence from observational 
studies with special strengths
Low Our confidence in the effect estimate is 
limited: The true effect may be substantially 
different from the estimate of the effect
Evidence from observational 
studies
Evidence from RCTs or 
meta-analyses of RCTs with 
multiple serious or very 
serious limitations
Very low We have very little confidence in the effect 
estimate: The true effect is likely to be 
substantially different from the estimate of 
effect
Evidence from observational 
studies with serious limitations
Good clinical practice/expert 
opinion
The quality of evidence according to the GRADE approach (Grading of Recommendations, 
Assessment, Development, and Evaluation) reflects the extent to which our confidence in an esti-
mate of therapeutic effect is adequate to support a particular recommendation (left and middle 
column) (Schünemann et al. 2013). The right column provides examples how the categories were 
applied in the context of this book and its chapters.
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that desirable effects of an intervention outweigh undesirable effects in case of a 
positive recommendation, or that undesirable effects of an intervention outweigh 
desirable effects in case of a negative recommendation.
GRADE specifies two categories of strength of recommendation, i.e. a weak or 
a strong recommendation in favour or against an intervention (Schünemann et al. 
2013). For a strong recommendation, it is necessary to be certain about the various 
factors that influence the strength of recommendation and to have the information at 
hand that supports a clear balance towards either the desirable or the undesirable 
effects of an intervention. When the information is such that the desirable effects of 
an intervention probably outweigh the undesirable effects (or vice versa), but appre-
ciable uncertainty exists, a weak recommendation for (or against) an intervention is 
warranted. In a first approach, high-quality evidence qualifies for a strong, moderate- 
quality evidence for a weak recommendation.
In rehabilitation as in other medical fields, we frequently have some positive, 
yet low- or even very low-quality evidence favouring an intervention that strictly 
speaking is not yet sufficient to qualify for a weak recommendation. Nevertheless, 
this could still be the best available evidence and relevant for clinical guidance. 
Therefore, a third category of recommendation was introduced indicating a thera-
peutic “option” (Muche-Borowski et al. 2012; Platz 2017, 2021).
Furthermore, apart from the quality of evidence, other factors influence the 
grading of recommendations such as the clinical relevance of outcomes assessed, 
the value attributed by stroke survivors and the acceptability of a therapeutic 
option, the feasibility of its implementation, and the corresponding resource use. 
When such other factors contribute substantially to a recommendation’s category, 
this was specifically indicated. Table 6 gives an overview of the recommendation 
categories used with the corresponding verbal descriptors for the text and the 
symbols used.
5.4.6  Dissemination, Implementation, Monitoring, and Auditing
This book is published under an open access schema. Thereby, it is accessible glob-
ally free of charge as electronic version and with a flat rate in print version. Being 
authorized by the WFNR, an umbrella organization for the national societies of 
neurological rehabilitation as well as for individuals working in countries without 
their own national society, a wide dissemination through national member societies 
Table 6 Categories for recommendations
Recommendation 
category
Verbal description (as used in text) for positive/negative 
recommendation Symbol
Strong “Ought to”/“ought not to” A+/A−
Weak “Should”/“should not” B+/B−
Option “Can” 0
GRADE specifies two categories of strength of recommendation, i.e. a weak or a strong recom-
mendation in favour or against an intervention, mainly for high- or moderate-quality evidence 
(Schünemann et al. 2013). A third category of recommendation was introduced indicating a thera-
peutic “option”, mainly based on low- or very low-quality evidence (Muche-Borowski et  al. 
2012; Platz 2017, 2021)
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and key stakeholders worldwide is foreseen. While written in the “universal” lan-
guage English, a language barrier for dissemination still needs to be taken into 
account. It is therefore intended to translate these practice recommendations into 
other languages to enhance their dissemination.
As stated above, contextualization, implementation, monitoring, and auditing 
of these practice recommendations relies on local initiatives. For instance, the 
recommendations can easily be used as building blocks for generating clinical 
pathways while taking the local health care settings into account. With their 
structured format they support both the formulation of local clinical pathways 
and can help to develop the regional health care architecture in a way that sup-
ports evidence-based stroke rehabilitation. Contextualized implementation 
cycles are suggested that engage all stakeholders such as providers (personnel, 
clinicians, healthcare workers), policymakers, patients, populace (communities), 
partners, and payers (Owolabi et al. 2016). This will motivate stakeholders, over-
come the obstacle that guidelines developed in high-income countries are not 
easily applicable in low-and middle-income countries (Platz 2019), and create an 
enabling environment for the implementation of the evidence-based solutions 
presented. An illustration is given that addresses the interaction between WFNR-
authorized practice recommendations and continuous quality improvement by 
use of contextualized clinical pathways, their communication, implementation, 
evaluation, and adjustment (compare Fig. 1).
WFNR: Evidence-based clinical practice recommendations for major topics in stroke rehabiliatiuon










































































Fig. 1 Illustration of the interaction between WFNR-authorized practice recommendations and 
continuous quality improvement by use of contextualized clinical pathways, their communication, 
implementation, evaluation, and adjustment based on the plan-do-check-act (PDCA) cycle
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5.4.7  Process of Updating the Clinical Practice Recommendations
The practice recommendations are considered valid for 5 years from their time of 
publication and are intended to be updated thereafter.
5.4.8  Funding of the Work
The WFNR Research and Education Foundation sponsored the publication charges 
of this book under an open access schema. Thereby, its universal accessibility was 
supported. Other sources of funding that might apply for individual book chapters 
are noted in the respective acknowledgements. Funding did not involve commercial 
sources.
6  Conclusions
Stroke-related disability of any given stroke survivor is a consequence of a highly 
individual combination of various possible sensory, motor, cognitive impairments, 
emotional disorders, and associated activity limitations. Stroke rehabilitation aims 
to reduce disability and promote participation, while improving quality of life and 
sense of meaning and purpose in life (stroke recovery cycle) (Owolabi 2013). 
Related therapeutic goals are addressed by patient-tailored combinations of reha-
bilitation interventions that address specific stroke-related clinical problems. 
Evidence-based practice recommendations help to take clinical decisions related to 
these problems in a way that gives the best changes to promote functional recovery 
and to regain capacities to perform activities of daily living.
The evidence-based practice recommendations provided by the WFNR in this 
book are premised on a search for the best available valid up-to-date evidence, its 
critical appraisal, the collation of the evidence across trials, and systematic reviews 
in a clinical problem- and outcome-centred way. By knowing the evidence and 
judging its (un)certainty as well as other relevant aspects such as acceptability, fea-
sibility, and resource implications, weak or strong recommendations (or therapeutic 
options) could be formulated both in favour or against an intervention of concern.
The degree of systematic search and critical appraisal varied across chapters in 
the book (as indicated in individual chapters) secondary to resources available for 
the work. The same methodology for classifying the level of evidence, grading the 
quality of evidence, and any recommendation given as outlined above was, how-
ever, used throughout this book.
Expert author groups provided both a best evidence synthesis and recommenda-
tions as draft versions for each clinical problem addressed. The recommendations 
were regarded as final and ready to be published after the contributions and feed-
back of the panel of all authors, further experts, and the representatives of stroke 
survivor support groups were incorporated.
These stroke rehabilitation practice recommendations are published under an 
open access schema (sponsored by the WFNR Research and Education Foundation) 
and distributed through the many national member societies for neurorehabilita-
tion ensuring global dissemination. Together with knowledge about the regional 
health care settings, they can directly be used for the development of evidence-
based clinical pathways for stroke rehabilitation locally. Their development was 
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free of commercial funding. It is intended to provide an update 5  years after 
publication.
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Stroke is among the leading causes for adult disability. The impairments associated 
with a stroke display a wide variety of clinical signs and symptoms. Therefore, an 
interdisciplinary team approach with different experts working cohesively and 
closely together has been identified as fundamental for effective stroke rehabilita-
tion programs (Teasell et al. 2016a). There is high-confidence evidence on the ben-
efits of the stroke care units and moderate-confidence evidence that integrated, 
multidisciplinary care teams improve stroke outcome. Within this team approach, 
coordination and cooperation appear to be key factors for reaching best results 
within the limitations imposed by stroke-related impairments as well as by contex-
tual factors such as limited time for in-patient rehabilitation or limited resources in 
community-based rehabilitation programs (see chap.14).
The long-term and transversal nature of care and treatment for stroke have all 
served to confound hospital traditional, fragmented and top-down led responses. 
Meanwhile, it became apparent that stroke patients, like all patients with chronic 
health conditions, are in special need of continuous care, requiring a longitudinal, 
integrated and multidisciplinary network approach linking health and social care 
(paradigm shift). Policies, system and services, including payment systems, should 
be able to cope with care provided in more than one setting. To address the issue of 
fragmentation and overcome treatment gaps from a health services delivery per-
spective, it is necessary to ‘optimize care and rationalize costs’. There is a need for 
a healthcare system transformation based on shared-vision and a practical roadmap 
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to implementation of a coordinated system at national and regional level (WHO and 
UNESCO 2010).
In such a system early diagnosis, treatment and rehabilitation are seen as one 
seamless process of actions across different healthcare professionals and comple-
mentary disciplines (e.g. hospitals, specialists care, primary care, community care, 
homecare, institutional care or nursing home, pharmacies) that should work together 
according to a team-based approach in order to deliver patient care and improve 
health outcomes.
To ensure the continuity of care from the very beginning after a stroke, early 
intervention is key for optimal management of the disease and for achieving better 
clinical outcomes. A large body of research links early intervention to measurable 
health gains such as improved survival rates, reduced disability and complication 
rates, better quality of life and lower treatment costs (Stroke Unit Trialists 2013).
Optimizing healthcare processes with an outcome-based approach achieving 
high value for patients is the overarching goal of healthcare delivery, with value 
defined as the health outcomes achieved per money spent. Treatment is based on the 
needs of the patient (‘demand’) instead of on the offer/supply of treatment struc-
tures. Each age group according to disease stage has specific needs to be addressed 
along the care process (biological, psychological, healthcare services, social needs). 
Care for persons with stroke usually involves multiple specialties and numerous 
interventions, with final outcomes determined by interventions across the full cycle 
of care. Measuring, reporting and comparing outcomes are essential to improve 
outcomes and make informed choices about how to optimize healthcare and ratio-
nalize costs (Teasell and Hussein 2016).
Goal setting has been recognized as a core process in managing complex situa-
tions, which are challenging service providers in daily routine. Nevertheless, agreed 
standards on goal setting and evaluation still need to be defined. Many factors such 
as types and number of goals, the impact of patient involvement in the goal setting 
and evaluation process or the influence of goal attainment on adherence, self- 
efficacy and health-related quality of life (HR-QoL) have not been evaluated in the 
context of stroke rehabilitation in a rigorous way including randomized controlled 
trials (RCTs). (Rosewilliam et  al. 2011; Sugavanam et  al. 2013). Currently only 
low-to-moderate evidence on effectiveness of goal setting and evaluation practice 
on psychosocial factors (HR-QoL, emotional status and self-efficacy) is available 
(Levack et al. 2015).
For years, neurorehabilitation has been searching for an agreed framework suit-
able for interdisciplinary documentation. The International Classification of 
Functioning, Disability and Health (ICF), (WHO 2001) based on a biopsychosocial 
model of health and disability, offers such a framework. ICF is helpful in establish-
ing a common language between different professionals and different stakeholders 
such as stroke patients, caregivers, administrative and health policy providers. It 
might also serve as the basis for a shared documentation system. Disability in ICF 
is defined as the interaction of health condition with hindering or facilitating envi-
ronmental factors.
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In this chapter, we highlight some aspects with relevance for multidisciplinary 
team building and coordination and for using the ICF in the context of stroke reha-
bilitation; in detail, how to describe individual levels of functioning and to set treat-
ment goals as well as to identify barriers and facilitators to functioning and health.
2  Methodological Considerations
This chapter fulfils an educational purpose by introducing concepts and their appli-
cation in stroke rehabilitation related to the ICF (WHO 2001) as a common lan-
guage to describe individual functioning in a given context, multidisciplinary team 
building and coordination as well as goal setting. As such, it is primarily heuristic 
and not evidence-driven.
Hence, a systematic search for evidence is not the basis for this chapter. The most 
up-to-date relevant evidence is nevertheless reported.
The recommendations given in this chapter follow the same rules as outlined in 
chapter “Clinical Pathways in Stroke Rehabilitation: Background, Scope, and Methods” 
(see chap. 2): The level of evidence that served as basis for a recommendation is pro-
vided according to the ‘Oxford Center for Evidence-Based Medicine  - Levels of 
Evidence’ (CEBM 2009) ranging from ‘expert opinion’ (‘5’) to ‘systematic review 
(with homogeneity) of RCTs’ (‘1a’). The quality of the evidence is rated with the 
GRADE approach (Grading of Recommendations, Assessment, Development and 
Evaluation) (Schünemann et al. 2013) reflecting our confidence in an estimate of thera-
peutic effect that can range from very low to high. In addition, GRADE specifies two 
categories of strength of recommendation, i.e. a weak (‘B’, ‘should’) or a strong (‘A’, 
‘ought to’) recommendation in favour (‘+’) or against (‘−’) an intervention, mainly for 
high- or moderate-quality evidence (Schünemann et al. 2013). A third category of rec-
ommendation was introduced indicating a therapeutic ‘option’ (‘0’, ‘can’), mainly 
based on low- or very low- quality evidence (Platz 2017). Deviations are indicated by 
their reason, e.g. when upgrading a recommendation that is supported by low quality of 
evidence only to a ‘week recommendation’ instead of formulating an ‘option’: ‘B+ 
[clinical reasoning]’.
3  Multidisciplinary Team Building and Coordination
Organized stroke care has been identified as an important factor for better overall 
outcomes for individuals with stroke (Teasell et al. 2016b).
3.1  Improving Quality of Stroke Care
Stroke is a leading cause of disability and death among adults. It is the second cause 
of death worldwide and the first cause of acquired disability. Despite improvements 
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in care, around one-third of the 1.3 million people who have a stroke in Europe each 
year will not survive. One-third will make a good recovery, but one-third will live 
with long-term disability. Furthermore, stroke might lead to post-stroke dementia, 
depression, epilepsy and falls that cause substantial morbidity and economical 
costs. Strokes are more likely to occur with ageing with 75% of strokes happening 
to people older than 65 years. However, 25% of strokes still occur in younger people 
of working age, resulting in a significant loss of productivity.
Care for stroke patients starts before a stroke has happened (primary prevention) 
with the identification of people at risk for stroke, modification of lifestyle patterns 
and treatment of vascular risk factors in the primary care setting. It then focuses on 
optimal treatment of acute stroke in stroke units and on avoiding further vascular 
events (secondary prevention), ideally delivered through a comprehensive stroke 
service (Stroke units Trialists 2013). The effect of acute treatment is dependent on 
the time from stroke onset. Every step of the patient trajectory from symptom onset 
to the start of treatment within the hospital should be optimized in order to save time 
and to offer all opportunities for minimizing brain tissue damage. A shorter delay 
from onset of symptoms to treatment with intravenous thrombolysis (IVT) and 
thrombectomy can make the difference between being independent or dependent on 
help from others. During and after the acute phase, targeted rehabilitation is needed 
to reduce the remaining deficits to a minimum, to optimize the level of individual 
functioning and to reintegrate stroke victims into normal life.
3.2  Low Access to Rehabilitation
Many stroke survivors experience impairments making them dependent on others for 
their daily tasks. As stated in article 26 of the UN Convention on the Rights of Persons 
with Disability, rehabilitation aims to ‘enable persons with disabilities to attain and 
maintain maximum independence, full physical, mental, social and vocational ability, 
and full inclusion and participation in all aspects of life. To that end, States Parties 
shall organize, strengthen and extend comprehensive habilitation and rehabilitation 
services and programmes, particularly in the areas of health, employment, education 
and social services...’ (UN 2007). The early rehabilitation process after stroke is best 
initiated in a stroke units. However, it is rarely complete when it is time to leave hos-
pital, impacting on goal pursuit and goal adaption (Brands et al. 2014). Although it has 
been shown that continued rehabilitation after discharge during the first year after 
stroke reduces the risk of disability, only very few clinical trials have been conducted 
in this field. Therefore, many of the recommendations for treatment in this field are 
weak, and investment in research in this area is essential.
Improving the access to timely and effective rehabilitation is a crucial point for 
stroke patients. Access to timely and individualized rehabilitation should be avail-
able to all stroke patients, through development of stroke units linked with rehabili-
tation services matched to patient needs, from community-based early supported 
discharge up to comprehensive inpatient rehabilitation units.
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To address the complex disabilities arising from stroke, an interdisciplinary 
group of professionals with complementary skills is essential. Team composition 
and size may vary in different settings. Core disciplines in most stroke rehabilitation 
units include neurology and rehabilitation medicine, nursing, occupational therapy 
(OT), physiotherapy (PT), speech and language therapy (SLT) and case manage-
ment/social work. (Teasell et al. 2016b). While frequently not available, a neuropsy-
chologist would be important to integrate in teams given the high prevalence of 
cognitive and emotional disorders post-stroke and their relevance for disability 
(Ayerbe et al. 2013; Wagle et al. 2011).
Strasser (Strasser et al. 2005, 2008) demonstrated relations between team pro-
cesses—how a team deals with coordinating and communicating its work, and 
the attitudes and perceptions expressed by its members—and patient outcomes. 
If patients were treated by more structured teams that made greater use of patient 
outcome data, patients experienced greater functional gains. Regular meetings to 
discuss patients’ progress and plan treatment are the main process by which mul-
tidisciplinary teams operate and coordinate. Tyson developed—and subsequently 
tested—a framework of features for successful team meetings, including pre-
meeting preparation of participants, setting an agenda, skilled chairing, using a 
structured documentation and the formal use of standardized measurement tools. 
Following implementation, all aspects of meeting quality improved by 5%–58% 
without loss of staff productivity or additional resources. In a longitudinal fol-
low-up design, they found a greater increase in Barthel Index score after imple-
mentation, indicating greater functional recovery (Tyson et  al. 2014a, 2015) 
(Fig. 1).
CONTEXT FACTORS: room / facilities / time resources; service model (in- / outpatient service);  




knowledge about patient history 
current capacity / performance 
barriers / facilitators 




• Action plans agreed
• Goals reviewed
• Actions allocated
MEETING INPUTS MEDIATING PROCESSES MEETING OUTPUTS
• Specific meeting agenda
• Specific documentation
• Use of standardised assessment 
tools
• Goal setting and action planning
MEETING STRUCTURE
• Comprehensive / holistic
• Objective, relevant
• Patient focussed, respectful




TEAM / SOCIAL CLIMATE
• Professional vs patient focus
• Professional vs team role
• Atmosphere
• Team interaction and interpersonal 
relationships
LEADERSHIP
• Chairing skills: Time keeping;  
• Nature of the talk; accuracy
• Leadership style  
• Power relationships
Fig. 1 Conceptual framework for multidisciplinary team meetings in stroke rehabilitation. 
(Modified from Tyson et al. 2014a)
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3.3  The Chronic Care Model for Stroke Patients
From an international perspective, the paradigm shift is leading to the transformation 
of health care and illustrates one or perhaps the most applied strategy for improving 
the quality of care for people with chronic conditions such as many brain disorders 
which is the Multimorbidity Chronic Care Model (Palmer et  al. 2018). This care 
model is of particular interest for the management of stroke and its high complexity. 
This complexity must be better understood if people’s needs are to be properly 
addressed. The EU joint action JA-CHRODIS (2013–16) identified best practices 
and effective interventions for management of chronic diseases and developed this 
Multimorbidity Chronic Care Model (MCCM). To develop it, first, the five compo-
nents from the Chronic Care Model (Wagner 1998) and the Innovative Care for 
Chronic Conditions Model (Epping-Jordan et al. 2004) were identified: self-manage-
ment support; delivery system design; decision support; clinical information systems 
and interaction with community partners. The aim of MCCM is to meet patient’s 
needs and transform daily care for patients with chronic diseases from a system that 
is essentially reactive—responding mainly when a person is sick—to one that is pro-
active and focused on patient-oriented care. It is designed to accomplish these goals 
through a combination of effective team care and planned interactions with the 
patients; self-management support; patient registries and other supportive informa-
tion technology such as digital solutions allowing better exchange of information.
These elements are designed to work together to strengthen the healthcare pro-
viders–patient relationship and improve health outcomes. MCCM could be the 
model for better stroke patients’ management and care and summarizes the basic 
elements for improving care in health systems at the community, organization, prac-
tice and patient levels.
Another important concept for the organization of care is emerging with the prin-
ciple of ‘patient-centred care’: a person living with stroke has needs that evolve 
according to the stage of his/her disease (Brands et al. 2012, 2014):
• biological needs (mainly the relief of the physical symptoms, as pain),
• psychological needs (need for tailored information, e.g. on treatment options, 
evolution of the disease; and need for psychological support to deal with emo-
tions such as fear, frustration, depression and distress),
• need and implementation of care plans may be an additional support to coordi-
nate medical care, paramedical care and well-being,
• ongoing support in areas such as housing, employment, social relationships and 
community participation.
The reorganization of care delivery requires a paradigm shift and the adoption of 
three intertwined principles, namely: patient-centred care, improved hospital effi-
ciency and interventions in an optimal setting, either in hospitals, at home or in 
communities. All these developments underpin the need to address the integration 
between the different healthcare providers and the different settings.
Efforts to empower stroke patients to be engaged in responding to their health 
needs may improve health outcomes, adherence to treatment and has the potential 
for patients to make more informed decisions with regard to their health.
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By overcoming fragmentation and by creating linkages between services 
along the full continuum of care improved quality, continuity and efficiency in 
the delivery of services may be realized and ultimately improved health out-
comes secured.
In stroke rehabilitation, a holistic view on functioning and disability of the 
individual beyond impairments is necessary to establish an individualized and 
comprehensive treatment program. Information on personal factors such as edu-
cation, work and employment, recreation and leisure as well as information on 
environment such as housing, support and relationship should be available to all 
members of the interdisciplinary team responsible for the patient. Furthermore, a 
capacity check in different areas of interest, such as swallowing, mobility, self-
care and interpersonal interactions, is necessary for setting goals and planning 
appropriate interventions.
The World Health Organization’s International Classification of Functioning, 
Disability and Health (ICF) (WHO 2001) based on an integrative model of health 
provides a holistic, multidimensional and interdisciplinary understanding of health 
and health-related conditions. According to the ICF, the problems associated with a 
disease may concern body functions and body structures and activities and partici-
pation in life situations. Health states and the development of disability are modified 
by contextual factors, including environmental factors and personal factors, these 
latter not classified in the ICF.
Increasingly, countries are enhancing their data about functioning and disability 
using the ICF. The ICF is an international standard for health and disability informa-
tion—key for collecting valid, reliable and comparable health and disability data. To 
be a standard for harmonization and comparability, however, the ICF has to be 
applied consistently around the world by all users. Therefore, the aims and rationale 
of the ICF, and the specific skills needed to use it, must be taught in an accessible 
and standardized manner (Raggi et al. 2010; Tempest et al. 2012, 2013).
The ICF comprises 1424 categories from the components: body functions, body 
structures, activities and participation and environmental factors, which are orga-
nized in a hierarchical structure (Fig. 2). Categories are divided into chapters, which 
constitute the first level of specification. High-level categories (e.g. second, third or 
fourth level) are more detailed.
An ICF category is coded by the component letter and a suffix of 1 to 5 digits. 
The letters b, s, d and e refer to the components: body functions (b), body structures 
(s), activities and participation (d) and environmental factors (e). This letter is fol-
lowed by a one-digit number indicating the chapter, the code for the second level (2 
digits), and the codes for the third and fourth levels (1 digit each). The component 
letter with the suffixes of 1, 3, 4 or 5 digits corresponds to the code of the ICF cat-
egories. Within each component, the categories are arranged in a stem/branch/leaf 
scheme. This scheme indicates that a more detailed, high-level category covers all 
the aspects applicable for the low-level category, of which it is a member, but not 
vice versa. Numerous reports on the use of the ICF have been published both in 
theoretical and clinical context (Cerniauskaite et  al. 2011; Maribo et  al. 2016). 
There is a trend towards development of ICF-based assessment tools through iden-
tification of relevant categories. The most common ICF-derived generic assessment 
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tool is the WHO DAS 2.0 Disability Assessment Schedule (Ustun et al. 2010; Garin 
et al. 2010; Schlote et al. 2009). For stroke, a disease-specific core set was released 
in 2004 (Geyh et al. 2004).
4  ICF-Based Common Language in Reporting 
and Documentation Along the Care Pathway 
of Stroke Patients
Using the ICF as the common language to describe clinical findings at different time 
points and between different specialists makes it easy to establish a shared reporting 
system avoiding ambiguities and inconsistencies arising from sectoral reports (i.e. 
‘transferring oneself’ might be labelled as ‘mild activity limitation’ by one and 
‘moderate activity limitation’ by another team member). Here it is noteworthy to 
separate description of clinical findings from description of interventions, which 
arise as a consequence to findings at different time points. A classification of inter-
ventions is currently under development by WHO to provide a common tool for 
reporting and analysing health interventions for statistical purposes. The 
International Classification of Health Interventions (ICHI) is built around three 
axes: Target (the entity on which the action is carried out), Action (a deed done by 
an actor to a target) and Means (the processes and methods by which the action is 





























































Fig. 2 Structure of the World Health Organization’s International Classification of Functioning, 
Disability and Health (ICF)
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Establishing such a shared reporting system is helpful to monitor progresses 
from admission to discharge travelling through milestones (in terms of progress or 
setbacks) in a reasonable way minimizing reporting efforts. Prior to that, a common 
understanding on reasons for and content of reporting as well as a common under-
standing of the basic concepts of the framework should have been elaborated within 
the rehabilitation team (Raggi et  al. 2010; Tempest et  al. 2012, 2013). Having 
achieved an agreement on individual responsibilities for reporting, a shared ICF- 
based documentation system can be established easily, fulfilling all legal require-
ments for traceability.
4.1  ICF-Based Scales and Assessments
Standardized measurement tools support and inform clinical decision-making and 
communication with others (Tyson et  al. 2010; Rosewilliam et  al. 2011; Brown 
et al. 2013; Plant et al. 2016). Also, feedback on progresses to patients and relatives 
are much more likely to be understood if standardized assessments are used (Tyson 
et al. 2014b; Levack et al. 2015). To enhance comparability of health information 
collected in different settings, linking rules are available to serve as a basis for 
evidence- based decision-making across all levels of health systems (Cieza et  al. 
2004, 2016). The Academy for Neurologic Physiotherapy (ANPT) published a 
review on a total of 54 outcome measures in the ICF categories. Most of them are 
linked to body function (mostly musculoskeletal and sensation) and Mobility and 
Self-Care Activities and participation codes (ANPT 2015).
4.2  ICF-Based Goal Setting
In a systematic review of the ICF, Yen and colleagues found benefits for integrating 
the ICF into goal-setting practice. They concluded that the use of the ICF in health-
care goal-setting provides clinicians and patients with specific steps to follow when 
attempting to set goals collaboratively (Yen et al. 2014).
5  Theoretical Background in Goal-Setting Practice
5.1  Goal-Setting Theory (Locke and Latham)
According to goal-setting theory, three types of goals are to be distinguished: out-
come goals (winning), performance goals (doing well by your own standards) and 
process-oriented or learning goals (learning skills for improving performance). This 
triad, originally developed in sports, might also be useful in rehabilitation.
• Outcome goals play an important role, where goal attainment depends on the 
performance of competitors. Within the context of neurorehabilitation, this type 
of goals has not been investigated so far but might play a role in group settings 
when patients compare among themselves.
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• Performance goals prompt individuals to use routines or strategies that they 
have previously acquired and which are effective in performing the task. 
Individual ability is a key factor, and key questions are: How often, how well, 
under which circumstances will you act?
• In contrast, process/learning/mastery goals frame the goal instructions in terms 
of knowledge or skill acquisition (e.g. discover effective strategies to cope with 
impairments). Consequently, a learning goal draws attention away from a spe-
cific end result towards discovering and acquiring appropriate strategies, pro-
cesses or procedures necessary to perform a given task. The key questions are: 
How will you achieve it? What can you do?
Stretch goals are intentionally set at levels that are ‘seemingly unattainable with 
present resources’. Stretch goals have been used in business units as a supplement 
to ‘required’ or ‘minimally acceptable’ goals. Their purpose is to stimulate creative, 
‘outside-the-box’ thinking with the intent to generate new ideas for improving busi-
ness units’ performance. (Kerr and Lepelley 2013). In the context of neurorehabili-
tation, stretch goals may not be applicable for individual goal setting but for team 
development. Furthermore, if individuals self-set their goals at an unrealistic level, 
it might be helpful to label them as stretch goals and put in relation individuals’ 
importance with experts’ views of difficulty to achieve this stretch goal, alongside a 
number of sub-goals including goals related to ‘perceiving and appreciating indi-
vidual’s task capacity/performance’ and ‘managing risk behaviour’. Furthermore, it 
will be helpful to establish a commitment on short-time sub-goals, which mediate 
the relationship between actual performance and self-efficacy.
Already in 1967, Locke has demonstrated a clear linear relationship between the 
degree of goal difficulty and performance, if set within the limit of the individual’s 
ability. This has been confirmed in several studies since then. (Locke and Latham 
2002). Goal setting was found to have a greater positive effect on tasks that were 
straightforward (uncomplicated and easy to do) and on tasks that people already had 
the knowledge and skills to perform well.
Approach-oriented goal statements (‘mind obstacles’) induce self-efficacy and 
search-for-information behaviour, whereas avoidance-oriented goal statements 
(‘avoid falls’) are associated with reduced goal adherence (Wood et  al. 2013). 
Furthermore, a positive relationship between goal specificity, goal importance and 
goal commitment has been demonstrated. Therefore, wording of goals and instruc-
tions might impact on goal commitment and adherence. Here, the acronym: RUMBA 
(relevant, understandable, measurable, behavioural, achievable) has turned out to be 
an appropriate mnemonic (Braun et al. 2010).
5.2  Goal Setting and Action Planning (Scobbie)
Scobbie et al. (2011, 2013) developed and implemented theory-based Goal setting and 
Action Planning framework (G-AP, Fig. 3) suitable for in-patient and community-based 
stroke rehabilitation. The framework is based on three main pillars: the Goal-Setting 
Theory (Locke and Latham 1990, 2013a), the Social Cognitive Theory (Bandura 2010, 
2013) and the Health Action Process Approach (Sniehotta et al. 2005, 2016).
M. Leonardi and K. Fheodoroff
45
The framework starts with a capacity check in relevant life domains (with/with-
out assistance/devices) to identify a baseline level and develop possible goal inten-
tions. Here, the beneficial effects of legitimate authorities/experts and a supportive 
leadership must not be underestimated (Locke and Latham 2013b). Nevertheless, 
active engagement of the stroke survivors in goal setting and treatment planning 
appears to be a central factor for developing self-management skills and for social 
participation after stroke (Woodman et al. 2014).
Having established specific, attractive, difficult and agreed goals, the next step—
setting up action plans and reviewing coping strategies with respect to individual’s 
confidence to accomplish a task successfully—forces us to think about treatment 
strategies which patients are likely to follow. To optimize self-regulation, planning 
has proven useful (Sniehotta et al. 2005). This planning can be divided into two sub 
constructs serving different purposes. The first sub construct, action planning, spec-
ifies the intended action in terms of when, where, and how to act (implementing 
intentions to act). The second sub construct, coping planning, refers to coping strat-
egies to prioritize the intended behaviour over the habitual responses when obsta-
cles or barriers are faced.
Successful engagement in everyday activities is influenced by feedback from 
others, usually accepted persons such as family, friends and experts. Cianci and col-
leagues found that healthy individuals with learning goal instructions performed 
better after negative feedback but worse after positive feedback, whereas perfor-
mance declined when negative feedback was combined with performance goals 
(Cianci et al. 2010).
Feedback also has affective consequences. Individuals feel joy or disappoint-
ment based in part on feedback regarding their success or failure to attain a goal. As 
feedback represents attention from a (usually accepted) person in the environment, 
a social component may also play an important role. Simply knowing that someone 
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• Goal achieved: check for carry-over / 
generalisation
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FEEDBACK
Fig. 3 Goal setting—action planning framework. (Modified from Scobbie et al. 2011)
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cares and is attending to the individual’s progress may motivate him or her (Ashford 
and de Stobbeleir 2013).
5.3  Goal Achievement and Goal Attainment Scaling
Outcome measurement is required to determine the effectiveness of rehabilitation 
interventions. Goal achievement has been considered to be an important outcome 
measure (Hurn et al. 2006). It depends on two things: the patient’s ability to achieve 
their goals and the clinician’s ability to predict outcome, which requires knowledge 
and experience (Turner-Stokes 2009). Within the G-AP framework, evaluation of 
goal achievement (appraisal and feedback) is a distinct and important intervention 
aiming to enhance self-efficacy and set the basis for (guided) self-management, 
marking the transition from ‘therapy’ (receptive) to ‘training’ (active, self-set).
If goals are ‘achieved as expected’, interventions usually come to an end and 
patients should have gained a higher level of independence. If goals are ‘partially 
achieved’, further treatment and/or changes of action plans might be required. Goals 
will be ‘not achieved’, if individuals (self-)set their goals at an unrealistic level. 
Allowing difficult stretch goals alongside, ‘realistic’ goals during goal negotiation 
might be helpful to increase insight into and acceptance of limited recovery.
One way of quantifying the achievement of goals for statistical and research 
purposes beyond simply recording achievement as a ‘pass’ or ‘fail’ is through goal 
attainment scaling (Kiresuk and Sherman 1968). Goal attainment scaling (GAS) is 
a method of scoring the extent to which patient’s individual goals are achieved in the 
course of intervention. When using goal attainment scaling, tasks are individually 
identified and set around current and expected levels of performance. In effect, each 
individual has its own outcome measure, but this is scored in a standardized way as 
to allow statistical analysis. (Turner-Stokes 2009). If goal performance at baseline 
is rated –1 (some activities, could worsen), an initial T-score around 35–40 (depend-
ing on the number of goals) will result. If all goals are achieved as expected (rating 
0), a T-score of 50 will be achieved. An overachievement of goals leads to a value 
above, an under or partial achievement below 50.
Concerns about GAS have been raised about non-linearity of the scaling and lack 
of uni-dimensionality (Tennant 2007). Multiple variations on the original GAS 
approach have been published such as using a different number of levels of goal 
achievement (from −3 to +3) (Turner-Stokes and Williams 2010) and a different 
scoring system than was originally proposed, involving greater patient participation 
in goal selection and having the treating therapist rather than an independent third- 
party select and re-evaluate the GAS goals (Cytrynbaum et al. 1979; Turner-Stokes 
2009). Finally, there is no agreed approach to goal setting (McPherson et al. 2014; 
Wade 2009). Some authors have proposed the development of standardized goals or 
‘item banks’. (Tennant 2007). Nevertheless, there is growing evidence that goal 
attainment scaling is a good person-centred outcome measure for rehabilitation 
(Hurn et  al. 2006; Ashford and Turner-Stokes 2006; Turner-Stokes et  al. 2009), 
although GAS is not a measure of outcome per se, but a measure of achievement of 
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intention. It depends on the quality of goal setting as well as on the quality of treat-
ment. Hence, it does not replace standardized measures at the moment until validity 
of GAS has been demonstrated by studies investigating correlations with standard-
ized measures. Finally, important but difficult (stretch)goals likely to be ‘not 
achieved’ will lead to lower T-scores, if counted. Therefore, no added value arises 
from calculating individual T-scores in clinical practice, as patients and clinicians 
prefer words to numbers.
5.4  Examples on ICF-Based Goal Setting
ICF-based goal statements usually denominate a task/an action (what?) followed by 
modifiers describing circumstances (how?) for successfully accomplishing the task 
(such as time, number repetitions and contextual factors such as aids and devices, 
assistance).
In early phases of stroke rehabilitation, gaining or improving functioning and 
establishing independence is in the center of all attempts (Wood et al. 2010). In ICF 
terminology, most relevant goals are about mobility (d4) and self-care (d5). After 
discharge home, stroke survivors are confronted with the remaining impairments of 
several body function impacting on their usual activities (d6 domestic life, d7 inter-
actions and relations and d9 social and civic life). Usually these areas are not very 
likely to be covered by initial goal setting, such is not ‘handling stress and other 
psychological demands’ (d240). Especially in persons with several impairments 
causing severe disability, goals related to interactions and relations such as ‘making/
holding eye contact—for a few minutes in quiet/lively environment’ or ‘signalling 
discomfort/agreement/dissent—spontaneously/after being asked…’ are very useful 
to guide caregivers and the team to work towards the same goal. The classification 
of environmental factors allows also to define what facilitates or hinders the func-
tioning of the patients.
Currently, only a few attempts have been made to develop standardized goals or 
‘item banks’. Here, the ICF offers an agreed framework for goal areas, which easily 
can be adopted for individual goal setting. Examples are given in Table 1.
6  Goal Setting in Stroke Patients in Practice
In a Cochrane review on goal setting and strategies to enhance goal pursuit in neuro- 
rehabilitation, Levack et  al. (2015) found 39 studies published before December 
2013, involving a total of 2846 participants receiving rehabilitation in a variety of 
countries and clinical situations. They identified at least 12 different approaches to 
goal setting with a lot of variations regarding goal identification, selection, prioritiz-
ing, goal characteristics, the use for intervention planning, etc. Yet, they identified 
two common features in goal setting: having measurable goals and involving 
patients in goal setting. The review found an increase in health-related quality of life 
or self-reported emotional status (8 studies, 446 participants; standardized mean 
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Table 1 ICF-based goal examples—setting up a goal agreement document
d1 Learning and applying knowledge Context (how?)
Observing obstacles Spontaneous/on advice/in quiet/lively environment—
Despite hemianopia/neglect…
Observing the left side of space Spontaneous/on advice/in quiet/lively environment—
Despite hemianopia/neglect…
Recognising danger (at home) Spontaneous/after feedback/with cues/under 
supervision …
Recognising own capabilities 
(potential)
With regard to …
Spontaneous/after feedback/with support …
Focussing attention up to … mins In in quiet/lively environment/with distractors…
Solving (simple/complex) problems Spontaneous/with advice/feedback/assistance …
Taking decisions regarding … Spontaneous/with advice/feedback/assistance …
…
d2 General tasks and demands Context (how?)
Using means of orientation, memory, 
…
Spontaneous/with advice/cues/assistance …






Planning and conducting daily routine Independently/with assistance/considering own level 
of resources…
Taking breaks before overtiredness, 
pain attacks
Spontaneous/with advice/cues/assistance …
Using pain control strategies 
(breathing, muscle relaxation, …)
Spontaneous/with advice/cues/assistance …




d3 Communication Context (how?)
Understanding short/long messages After first hearing/after one repetition/in quiet/lively 
environment …
Starting/sustaining/ending a 
conversation with one person/several 
persons
Spontaneously, about familiar/current topics; with/
without help from communication partner …
Participating in a conversation with 
(more than) one person(s)
With - w/o help from a familiar partner/despite word 
finding difficulties
Communicating ones needs and 
wishes
Verbally/with gestures/by signing/writing …
Using communication devices (e.g. 
phone, text, emails …)
Independently/with the help of a familiar person in a 
protected environment
…
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Table 1 (continued)
d4 Mobility Context (how?)
Getting out of bed; standing up; 
sitting down…
Independently/with a rail/supervised/guided/with help 
of (un-)skilled person…
Sitting, standing, squatting, kneeling For # mins., independently/holding on a rail/
supervised/with help of (un-)skilled person…
With additional activity, in quiet/lively environment
Getting up from the floor Spontaneously, without help, with layperson’s/
professional help, …
Walking in house/out of the house/for 
short – Long distance
Independently/with an orthosis/cane/wheeled walker
Supervised/with help of (un-)skilled person…
On slopes, on grass/snow/gravel …
Grasping, lifting and carrying objects 
such as a pencil/a coin/a glass/…
With one hand/both hands; up to … kg, while sitting/
standing …
Opening water bottles With both hands, despite reduced strength, with 
eye-hand-control …
Manipulating small objects such as 
coins, needles, buttons, …
With both hands, spontaneously, after instruction ….
…
d5 Self-care Context (how?)
Washing face/arm/chest/legs/oneself Independently/prepared utensils/final control/
supervised/guided/with help of (un-) skilled person, in 
adequate time/in customized/unexperienced 
environment…
Dressing oneself Independently/prepared clothes/final control/
supervised/guided/with help of (un-) skilled person, in 
adequate time/in customized/unexperienced 
environment…
Showering/bathing Independently, prepared utensils …
Brushing one’s teeth, combing, 
shaving …
Independently, prepared utensils …
Eating/drinking (food/drink 
consistency to be defined according 
level of functioning)
Independently/supervised/with help of (un-)skilled 
person; with -w/o swallowing strategy, adapted cutlery, 
drinking straw; …
Taking care for the paretic arm Independently/with reminder/supervised/guided
In customized /unexperienced environment…
Taking one’s medicine Independently/with reminder/supervision/help…
…
d6 Domestic life Context (how?)
Shopping With a shopping list, by using an ‘aphasia id’, 
independently/supervised/with the help of …,
Preparing simple/complex meals Independently/supervised/with the help of …,
By using aids such as …, in adequate time ….
Cleaning the kitchen/the bath/…
Using a vacuum cleaner …
Independently/supervised/with the help of …,




Carrying out garden work (using a 
shovel/rake/shears …)
For … mins./taking pauses after …. mins.,
Independently/with reminder/supervision/help…
Looking after the (grand-)children, 
animals…
For … hours, …
….
(continued)
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Table 1 (continued)
d7 Interpersonal interactions and 
relationships
Context (how?)
Making eye contact/holding eye 
contact




Spontaneously/after having been asked, …
Showing respect/warmth/appreciation 
(to familiar/unknown persons, in a 
group of peers, …)
Spontaneously, with cues, on advice, with (un-)
structured feedback, with help…
Maintaining social distance (gender 
related, in a group of peers, towards 
staff members…)
Spontaneously, with cues, on advice, with (un-)
structured feedback, with help…
Accepting help (for walking/eating/
toileting …)
Spontaneously, with cues, on advice, with (un-)
structured feedback, …
Sticking to agreements/rules 
(regarding walking/eating/toileting 
…)
Spontaneously, with cues, on advice, with (un-)
structured feedback, …
Getting in touch/maintain contact 
with peers (Parkinson, Aphasia, MS 
…)
After preparation, with an escort, …
…
d8 Major life areas Context (how?)
Working on a computer Independently, for … mins., with adapted keyboard, in 
quiet/noisy environment …
Conducting voluntary work For up to # hrs/week, with guidance/supervision/help 
of …
Taking part in a professional 
retraining course
Independently/with help, …
Paying one’s bills Independently/with the help of …,
Conducting one’s bank affairs Independently/with the help of …,
…
d9 Community, social and civic life Context (how?)
Participating in family/social life Spontaneously/with help, for … hrs/day, with familiar 
people/strangers, …
Visiting friends …
Playing cards/chess/boards games … Independently, with familiar people, …
Going swimming/horse riding/
climbing/cycling …
Independently/with help, regularly, …
Voting in elections Independently …
….
First column: to denominate goal agreement status (agreed with patient/relatives/significant others)
Second column: to denominate the task/action (what task?)
Third column: to denominate the context/circumstances (how will it work?)
Fourth column: level of goal attainment at date of follow-up (achieved—partially—not achieved—
overachieved) (not included here)
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difference (SMD) 0.53, 95% confidence interval (CI) 0.17 to 0.88; quality of evi-
dence very low) and self-efficacy (3 studies, 108 participants; SMD 1.07, 95% CI 
0.64 to 1.49; quality of evidence very low) when some form of goal setting (plus or 
minus strategies to enhance goal pursuit) was used in comparison to no goal setting. 
No consistent evidence was found that goal setting impacts on impairments. There 
was insufficient information whether goal setting increases or reduces the risk of 
adverse events or justifies additional costs for goal setting and action planning. 
Because of the variety of approaches to studying goal setting in rehabilitation and 
because of limitations in the design of many studies completed to date, the authors 
expect that ‘it is very possible that future studies could change the conclusions of 
this review’ (Levack et al. 2015).
Two reviews of goal setting within the context of stroke rehabilitation concluded 
that active patient participation in goal setting appeared to be something that patients 
value and that structured methods of goal setting seem to increase patients’ percep-
tions of their level of involvement in clinical decision-making (i.e. enhancing a 
sense of self-determination); however, the effects of a patient-centred goal-setting 
practice in stroke rehabilitation have been studied mostly with weak methodologies 
(Rosewilliam et al. 2011; Sugavanam et al. 2013).
Plant and colleagues reviewed barriers and facilitators to goal setting during 
stroke rehabilitation. Nine qualitative papers were selected, involving 202 partici-
pants in total: 88 patients, 89 healthcare professionals and 25 relatives of participat-
ing patients (Plant et  al. 2016). The main barriers to goal setting during stroke 
rehabilitation were: a mismatch between patients’ and staff’s perspective; lack of 
confidence by the staff to manage patient expectations; patients’ stroke-related 
impairments and lack of time and ineffective organizational systems. The main 
facilitators were: early, frequent, active communication with patient and family; 
individually tailoring the goal-setting process; effective, confident and encouraging 
staff; education of patients and families; providing support and educational materi-
als and adequate resources. They concluded that current methods of goal setting 
during stroke rehabilitation are not fit for purpose.
7  Recommendations for Multidisciplinary Team Approach 
and ICF-Based Goal Setting in Stroke Rehabilitation
If possible, stroke rehabilitation should be delivered by interdisciplinary teams with 
specific training and experience in the field (level of evidence 1a, quality of evi-
dence moderate, B+).
The early rehabilitation process after stroke should be initiated in a stroke units 
(level of evidence 1a, quality of evidence moderate, B+).
Since the rehabilitation process after stroke will rarely be complete when it is 
time to leave hospital, rehabilitation should be continued after discharge especially 
during the first year after stroke to reduce the risk of disability and may individually 
be needed at later stages (level of evidence 5, quality of evidence very low, B+ 
[clinical relevance]0).
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For delivering high-quality healthcare for stroke survivors, the integration (in 
contrast with fragmentation) of care providers (e.g. specialists, general practitioners 
and other healthcare providers such as pharmacists, nurses, psychologists, physio-
therapists) and close coordination (multidisciplinary care) of their activities across 
levels of care and multiple sites is warranted, all of which can be optimally embed-
ded within a system that promotes patient empowerment (level of evidence 5, qual-
ity of evidence very low, 0).
Heightened attention should be spent to evaluate team processes related to 
assessing/reporting of clinical findings and to goal setting and action planning pro-
cesses. This includes to review the structure of team meetings, encourage the use of 
standardized measurement tools and assessments for clinical status and progress 
monitoring and the explicit method used for goal setting and action planning. (Level 
of evidence 2b, quality of evidence low, B+ [clinical relevance]).
All domains, including the body functions and structures (impairment), the activ-
ity and participation as well as the environmental factors domain of the ICF, can be 
used as a common language for professionals when setting goals in a semi- 
structured, ‘guided’ manner. Using the main ICF activity and participation domain 
as broad goal categories will prevent from missing important goal areas, such as, 
interactions and relations and social and civic life. (Level of evidence 5, quality of 
evidence very low, 0).
Heightened attention can be spent to the goal syntax (starting with a verb, 
denominating a task, followed by modifiers, denominating the circumstances to 
accomplish the task). Patient’s perceptions/appraisal of goal importance, goal 
difficulty, self-efficacy and emotional stability can be checked, as they will 
mainly impact on individual goal choice and ranking and how to avoid goal con-
flicts. Evaluation of goal achievement (appraisal and feedback) can be used as a 
distinct and important intervention aiming to enhance self-efficacy and set the 
basis for (guided) self-management, marking the transition from ‘therapy’ 
(receptive) to ‘training’ (active, self-set). (Level of evidence 5, quality of evi-
dence very low, 0).
8  Summary
Here, we highlight the importance of developing a common understanding of the 
basic concepts for reporting clinical findings at different time points and in the dif-
ferent setting of the care pathways as well as for goal setting using the ICF and its 
biopsychosocial model as an agreed language and framework.
Overcoming fragmentation by a person-centred approach in line with the 
Multimorbidity Chronic Care Model supports a fact-based identification of indi-
vidual goals to be pursued and reached in each specific phase of the care and reha-
bilitation process. Goal setting and action planning processes are described 
alongside the underlying theoretical assumptions.
Goal setting has become a central component of effective rehabilitation practice, 
both as a part of the communication and decision-making process and as a 
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person- centred outcome measure for stroke rehabilitation. The evidence regarding 
the individual contribution of specific components of the goal setting process (e.g. 
levels of patient involvement, levels of goal difficulty) remains inconclusive. 
Therefore, agreed standards on goal setting and evaluation are still lacking and cur-
rent methods of goal setting in stroke rehabilitation are still quite arbitrary. This 
chapter provides the rationale for a more organized process along all the care path-
way of stroke patients, from acute event to social reintegration and inclusion, having 
an ICF-based methodology that will allow the definition of all the steps.
Translating the evidence from the huge research body on goal-setting theory into 
clinical practice will lead to a higher impact and a more structured approach in uti-
lizing the power of individual goal setting and action planning in the future.
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Consciousness is defined as the state of awareness of the self and environment with 
appropriate arousal or wakefulness (Giacino et  al. 2018a, b). Disorders of 
Consciousness (DoC) are a wide spectrum of correlates of brain’s disruptions of 
arousal and awareness that may result from altered functional neural activities from 
cortico-cortical connectivity to subcortico-cortical and global connectivity of all 
networks such as default mode network (DMN) and others (Giacino et al. 2014; 
Hodelìn-Tablada 2016).
The mentioned neural networks that define consciousness are primarily assessed 
by clinical means (i.e., scale like CRS-r—Coma Recovery Scale revised) to detect 
patient’s behavior and capability to have and show conscious experience; these are 
the only validated means, while some critics recently arose (Bayne et al. 2017; Seel 
et al. 2010).
Arousal is clinically assessed by evidence of eye opening and brain stem reflexes 
and is defined by a spectrum of conditions from sleep to complete wakefulness.
Awareness may be clinically evaluated by the examination of motor and com-
munication behaviors assessing visual pursuit, localization to noxious stimulation, 
command following, intelligible verbalization, and object recognition in order to 
define the perceiving of the external environment and the voluntary interaction with 
it (Laureys et al. 2004).
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Perturbations of arousal and awareness depict different clinical syndromes of 
DoC including coma, different sleep stages, drug anesthesia, vegetative state, mini-
mally conscious state, and emerging state (Blume et al. 2015).
Coma, defined by the absence of arousal and consciousness, sleep stages and 
drug-induced alterations are not at center of our interest while we refer to the other 
mentioned syndromes on a rehabilitation point of view.
DoC are defined on the basis of assessment of motor and communication behav-
iors; a coma lasting more than 28 days may lead to different DoC, starting from 
vegetative state (VS) or otherwise named “unresponsive wakeful syndrome” 
(UWS): in this case, patients are unaware but awake showing eye opening (both 
spontaneously or induced) and reflexive movements (Giacino et  al. 2018a, b; 
Laureys et al. 2010).
In case the VS (UWS) clinical condition will last more than 1 month, it should be 
classified as “persistent” and not as “permanent.”
When patients show voluntary behavior, usually beginning with visual pursuit, 
they are in the clinical condition of the minimally conscious state (MCS) with 
inconsistent but reproducible behavior demonstrating awareness of external or 
internal world (Giacino et al. 2014).
Recently, the complexity of behavioral responses allows to classify MCS patients 
in “plus or minus” (MCS −/MCS +): in the first case, patients show interactions 
with external environment only through motor behavior and in the latter also some 
preserved language function. Any functional object use or evidence of accurate and 
functional communication will define the emerging state from MCS (EMCS) 
(Bruno et al. 2011; Giacino et al. 2014).
We refer to Table  1 and to the cited articles for detailed description of DoC 
conditions.


















MCS− Present Present Present Present Absent
MCS+ Present Present Present Present Present
Emerging 
state
Present Present Present Present Present: Reliable 
communication; use of 
functional object
aMotor purposeful behavior: visual pursuit, localization to noxious stimulation, simple command 
following
bPreserved language function: intelligible verbalization, object recognition, command following
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While the definition and our understanding of the pathomechanisms of DoC 
improved in recent years, we are still facing the difficulty of correct diagnosis and 
related procedures such as appropriate assessment of awareness and alertness and 
partially as a consequence have limited valid evidence regarding beneficial treat-
ment options including rehabilitation or medication (Bender et  al. 2015; Bodien 
et al. 2017).
Recent data on the annual incidence of VS/UWS in the US is 4200 persons/year 
with reported prevalence rates ranging from 5000 to 42,000 (112,000–280,000 for 
MCS); while prevalence on a world basis of UWS/VS is 0.2–6.1/100,000 inhabit-
ants (Giacino et al. 2018a, b; Van Erp et al. 2014).
The repeatedly cited 42% rate of misdiagnosis is now decreasing to a 37% mini-
mum but has yet to be precisely defined (Bender et al. 2015; Peterson et al. 2015; 
Wade 2018).
In fact, the proper means and clinical algorithm to perform a correct diagnosis of 
UWS/VS and MCS are still a matter of debate (Giacino et al. 2013).
Nontraumatic coma (NTC) is primarily caused by stroke (6–54%) when com-
pared to post-anoxic or metabolic injuries; but it is still difficult to describe DoC 
while the patients is in the acute hospital ward and only the presence of a coma 
lasting more than 28 days may depict the consciousness impairment as a steady 
disorder such as UWS/VS or MCS and not as a transient event (Woimant et al. 2014).
The available literature relates to either traumatic (TBI) or nontraumatic (nTBI) 
DoC mainly. Few studies consider cerebrovascular accidents (CVA) specifically 
and fewer discriminate cerebral infarction, parenchymal hemorrhage, and subarach-
noidal bleeding; a recent systematic review could not describe more precisely DoC 
in stroke alone (Horsting et al. 2015).
Evidence is lacking regarding diagnosis and natural history in nTBI MCS 
patients while four studies with nTBI VS patients note a survival rate of 80% on 
average (95% confidence interval, 95% CI “67% to 93%”) at 3 months (Hannawi 
et  al. 2015; Horsting et  al. 2015; Kondziella et  al. 2016; O’Donnel et  al. 2019). 
Little is known about any differentiation between CVA, cardiac arrest, and meta-
bolic DoC.
While a systematic approach to the rehabilitation of DoC exists since almost 
30 years, many problems related to clinical diagnosing, assessments, and treatment 
remain unsolved (De Tanti et al. 2015;  Kondziella et al. 2016; Giacino et al. 2018a, 
b). As one example, the use of the reliable and valid assessment tools is essential to 
properly define the clinical pattern, to plan the care process adequately, and ensure 
a precise prognosis (Di Perri et al. 2014; Eapen et al. 2017; Giacino et al. 2014).
This chapter reviews the available evidences regarding DoC after a stroke and as 
a whole.
Topics for our evidence synthesis and practice recommendations are: (1) DoC 
assessment including technical diagnostic tools and clinical assessments; (2) gen-
eral DoC rehabilitation; (3) specific DoC treatment options including drug therapy, 





We systematically searched for guidelines, reviews, and clinical trials that 
provide evidence and clinical decision guidance for DoC assessment includ-
ing technical diagnostic tools and clinical assessments; general DoC rehabili-
tation; or specific DoC treatment options. Exclusion criteria were: non-English 
papers, commentaries, case series, case reports, book chapters, and confer-
ence reports.
We, in January 2019, searched for articles published from 1997 to January 
2019 in the PubMed, Cochrane Library using medical subject heading (MeSH) key-
words and the search algorithm “(rehabilitation OR stroke OR cerebral hemorrhage 
OR cerebral infarction) AND (disorders of consciousness OR persistent vegetative 
state OR vegetative state OR minimally conscious state),” and in the EMBASE via 
the EMTREE with following keywords and algorithm “(Cerebrovascular accident) 
AND (disorders of consciousness OR persistent vegetative state OR vegetative state 
OR minimally conscious state).”
We found a total of 862 articles: two independent raters screened the 862 articles, 
solving disagreement by discussion.
Systematic reviews (n = 11), nonsystematic reviews (n = 13), RCT (N = 2), 
observational studies (N = 12) were selected together with two guidelines for 
full-text review to critically appraise and collate the evidence, to rate the over-
all quality of evidences, and to provide recommendations.
Two clinical evidence and practice guidelines (GL) were found (De Tanti et al. 
2015; Giacino et al. 2018a, b).
The level of evidence used for recommendations was categorized according to 
the Oxford Centre for Evidence-Based Medicine Levels of Evidence (CEBM, 2009 
version).
Further, the quality of the evidence was rated with four categories according to 
“GRADE” (“Grades of Recommendation, Assessment, Development, and 
Evaluation”) (Owens et al. 2010):
• High quality: further research is unlikely to affect our confidence in the estima-
tion of the (therapeutic) effect;
• Medium quality: further research is likely to affect our confidence in the estima-
tion of the (therapeutic) effect and may alter the estimate;
• Low quality: further research will most likely influence our confidence in the 
estimation of the (therapeutic) effect and will probably change the estimate;
• Very low quality: any estimation of the (therapy) effect or prognosis is very 
uncertain.
• The grading of the recommendations was performed in accordance with GRADE 
with the categories “ought to” (A) (strong recommendation), “should” (B) (weak 
recommendation) (Schünemann et al. 2013). As a third category had been intro-
duced “can” (0) (option) (Platz 2017).
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3  DoC Assessment: Clinical Behavioral and Instrumental 
Diagnostic Tools
3.1  Clinicals and Behavioral Tools for DoC Assessments
A systematic review of the main assessment behavioral means for clinical practice 
identified 13 DoC scales and reported on their inter-rater reliability (IRR), internal 
consistency (IC), and test–retest reliability (TRR) qualities (Seel et al. 2010).
Authors of this review also studied other features of assessment scales such as 
existent guidelines for their application, their power to detect DoC, i.e., VS and 
MCS, to differentiate between the two syndromes and their feasibility to be used in 
clinical practice. Considered scales were: the Coma Recovery Scale-revised (CRS- 
r), Sensory Stimulation Assessment Measure (SSAM), Wessex Head Injury Matrix 
(WHIM), Western Neuro Sensory Stimulation Profile (WNSSP), Sensory Modality 
Assessment Technique (SMART), Disorders of Consciousness Scale (DoC), Coma/
Near-Coma Scale (CNC), Full Outline of UnResponsiveness Score (FOUR), 
Comprehensive Levels of Consciousness Scale (CLOCS), Innsbruck Coma Scale 
(INNS), Glasgow-Liege Coma Scale (GLS), Loewenstein Communication Scale 
(LOEW), and the Swedish Reaction Level Scale-1985 (RLS85).
CRS-r was considered superior to the other scales while review states that many 
unproven features still remain; in Table 2 are summarized diagnostic features of all 
mentioned scales.
Overall diagnostic validity of the assessment scales was unproven; in particular, 
the prognostic and the diagnostic validity of CRS-r are not proven. The only scale 
with a good predictive power for good recovery at 30 days was FOUR (Wolf et al. 
2007). Systematic review conducted to define the American Academy of Neurology 
guidelines found little evidences with no recommendation possible: a study consid-
ered 43 patients and found CRS-r as an independent predictor of recovery with wide 
CIs limit (95% CI “1.05 to 11643.58”) of interpretation (Estraneo et  al. 2013; 
Luauté et al. 2010).
Recommendation:
Clinical assessment of DoC, i.e., VS and MCS should be performed with stan-
dardized assessment tools in patients with prolonged DoC (CEBM classification: 
level 1a, GRADE moderate; recommendation B+). The CRS-r appears to have 
advantages concerning its psychometric properties; its use is suggested (CEBM 
classification: level 1a, GRADE moderate; recommendation B+).
3.2  Instrumental Diagnostic Tools for DoC Assessment
One systematic review (SR), following established recommendations for conduct-
ing SR including Preferred Reporting Items for Systematic review and Meta- 
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of Diagnostic Accuracy Studies-2 (QUADAS-2), analyzed the usefulness of neuro-
physiological recordings to assess DoC patients, focusing on electroencephalogra-
phy (EEG), electromyography (EMG), Event-related Potentials (ERP), and 
Mismatch Negativity (MMN) (Hauger et  al. 2017; Kable et  al. 2012; Mother 
et al. 2015).
Results in this SR are not conclusive: specificity rates of different methods were 
highly variable from 0% to 100%, with a high rate of false-positive classifications. 
Two studies report a rate of 17% and 33% of false-positive classifications of UWS 
instead of MCS (King et al. 2013; Sitt et al. 2014).
An SR and meta-analysis considered 20 clinical studies with a total sample of 
470 MCS patients and 436 VS patients studied with quantitative method EEG 
(qEEG), ERP, functional magnetic resonance imaging (fMRI): qEEG showed the 
highest sensitivity (90% on average; 95% CI “69% to 97%”) and high specificity 
(80% on average with 95% CI “66% to 90%”) compared to ERP and fMRI; the 
sensitivity of fMRI was 44% on average (95% “CI 19% to 72%”) and specificity 
67% on average (95% CI “55% to 77%”), while the sensitivity of ERP was 59% on 
average (95% CI “26% to 85%”) and specificity 75% on average (95% CI “51% to 
90%”) (Bender et al. 2015).
A third SR included 36 studies with 687 patients (10.3% with ischemic stroke 
and 6.6% with intracerebral hemorrhage and 2.7% with subarachnoid hemorrhage) 
studied with fMRI, fluorodeoxyglucose (FDG)-positron emission tomography 
(PET), single-photon emission computed tomography (SPECT) with different trac-
ers (Hannawi et al. 2015). These approaches could detect reduced activity in several 
brain areas and may be useful in clinical DoC diagnosis, in particular considering 
modifications of the Default Mode Network (DMN); but the heterogeneity observed 
in study results and the meta-analysis conducted in 13 studies (272 patients and 259 
controls) showed that the small number of studies that reported increased functional 
connectivity limited the importance of results with little support in clinical practice 
(Hannawi et al. 2015).
An SR included 1041 patients from 44 originals articles (54.1% VS and 45.9% 
MCS; 25% of all DoC patients had CVA) to study EEG, fMRI (ERP were excluded 
in this SR) to detect consciousness with active and passive paradigms such as the 
cortical functional connectivity or resting-state studies, and on same sample of 
patients a meta-analysis was performed on 37 studies: researchers failed to indicate 
a diagnostic superiority for the analysis of active and passive paradigms considering 
both command–no command following and cortical–no cortical connectivity on an 
fMRI motor imagery task to distinguish MCS and VS compared to EEG: Odds ratio 
(OR) of EEG versus fMRI were 0.73 (95% CI “0.50 to 1.07”) in the active para-
digms and 1.78 (95% CI “1.16 to 2.74”) in the passive paradigms; the authors con-
cluded that EEG protocols were two times more likely to be interpreted as compatible 
with preserved consciousness compared to fMRI (Kondziella et al. 2016).
A study on EEG mainly showed that MCS patients had less abnormal EEG find-
ings (61%, 95% CI “41% to 78%”) compared to VS patients (25%, 95% CI “7% to 




There is, however, no evidence available to support EEG as a diagnostic tool to 
distinguishing VS from MCS on an individual basis.
There is insufficient evidence that electromyography (EMG) may support the 
diagnostic value of the presence of EMG activity to a command: a study considered 
38 DoC patients and in only one VS patient and three MCS patients an EMG 
response to command was found (sensitivity for MCS 21%, 95% CI “5% to 51%”, 
and specificity 90% 95% CI “56% to 100%”) (Habbal et al. 2014).
In conclusion, the accuracy in diagnostic approach of neurophysiological and 
other technical tools is limited. (1) EEG evaluation seems to be the best method, 
with good balance between rates for sensitivity and specificity; (2) ERP may help to 
detect reactivity to few sensory stimuli; (3) fMRI may be useful to specifically study 
the activity of different functional networks; and (4) EMG may be only of little help 
to distinguish MCS from VS patients with reference to voluntary movements.
Recommendation:
Assessment of DOC with qEEG can be performed in patients with prolonged 
DOC as a supplementary diagnostic approach (CEBM classification: level 1, 
GRADE moderate; recommendation 0). For all other approaches, i.e., EMG, ERP, 
and fMRI the evidence is too weak to give a recommendation for their routine diag-
nostic use in prolonged DOCs (CEBM classification: level 1, GRADE moderate).
4  DoC Rehabilitation
The complex approach of rehabilitation for DoC patients, though it is highly recom-
mended, is difficult to appraise critically. There are only very few randomized con-
trolled trials (RCT) available.
RCTs are of course difficult to perform in DoC patients because of the control 
groups required, long-lasting follow-up, little acceptance to participate while caregiv-
ers are easily reluctant to consent to trials limiting treatment options if not as “last 
option” that might induce a lack of valid samples for studies (Giacino et al. 2013).
A small number of studies have evaluated issues related to the early rehabilita-
tion phase of DoC (Pistarini and Maggioni 2018). Seel made, based on a single- 
center retrospective study, six recommendations for a better ER management but 
little evidences arise (Seel et al. 2013). Authors studied data on CRS-r scale scores 
pre–post rehabilitation and discharge disposition in a sample of 210 patients with 
DoC (VS and MCS) and 53% of patients showed at least one or more signs of emer-
gence into full consciousness (26% emerged from MCS in 2 CRS-r criteria and 27% 
in 1 of CRS-r criteria (Seel et al. 2013).
Rehabilitation methods used range from stretching exercises, postures (early 
mobilization/verticalization), splinting, casting, range of motion mobilization, but 
no RCT studied them. Only case studies, observational studies, and nonsystematic 
reviews are available (Giacino et al. 2013).
Previous systematic and nonsystematic reviews stated that structured sensory 
stimulation could not positively be recommended, if it was to be based on relevant 
clinical evidence (Georgiopoulos et al. 2010; Lombardi et al. 2002).
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One systematic review retrieved 157 articles with 18 studies investigating MCS/
VS patients with spasticity (Martens et al. 2017). Three prospective studies reported 
an occurrence of spasticity in DoC patients. Six articles focused only on spasticity 
treatments as primary outcome: 2 were clinical trials, 2 case reports, and last 2 were 
reviews. The rehabilitation methods studied were splinting and acupuncture, but no 
outcome differences were elicited when comparing splinting to physiotherapy ses-
sions, and the hypothesis of decreasing overexcitability in muscle hypertonia 
induced by acupuncture is not yet validated (Thibaut et al. 2015).
Available treatments for spasticity range from the use of drugs such as phenol, 
botulinum toxin, baclofen, tizanidine, dantrolene sodium, diazepam to physical 
treatments, in particular passive range of motion and stretching, splinting orthoses, 
casting, positioning, to surgical approaches such as intrathecal baclofen therapy and 
selective posterior rhizotomy. All available studies show little evidences of efficacy 
with a low-GRADE quality scoring. Other nine reports (2 clinical trials, 1 open- 
label study, 4 case reports, and 2 reviews) observed and studied spasticity treatments 
as secondary outcome, including deep brain stimulation to induce Cortical Activation 
by Thalamic Stimulation (CATS) and intrathecal baclofen (ITB) pump: no RCT 
among all selected studies are existing (Magrassi et al. 2016; Margetis et al. 2014). 
All studies analyzed could not depict any evidence for differential treatment effects.
While no evidence is available to support specific forms of rehabilitation treat-
ment in DoC patients, the experience from clinical practice indicates that an inter-
disciplinary rehabilitation approach that addresses the various therapeutic needs of 
DoC patients should be stated as early as possible and continued for a reasonable 
time to promote functional recovery including recovery of arousal and awareness as 
well as of emerging motor and communication functions.
At a later stage, such interdisciplinary rehabilitation treatment might be repeated 
to reevaluate the potential for functional recovery.
Recommendation:
Complex interdisciplinary rehabilitation should be provided by a team experi-
enced with patients with prolonged DOCs, started in an early phase, as soon as the 
clinical condition allows, with an individualized approach (CEBM classification: 
level 5, GRADE quality: very low [expert opinion], recommendation grade: B+). It 
should be continued for a reasonable time to ensure that a potential for gradual 
recovery has a chance to evolve under specialized treatment and might be repeated 
at later stages to reevaluate the potential for recovery (CEBM classification: level 
5, GRADE quality: very low [expert opinion], recommendation grade: B+).
5  Pharmacological Therapies for DoC
Several drugs have been used in the therapy of patients with DoCs. Most frequently 
used were centrally acting drugs including dopamine and GABA agonists. Among 
the first mentioned class are bromocriptine, levodopa, and apomorphine. Most fre-
quently used GABA agonists are zolpidem and baclofen (both oral and intrathe-
cal—ITB). Among most used drugs are then amantadine and methylphenidate.
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Studies on dopamine agonists either have considerable methodological restric-
tions or used very small samples; they often do not consider effects of spontaneous 
recovery and/or do not describe correctly clinical conditions with reference to 
comorbidities: neither results nor any suggestions may then be reported from those 
studies (Gosseries et al. 2014).
Only studies on amantadine report results that provide sufficient evidence for 
clinical decision-making. Specifically, an RCT compared the effects of a prescrip-
tion of amantadine versus placebo over a treatment course of 4 weeks in 184 DoC 
(only traumatic DoC in VS-MCS) patients (Giacino et al. 2012).
The outcomes were disability measured with the Disability Rating Score scale 
(DRS) and clinical DOC assessment with the CRS-r.
Results showed a significantly faster recovery in the treatment group (mean dif-
ference 0.24 DRS point per week 95% CI “0.07% to 0.4%”). At 2  weeks, after 
washout, the difference decreased while remaining significant and at 6 weeks fol-
low- up, the DRS scores were similar between control and treatment group with no 
significant difference (mean difference—0.7 DRS point per week 95% CI “−2 to 
10.7”). No significant differences in result arose when considering the analysis 
of CRS-r.
Data available on zolpidem are conflicting. In a non-randomized, placebo- 
controlled trial only one out of 15 DoC (12 VS and 3 MCS) patient showed improve-
ment in CRS-r scoring, being able to open her eyes sustainably (Whyte and 
Myers 2009).
All other studies reviewed are not of high quality (no RCT); while it has been 
reported in at least 6 studies and 23 clinical reports that zolpidem may induce EEG 
activation, may enhance BOLD signal in different brain regions, and activate meta-
bolic and neuronal activity studied with PET scans, M-EEG, Magnetoencephalography, 
and MRI imaging, a clinically relevant beneficial therapeutic effect of zolpidem on 
DOC had not been shown with an appropriate clinical trial to address this question 
(Gosseries et al. 2014).
No RCTs are available on ITB: few clinical reports support that the use of ITB, 
mainly for spasticity treatment purposes, may facilitate recovery; these articles are 
mainly clinical reports on a small sample and do not provide sufficient evidence for 
clinical decision-making process (Francois et al. 2001; Shrestha et al. 2011; Thibaut 
et al. 2015).
Recommendation.
A course of amantadine treatment over a couple of weeks can be used in the 
beginning of the rehabilitation treatment of stroke survivors with DoC (VS-MCS) to 
promote recovery in the disability domain (CEBM classification: level 1b, GRADE 
quality: moderate, recommendation grade: 0 [indirectness of evidence]).
The evidence is too limited to guide clinical decision-making with respect to 
long-term use and discontinuation of amantadine, or the prescription of other drugs 
to treat DoC in stroke survivors.
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6  Other Specific Therapies for DoC
One RCT enrolled 44 out of 50 initially considered patients with DoC (14 VS and 
30 MCS) and analyzed the results from the use of a tilt table therapy compared to 
tilt therapy integrated with a stepping device (product Erigo® by Hocoma, 
Switzerland); both groups received 1 h sessions over a course of 3 weeks (Krewer 
et al. 2015).
The primary outcome was the improvement rate of CRS-r scores after treatment, 
and the secondary outcome was the difference in the Modified Ashworth Scale 
(MAS) again after treatment. Both control and treatment group improved, and the 
intervention effect for the stepping device was less when changes scores from base-
line to week 6 were analyzed (median (25%–75% percentile): Erigo® 4 (−1–6); tilt 
table: 9 (5–10); U-Test = 122.0; z = −2.824, p = 0.005, r = −0.42). Changes in MAS 
scoring did not significantly differ between the two patient groups.
A case series investigated the effects on CRS-r scoring and electrophysiological 
criteria in response to the use of deep brain stimulation (DBS) in 21 VS patients 
with an increase odd of recovery (OR 88.0; 95% CI “5.4 to 1219.0”) (Yamamoto 
et al. 2010). No control group was considered and the sample was very small.
Other specific therapies used to treat DoC that were investigated are music ther-
apy, noninvasive brain stimulation (NIBS) such as 20  Hz repetitive transcranial 
magnetic stimulation (rTMS) and transcranial direct current stimulation (tDCS) 
(Bai et al. 2017; He et al. 2018; Rollnik and Altenmuller 2014).
Only clinical studies on a small sample basis are available. Few considerations 
are reported in nonsystematic reviews like the targeting of the left dorsolateral pre-
frontal cortex in DoC when using tDCS or rTMS, but no evidence that would be 
sufficient for clinical decision-making process (Hodelìn-Tablada 2016; Pignat 
et al. 2015).
Recommendation:
The evidence is too limited to guide clinical decision-making for therapies such 
as tilt therapy with integrated stepping device, rTMS, or tDCS when used with the 
intention to treat DoC in stroke survivors. Their use is discouraged for routine clini-
cal practice with the therapeutic goal to improve DoC in stroke survivors (CEBM 
classification: level 4 to 1b, GRADE quality: very low to moderate, recommenda-
tion grade: B−).
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More patients with severe neurological deficits are surviving because of improve-
ments in the management of stroke, traumatic brain injury, resuscitation, and sepsis. 
Advances in neurology and neurosurgery enable survival for many patients with 
malignant ischemic stroke (when more than two-thirds of the area supplied by a 
cerebral artery is affected), intracerebral haemorrhage, or other intracranial masses. 
These patients are often so severely affected that they require mechanical ventila-
tion and cannot be successfully weaned from ventilation during their stay at the 
acute admitting hospital (Rollnik et al. 2017).
While this book focusses on stroke, we have chosen to write this chapter with a 
broader perspective as critically ill patients with stroke share similarities and risks 
with patients having other neurological conditions. In Europe, neurological- 
neurosurgical early rehabilitation (NNER) centres provide care for such patients by 
bundling neurological, neurosurgical, intensive care, and neurorehabilitation exper-
tise (Rollnik et al. 2017). These NNER centres have successfully proven themselves 
as a link between acute medical intensive care and rehabilitation and are also estab-
lished as weaning centres for these severely neurologically ill patients (Rollnik et al. 
2017; Pohl et al. 2016).
Patients relocated to weaning centres have been ventilated on average for 
more than 3 weeks in their primary care acute hospital (Oehmichen et al. 2012a). 
Their average age is older and they often have significant and multiple 
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morbidities (Oehmichen et al. 2012a). Ventilation for this duration leads to mus-
cular weakness in non-neurological patients through inactivity (disuse atrophy) 
and through pathologies such as critical illness neuropathy (CIP) or myopathy 
(CIM) (Oehmichen et al. 2012b; Prange 2004; Ponfick et al. 2014). Neurologic-
neurosurgical early rehabilitants often show significant immobility and nursing 
dependency. They may have a centrally induced paralysis or neuromuscular dis-
ease that may considerably complicate the weaning process. In addition, these 
patients also suffer neurological or neurosurgical complications, e.g. increased 
intracranial pressure or epileptic seizures, that requires ongoing involvement of 
neurological-neurosurgical expertise in the early rehabilitation process. These 
patients thus require a special setting, such as that provided in neurological 
weaning and rehabilitation centres. Through the possibilities of neurologically 
oriented multi-professional rehabilitation, the goal of the best possible interac-
tion can be achieved.
With regard to the technical processes of weaning and the pathophysiology of 
weaning failure, reference is made to guidelines on “prolonged weaning” 
(Schönhofer et al. 2014). These do not differentiate between weaning of neurologi-
cal patients compared to non-neurological patients, e.g. those with primary pulmo-
nary disease. Differences between these specialist weaning centres can be seen, 
however, both in terms of staffing (multi-professional rehabilitation team, neuro-
logical, and neurorehabilitation expertise) and the therapies used.
2  Clinical Evidence and Reasoning
There is no strong evidence base as to how a prolonged weaning stroke patient 
should be best managed. The few studies involving stroke patients have examined 
heterogeneous groups of patients and a small proportion of neurological or neuro-
muscular disorders. Neurological patients are often excluded from automated wean-
ing programs by some ventilator manufacturers (Neumann and Schmidt 2018). 
Basically, three different methods are used (Schönhofer et al. 2014):
• Gradual reduction of pressure support.
• Combination of full and partial relief with phases of full load.
• Increasing phases of full load.
Which of these three methods, or a combination thereof, most benefit stroke 
patients is unclear (Ladeira et al. 2014). The use of so-called weaning protocols has 
not been studied in randomized controlled trials. In a recent PubMed search, the 
combination of terms “weaning from mechanical ventilation” AND “stroke” iden-
tified only 71 matches while the combination of “prolonged weaning” AND “stroke” 
identified only 28 matches. None however provided any evidence of optimal 
approach.
Thus, all the following recommendations are derived from guidelines or the 
experience of the authors in the context of good clinical practice.
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2.1  Weaning of Neurological Patients
Weaning from mechanical ventilation generally takes between 40–50% of total 
mechanical ventilation time (Schönhofer et al. 2014). The duration of mechanical 
ventilation is associated with an increase in mortality and complication rates (Boles 
et al. 2007; Schönhofer et al. 2014). While the underlying condition of the patient 
obviously plays an important part, there is a significant iatrogenic contribution from 
ventilator-induced volu barotrauma, cardiovascular sequelae and hemodynamic, 
and immunosuppressive side effects of sedative agents. Safe and rapid withdrawal 
from the ventilator is therefore a top priority. According to an international consen-
sus conference of 2005, a distinction is made between simple, difficult, and pro-
longed weaning (Boles et al. 2007, Schönhofer et al. 2014). Patients who need to be 
intubated and ventilated due to a neurological condition usually require prolonged 
weaning according to this definition (Rollnik et al. 2017).
Among patients with prolonged weaning, the initial reason for mechanical ven-
tilation is an acute illness in more than half of the cases (Schönhofer et al. 2014). 
The cause of ongoing ventilation is however multifactorial, most commonly respira-
tory tract disorders, oxygenation problems, oxygen distribution disorders, and 
respiratory pump failure (Schönhofer et al. 2014). Respiratory muscle weakness is 
often related to critical illness polyneuropathy (CIP) and/or myopathy (CIM). These 
are diagnosed in one-third of patients with ARDS, one quarter of those who have 
ventilation duration of more than seven days, and more than two-thirds of patients 
with sepsis who require prolonged ventilation and hospitalization (Oehmichen et al. 
2012b; Ponfick et  al. 2014; Oehmichen and Ragaller 2012). In addition to these 
weakness syndromes acquired in the intensive care unit (ICU), other neurological 
and psychological consequences of intensive care management (e.g. delirium, post- 
traumatic stress disorder) also have an unfavourable influence on weaning 
(Oehmichen and Ragaller 2012; Rollnik et al. 2017).
Primary neurological conditions are also a frequent cause of prolonged weaning 
(Oehmichen and Ragaller 2012; Oehmichen et  al. 2012a; Rollnik et  al. 2010; 
Bertram and Brandt 2013). Twenty-seven percent of ventilated patients with under-
lying neurological-neurosurgical disorders were reported as experiencing “weaning 
failure” (Coplin et al. 2000; Oehmichen et al. 2012a).
Such patients may benefit from relocation to specialized facilities (weaning cen-
tres) (Rollnik et al. 2017; Schönhofer et al. 2014). In a retrospective study of 1486 
patients enrolled in seven neurological weaning centres in 2009, the underlying 
causes of long-term ventilation were neurological in 69.2% of cases (52.6% central 
nervous, 45.2% peripheral neurological, 2.2% mixed), pulmonary in 22.8% of 
cases, and cardiac disorders in 3% (Oehmichen et al. 2012a). Neurological patients 
who could not be weaned from mechanical ventilation in primary care require a 
seamless continuation of rehabilitation measures in secondary care, taking into 
account an ongoing requirement for intensive care. These specialized NNER wean-
ing centres fulfil specific tasks and requirements for the care of these long-term 




2.2  Existing Studies on Weaning Success
Uncontrolled studies in NNERs reported that prolonged weaning from mechanical 
ventilation is often successful (Oehmichen et  al. 2012a; Rollnik et  al. 2010; 
Hoffmann et al. 2006; Pohl et al. 2016). However, comparative studies examining, 
for example weaning of neurological patients with and without the intervention of 
NNER, are hard to achieve. In many countries, this would conflict with the right to 
rehabilitation guaranteed in social legislation.
The published literature mainly deals with descriptions of the approach to wean-
ing, or provides expert opinions and conceptual representations (Bertram and 
Brandt 2013; Oehmichen and Ragaller 2012), retrospective data collections (Pohl 
et  al. 2016; Oehmichen et  al. 2012a; Rollnik et  al. 2010), concepts of weaning 
(Oehmichen et al. 2013), or presentations of results for weaning in the context of 
neurological-neurosurgical early rehabilitation (Hoffmann et al. 2006; Bertram and 
Brandt 2007).
Table 1 shows results in various NNER weaning centres. Comparison of wean-
ing rates to pneumological weaning centres is particularly difficult due to different 
admission criteria, inconsistent definition of a primary end point, and the therapeu-
tic goal being sought (Oehmichen et al. 2012a; Rollnik et al. 2017). Comparability 
of results between different weaning centres can only be achieved if a consistent 
interdisciplinary dataset is developed. Process and result data must therefore be 
precisely defined. In our opinion, there is a pressing need for clarification, e.g. for a 
uniform allocation of essential treatment phases for hospital or rehabilitation treat-
ment, a description of inclusion or rejection criteria for admission, criteria to 










193 66.8 20.2 12.9 Hoffmann et al. 
(2006)
133 78.2 5.3a/?b ? Bertram and Brandt 
(2007)
82 68.3 6.1a/19.5b 6.1 Rollnik et al. 
(2010)
1486 64.9 11.3a/7.1b 16.6 Oehmichen et al. 
(2012a)
644 59.5 9.8a (8.2c/1.6d)/7.8b 23.0 Oehmichen et al. 
(2013)
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describe disease severity, a precise definition of weaning, and evaluation of results 
in relation to the therapeutic goal.
2.3  Difficulties in the Weaning Process
In prolonged weaning of neurological patients, the weakened “respiratory muscle 
pump” (resulting from peripheral and/or central paresis) and/or a respiratory drive 
disorder (from brain stem dysfunction) are of primary relevance (Rollnik et  al. 
2017). In addition to these primary neurological conditions, there may also be 
development of an ICU-acquired weakness syndrome (Ponfick et al. 2014; Pohl and 
Mehrholz 2013). Both may lead to pronounced weakness thereby complicating the 
weaning process (Rollnik et al. 2017). A third of patients transferred to an NNER 
facility had a main diagnosis of CIP or CIM (Oehmichen et al. 2012a; Pohl et al. 
2016). The average age of patients in these centres was 63.7 years (Oehmichen et al. 
2012a), thus relevant comorbidities are likely. As mentioned earlier, this particular 
study classified 22.8% of cases as having an underlying pulmonary cause for 
mechanical ventilation and 3% a cardiac cause (Oehmichen et al. 2012a).
2.4  Weaning Strategies
Weaning strategies are used with a combination of synchronized intermittent man-
datory ventilation (SIMV) and/or pressure support ventilation (PSV) and/or pro-
gressively extended spontaneous breathing phases (Rollnik et al. 2017). However, it 
is known that respiratory muscle recovery does not occur through pressure-assisted 
ventilation or SIMV and that assisted spontaneous breathing modes may be more of 
a burden on the breathing pump due to ineffective triggering (Rollnik et al. 2017). 
Therefore, especially in cases of respiratory muscle pump weakness, weaning strat-
egies with intermittent spontaneous breathing alternating with controlled mechani-
cal ventilation should be used (Rollnik et al. 2017).
The question as to whether one ventilation mode is superior to another in wean-
ing neurological/neurosurgical patients is currently uncertain due to a lack of stud-
ies. This question is also controversial in non-neurological patients or in unselected 
patient groups. Sample sizes are generally small and the use of now outdated techni-
cal equipment means that ventilation modes were not used in a way that would have 
allowed an exact separation between assisted spontaneous breathing and controlled 
ventilation. In more recent investigations, combinations of assisted spontaneous 
breathing (ASB) and controlled ventilation (assist-control ventilation and BIPAP) 
were used during the phases of controlled ventilation (Rollnik et al. 2017).
The aim of weaning in neurological patients is independent breathing, with-
out equipment support. Non-invasive ventilation is used as a de-escalation 
therapy in patients with good swallowing function and persisting respiratory 
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pump insufficiency (Rollnik et al. 2017). To summarize, during prolonged wean-
ing of neurological patients, weaning strategies can be used that incorporate pro-
gressively expanded spontaneous breathing phases, taking into account the 
underlying pathology and a constant re-evaluation of patient response. With dis-
turbances in neuromuscular transmission, additional pressure support may be 
useful during the spontaneous breathing phases. Weaning in patients with central 
respiratory dysregulation disorders should be individualized, taking into account 
their underlying injury and regular adjustment according to patient response.
2.5  Weaning Protocols and Special Ventilation Techniques
Protocols are generally recommended when weaning long-term mechanically ven-
tilated patients (Rollnik et al. 2017; Schönhofer et al. 2014). These should include a 
gradual extension of spontaneous breathing attempts. During spontaneous breath-
ing, the patient is disconnected from the ventilator for temporary periods; this is 
intended to achieve recovery of respiratory muscles with replenishment of energy 
stores. Such weaning protocols are therefore used in all patients in neurological 
weaning centres, regardless of whether the patients are suffering from a central 
nervous disorder, a neuromuscular weakness, a primary hypoxic disorder due to 
pulmonary insufficiency, or a combination thereof.
Oehmichen et al. described in detail standardized extensions of spontaneous 
respiration phases (Oehmichen et  al. 2013). The documentation of compliance 
with the protocol (i.e. individual steps in the development of spontaneous breath-
ing phases) is made by the nursing staff. The medical team monitors protocol 
compliance (per daily documentation) and sets different individualised plans. 
They reported that this protocol was followed in 86% of ventilator-weaned 
patients. The authors thus concluded that the use of this spontaneous breathing 
protocol is well suited to successful weaning of neurological intensive care 
patients requiring prolonged weaning.
The central notion of all protocol-based weaning strategies is to check respira-
tory status daily and to continually adjust the plan for the next weaning steps. 
Whether such a procedure is the subject of a formal treatment protocol led by care-
givers, or whether the process is ensured by a structured medical visit, seems to be 
of minor importance for the outcome but more dependent on the particular circum-
stances of an intensive care unit.
There is no evidence of superiority to the discontinuous cessation approach 
described above for continuous weaning in modes such as SIMV or BiLevel ventila-
tion with a gradual reduction of pressure support (Bertram and Brandt 2013; Jubran 
et al. 2013).
Pressure-assisted spontaneous breathing—inspiratory pressure support of spon-
taneous breathing (IPS), assisted spontaneous breathing (ASB), pressure support 
ventilation (PSV)—is another spontaneous breathing mode suitable for weaning of 
neurological patients with an intact respiratory drive, for example those with severe 
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damage to the peripheral nervous system such as Guillain-Barré syndrome. Without 
disconnection periods, the muscular respiration pump can be trained by gradually 
reducing inspiratory pressure, i.e. a gradual “transfer” of ventilation to the patient 
takes place (Jubran et  al. 2013). It is an alternative process to the discontinuous 
weaning protocols.
Adaptive support ventilation (ASV) is a modern advancement of mandatory 
minute ventilation (MMV) with a complex adaptive control taking into account the 
anatomical dead space. In experienced hands, this procedure allows compliance 
with pulmonary protection rules, targets minute ventilation, an optimal target 
breathing pattern (Otis formula), and a safe, patient-based weaning. However, no 
advantage has yet been shown over other modes for ventilated, tracheotomized 
patients (Bertram and Brandt 2013).
The intermittent use of CPAP in the late weaning phase may possibly assist with 
better alveolar recruitment in preventing atelectasis and reducing the work of breath-
ing (Bertram and Brandt 2013). In the case of unsupported spontaneous breathing 
using a T-piece, automatic tube compensation (ATC) can compensate for an 
increased work of breathing due to tube resistance (Bertram and Brandt 2013). 
However, whether the use of these procedures in ventilated patients with neuromus-
cular weakness and/or respiratory drive disorders shortens the time of weaning or 
increases the weaning rate has not been adequately studied (Bertram and Brandt 
2013). In general, unsupported spontaneous respiratory phases should be performed 
using a T-piece under close nursing control.
Neurally adjusted ventilatory assist (NAVA) is a “neuronal” controlled ventila-
tion (Moerer et al. 2008; Navalesi and Longhini 2015). The support is synchronous 
and proportional to the activity of the diaphragm. The diaphragmatic activity is 
measured by a special electrode applied on a nasogastric tube. This is intended to 
achieve improved synchronization between the respiration trigger and the patient’s 
breathing demand in order to reduce false triggering and thus an increased work of 
breathing. In the case of this procedure, it is also unclear as to whether a shortening 
of the time to successful weaning or an improved outcome can be achieved (Moerer 
et al. 2008, Navalesi and Longhini 2015).
In principle, the frequency and duration of spontaneous respiration at the T-piece 
should be successively increased in a fixed step pattern. If successful, the patient can 
be moved to the next level, and in case of failure they can be moved back to the 
previous level or the same level re-applied (Bertram and Brandt 2013; Oehmichen 
et al. 2013). If this step scheme (or weaning protocol) cannot be met, it requires an 
individual, medically guided weaning plan with close patient surveillance (Bertram 
and Brandt 2013, Oehmichen et al. 2013).
Classic weaning protocols are aimed at rapid extubation of patients in intensive 
care units who are ventilated for longer than 24 hours. An important premise of 
these protocols is the presence of adequate alertness and the ability to assess the 
patient’s neurological status. Weaning and sedation protocols are thus often coupled 
(Girard et al. 2008). However, for neurological/neurosurgical patients, these con-
ventional weaning parameters can only be used to a very limited extent, if at all 
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(Ko et al. 2009). This may be due to a lack of consideration of certain aspects of 
neurological/neurosurgical patients:
• As most prolonged weaning ventilated patients are already tracheotomised—
between 91 and 96% (Pohl et al. 2016), there should not be a dichotomous yes/
no decision to extubate but rather a plan involving gradual weaning from the 
ventilator. This is often achieved by daily extension of time without ventilator 
support.
• There are often problems with the respiratory pump/respiratory muscles, for 
example due to CIP/CIM. In contrast, pulmonary insufficiency (as in the case of 
the classic COPD patient) often plays only a subordinate role or, at most, repre-
sents comorbidity.
• The problems of reduced vigilance and neurogenic dysphagia are mostly com-
pletely disregarded.
A weaning protocol in neurological patients therefore has fundamentally differ-
ent requirements compared to a conventional protocol. Examples of a weaning pro-
tocol used in the NNER can be found in the literature (Oehmichen et al. 2013).
2.6  Special Features of Prolonged Weaning 
in Neurological Patients
2.6.1  Definition of Successful Weaning 
from Mechanical Ventilation
In the respiratory literature, a weaning end point is inconsistently defined. Although 
non-invasive ventilation is recognized as full-fledged ventilation in the Diagnosis- 
Related Group (DRG) coding system (Institut für das Entgeltsystem im Krankenhaus 
(InEK GmbH) 2015), the respiratory literature often suggests that successful wean-
ing is achieved after switching from invasive to non-invasive mechanical ventilation 
(Schönhofer et al. 2014). Thus, successful withdrawal from ventilation is equated to 
the removal of invasive ventilation access (endotracheal/tracheostomy tube). In con-
trast to these patients, the indication for an endotracheal/tracheostomy tube in neu-
rological patients is not only for (invasive) ventilation but also often because of 
dysphagia and the risk of aspiration (see below). Thus, in principle, there are two 
indications for an endotracheal/tracheostomy tube.
Patients undergoing early neurological-neurosurgical rehabilitation are consid-
ered to have been successfully weaned from respiration if patients manage for at 
least 48 hours without any mechanical ventilation (Rollnik et al. 2017). Removal 
of the tracheal cannula occurs when there is no longer a risk of aspiration. This is 
one of the main differences between respiratory patients who rarely have such 
dysphagia, and neurological-neurosurgical early rehabilitants (Rollnik et  al. 
2017). The use of non-invasive ventilation, which plays a fundamental role in 
early extubation and successful weaning, plays a subordinate role in neurological-
neurosurgical early rehabilitation as, in the majority of cases, there are 
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contraindications to this form of ventilation. Examples include lack of coopera-
tion, retention of secretions with impaired/absent coughing, missing protective 
reflexes, central respiratory drive disorders, and complex dysphagia with risk of 
aspiration and/or disorders of gastric motility with frequent vomiting (Rollnik 
et  al. 2017). Non-invasive ventilation (NIV) in these patients requires special 
expertise and close monitoring. It was used as an integral part of the weaning 
process in only 4.4% of patients according to the NNER study on ventilatory ces-
sation in neurological weaning centres (Oehmichen et al. 2012a). Studies on the 
use of NIV with pressure support in neurological- neurosurgical patients are lack-
ing. This application remains reserved for experts who are familiar with this type 
of ventilation and can afford the specific treatment risks and the considerable 
mechanical and, above all, human resources necessary.
2.6.2  Invasive and Non-Invasive Ventilation
Most patients are invasively ventilated when transferred to a neurological wean-
ing centre—96.7% in one multicentre observational study (Oehmichen et  al. 
2012a), in whom 99.9% were ventilated via a tracheostomy (Oehmichen et al. 
2012a). Comparable data were found in two other multicentre studies (Pohl 
et  al. 2016; Hoffmann et  al. 2006). It thus follows that neurological weaning 
centres need a structured approach to the handling and weaning of the tracheos-
tomy tube.
Non-invasive ventilation (NIV) can be used for hypercapnic respiratory failure 
or global respiratory insufficiency. This has the advantage that a tracheostomy is 
avoided, thereby preserving the body’s own filtering, moistening and warming of 
inhaled air. However, NIV with mask ventilation is only possible in cooperative 
persons without disturbances of consciousness, significant dysphagia and secretion 
clearance, and with intact swallowing reflexes. Accordingly, their use in neurologi-
cal weaning centres is severely limited. Non-invasive ventilation should not be used 
in patients with neurogenic dysphagia or prolonged reduced vigilance and high 
aspiration risk (Rollnik et al. 2017). In these patients, a blocked-off tracheostomy 
tube should remain in situ until there is no danger of macro-aspiration (Rollnik et al. 
2017). Swallowing status in patients with dysphagia should be determined by a 
controlled clinical examination (Rollnik et al. 2017).
2.6.3  Accompanying Neurological-Neurosurgical 
(Early) Rehabilitation
Weaning of neurological patients should always include (early) rehabilitation of 
various concomitant aspects to achieve the best possible patient participation 
(Rollnik et al. 2017). Examples include:
• Management of the tracheostomy tube.
• Dysphagia and secretion management.
• Treatment of patients with organic brain syndromes and neurocognitive 
dysfunction.
• Treatment of patients with spinal cord injury.
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• Increasing independence in the activities of daily living.
• Accompanying therapies in neurological-neurosurgical early rehabilitation.
• Nursing techniques and activities.
• Psychological interventions.
3  Clinical Practice Recommendations for Weaning 
in Stroke Patients (and Other Patients 
with Neurological Conditions)
3.1  Methodological Explanations
In general, the recommendations given in this book, authorized by the World 
Federation for NeuroRehabilitation (WFNR), are accompanied by an indication of 
the level of evidence, e.g. from expert opinion (level 5) to systematic reviews (with 
homogeneity) of RCTs (level 1a). The overall quality of evidence supporting the 
recommendations ranges from “very low” when no systematic evidence is available 
to “high” when there is substantial high-quality evidence and when further evidence 
is unlikely to change the estimates of therapy effects (and harm). The grading of the 
recommendations will vary from “can” (option), e.g. when based on expert opinion 
only to “ought to” (strong recommendation) when based on high-quality evidence 
or clinically mandated for ethical reasons.
Levels of evidence for recommendations are indicated below using the “Oxford 
Centre for Evidence-Based Medicine (CEBM) Levels of Evidence” (version dating 
from March 2009, http://www.cebm.net/Oxford-centre-evidence-based-medicine). 
Here, the quality of evidence was rated into four categories according to the 
“GRADE” (“Grades of Recommendation, Assessment, Development, and 
Evaluation”) system (Owens et al. 2010):
• High quality: further research is unlikely to affect confidence in the estimation of 
the (therapeutic) effect.
• Medium quality: further research is likely to affect confidence in the estimation 
of the (therapeutic) effect and may alter the estimate.
• Low quality: further research will most likely influence confidence in the estima-
tion of the (therapeutic) effect and will probably change the estimate.
• Very low quality: any estimation of the (therapy) effect or prognosis is very 
uncertain.
The GRADE rating of recommendations corresponds to the categories of “ought 
to” (A—strong recommendation) or “should” (B—weak recommendation) 
(Schünemann et al. 2013). As third category “can” (0—option) had been intro-
duced (Platz 2017). Recommendation category A is granted for clinically effective 
interventions with high-quality evidence support; category B for medium- quality 
evidence, and category 0 for low- or very low-quality evidence. Deviations from 
this rule could be indicated based on clinical judgement, with individual reasons 
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denoted in [brackets]. A+ and B+ denote a strong or weak recommendation in 
favour on an intervention, while A− and B− recommend against its use.
3.2  Recommendations
3.2.1  Organizational Setting
Prolonged weaning in stroke patients requires a special setting which can best be 
provided in neurological weaning and rehabilitation centres. Through the integrated 
possibilities of an adequate weaning process and a neurologically oriented multi- 
professional rehabilitation both successful weaning and the goal of the best possible 
interaction may simultaneously be achieved (CEBM classification: level 2c, 
GRADE quality: low, recommendation: B+ [clinical reasoning]).
3.2.2  Weaning Strategy
For prolonged weaning of stroke patients, strategies with progressively expanded 
spontaneous breathing phases can be used, taking into account the underlying 
pathology and a constant re-evaluation of patient response. In cases of disturbances 
of neuromuscular transmission, additional pressure support during the spontaneous 
breathing phases can be useful. Weaning in patients with central respiratory dys-
regulation disorders should be individualized, taking into account the underlying 
injury and also regular adjustments according to patient response (CEBM classifica-
tion: level 5, GRADE quality: very low, recommendation: 0).
Non-invasive ventilation ought not to be used in patients with neurogenic dys-
phagia or prolonged reduced vigilance and a high risk of aspiration; in these patients, 
a blocked-off tracheostomy tube should remain as a portal for ventilator access until 
there is no danger of macro-aspiration (CEBM classification: level 5, GRADE qual-
ity: very low, recommendation: A− [clinical reasoning]).
Weaning in stroke patients ought to include (early) rehabilitation of various con-
comitant aspects of care to achieve best possible patient participation (CEBM clas-
sification: level 5, GRADE quality: very low, recommendation: A+ [clinical 
reasoning]).
3.2.3  Weaning Process Characteristics
Weaning protocols can be used during the weaning process of long-term mechani-
cally ventilated stroke patients (CEBM classification: level 5, GRADE quality: very 
low, recommendation: 0).
The frequency and duration of spontaneous respiration using a T-piece can be 
increased in a fixed step pattern; if successful, the patient can move to the next level, 
in case of failure the patient returns to the previous level or the same level is re- 
applied (CEBM classification: level 2c, GRADE quality: low, recommendation: 0).
Patients undergoing early neurological-neurosurgical rehabilitation are consid-
ered to have been successfully weaned if they manage at least 48 h without any 
mechanical ventilation (CEBM classification: level 5, GRADE quality: very low, 
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Dysphagia is one of the common impairments after stroke, which ranges widely 
from 29% to 81% according to the timing of the survey after stroke or the methods 
used for dysphagia assessment (e.g., questionnaire, clinical examination, instrumen-
tal test) (Martino et al. 2005). Pharyngeal phase dysphagia is more prevalent (Han 
et al. 2001) and brain stem or specific cortical lesions may attribute more for post-
stroke dysphagia (Galovic et al. 2013; Martino et al. 2005). Dysphagia is associated 
with the higher risk of non-silent or silent aspirations and aspiration pneumonia 
(Ding and Logemann 2000; Falsetti et al. 2009; Perry and Love 2001). In addition, 
dysphagia is associated with other medical complications such as dehydration, mal-
nutrition, mortality, and recovery after stroke (Perlman 1996). Therefore, detecting 
and managing dysphagia after stroke could prevent medical complications and 
reduce the length of hospital stay and socioeconomic burdens (Smithard et al. 1996).
In this chapter, we reviewed the clinical evidence related with dysphagia assess-
ment and management after stroke. The topics selected are: (1) Dysphagia screening; 
(2) Instrumental assessment of dysphagia; (3) Treatment of dysphagia including 
behavioral interventions, neuromuscular electrical stimulation, noninvasive brain 
stimulation, and oral hygiene; and (4) Enteral tube feedings. Five clinical practice 
guidelines were selected for the review and adaptation (Boddice et al. 2010; Hebert 
et al. 2016; Smith 2010; Winstein et al. 2016; Kim et al. 2016). Articles published 
frvom 2014 to 2017 were additionally searched in the PubMed and Cochrane Library 
using the MeSH keywords “(cerebrovascular disorders OR stroke OR cerebral hem-
orrhage OR cerebral infarction) AND (Dysphagia OR Deglutition OR oral hygiene),” 
and in the EMBASE using EMTREE with the keywords, “(cerebrovascular disease) 
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AND (Dysphagia OR swallowing disorder OR deglutition).” Total 2118 articles were 
found by these electronic searches. Titles and abstracts were reviewed for screening 
and non-English papers, commentaries, case series, narratives, book chapters, edito-
rials, nonsystematic reviews, and conference papers were excluded. Two indepen-
dent raters screened all 2118 articles and any disagreement was resolved by 
discussion. In each topic, the systematic review, meta-analyses, and randomized con-
trolled trials (RCTs) were considered for inclusion first, but if no articles were avail-
able for the topic, observational studies were additionally selected.
Systematic reviews and meta-analyses (n = 11), RCTs (n = 5), and observational 
studies (n = 10) relevant to each selected topic in dysphagia (31 articles in total 
including five clinical practice guidelines) were selected for full-text review for 
summarizing the currently best available evidence, assessing its overall quality of 
evidence and for the provision of recommendations. A complete list of selected 
references is presented online at www.clinical-pathways.org. The recommendations 
given in this chapter follow the same rules as outlined in chapter “Clinical Pathways 
in Stroke Rehabilitation: Background, Scope, and Methods” (see Chap. 2).
2  Dysphagia Screening Early after Stroke
One systematic review included 14 studies to detect oropharyngeal dysphagia with bed-
side screening in patients with neurological disorders. The sensitivity and specificity to 
detect aspiration ranged from 45% to 100%, and 29% to 86%, respectively (Kertscher 
et al. 2014). In one systematic review of swallowing screens after acute stroke, four 
screening protocols that met the quality criteria showed high sensitivities (≥87%) and 
specificities (≥91%) (Schepp et al. 2011). A recent prospective, double-blind study in 
patients with stroke demonstrated that a dysphagia screen protocol has the high sensitiv-
ity (96.5%) and acceptable specificity (55.8%) as a screening tool to detect aspiration 
(Warnecke et al. 2017). Multiple observational multicenter prospective or registry-based 
studies with large sample size showed that the screening failure of dysphagia after stroke 
is associated with higher risk of pneumonia or mortality (Hinchey et al. 2005; Joundi 
et al. 2017a; b; Lakshminarayan et al. 2010). Bedside screening for dysphagia by the 
trained nurses after acute stroke demonstrated the significant reduction in the time to 
dysphagia screening and pneumonia rate compared to the screening by speech thera-
pists in the pre- and post- intervention trial (Palli et al. 2017).
Recommendation: Dysphagia screening ought to be administered by the trained 
healthcare provider early after stroke onset before starting oral feeding to prevent 
pneumonia and other adverse events such as malnutrition, dehydration, and to 
reduce the mortality (CEBM classification: level 1, GRADE quality: moderate, rec-
ommendation grade: A+).
One of the dysphagia screening tools that showed acceptable reliability, higher 
sensitivity, and negative predictive value, which consists of items such as alertness 
assessment, dry swallowing test, and direct swallowing test with water or semisolid 
and solid foods, should be used (CEBM classification: level 1, Grade quality: mod-
erate, recommendation: B+).
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3  Instrumental Assessments to Detect Dysphagia 
or Aspiration
A bedside screening test alone has a limitation to assess dysphagia after stroke 
because patients with stroke can aspirate without overt clinical signs or symptoms 
(silent aspiration), and the assessment for sequential swallowing function (oral, 
pharyngeal, and esophageal phase) is difficult by a bedside screening tool (Singh 
and Hamdy 2006). The widely used instrumental assessments for dysphagia are 
videofluoroscopic swallowing study (VFSS) or fiberoptic endoscopic evaluation of 
swallowing (FEES), which have advantages to assess the physiological or structural 
causes of dysphagia necessary for providing the appropriate instruction for dyspha-
gia management (e.g., swallow therapy, compensation maneuver, dietary modifica-
tion). In a systematic review including 24 observational studies, dysphagia incidence 
after stroke was higher with the VFSS (64–78%) than those with bedside screening 
or structured clinical assessments (37–55%) (Martino et al. 2005). High silent aspi-
ration rate (67% of silent aspiration among patients with aspiration) detected by 
VFSS in one observational study with acute stroke patients indicated that the clini-
cal bedside test alone could not predict the risk of aspiration or pneumonia (Daniels 
et al. 1998). In a prospective observational study to compare the bedside screening 
test versus VFSS in patients with acute stroke, 14% of patients who passed the 
screening test showed aspiration in VFSS and diet recommendations were changed 
to the more conservative level in 28% of the patients after VFSS (Leigh et al. 2016). 
One retrospective observational study showed that selective FEES significantly 
reduced pneumonia (Bax et al. 2014). However, no high-quality study has shown 
that the instrumental test can reduce the pneumonia rate significantly more than the 
bedside screening test (Doggett et al. 2001; Kjaersgaard et al. 2014), although one 
recent study using a decision-analysis model from multiple data sources including 
meta-analyses and other relevant clinical studies demonstrated that VFSS screening 
for dysphagia was more cost-effective than a bedside examination alone or a com-
bination of bedside examination with VFSS (Wilson and Howe 2012). The superior-
ity of one method to another between VFSS and FEES was not significant and both 
can be applied according to the clinical situations (Aviv 2000; Boddice et al. 2010; 
Hebert et al. 2016; Smith 2010).
Recommendation: Instrumental assessments such as VFSS or FEES ought to be 
performed to verify the aspiration and to set the appropriate dysphagia management 
plan in stroke patients who showed the risk for pharyngeal dysphagia or aspiration 
in the initial or ongoing swallowing screens (CEBM classification: level 1, GRADE 
quality: moderate, recommendation grade: A+).
4  Treatment of Dysphagia
Early and comprehensive treatment of dysphagia is important, if the dysphagia is 
detected by the screening or instrumental tests. Conventional dysphagia treatment 
usually includes the swallowing exercise, compensatory techniques, and 
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appropriate dietary modifications. In this chapter, the evidence for behavioral inter-
vention programs including the conventional dysphagia treatment components were 
reviewed, because these components are usually provided by rather a program than 
an isolated component, and the effects of each isolated component cannot be evalu-
ated sufficiently. Based on the current evidence, the evidence for neuromuscular 
electrical stimulation (NMES), which is commonly used with the behavioral inter-
ventions, was reviewed. And since meta-analyses of acupuncture studies were avail-
able, the reviews of evidence and recommendation for acupuncture were included. 
Noninvasive brain stimulations such as repetitive transcranial magnetic stimulation 
(rTMS) or transcranial direct current stimulation (tDCS) for dysphagia were also 
reviewed for their evidence because of presence of more recent RCTs and system-
atic reviews. Lastly, the evidence of oral hygiene to prevent pneumonia in stroke 
patients with dysphagia was reviewed.
4.1  Behavioral Interventions
One RCT investigated the effect of behavioral interventions on dysphagia in acute 
stroke with the primary outcome of survival free of an abnormal diet at 6 months 
(Carnaby et al. 2006). Patients were randomly allocated to usual care (n = 102), 
standard low-intensity intervention (n = 102) consisting of compensation strategies 
(e.g., environmental modification such as the upright positioning for feeding), safe 
swallowing advice, and appropriate dietary modification, three times per week for a 
month or standard high-intensity intervention (n = 102) comprising direct swallow-
ing exercises and appropriate dietary modification, every working day for a month. 
A significant reduction in swallowing-related medical complications (RR = 0.73, 
95% CI: 0.6 to 0.9), chest infection (RR = 0.56, 95% CI: 0.4 to 0.8), death or insti-
tutionalization (RR = 0.73, 95% CI: 0.55 to 0.97), and a significant increased pro-
portion of patients who recovered from swallowing (RR = 1.41, 95% CI: 1.03 to 
1.94) were verified in the standard intervention compared to the usual care. Further, 
a dose–response relation was also apparent with improved recovery of swallowing 
function and less chest infection in patients receiving intensive standard swallowing 
therapy compared to less intensive standard therapy and usual care.
One systematic review including 15 RCTs with a broad range of swallowing 
treatment demonstrated that the general dysphagia treatment programs were related 
with a less risk of pneumonia in patients with acute stroke (Foley et al. 2008). In a 
Cochrane systematic review including five studies with behavioral interventions 
(n = 423) consisting of swallowing exercise, environment modifications, and appro-
priate dietary modification, behavioral interventions reduced the dysphagia at the 
end of trial (t = 5; n = 423; OR = 0.52; 95% CI: 0.30 to 0.88); in addition, a nonsig-
nificant reduction in chest infection/pneumonia was noted (t = 5; n = 423; OR 0.50; 
95% CI 0.24 to 1.04; I2 = 34%; P = 0.06), but not for case fatality (t = 2; n = 306; 
OR 0.83; 95% CI 0.46 to 1.51) or institutionalization (t = 2; n = 306; OR 0.76; 95% 
CI 0.39 to 1.48) (Geeganage et al. 2012). Risk of bias assessment indicated a con-
siderable proportion of unclear or high risk of bias of included studies.
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Recommendation: Dysphagia treatment program including behavioral interven-
tions should be provided for the dysphagia patients after stroke to prevent dysphagia- 
related complications and to recover the swallowing (CEBM classification: level 1, 
GRADE quality: moderate, recommendation grade: B+).
4.2  Neuromuscular Electrical Stimulation (NMES)
One systematic review investigated the effect of NMES on the post-stroke dyspha-
gia (Chen et al. 2016). Six RCTs involving 243 patients with stroke were included 
for meta-analysis to compare the effect of swallowing treatment with NMES and 
swallowing treatment without NMES. Swallowing treatment with NMES showed 
better recovery immediately after the intervention than the swallowing treatment 
without NMES, with a significant standardized difference of 1.27 (95% CI: 0.51 to 
2.02). However, the outcome measures used and the results in included studies were 
heterogeneous (I2 = 85%) and long-term effect could not be analyzed. A subgroup 
analysis suggested that both patients with acute/subacute and with chronic stroke 
might benefit. Treatment regimens varied with 20- to 60-min sessions applied 3 to 
5 days per week for 2 to 4 weeks. A recent randomized controlled trial in subacute 
stroke patients (n  =  162) with dysphagia (penetration aspiration score (PAS) in 
VFSS ≥3) demonstrated no significant effect of NMES for three consecutive days 
compared to the sham NMES (Bath et  al. 2016). The mean treatment current of 
NMES was 14.8 ± 7.9 mA and duration was 9.9 ± 1.2 min per session, which may 
be a suboptimal stimulation level. In another recent RCT, 82 patients with dyspha-
gia after acute medullary infarction were allocated to three intervention groups: 
traditional swallowing treatment, swallowing treatment with NMES of sensory 
approach, and swallowing treatment with NMES of motor approach. NMES were 
for 20 min, twice a day, for 5 days/week, over a 4-week period (Zhang et al. 2016). 
Both sensory and motor NMES with traditional swallowing treatment showed sig-
nificantly greater improvement than the traditional swallowing treatment alone, and 
sensory NMES showed better improvement than the motor NMES.
Recommendation: NMES can be used to improve the swallowing function in 
patients with dysphagia after stroke, combined with a traditional swallowing treat-
ment program including behavioral interventions (CEBM classification: level 1, 
GRADE quality: low, recommendation grade: 0).
4.3  Acupuncture
Acupuncture has been used as a complementary intervention for stroke recovery in 
some countries, although its mechanism of action is unclear (Zhang et al. 2014). In a 
recent Cochrane review, four acupuncture RCTs involving 256 patients were included 
for the meta-analysis with the outcome of dysphagia at the end of trial, which showed 
the significant favorable effect (OR = 0.24, 95% CI: 0.13 to 0.46) (Geeganage et al. 
2012). In a recent systematic review, efficacy of acupuncture was analyzed with the 
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pooling data from 71 RCTs involving 6010 patients, which showed the superior effect 
over the control (RR = 1.17, 95% CI: 1.13 to 1.21) (Ye et al. 2017). Although, the 
pooled effect from these meta-analyses showed the positive effect of acupuncture for 
the swallowing recovery after stroke, most of the included RCTs in the systematic 
review by Ye et al. were conducted with small sample sizes and risk of bias (i.e., detec-
tion, performance, attrition and reporting bias) was high or unclear for most of the 
studies included (Ye et al. 2017). In addition, the included RCTs may have been con-
founded due to the use of routine acupuncture or a different type of acupuncture as 
control and the variations in the delivery of therapy (Geeganage et al. 2012).
Recommendation: Acupuncture can be considered to treat post-stroke dyspha-
gia. (CEBM classification: level 1, GRADE quality: low, recommendation grade: 0).
4.4  Noninvasive Brain Stimulation (NIBS)
Recovery of swallowing after stroke is associated with the reorganization of the 
swallowing motor cortex (Hamdy et al. 2000). NIBS, such as repetitive transcranial 
magnetic stimulation (rTMS) or transcranial direct current stimulation (tDCS), is 
expected to modulate the swallowing motor cortex reorganization. Traditionally, the 
concept of interhemispheric rivalry is applied to decide the stimulation site or 
parameters for NIBS after stroke (Hummel and Cohen 2006) but stimulating either 
hemisphere can theoretically improve the swallowing because the swallowing mus-
culature is dually innervated by both hemispheres (Hamdy et al. 1996). In recent 
years, the number of clinical trials investigating the effect of NIBS on post-stroke 
dysphagia has increased. One recent meta-analysis and systematic review including 
six RCTs (three rTMS and three tDCS studies) demonstrated that NIBS showed 
significant improvement of dysphagia compared with the sham stimulation (stan-
dardized mean difference = 1.08, 95% CI: 0.29 to 1.88) (Yang et al. 2015). In a 
subgroup analysis, only rTMS showed significant beneficial effect and no statisti-
cally significant difference was found between the stimulation sites (ipsilesional vs. 
contralesional). No complications of NIBS were reported in these studies. Another 
systematic review included seven RCTs (four rTMS and three tDCS studies) 
(Pisegna et al. 2016). A pooled analysis of eight studies showed a significant, mod-
erate pooled effect size (0.55, 95% CI: 0.17 to 0.93). Studies stimulating the contral-
esional hemisphere showed numerically a somewhat bigger effect size (0.65, 95% 
CI: 0.14 to 1.16) than that of studies stimulating ipsilesional hemisphere (0.46, 95% 
CI: 0.17 to 0.93). The long-term effect with pooled analysis of three studies was not 
statistically significant. A very recent systematic review including only six RCTs 
with a total of 163 acute and subacute stroke patients with dysphagia investigating 
rTMS effect showed a significant effect size of 1.24 (95% CI: 0.67 to 1.81) for dys-
phagia outcome and effect was maintained until 4 weeks after the last session of 
rTMS (Liao et  al. 2017). In a subgroup analysis, both high (SMD  =  1.38, 95% 
CI = 0.47 to 2.29) and low frequency stimulation (SMD = 1.02, 95% CI = 0.51 to 
1.53) were significantly effective. Stimulating the contralesional (SMD = 0.91, 95% 
CI = 0.48 to 1.35) or bilateral hemisphere (SMD = 1.60, 95% CI = 0.57 to 2.63) was 
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effective but ipsilesional stimulation yielded more variable effects and therefore 
was not significantly effective (SMD = 1.59, 95% CI = −0.14 to 3.31) in a subgroup 
analysis. Based on these recent systematic reviews and meta-analyses, NIBS in the 
form of rTMS may be effective on post-stroke dysphagia early after stroke (within 
3 months), but the included studies were heterogeneous in terms of stimulation site, 
mode of stimulation and outcomes, which requires further well-designed clinical 
trials with larger sample sizes. As a note of caution, international safety standards 
(Rossi et al. 2009), individual exclusion criteria for rTMS, and medico-legal aspects 
related to the rTMS device used all need to be taken into consideration.
Recommendation: rTMS can be considered to treat post-stroke dysphagia by the 
clinical expert in this field as an additional treatment modality to the traditional 
swallowing treatment, especially within 3 months post-stroke (CEBM classifica-
tion: level 1, GRADE quality: low, recommendation grade: 0).
4.5  Oral Hygiene
Bacterial species colonized in the oral cavity has been suggested as one of the 
important sources of pathogens for respiratory infections (Scannapieco et al. 2003). 
Patients with stroke may have poor oral hygiene due to the limitation of basic activi-
ties of daily living. One systematic review included four RCTs to investigate the 
effect of oral hygiene on pneumonia or respiratory tract infection in elderly people 
living in the institutions and reported positive preventive effects of oral hygiene on 
pneumonia and respiratory tract infection with absolute risk reductions from 6.6% 
to 11.7% (Sjögren et al. 2008). A prospective-controlled trial allocated patients with 
acute stroke to three groups: intervention (dysphagia screening with Gugging 
Swallowing Screen and intensified oral hygiene, n  =  58), internal (n  =  58), and 
external control groups (clinical dysphagia screening plus usual care) (n  =  30) 
(Sørensen et al. 2013). The incidence of X-ray verified pneumonia was significantly 
lower in the intervention group (7%), compared with internal (28%) or external 
control groups (27%). A recent pre- to post-intervention (oral hygiene care) trial 
with the historical control (n = 707 in the historical control, n = 949 in the interven-
tion group) in hospitalized patients with acute stroke demonstrated that the oral 
hygiene care significantly reduced the hospital-acquired pneumonia after adjusting 
for possible confounders (OR = 0.71, 95% CI: 0.51 to 0.98) (Wagner et al. 2016).
Recommendations: Oral hygiene care should be implemented to reduce the risk 
of pneumonia after stroke (CEBM classification: level 2, GRADE quality: moder-
ate, recommendation grade: B+).
5  Enteral Tube Feedings
In stroke patients with dysphagia who cannot eat orally safely, enteral tube feed-
ing is often required to provide enough nutrition for short or prolonged periods 
after stroke. Therefore, the decision on timing and maintenance of enteral feeding 
Recovery of Swallowing
92
and type of enteral feeding (e.g., nasogastric tube or percutaneous gastrostomy) is 
important. In the well-designed, large sample-sized pragmatic multicenter ran-
domized controlled trial, Feed or Ordinary Diet (FOOD) trials, the effect of tim-
ing and method of enteral tube feeding for stroke patients with dysphagia was 
investigated (Dennis et al. 2005). Dysphagic patients early after stroke who were 
uncertain when to start enteral tube feeding by the clinician were randomly 
assigned to early enteral tube feeding (n = 429) or avoidance of enteral tube feed-
ing for more than 7 days (n = 428). Although it was not statistically significant, 
early enteral tube feeding showed the trend of reduction in risk of death of 5.8% 
(95% CI: −0.8 to 12.5), but not for death or poor outcome (modified Rankin scale 
4 or 5) of 1.2% (−4.2 to 6.6). In the same trial, 321 dysphagic patients who require 
enteral feeding by the clinician’s decision were randomly allocated to early per-
cutaneous gastrostomy (n = 162) or nasogastric tube (n = 159). Early percutane-
ous gastrostomy showed the trend of increase in death or poor outcome of 7.8% 
(95% CI: 0.0 to 15.5), but not for risk of death alone, i.e., 1.0%, 95% CI: −10.0 to 
11.9. Therefore, early gastrostomy cannot be advocated based on this study. In a 
recent Cochrane systematic review including a small number of studies with small 
number of total subjects for the pooled analysis, gastrostomy showed better results 
compared with nasogastric tube feeding, in terms of treatment failure, feed deliv-
ery, and albumin concentration (Geeganage et al. 2012). Therefore, if oral intake 
is not possible after stroke for a prolonged period, it is reasonable to change the 
nasogastric tube feeding to tube feeding via gastrostomy. Individual factors are 
also taken into consideration, e.g., a nasogastric tube vs. percutaneous can create 
a different degree of discomfort for individuals and their family, and some indi-
viduals are more prone to risk for accidental nasogastric tube displacement and 
hence aspiration.
Recommendation: Early enteral tube feeding should be implemented in stroke 
patients with dysphagia who cannot swallow safely and intake sufficient nutrition 
orally. (CEBM classification: level 1, GRADE quality: moderate, recommendation 
grade: B+). Early gastrostomy within 4 weeks after stroke does not have to be pri-
oritized over nasogastric tube feeding, unless there is a mandatory reason for percu-
taneous gastrostomy (CEBM classification: level 1, GRADE quality: low, 
recommendation grade: 0). Percutaneous gastrostomy placement should be consid-
ered in stroke patients with dysphagia who require enteral tube feeding for a pro-
longed period (more than 4 weeks) (CEBM classification: level 1, GRADE quality: 
moderate, recommendation grade: B+).
6  Summary
A decision tree for the rehabilitation of swallowing after acute stroke is suggested 
in Fig. 1.
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scopic swallowing study, FEES fiberoptic endoscopic evaluation of swallowing, NMES neuromus-
cular electrical stimulation, rTMS repetitive transcranial magnetic stimulation
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1  Introduction
Stroke is the leading cause of long-term disability among adults. Even with appro-
priate acute care and neurorehabilitation, recovery of motor function after stroke is 
usually incomplete (Ward and Cohen 2004). More than 60% of stroke survivors 
suffer from persistent neurological deficits with impaired motor function compro-
mising their independence with activities of daily living (Feigin et al. 2003; Levin 
et al. 2009). Motor function of the affected arm can explain up to 50% of the vari-
ance in functional autonomy in stroke patients (Mercier et al. 2001). Further, both 
arm impairment (i.e. the ability to move the arm and its segments selectively) and 
arm activities (i.e. the ability to handle objects successfully) as assessed at discharge 
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from rehabilitation are associated with the level of activity and participation 
6 months later, that is, the degree of difficulty and help needed in daily life and 
instrumental activities, and in social roles (Desrosiers et al. 2003).
Thus, arm paresis after stroke and its therapeutic management is a key element of 
stroke rehabilitation. Treatment of arm paresis has been ranked among the top ten 
research priorities relating to life after stroke by stroke survivors, caregivers, and 
health professionals (Pollock et al. 2014a). A wide variety of therapeutic interven-
tions exist that aim to improve arm impairment, activity limitations, and the amount 
of actual use of the affected arm in daily life (Pollock et al. 2014b). Therapeutic deci-
sions need to be individualized based on factors such as individual therapeutic goals, 
time post-stroke, and severity of paresis. Indeed, arm paresis after stroke shows a 
bimodal distribution: there are many people with either mild or severe arm activity 
limitations, but fewer with moderate activity limitations (Nakayama et al. 1994). And 
the course and expected level of recovery are different for patients with more or less 
profound arm paresis initially after stroke (Kwah and Herbert 2016). Therefore, sub-
groups with different severity of arm paresis do have different therapeutic needs.
Based on a systematic search of the best evidence available, i.e. randomized 
controlled trials (RCTs) and systematic reviews (SRs), with or without meta- 
analysis, and their critical appraisal, a best evidence synthesis was performed for 
treatment of arm paresis post-stroke, and clinical practice recommendations are 
given based on this synthesis.
2  Methods for the Best Evidence Synthesis
 Within the framework of stroke rehabilitation guideline development of the German 
neurorehabilitation society (DGNR) (Platz 2017), systematic PubMed searches for 
RCTs and SRs addressing rehabilitative therapy for arm paresis after stroke had 
been performed in 2006, 2013, 2016, and on 23.07.2017 (PubMed and Cochrane 
Library). Search terms had been (((Cerebrovascular Accident OR Stroke OR cere-
brovascular disorders)) AND (Upper Extremity OR arm)) AND (Rehabilitation 
OR Physical Therapy Modalities OR Biofeedback OR Durable Medical Equipment 
OR Occupational therapy OR exercise therapy OR physiotherapy OR therapy); 
few additional reports (3 SRs, 1 RCT) were included based on hand search. 
Retrieved abstracts and, if necessary, full-text references were checked for defined 
eligibility criteria by two independent raters and any disagreement was resolved by 
a third author. Overall, a total of 411 RCT and 114 SR reports were eligible and 
selected for the best evidence synthesis provided below. The following steps were 
taken from critical appraisal of evidence to the provision of recommendations 
(Chap. 2):
 I. For each included source (original paper, systematic review), the following was 
performed:
 1. Standardized evaluation of the methodology (internal validity with regard to 
study design issues and risk of bias).
 2. Classification of evidence level (1a to 5 according to the “Oxford Center for 
Evidence-Based Medicine—Levels of Evidence”, last version from March 




 3. summarizing the results, conclusions, and deriving recommendations as 
applicable to the individual source,
 II. Based on data from all sources on a specific therapy method (across original 
papers, systematic reviews, and meta-analyses), the following steps were taken:
 4. rating the overall quality of evidence of the sources included and thereby the 
confidence in the estimation of the effect strength (of a therapy) and,
 5. provision of graded recommendations.
The quality of evidence is grouped into four categories according to the 
“GRADE” system (“Grades of Recommendation, Assessment, Development and 
Evaluation, GRADE”, www.gradeworkinggroup.org) (Schünemann et al. 2013):
• High quality: further research is unlikely to affect our confidence in the estima-
tion of the (therapeutic) effect or prognosis.
• Medium quality: further research is likely to affect our confidence in the estima-
tion of the (therapeutic) effect or prognosis and may alter the estimate.
• Low quality: further research will most likely influence our confidence in the esti-
mation of the (therapeutic) effect or prognosis and will probably change the estimate.
• Very low quality: any estimation of the (therapy) effect or prognosis is very 
uncertain.
The grading of the recommendations according to GRADE (Schünemann et al. 
2013) corresponds to the categories “ought to” (A) (strong recommendation) and 
“should” (B) (weak recommendation); for the purpose of this practice recommendation 
project, we added the category “can” (0) (option) (Platz 2017; Chap. 2). Recommendation 
category A is granted for clinically effective interventions with high-quality evidence 
support; with medium-quality evidence category B; and with low- or very low- quality 
evidence category 0 can be appropriate. Grading of recommendations is based on both 
quality of evidence including risk of bias, imprecision or heterogeneity of results, publi-
cation bias and other relevant factors for clinical decision- making such as clinical rele-
vance of the approach, effect sizes reported, the benefit-risk ratio, scientific plausibility, 
and ease to transfer an approach to routine clinical practice.
3  Assessment
A systematic Cochrane overview performed a data synthesis across all Cochrane 
reviews for interventions targeting upper limb function after stroke. It describes a 
large variety of assessment tools for arm/hand impairment and function (activity 
limitations) (Pollock et al. 2014b). Some of the more frequently used measures that 
can be considered as valid, reliable, and with a clinically important focus are pre-
sented below. An indication is given whether the tests can be used for patients with 
mild, moderate, or severe arm paresis. These measures can be recommended for 
clinical use when the construct measured is of importance for clinical assessment, 
monitoring, or decision-making. It should be noted that no single measure is right 
or wrong, but has its role depending on the specific intention for assessment.
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3.1  Measures of Impairment
3.1.1  Active Motor Control
• Fugl-Meyer Assessment of Sensorimotor Recovery after Stroke (upper limb sec-
tion) (FM Arm) (Fugl-Meyer et al. 1975) (mild-to-severe paresis).
• Wolf Motor Function Test (WMFT) (Wolf et al. 2001) (mild-to-moderate paresis).
• Rivermead Motor Assessment, arm section (RMA arm) (Lincoln and Leadbetter 
1979) (mild-to-severe paresis).
• Motricity Index (MI) (Demeurisse et al. 1980) (mild-to-severe paresis).
• Dynamometer scores (including Jamar) (Bohannon 1997) (mild-to-moderate paresis).
The arm section of the Fugl-Meyer test is among the most widely used assess-
ments in post-stroke rehabilitation research; it measures selective motion capacity 
with its motor subscale (range 0–66), somatosensory function (range 0–24), and 
passive joint motion/pain (range 0–44). Individual items are ordinally scaled (0–2). 
The Wolf Motor function test includes selective movement tasks and handling 
object tasks, each item ordinally scaled (0–5). In addition, time to complete tasks is 
measured. The Rivermead Motor Assessment arm section has 15 movement tasks 
with dichotomous evaluation. It is a hierarchical test (range 0–38). The Motricity 
Index is a simple three-item measure of degree of arm paresis (range 1–100); it is 
based on a weighted grading of MRC strength grades (Medical Research Council 
1975). Dynamometer measure strength for a given movement, e.g. grip, numerically.
3.1.2  Spasticity/Resistance to Passive Movement
Ashworth Scale (AS) (Ashworth 1964), or Modified Ashworth Scale (MAS) 
(Bohannon and Smith 1987) or Resistance to Passive movement Scale (REPAS) 
(Platz et al. 2008).
Spasticity as clinically assessed with resistance to passive joint movements has 
most frequently been measured with the ordinally scaled Ashworth or Modified 
Ashworth Scale (range 0–4). The REPAS is a summary rating scale across joints 
based on the Ashworth scale and provides detailed instructions for performance and 
scoring to support reliability.
3.2  Measures of Arm, Hand, and/or Finger Function
• Action Research Arm Test (ARAT) (Lyle 1981) (mild-to-moderate paresis).
• Box and Block Test (BBT) (Desrosiers et al. 1994) (mild-to-moderate paresis).
• Nine-Hole Peg Test (NHPT) (Kellor et al. 1971) (mild paresis).
• Wolf Motor Function Test (WMFT) (Wolf et al. 2001) (mild-to-moderate paresis).
The ARAT is a hierarchical assessment of the ability to grasp, handle, and trans-
port larger and smaller objects with different grips, which consists of four subtests 
and a total of 19 tasks (score ranges from 0 to 57). It has widely been used in stroke 
rehabilitation research. The BBT is a measure of manual dexterity. The number of 
one-inch cubes grasped and transported from one compartment of a box to the 
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adjacent compartment within 1 min is measured. The NHPT measures finger dex-
terity by the time needed to grasp and place nine pegs in their holes.
3.3  Measure of Self-Perceived Usefulness of the Affected Arm 
in Daily Life
• Motor Activity Log, MAL (Taub et al. 1993) (mild-to-moderate paresis).
The MAL is a structured interview intended to examine how much and how well 
people use their more-affected arm outside of the laboratory setting. Participants are 
asked standardized questions about the amount of use of their more-affected arm 
(amount of use, AOU) and the quality of their movement (QOM) during the 30 dif-
ferent functional activities indicated. Each item and subscale are rated between 0 
(not used) and 5 (as before stroke) with half scores when indicated, i.e. 0.5, 4.5.
4  Therapy
The best evidence synthesis was grouped in the following sections: training, 
technology- supported training, and medication. Only a selection of relevant refer-
ences has been cited. The complete list of references is presented online (www.
clinical-pathways.org) for further information.
4.1  Training
A large variety of training strategies without the need for specific technical support 
is available for stroke survivors with arm paresis.
4.1.1  Dosage of the Therapeutic Time Prescribed 
and Organizational Forms of Therapy
A simple dose–response relationship does not exist for arm rehabilitation. In addi-
tion, it seems that a dedicated active arm motor training is a prerequisite to achieve 
further improvements when dosages are increased. Such a training provided for 2.5 h 
(Kwakkel et al. 1999) to 4–5 h (Winstein et al. 2004) per week over 4–20 weeks can 
accelerate arm motor recovery in the acute and subacute phase post-stroke. Two 
hours of training per week (Sehatzadeh 2015) or a total of more than 15 h of training 
seem to be necessary to achieve measurable effects on arm motor recovery (Pollock 
et al. 2014). Increasing therapy time up to 2 or 3 h per day has been shown to gener-
ate an additional benefit in the subacute phase post- stroke (Han et  al. 2013). 
Improvement in the chronic phase was demonstrated after prolonged specific active 
motor training of ≥3 h per week (Cauraugh et al. 2011; Corti et al. 2012), while that 
was not the case for more passive “mobilization and tactile stimulation” therapy 
(Hunter et al. 2011). Of note, there was no significant effect for additional time spent 
in exercise therapy for very high intensity (6 h per day) vs. moderately high intensity 
(up to 3 h per day) constraint-induced movement therapy (Kwakkel et al. 2015).
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Aside from one-to-one therapy, treatment can be organized as arm rehabilitation 
circuit training (Blennerhassett and Dite 2004; Pang et al. 2006) or as supervised 
home training (e.g. Harris et al. 2009; Almhdawi et al. 2016). For the latter, dedi-
cated manuals for patients with mild, moderate, or severe paresis with repetitive 
impairment- and activity-oriented training seem to support therapeutic success in 
the subacute phase and client-centred individualized functional goal-oriented prac-
tice in the chronic phase.
An alternative form of organizing rehabilitation service is telerehabilitation that 
with limited evidence has been shown to be feasible (Wolf et al. 2015) and equally 
effective as institution-based arm therapy (Laver et al. 2013). Caregiver-mediated 
exercises have not been shown to be beneficial for arm rehabilitation post-stroke 
(Vloothuis et al. 2016).
In case an individual has very poor predicted recovery (complete arm paralysis 
with diagnosed severe corticospinal tract damage; i.e. loss of motor evoked poten-
tials (MEP) with transcranial magnetic stimulation (TMS), posterior limb of inter-
nal capsule damage on MRI diffusion tensor imaging (DTI)), a therapeutic focus on 
prevention of secondary complications (only) for the plegic arm and teaching com-
pensatory strategies already early after stroke can be effective and show little risk to 
miss out a recovery potential (Stinear et al. 2017).
4.1.2  “Schools” of Therapy
Bobath therapy (neurodevelopmental therapy, NDT) and other “schools” of therapy 
have not been shown to specifically support arm motor recovery post-stroke 
(Langhorne et al. 2009).
4.1.3  Type of Feedback Given
Extrinsic feedback has its role in clinical practice. Proof of clinical effectiveness is, 
however, rather limited (e.g. Israely and Carmeli 2016).
4.1.4  Bilateral Training
Quite a few RCTs compared bilateral to unilateral training approaches. Overall, 
equivocal or inferior benefits after bilateral training were reported. Among mildly 
affected chronic stroke survivors, activities and actual amount of use were better 
promoted with unilateral training: a Cochrane review (Pollock et al. 2014) indicated 
better arm function (6 trials, 375 participants; standardized mean difference, SMD 
0.20, 95% confidence interval, 95% CI 0.00 to 0.41) and ADL improvement (3 tri-
als, n = 146) after unilateral compared to bilateral training. Effects at impairment 
level had been comparable (4 trials, n = 228).
When repetitive bilateral symmetrical active–passive movements were, however, 
used as priming before active rehabilitation of the affected limb, recovery could be 
accelerated in subacute stroke patients (Stinear et al. 2014).
4.1.5  Impairment-Oriented Training
One single-centre (n = 60) and two multicentre RCTs (n = 60 and n = 148, resp.) 
demonstrated a superior effect of the impairment-oriented arm training, i.e. the arm 
basis training for severe arm paresis and the arm ability training for mild arm 
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paresis. The arm basis training had a bigger effect on selective motion capacity (FM 
Arm) with incomplete severe arm paresis compared to therapeutic time equivalent 
control therapies, i.e. Bobath therapy or “best conventional” therapy (Platz et al. 
2005; Platz et al. 2009). The graded training enhances selective motion capacities 
by a systematic repetitive training of individual joint motions without gravity influ-
ence to start with, with gravity influence next, and finally multi-joint movements in 
a progressive training scheme. The arm ability training improved sensorimotor effi-
ciency with arm activities (TEMPA; Desrosiers et al. 1993) with a long-term effect 
(Platz et al. 2001) and superiority compared to therapeutic time-equivalent “best 
conventional” therapy (Platz et al. 2009). It specifically trains speed and accuracy of 
abilities such as fast finger movements, aiming, visuomotor tracking, steadiness, 
and dexterity as well as endurance. Taken together, the training techniques provide 
a comprehensive modular approach for arm paresis after stroke with a moderate 
differential beneficial effect compared to an active control arm therapy of the same 
therapeutic time (SMD 0.47, 95% CI 0.12 to 0.81; two studies, number of partici-
pants analyzed by individual patient data meta-analysis = 135) (Platz et al. 2015/in 
preparation).
4.1.6  Task-Specific Training
Task-specific training where training tasks resemble an activity received substantial 
attention in RCTs with variable results, mostly indicating no or a comparable effect to 
control therapies both for subacute and chronic patients and a lack of dose–response 
relationship. A Cochrane review summarized that there is low-quality evidence that 
repetitive task training (RTT) improves arm function (SMD 0.25, 95% CI 0.01 to 
0.49; 11 studies, number of participants analyzed = 749), hand function (SMD 0.25, 
95% CI 0.00 to 0.51; eight studies, number of participants analyzed = 619) with sig-
nificant differences between groups up to 6 months post- treatment (SMD 0.92, 95% 
CI 0.58 to 1.26; three studies, number of participants analyzed = 153), but not after 
6 months; effects were not modified by intervention type, dosage of task practice, or 
time post-stroke and were no longer significant when studies with high or unclear risk 
of bias were removed from the meta-analysis (French et al. 2016).
A stronger benefit had been substantiated in one RCT included in the meta- 
analysis where patients received training tasks that resemble a meaningful activity 
while the therapist nevertheless focused on motor control issues (impairment level) 
as therapeutic target (Arya et al. 2012). This was similarly demonstrated for task- 
oriented mirror therapy (Arya et al. 2015).
4.1.7  Constraint-Induced Movement Therapy (CIMT)
The constraint-induced movement therapy (CIMT) is a response to the observed 
behaviour that some stroke survivors who suffer from arm paresis learn to cope with 
their non-affected arm. Even when their affected arm recovers, the learnt non-use 
behaviour persists. The psychologist Edward Taub, Ph.D. provided a therapeutic 
approach that reverses the learnt non-use behaviour by restraint of the non-affected 
arm and massed practice of the affected arm with gradual increase of motor chal-
lenges, i.e. “shaping” (Taub et al. 1993). The original CIMT includes 6 h of “shap-
ing” as one-to-one therapy and 90% of waking hours restraint of the non-affected 
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arm. Modified versions, i.e. mCIMT, use up to 3 h therapy sessions with massed 
practice and less than 90% of waking hours restraint (if any), e.g. a couple of hours 
per day. The approach (CIMT and mCIMT) is suitable for individuals with learnt 
non-use and only moderate arm paresis with some preserved hand function and no 
severe pain or spasticity problem in their affected arm.
CIMT is the arm rehabilitation technique with the broadest evidence base includ-
ing >50 RCTs and many systematic reviews.
A Cochrane review (Corbetta et al. 2015) (systematic search up to January 2015) 
with 42 RCTs (1453 participants) and 40 RCTs being used for meta-analysis 
assessed effects of CIMT and mCIMT or “Forced Use, FU” (restraint only) com-
pared to different control interventions. A high risk for bias by small trials was noted.
Immediate post-training effects were non-significant for ADL activities 
(Functional Independence Measure, FIM or Barthel Index, BI; 11 studies, 344 par-
ticipants; SMD 0.24, 95% CI −0.05 to 0.52). A small significant effect on arm 
motor function (ARAT, WMFT, Emory Motor Function Test, Manual Function 
Test, RMA; 28 studies, 858 participants; SMD 0.34, 95% CI 0.12 to 0.55) was 
documented. A moderate significant effect was found for dexterity (Peg Tests, 
BBT; 4 studies, 113 participants; SMD 0.42, 95% CI 0.04 to 0.79), a significant 
effect on perceived arm motor function (MAL quality of movement, 24 studies, 
891 participants; +0.68 points, 95% CI 0.47 to 0.88; MAL amount of use, 23 stud-
ies, 851 participants; +0.79 points, 95% CI 0.50 to 1.08), a moderate to large sta-
tistically significant effect on arm motor impairment (FM arm, Chedoke McMaster 
Impairment Inventory, grip strength, isometric strength; 16 studies, 372 partici-
pants; SMD 0.82, 95% CI 0.31 to 1.34), and a non-significant effect on quality of 
life, QoL (SIS, 3 studies, 96 participants; mean difference, MD +6,54 points, 95% 
CI −1.2 to 14.28). Three studies involving 125 participants explored disability 
after a few months of follow-up and found no significant difference (FIM or BI; 
SMD −0.20, 95% CI −0.57 to 0.16), yet numerically in favour of conventional 
treatment.
Overall, small effects on arm motor function and perceived arm motor function, 
moderate effects on dexterity, and larger effects on arm motor impairment could be 
substantiated after training, while effects on disability and QoL remained non- 
significant; evidence for long-term effects is rather limited.
Time post-stroke and type of CIMT (mCIMT vs. CIMT) seem not to be critical 
factors for its effectiveness (Kwakkel et al. 2015) with the exception that early after 
stroke mCIMT seems preferable over CIMT (Nijland et al. 2011).
A restraint outside therapeutic sessions promotes actual amount of use (only) 
when combined with a “transfer package”, i.e. an individualized critical reflection 
of “obstacles” to use the affected arm in daily life and how to overcome them indi-
vidually (Taub et al. 2013).
4.1.8  Strength Training
Strengthening exercises, at least when offered as one component of training, were 
shown to have a positive effect on grip strength (SMD 0.97, 95% CI 0.05 to 1.85; 6 
studies, 306 participants) and arm function (SMD 0.21, 95% CI 0.03 to 0.39; 11 
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studies, 465 participants), but not on disability (ADL) for patients with (mild to) 
moderate arm paresis (subacute and chronic phase) as indicated by a systematic 
review (Harris and Eng 2010).
In a large multicentre RCT recruiting acute/subacute stroke patients with signifi-
cant, yet incomplete arm paresis (288 participants, 2 to 60 days post-stroke) received 
up to 1.5 h daily training for 6 weeks either as functional strength training (FST) or 
movement performance therapy (MPT), each combined with conventional therapy. 
FST consisted of progressive resistive exercise during functional tasks and MPT of 
“hands on” guidance for smooth and accurate movements. No significant intergroup 
differences were observed at the end of intervention (ARAT, WMFT, hand and 
pinch grip force) (Pomeroy et al. 2018).
4.1.9  Mirror Therapy
During mirror therapy a patient performs certain movements with their non-affected 
arm while looking into a mirror. The mirror is placed in the patient’s midsagittal 
plane and therefore reflects the non-paretic side as if it were the affected side that 
moves. It is assumed that by the virtual visual image of the normally moving affected 
arm, the brain network subserving its control is activated. If this therapy is per-
formed for about 30 min every day for several weeks, motor function has improved 
and disability reduced in both subacute and chronic phases.
A Cochrane review (Thieme et al. 2018) included 62 studies (ten studies address-
ing the lower limb) with a total of 1982 participants that compared mirror therapy 
with other interventions. When compared with all other interventions, mirror ther-
apy for the arm had a significant effect on motor function (activity level) (post- 
intervention data: SMD 0.46, 95% CI 0.23 to 0.69; 31 studies, 1048 participants). In 
addition, mirror therapy improved the capability for selective movements (post- 
intervention data: FM, arm motor score MD 4.32, 95% CI 2.46 to 6.19; 28 studies, 
898 participants). The authors found a significant positive effect on pain (SMD 
−1.10; 95% CI −2.10 to −0.09) which is influenced by patient population and a 
non-significant positive effect on visuospatial neglect (SMD 1.06; 95% CI −0.10 to 
2.23). The effects on motor function could not be substantiated at follow-up assess-
ment after 6 months. The therapeutic effects on motor function were statistically 
significant when mirror therapy was compared with a sham intervention where the 
affected arm was invisible, but not when it could be seen.
Therefore, mirror therapy could be applied as an additional intervention in the 
rehabilitation of patients after stroke. This includes supervised training, including 
home training for selected patients with a high degree of compliance (Tyson et al. 
2015). It is still unclear whether mirror therapy can replace other interventions for 
improving motor function of the arm. It might especially be suitable as additional 
training for patients with more severe arm paresis who could not train their affected 
arm actively by themselves.
4.1.10  Mental Practice
During mental practice (MP) a subject repeatedly mentally rehearses an action or 
task without physically performing it. In rehabilitation trials, MP was typically used 
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after an actual training session with the paretic arm, ranging from twice a week to 
daily sessions, each lasting 10 to 60 min for 3–10 weeks.
According to two Cochrane reviews, MP in combination with other treatment 
appeared more effective in improving upper extremity (impairment and) activity 
than the other treatment alone (5 studies, 105 participants; SMD 1.37, 95% CI 0.60 
to 2.15; Barclay-Goddard et al. 2011; 7 studies, 197 participants; SMD 0.62, 95% 
CI 0.05 to 1.19; Pollock et al. 2014b). Effects on disability (ADL) were not substan-
tiated. Due to small numbers in each group, subgroup analyses based on time since 
stroke and dosage of MP were not feasible.
4.1.11  Action Observation
The evidence reviewed is too weak and inconsistent to serve as a basis for clinical 
practice recommendations.
4.1.12  Music Therapy and Rhythmic Auditory Stimulation
A Cochrane review (Magee et al. 2017) examined the effects of music interventions 
on upper extremity function. The review included nine studies with a total of 308 
participants and found no evidence of effect for music interventions for general 
upper extremity function, range of motion (shoulder flexion), hand function, upper 
limb strength, and manual dexterity; two studies indicated that music therapy 
improved timed performance somewhat.
Further, the addition of rhythmic auditory stimulation or rhythmic auditory cue-
ing with repetitive training of reaching movements might generate some benefit 
(Yoo and Kim 2016).
4.2  Technology-Supported Training
4.2.1  Passive Devices for Repetitive Arm and Hand Training
A variety of passive devices have been developed for repetitive practice in arm and 
hand rehabilitation. They include a “reha-slide” the “Bilateral Arm Training with 
Rhythmic Auditory Cueing, BATRAC”, an “Upper Limbs’ Encircling Motion, 
ULEM” apparatus, an arm ergometer (bidirectional hand cycle commonly used for 
upper body aerobic exercise), and hand orthoses that passively assist finger exten-
sion. The devices have been tested in a few RCTs with subacute and chronic stroke 
patients with moderate-to-severe arm paresis without big effects or superiority; they 
are an option, e.g. when integrated in a circuit class approach.
4.2.2 Trunk Restraint
Trunk restraint has been used when reaching movements are trained and accom-
panied by excess trunk movements as compensation for limited shoulder flexion. 
It has a moderate effect on reduction of upper extremity impairment (improve-
ment of FM Arm score) and increase of active shoulder flexion during reaching 
as shown for chronic stroke patients with (mild to) moderate upper extremity 
impairment (FM Arm: SMD 0.54, 95% CI 0.06 to 1.01; 3 trials with 71 
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participants; active shoulder flexion: SMD 0.45, 95% CI 0.11 to 0.79; 5 trials 
with 138 patients) (Wee et al. 2014).
4.2.3 Splints and Strapping
Using splints and other orthoses to immobilize joints, e.g. the wrist of the severely 
affected arm, or shoulder strapping (glenohumeral, sacapulo-thoracal) does not 
facilitate motor recovery (Veerbeek et al. 2014). It can have a positive therapeutic 
and prophylactic effect on pain of the joint treated (wrist orthosis and shoulder 
strapping) (Appel et al. 2014; Bürge et al. 2008).
4.2.4  Arm Rehabilitation Using Virtual Reality (VR) Applications
Both VR games using a commercially available gaming consoles and purpose-built 
VR-based rehabilitation systems have been used clinically and in clinical trials for 
arm rehabilitation post-stroke.
Laver et al. (2017) presented in an updated Cochrane review a meta-analysis, 
which indicated no differential effect on arm function and activities when compar-
ing virtual reality to conventional therapy (SMD 0.07, 95% CI −0.05 to 0.20; 22 
studies, 1038 participants, low-quality evidence). However, when virtual reality was 
used in addition to usual care (providing a higher dose of therapy for those in the 
intervention group), there was a statistically significant difference between groups 
in favour of VR (SMD 0.49, 95% CI 0.21 to 0.77; 10 studies, 210 participants, low- 
quality evidence). These results were mainly based on FM Arm scores (16 trials 
with 599 participants; MD 2.85, 95% CI 1.06 to 4.65). In subgroup analyses, benefi-
cial effects were corroborated for trials providing more than 15 h of intervention 
(trend) and when using a specialized rehabilitation training system rather than a 
commercially available gaming console; comparisons between subgroups were, 
however, not significant. Time after stroke and severity of arm paresis did not mod-
ify the effects significantly.
In one of these non-robot purpose-built VR intervention systems, the therapist’s 
arm movement with an object as shown in the VR (“end effector”-based training) 
has to be mimicked by a patient. The system provides both “knowledge of perfor-
mance” (quality of the arm movement) and “knowledge of result” (precision of the 
movement) based on movement tracking with an electromagnetic system. It has 
been tested in subacute to chronic stroke patients with mild-to-moderate arm paresis 
with 1 h VR training plus 1 h traditional arm training five times a week for 4 weeks 
compared to 2 h per day traditional training. This consistently showed some differ-
ential beneficial effect on selective motion capacity and disability (e.g. Kiper et al. 
2014). For subjects with more severe arm paresis, a system that integrates arm 
weight support can be used; the therapy is equally effective as time-equivalent con-
ventional therapy (e.g. Prange et al. 2015).
4.2.5  EMG- and Neuro-Biofeedback
Only low-quality evidence comparing EMG biofeedback with physiotherapy is 




Neurofeedback therapy activation of cerebral motor areas can either be used for 
direct feedback training, e.g. as target domain during motor imagery or as signal to 
induce electrical stimulation or robot-assisted movements of the paretic limb. Data 
from first clinical trials suggest that neurofeedback can have a therapeutic effect 
(e.g. Mihara et al. 2013; Ramos-Murguialday et al. 2013). Currently, the technology 
is seen as investigational.
4.2.6  Neuromuscular Electrical Stimulation (NMES)
NMES either can stimulate nerves and muscles cyclically independent of a person’s 
volition to move (cNMES) or triggered by an EMG signal induced by voluntary 
muscle activity (EMG-triggered NMES, EMG-NMES), controlled by voluntary 
movements of the non-affected side (“contralaterally controlled FES, CCFES”) or 
can be used within a functional task as functional electrical stimulation, FES, e.g. 
when single- or multi-channel NMES is used for grasp and release activities.
License and restrictions for use need to be considered for each device used as 
provided by its manufacturer.
Veerbeek et  al. 2014 have carried out a series of meta-analyses of RCT data 
related to electrical stimulation (49 RCTs, n  =  1521).
Their meta-analyses indicated that cNMES of wrist and finger flexors and exten-
sors (22 trials, 894 participants) (but not cNMES of wrist and finger extensors) 
improved selective movement capacity (modified FM Arm: SMD 0.91, 95% CI 0.29 
to 1.53; 41 participants) and hand function (Jebsen-Taylor hand function test, 
JTHFT: SMD 0.88, 95% CI 0.05 to 1.71; 23 participants), but not arm-hand activi-
ties. EMG-NMES of wrist and finger extensors (25 trials, 492 participants) improved 
active range of motion (SMD 1.16, 95% CI 0.28 to 2.03; 61 participants), selective 
movements (FM Arm, Chedoke-McMaster stroke assessment, CMMSA: SMD 
0.58, 95% CI 0.04 to 1.12; 49 participants), arm-hand activities (ARAT, BBT, 
JTHFT, 10CMT (10-cup moving test), and FTHUE (Functional test for the hemiple-
gic upper extremity: SMD 0.72, 95% CI 0.41 to 1.03; 162 participants), but had no 
significant effect on muscle strength and muscle tone. Subgroup analyses revealed 
no significant differences between post-stroke phases. No evidence revealed a ben-
eficial effect of transcutaneous electrical nerve stimulation (TENS) (four trials, 484 
participants).
cNMES of shoulder muscles decreased shoulder subluxation (x-ray: SMD 0.58, 
95% CI 0.15 to 1.01; 190 participants) while it did not significantly affect motor 
function, ROM, or pain; the effect might be restricted to the subacute phase (Vafadar 
et al. 2015).
For a selection of patients, FES can be used to facilitate high-intensity self- 
training, e.g. when hand opening is induced by EMG-NMES integrated in an 
FES orthosis for patients with severe finger extension paresis, and thereby 
motor function improved (effect size for intergroup differences of change 
scores: FM Arm- distal d = 1.16, 95% CI 0.21 to 2.10; 24 participants) (Shindo 
et al. 2011).
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4.2.7  Arm Robot Therapy
Arm robots have been developed to repetitively train shoulder and elbow move-
ments (e.g. MIT-manus, MIME, NeReBot, InMotion Linear Robot, UL-EX07, 
ReoGo), forearm and wrist movements (e.g. NeReBot, Bi-Manu-Track, Hand 
Mentor, UL-EX07), or finger movements (e.g. Reha-Digit, Amadeo, Hand Mentor, 
Gloreha). They have the advantage that with assistance by the robot (as needed) 
stroke survivors can repetitively train active movements even when they have severe 
arm paresis. High repetition rates for selective movements can thus be achieved dur-
ing training sessions.
Mehrholz et al. (2018) included 45 trials (involving 1615 participants) in their 
updated Cochrane review. In these trials, therapy has usually been applied five times 
a week for 20–105 min, mostly for 2–6 weeks.
Electromechanical and robot-assisted arm training improved activities of daily 
living scores (SMD 0.31, 95% CI 0.09 to 0.52; 24 studies, 957 participants, high 
quality of evidence), arm function (SMD 0.32, 95% CI 0.18 to 0.46; 41 studies, 
1452 participants, high quality of evidence), and arm muscle strength (SMD 0.46, 
95% CI 0.16 to 0.77; 23 studies, 826 participants, high quality of evidence). 
Electromechanical and robot-assisted arm training did not increase the risk of par-
ticipant drop-out (RD 0.00, 95% CI −0.02 to 0.02; 45 studies, 1615 participants, 
high quality of evidence), and adverse events were rare. The test for subgroup dif-
ferences between a subgroup of participants who received mainly training for the 
distal arm and the hand (finger, hand, and radioulnar joints) and a subgroup of par-
ticipants who received training mainly of the proximal arm (shoulder and elbow 
joints) revealed no significant difference for either arm function or activities of daily 
living scores at the end of intervention. Effects on ADL could be substantiated for 
the subgroup treated during the acute and subacute phase, but not for the subgroup 
with participants in the chronic phase (i.e. more than 3 months after stroke).
Taken together, people who receive electromechanical and robot-assisted arm 
and/or hand training during the acute/subacute phase after stroke improve their 
activities of daily living, arm and hand function, and muscle strength while effects 
in the chronic phase are uncertain.
Another systematic review with meta-analyses excluding RCTs of “insufficient 
quality” corroborated a small effect of robot therapy on motor function (FM Arm: MD 
2.23, 95% CI 0.87 to 3.59; 28 RCTs, 884 participants) and (only) at trend level for 
activities of daily living (SMD 0.27, 95% CI −0.05 to 0.59; 14 studies with 427 par-
ticipants) (Veerbeek et al. 2017). In dose-matched trials (i.e. equal therapeutic time 
allocated), a differential benefit of robot-assisted therapy on motor recovery was still 
observed (FM Arm: MD 2.28, 95% CI 0.89 to 3.68; 26 RCTs, 808 participants).
The high number of selective repetitive movements generated during robot ther-
apy is probably the main reason for its therapeutic effect.
A specifically task-oriented robot therapy used by high functioning stroke survi-
vors did not achieve a superior benefit at the activity level compared to task-oriented 
training without robot (Timmermans et al. 2014).
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4.2.8  Repetitive Transcranial Magnetic Stimulation (rTMS)
rTMS has been applied during the acute, post-acute, and chronic post-stroke phases 
to improve motor recovery in stroke patients having upper and/or lower limb pare-
sis. The rationale has been that priming the arm motor cortex by an excitatory stim-
ulation of the lesioned hemisphere or by an inhibitory stimulation of the non-lesioned 
hemisphere (that itself might inhibit the ipsilesional motor cortex) can promote arm 
motor recovery.
The following “inhibitory” (I) or “excitatory” (E) types of rTMS have been used 
in arm motor rehabilitation:
Low-frequency (LF) rTMS (I) of the contralesional primary motor cortex (M1),
Continuous theta burst stimulation (cTBS) (I) of the contralesional M1,
High-frequency (HF) rTMS (E) of the ipsilesional M1, and,
Intermittent theta burst stimulation (iTBS) (E) of the ipsilesional M1.
Thirty-four studies with 904 participants were included in the systematic 
review by Zhang et al. (2017). Upper limb function was measured by grip force, 
movement accuracy, keyboard, tapping, pinch and lift force, or complex hand 
movements. Pooled estimates show that rTMS significantly improved short-term 
(SMD 0.43, 95% CI 0.30 to 0.56) and long-term (SMD 0.49, 95% CI 0.29 to 0.68) 
manual dexterity. The mean effect size for the acute subgroup was 0.69 (95% CI 
0.41 to 0.97), for subacute stroke 0.43 (95% CI 0.16 to 0.70), and for chronic 
stroke 0.34 (95% CI 0.00 to 0.69; P = 0.048), respectively. The mean effect size 
for the high-frequency rTMS subgroup was 0.45 (95% CI 0.22 to 0.69) versus 
0.42 (95% CI 0.26 to 0.58) for the low-frequency rTMS subgroup. The mean 
effect size was significant for intermittent theta burst stimulation (iTBS) subgroup 
at 0.60 (95% CI 0.10 to 1.10), but was only at a trend level for continuous theta 
burst stimulation (cTBS) at 0.35 (95% CI −0.11 to 0.81; n.s.). The pooled effect 
size for the subcortical subgroup was 0.66 (95% CI 0.36 to 0.95); the mean effect 
size for non-specified subgroup was 0.39 (95% CI 0.24 to 0.54). In addition, 25 
studies were divided into four subgroups based on the numbers of sessions of the 
treatment: 1 session, 5 sessions, 10 sessions, and 15 to 16 sessions, with the mean 
effect sizes as follows: 0.55 (95% CI 0.29 to 0.81) for 1 session; 0.67 (95% CI 
0.41 to 0.92) for 5 sessions; 0.20 (95% CI −0.06 to 0.41; n.s.) for 10 sessions; and 
0.08 (95% CI −0.36 to 0.51; n.s.) for 15–16 sessions. Only three studies reported 
mild adverse events such as headache and increased anxiety.
In summary, the data showed a moderate short- and long-term benefit and only 
rarely reported mild adverse events, i.e. harm. Contralesional LF rTMS and ipsile-
sional HF rTMS or iTBS were effective with a maximum effect for trials applying 
5 sessions; the situation is less clear for contralesional cTBS. The modifiers of treat-
ment effect are to be taken into account with bigger benefits earlier after stroke and 
with patients suffering from subcortical stroke. Trials frequently included patients 
with mild-to-moderate arm paresis.
The systematic review by Xiang et al. 2019 including 42 RCTs with a total of 
1168 participants reported qualitatively similar results.
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Evidence for combined treatments (bilateral HF and LF rTMS within sessions 
or across series of sessions) also showed benefits. E.g., 2 weeks contralesional LF 
rTMS, followed by ipsilesional iTBS, had superior effects to the reverse order and 
sham stimulation in subacute stroke survivors with moderate-to-severe arm pare-
sis (Wang et  al. 2014). The database for such combinations is, however, still 
limited.
Although rTMS appears generally safe for stroke patients, it is necessary to fol-
low the safety guidelines to prevent or minimize the risk of side effects (Rossi et al. 
2009). In addition, characteristics of the medical product used for rTMS (including 
licensing) need to be taken into consideration.
4.2.9  Repetitive Peripheral Magnetic Stimulation (rPMS)
A Cochrane review documented one RCT (63 participants with spastic paresis) with 
no effect of rPMS in addition to rehabilitation treatment on arm function (FM Arm), 
while there was some effect on elbow spasticity (Momosaki et al. 2017).
4.2.10  Transcranial Direct Current Stimulation (tDCS)
Compared to rTMS, tDCS is a less focal non-invasive method. tDCS is used to 
modulate cortical excitability by applying a direct current to the brain; tDCS 
using anodal stimulation (a-tDCS) might lead to increased cortical excitability 
(e.g. of the lesioned hemisphere), whereas cathodal stimulation (c-tDCS) might 
lead to decreased excitability (e.g. of the non-lesioned hemisphere); in addition, 
anodal stimulation and cathodal stimulation may be applied simultaneously 
(dual-tDCS).
A systematic Cochrane review including 12 trials with a total of 431 participants 
measured upper extremity function at the end of a tDCS intervention period and 
revealed no evidence of an effect in favour of tDCS (a-tDCS, c-tDCS, dual-tDCS) 
compared to any type of placebo or passive control intervention (SMD 0.01, 95% CI 
−0.48 to 0.50 for studies presenting absolute values (low-quality evidence) and 
SMD 0.32, 95% CI −0.51 to 1.15 (low-quality evidence) for studies presenting 
change values) (Elsner et al. 2016). Regarding the effects of tDCS on upper extrem-
ity function at the end of follow-up, four studies with a total of 187 participants 
(absolute values) showed no evidence of an effect (SMD 0.01, 95% CI −0.48 to 
0.50; low-quality evidence). Similarly, a network meta-analysis failed to substanti-
ate an effect of tDCS on arm function among stroke survivors (16 RCTs, 302 par-
ticipants) (Elsner et al. 2017).
4.2.11  Somatosensory Stimulation
Somatosensory stimulation that can be provided as tactile, thermal, vibratory, pneu-
matic, or electrical stimulation might have a potential to enhance recovery not only 
in the somatosensory but also in the motor domain. Overall, the efficacy data from 
clinical trials is not yet convincing regarding its effects on motor recovery (Veerbeek 
et al. 2014). Moderate-quality evidence, arising from a small RCT (29 participants), 
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showed that sensory stimulation (alternating cold and “hot” thermal stimulation) 
combined with active movement efforts had a beneficial effect on arm activities and 
impairment, when compared to no treatment in acute and subacute stroke patients 
with moderate-to-severe arm paresis (Modified Motor Assessment Scale: MD 1.58, 
95% CI 0.98 to 2.18; Brunnstrom Score: MD 0.19, 95% CI 0.09 to 0.29; 29 partici-
pants) (Chen et  al. 2005). Similar results (Stroke Rehabilitation Assessment of 
Movement, ARAT) of thermal stimulation were reported for mostly chronic patients 
(23 participants; Wu et al. 2010).
4.2.12  Acupuncture
The evidence for acupuncture in arm rehabilitation post-stroke—more frequently 
assessed for the subacute phase—is considered of low quality due to design issues, 
heterogeneity, or lack of differential effects in clinical trials. A systematic review 
highlights the big issues of risk of bias in the published data (Cai et al. 2017). A 
bigger RCT randomizing 295 subacute stroke patients with moderate-to-severe arm 
paresis documented acupuncture for 30 min six times a week for 4 weeks to be 
equally effective as physiotherapy (60 min neurodevelopmental therapy) and occu-
pational therapy (45 min) or the combination of both acupuncture and physiother-
apy as well as occupational therapy (Zhuang et al. 2012).
4.2.13  Investigational Devices
Clinical evidence for post-stroke arm rehabilitation with other investigational 
devices such as the brain–machine interface-supported therapy, vagal nerve stimula-
tion, or epidural electrical motor cortex stimulation is too limited for a recommen-
dation for their use outside study protocols.
4.3  Medication
4.3.1  Botulinum Neurotoxin A (BoNT A)
Treatment of spasticity is covered in the corresponding chapter of this book. There 
is considerable evidence that BoNT A reduces spasticity, pain associated with spas-
ticity, and consequently difficulties to integrate a plegic severely spastic arm in daily 
activities (Andringa et  al. 2019); there is, however, less evidence to suggest that 
BoNT A improves active arm function even though this can be the case individually 
(e.g. Foley et al. 2013).
4.3.2  Drugs to Enhance Recovery
Medication thought to modify neuroplasticity and motor recovery post-stroke has 
not been investigated extensively. Any data regarding arm rehabilitation is regarded 
preliminary, e.g. for l-dopa, donepezil, d-amphetamine, fluoxetine, or cerebrolysin 
and not yet sufficient to recommend its routine clinical use. Individualized treat-
ment decisions (e.g. for l-dopa, fluoxetine, or cerebrolysin) are at the discretion of 
the physician in charge, mostly as “off-label” treatment.
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5  Clinical Pathway and Practice Recommendations
5.1 General Comments
As presented in the paragraph “therapy”, there is ample evidence for benefits 
gained by dedicated arm rehabilitation therapy in terms of improvement of active 
motor control (impairment) and activities. Self-perceived usefulness of the affected 
arm as well as disability has been shown to improve with some interventions. 
Overall, the immediate benefits from various interventions are moderate, long-
term effects were less systematically assessed. If applied appropriately, the inter-
ventions show little risk to harm and are by and large very acceptable for patients. 
The question of feasibility to apply these clinically effective therapies rests largely 
on access to and the availability of skilled human therapeutic resources. The use of 
technical devices such as arm rehabilitation “robots” ($$), NMES ($), or rTMS ($$) (), 
NMES ($) requires additional investment (high $$, moderate $) and therapeutic 
skills. Our knowledge of cost- effectiveness, i.e. the change in costs to the change 
in therapeutic effects, is limited.
Arm rehabilitation therapy is always embedded in the overall goal-oriented 
rehabilitation plan. As such, there is no tight link between an individual arm impair-
ment or activity limitations and a certain therapeutic intervention and strategy. 
Rather, arm rehabilitation needs individually to be tailored and therapeutic deci-
sions need to be weighed with a reflection of the overall rehabilitation goals and 
their priority.
In addition, therapeutic decisions in arm rehabilitation rest on underlying thera-
peutic principles, e.g. what are the next steps of motor control improvement to be 
taken. They might well be achievable by alternative therapeutic options as locally 
available. Teams might want to use the recommendations given below to structure 
their service and local “arm rehabilitation pathway” in such a way that the diverse 
patients’ needs can effectively be addressed. As stated above, this is not primarily a 
matter of technical devices: Evidence-based smart and skilled therapeutic approaches 
do not have to imply huge “costs” for equipment. Conversely, technical devices can 
reduce the workload for human resources and can be cost-effective.
This chapter gives insight into the currently best available evidence when 
improvement of (sensori)motor control, i.e. body functions, or activities performed 
with the affected arm and hand is a therapeutic goal. Therapeutic affordances will 
tentatively differ early after stroke, when functional restauration might be a prevail-
ing goal, while in the chronic stage therapeutic goals might more frequently focus 
on activities primarily. Further, therapeutic steps to be taken by patients with severe 
arm paresis are quite different from those with mild-to-moderate arm paresis and 
therapeutic interventions need to be chosen accordingly. Hence, the evidence-based 
recommendations provided below will be given for the acute, subacute, and the 
chronic phase and for patients with severe or mild-to-moderate paresis separately. 
On an individual basis, there might be good reasons to take different decisions based 
on a patient’s values and preferences and a healthcare professional’s expertise.
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5.2  Dosage and Organization of Treatment
5.2.1 Acute and Subacute Phase After Stroke
A dedicated active arm motor control training of at least 2 h per week over several 
weeks ought to be provided when acceleration of arm motor recovery is intended 
post-stroke (level of evidence 1a, quality of evidence high, A+). Increasing the ther-
apy time up to 3 h per day can create a benefit in the subacute stage and can be 
considered individually (level of evidence 1b, quality of evidence moderate, 0).
Depending on individual circumstances (patient and service) (I) one-to-one ther-
apy, (II) circuit class training that can integrate the use of passive training appara-
tuses, and (III) intermittently supervised home training, the latter ideally with 
dedicated training manuals for patients with mild, moderate, or severe paresis, resp., 
with a focus on repetitive impairment- and activity-oriented training, and documen-
tation of the training should be entertained as therapeutic options (level of evidence 
1b, quality of evidence moderate, B+).
In cases with an individually very poor prediction (complete paralysis with diag-
nosed severe corticospinal tract damage (loss of motor evoked potentials (MEP) 
with transcranial magnetic stimulation (TMS), posterior limb of internal capsule 
damage on MRI diffusion tensor imaging (DTI)), a therapeutic focus on prevention 
of secondary complications (only) for the plegic arm and teaching compensatory 
strategies with the non-paretic arm can be considered already early after stroke 
(level of evidence 2b, quality of evidence low [imprecision], 0).
5.2.2 Chronic Phase After Stroke
At least 3 h per week of dedicated active arm motor rehabilitation (including circuit 
class approaches and the use of training apparatuses or home practice with intermit-
tent supervision) with regular evaluation of therapeutic progress are recommended 
for prolonged therapy in the chronic stage when improvements at impairment or 
activity level are intended and can be observed (level of evidence 1b, quality of 
evidence moderate, B+).
When improved performance of the affected arm in individually valued func-
tional tasks is the therapeutic goal, intensified home practice with intermittent 
supervision for a couple of weeks is recommended; the training should then focus 
on client-centred individualized functional goal-oriented practice (level of evidence 
1b, quality of evidence moderate, B+).
5.3  Therapeutic Options (Table 1)
5.3.1  Therapeutic Options for Stroke Survivors with Severe Paresis
Daily arm basis training should be considered in the acute and subacute phase when 
improvement of selective motion capacity is the therapeutic goal for patients with 
incomplete severe arm paresis (level of evidence 1b, quality of evidence moderate, 
B+); it is an option in the chronic phase (0).
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If available, arm robot therapy should be offered on a daily base especially to 
increase dosage/intensity of repetitive selective movements in the acute/subacute phase 
when selective movement capacity recovery is therapeutic goal (level of evidence 1a, 
quality of evidence high, B+ [unclear long-term effects]); it is also an option in the 
chronic phase (level of evidence 1a, quality of evidence low [uncertain effects], 0).
Daily mirror therapy as additional training for several weeks, e.g. as supervised 
self-training, should be considered when motor improvement at impairment and/or 
activity level is intended (and likely to be achieved) (level of evidence 1a, quality of 
evidence moderate, B+); patients with neuropathic pain or neglect might have an 
additional benefit.
Bilateral training is a therapeutic option (level of evidence 1a, quality of evi-
dence moderate, 0).
cNMES of wrist and finger flexors and extensors, or when EMG-triggering is 
voluntarily possible, EMG-NMES of wrist and finger extensors, in selected 
cases as FES can be used to enhance selective motion capacity and arm activi-
ties (level of evidence 1a, quality of evidence low, 0). cNMES of shoulder 
Table 1 Clinical pathway—therapeutic options in arm rehabilitation post-stroke
Severity
Basic vs. 
optional Type of therapy
Acute/
subacute Chronic
Severe paresis Basic Arm basis training B+ 0
Arm robot therapy B+ 0
Mirror therapy (additional) B+ B+
Bilateral training 0 0
cNMES, EMG-NMES 0 0
Therapy with VR and arm 
weight support
0




Basic Arm ability training B+ 0
Repetitive task training 0 0
Strengthening exercises 0 0
Therapy with VR 0 0




Optional Trunk restraint (reaching) 0 0
Mental practice 0 0
rTMS 0 0
Transfer package B+ B+
Mild to severe Discouraged tDCS B− B−
The grading of the recommendations according to GRADE corresponds to the categories “ought 
to” (A) and “should” (B); the category (0) implicates “can”. Abbreviations: cNMES cyclical neu-
romuscular electrical stimulation; EMG electromyographically triggered; CIMT constraint-
induced movement therapy; rTMS repetitive transcranial magnetic stimulation; tDCS transcranial 
direct current stimulation; VR virtual reality.
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muscles can be applied to treat subluxation (level of evidence 1a, quality of 
evidence low, 0).
Purpose-built virtual reality therapy systems with arm weight support can be 
used to improve selective motion capacity and arm activities with severe incomplete 
arm paresis (level of evidence 1b, quality of evidence low, 0).
Somatosensory (especially thermal) stimulation is an option as adjunct therapy 
(level of evidence 1b, quality of evidence moderate, 0), in the subacute phase also 
acupuncture (level of evidence 1b, quality of evidence low, 0).
Using splints and other orthoses to intermittently immobilize joints, e.g. the wrist 
of the severely affected arm or shoulder strapping (glenohumeral, scapulo- thoracal), 
does not facilitate motor recovery and should not be used for this therapeutic goal 
(level of evidence 1a, quality of evidence moderate, B−). It can be used to prevent 
or treat pain associated with severe paresis at these joints (level of evidence 1a, qual-
ity of evidence low, 0).
Substantial difficulties to integrate a plegic and severely spastic arm in daily 
activities and spasticity-associated pain should trigger the evaluation of a botulinum 
neurotoxin A treatment of the affected muscle groups (level of evidence 1a, quality 
of evidence moderate, B+).
5.3.2  Therapeutic Options for Stroke Survivors with Moderate 
and Mild Paresis
A three-week course of daily arm ability training should be considered when 
improvement of sensorimotor skilfulness (e.g. dexterity) is the therapeutic goal for 
patients with mild-to-moderate arm paresis (level of evidence 1b, quality of evi-
dence moderate, B+).
Repetitive task training is a therapeutic option when improvement of arm activi-
ties is the therapeutic goal (level of evidence 1a, quality of evidence moderate, 0).
Strengthening exercises can be an element of individualized therapy (level of 
evidence 1a, quality of evidence moderate, 0).
Purpose-built virtual reality therapy systems (and gaming consoles) can be used to 
improve selective motion capacity (level of evidence 1a, quality of evidence low, 0).
For patients with moderate arm paresis showing compensatory trunk displace-
ment during reaching, using a trunk restraint while training reaching movements 
can be considered (level of evidence 1a, quality of evidence low, 0).
Daily mirror therapy as additional training for several weeks, e.g. as supervised 
self-training, should be considered when motor improvement at impairment and/or 
activity level is intended (level of evidence 1a, quality of evidence moderate, B+); 
patients with neuropathic pain or neglect might have an additional benefit.
Mental practice is an alternative option after actual motor training sessions with 
the paretic arm (level of evidence 1a, quality of evidence moderate, 0).
Contralesional LF rTMS or ipsilesional HF rTMS or iTBS of the primary hand 
motor cortex (e.g. five sessions) can be considered as adjunct therapy by experi-
enced personnel when available and when used within safety guidelines, preferably 
early after stroke (level of evidence 1a, quality of evidence moderate, 0 [resource 
implications]).
Patients showing learnt non-use while having only mild-to-moderate paresis 
with some preserved hand function and no major problems with pain or spasticity in 
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their affected arm should be offered mCIMT or CIMT (the latter when beyond the 
acute phase) when the actual amount of use of the affected arm is the therapeutic 
target, i.e. to reverse learnt non-use (level of evidence 1a, quality of evidence high, 
B+); wearing a restraint of the non-affected arm outside therapeutic sessions is rec-
ommended when a “transfer package” is offered during therapy (level of evidence 
1b, quality of evidence moderate, B+).
5.3.3  Therapeutic Options Independent of Stage of Disease or 
Severity of Paresis
For Bobath therapy (neurodevelopmental therapy, NDT), no recommendation can 
be given (level of evidence 1a, quality of evidence moderate).
The use of tDCS (a-tDCS, c-tDCS, dual-tDCS) to improve upper limb motor 
function is discouraged outside study protocols (level of evidence 1a, quality of 
evidence low, B−). The same holds true for rPMS (level of evidence 1a, quality of 
evidence low, B−).
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Stroke is one of the leading causes for disability in adults. Approximately two-thirds 
of stroke patients suffer initially from disturbed mobility (Jorgensen et al. 1995). 
The scope for functional recovery is greatest during the first few months (Kwakkel 
et al. 2006). Therefore, early and effective rehabilitation training is an important 
denominator for the final functional outcome of the patients and subsequently for 
their quality of life.
In the last years, more and more evidence has been accumulated for well-defined 
rehabilitative interventions including good-quality multicenter studies (e.g., Duncan 
et al. 2011) and Cochrane reviews (e.g., Saunders et al. 2009). In the German guide-
line about rehabilitation of mobility after stroke (ReMoS), this evidence has been 
structured according to clinical meaningful outcome variables separately for the 
acute/subacute and the chronic phase after stroke (ReMoS Working Group 2015). A 
similar approach has been chosen by most of the other guidelines the present results 
were compared with.
Practical therapy recommendations were given for restoration or improvement of 
gait separately in patients who are initially not able to walk without help and for 
those who are able to walk, for the improvement of gait velocity, of walking dis-
tance and of balance (Flowchart 1).
Unfortunately, there are hardly any high-quality studies of walking as part of 
everyday activities: e.g., getting up from a low, unstable chair, maneuvering a 
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slippery surface, and carrying fragile dishes or hot meals from the kitchen to the 
living room.
As it is very difficult to establish a meaningful, reliable, and standardized test for 
these basic activities, it might be more promising to search for the underlying ele-
mentary requirements for such movements. One of the most important requirements 
is the ability to balance oneself in many different positions and situations. These 
requirements and strategies to cope with these challenges have been studied in detail 
by Pérennou and coworkers in the last decades.
2  Best Evidence for Rehabilitations of Gait: Methodology
A German guideline about rehabilitation of gait after stroke (ReMoS Working 
Group 2015, Dohle et al. 2016) forms the basis for this chapter. As part of their 
systematic guideline development program, the German Society for 
Neurorehabilitation (DGNR) joined forces with “Physio Deutschland,” the German 
Society for Physiotherapy (Deutscher Verband für Physiotherapie), to develop a 
main aim: to (re-)gain the ability to walk
patients, who are not able to walk 
acute/subacute stage chronic stage
main aims: improvement of 
walking speed walking distance balance
patients, who are able to walk (with some help)
acute/subacute stage chronic stage
Flowchart 1 Practical therapy recommendations according to clinical status and recovery phase 
after stroke
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guideline for rehabilitation of gait after stroke (ReMoS). As an S2e-guideline, a 
systematic review of the literature has been performed using Medline (PubMed), 
Pedro und the Cochrane Library (2012), and performing additional hand search (in 
2012, 2014, and again in 2015). Eleven systematic reviews and 188 RCTs were 
identified. Forty- one different principles of interventions have been identified.
Many RCTs present the effect of an intervention for several of the outcome 
parameters: restoration or improvement of gait, improvement of gait velocity and 
walking distance, and improvement of balance. Functional Ambulation Categories 
(FAC) were the predominant assessment for the ability to walk, and the 10-m walk-
ing test and 6-min walking test were most commonly used to measure the walking 
speed and walking distance/walking capacity and the Berg Balance Scale and the 
Timed Up and Go (TUG) test are most often used to assess functional aspects of 
balance. In addition, we distinguished whether the intervention took place within 
the first 6 months in the acute or subacute phase after stroke, or after 6 months in the 
chronic phase after stroke.
For each intervention, a coherent evaluation was performed, separately for each 
outcome criteria and clinical phase. The evaluation was based on the evidence of all 
the available literature and performed according to the principles of the GRADE 
scheme. The resulting quality of evidence category (high, medium, low, or very low) 
served as a basis for our recommendations taking into account possible side effects: 
(A—“ought to,” B—“should,” 0—“can,” “therapeutic option”). The recommenda-
tions given in this chapter follow the same rules as outlined in chapter “Clinical 
Pathways in Stroke Rehabilitation: Background, Scope, and Methods” (see Chap. 2).
The specific ReMoS guideline methodology has been described in detail in German 
(ReMoS Working Group). The present version has been updated to include recent 
literature and developments. The German version of the guideline can be obtained in 
print by the Hippocampus Verlag, Bad Honnef, Germany (www.hippocampus.de) or 
downloaded from the website of the German Society for Neurorehabilitation (https://
www.dgnr.de/images/pdf/leitlinien/S2e_Leitlinie_Rehabilitation_der_Mobilitaet_
nach_Schlaganfall.pdf). Tables 1, 2, 3, 4 and 5 of the present publication are modified 
translations from the original German version of the ReMoS guideline.
The original evidence and the resulting recommendations were compared with 
the evidence and the resulting recommendations presented in four other interna-
tional guidelines, which also studied sensorimotor interventions after stroke 
in detail:
• Practice Guideline for Physical Therapy in patients with stroke (Royal Dutch 
Society for Physical Therapy 2014); (KNGF guideline).
• Guideline for adult stroke rehabilitation and recovery (American Heart 
Association/American Stroke Association 2016) (AHA/ASA guideline).
• Canadian Stroke Best Practice Recommendations, Canadian Heart and Stroke 
Foundation, 6th Edition, 2019 (Canadian guideline)
• Clinical Practice Guideline to improve locomotor function following chronic 
stroke, incomplete spinal cord injury, and brain injury; American Physical 
Therapy Association, 2020. (APTA guideline).
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Similarities and differences between the main recommendations of the different 
guidelines are discussed. The structure of the ReMoS guideline was used as the 
structural basis for the comparison. An additional paragraph has been added about 
early intensive training in the acute phase after stroke (paragraph 3).
3  Early Intensive Training in the Acute Phase (24 H) 
After Stroke
Early intensive training in the acute phase directly after stroke may be counterpro-
ductive: a steady, but less intensive training scheme leads to a less positive effect 
directly after the training session, but a more positive outcome 3 months later (e.g., 
Avert Trial Collaboration Group 2015). This result is in line with results in some 
animal studies, which show that early intensive training leads to additional damage 
of tissue at risk close to the lesion site (e.g., Humm et al. 1998). Marzolini et al. 
(2019) have studied this question in more detail and argue that initial therapy ses-
sions should be brief, and cerebral hypotension should be avoided. Furthermore, as 
stroke can also affect the function of the heart, possible cardiac manifestations 
should be kept in mind (Marzolini et al. 2019).
Thus, during the first 24 h, mobilization should be performed cautiously even in 
seemingly fit patients and exercise intensity should be light in the first days, slowly 
increasing to moderate. Specific clinical guidelines based on recovery stages from 
neurological and cardiovascular perspectives are provided by Marzolini et al. (2019).
4  Restoration of Gait in Severely Affected Patients Who 
cannot Walk Without Help
In patients who cannot walk without help, rehabilitation training with a high num-
ber of walking cycles early after stroke improves the chances of patients to walk 
independently at 6 months considerably (Pohl et al. 2007). The present literature 
suggests that several hundred walking cycles should be achieved in each training 
session during the first weeks after stroke (e.g., Pohl et al. 2007). This aim can be 
achieved by the dedicated personal effort of two or more therapists who help the 
patient to keep in an upright position and continue to move the feet of the patients 
continuously early after stroke (Peurala et al. 2009). This approach is dependent on 
a considerable physical effort by the therapists. Machine supported training regimes 
have also been used for the neurologically severely affected patients based on either 
exoskeletons or end-effector devices (e.g., Mehrholz and Pohl 2012). A recent 
Cochrane analysis showed comparable evidence for both technical approaches: 
Patients who received physiotherapy in combination with electromechanical- 
assisted gait training after stroke were more likely to achieve independent walking 
than people who receive gait training without these devices (Mehrholz et al. 2017). 
This justifies now an equal recommendation for both end-effector devices and exo-
skeletons, (B—recommendation; different to the original ReMoS recommendation 
(2015)).
K. M. Stephan and D. Pérennou
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An improvement of gait categories from non-ambulatory (FAC 0–1) to indepen-
dent ambulatory (FAC 4 + 5) was only seen in patients in their acute or early sub-
acute phases. It was not achieved, when intensive training of gait was commenced 
in non-ambulatory patients in their late subacute or chronic phases after stroke.
For patients, who are still bedridden, there is low quality of evidence that cyclic 
multichannel stimulation to generate movements similar to a walking pattern can 
facilitate the ability to walk later on (Yan et al. 2005); 0—recommendation, Table 1). 
Interestingly, an adjoining neglect training also facilitates the ability to learn to walk 
again (Paolucci et al. 1996); (low quality of evidence; 0—recommendation, Table 1). 
The same is true for motor imagery as a component of gait training (low quality of 
evidence, 0—recommendation, Table 1).
4.1  Discussion: Restoration of Gait 
in Non-Ambulatory Patients
“Intensive, repetitive mobility-task training” is recommended by the AHA/ASA 
guideline for all individuals with gait limitations after stroke (2016) based on a high 
quality of evidence. Intensive training of mobility is also advocated by the Dutch 
and Canadian guidelines with similarly high evidence levels. Even though there is 
only limited direct evidence for intensive conventional gait training in non- 
ambulatory patients (FAC 1–2; see for example, Peurala et al. 2009), there is strong 
In the subacute stage after stroke, intensive gait training should be per-
formed, in order to reestablish the ability to walk (low-to-moderate level of 
evidence). If available and appropriate, intensive physiotherapy should be 
combined with the use of an end-effector–based device or an exoskeleton 
(high quality of evidence; B—recommendation, see also Table 1).
Table 1 Restoration of gait in patients who cannot walk without help (modified from the original 
German version of the ReMoS guideline)





B (should) •  Intensive, progressive gait training, combining conventional 
physiotherapy and gait training with—If available and 
appropriate—End-effector or exoskeleton–based training
0 (can) •  Intensive gait training with motor imagery as one component
•  Intensive gait training, also using a treadmill if available and 
appropriate
•  Cyclic multichannel stimulation to generate movements 
similar to a walking pattern
•  For patients with neglect: Specific neglect training
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evidence for the benefit of higher number of steps during training sessions using 
mechanical devices in this patient group (Table 1, see discussion above).
Similar to the present recommendations for the use of an end-effector–based 
device or an exoskeleton in combination with conventional physiotherapy and gait 
training (Table 1, see above), the Dutch KNGF guideline (2014) stated that “it has 
been demonstrated that robot-assisted gait training for stroke patients who are unable 
to walk independently improves their … walking ability and performance of basic 
activities of daily living, compared to conventional therapy (including overground 
walking).” The two North American guidelines (AHA/ASA Guideline 2016; 
Canadian Guideline 2019) base their recommendations on basically the same evi-
dence as the two European guidelines of 2014 and 2015 and especially on the 
Cochrane reviews by Mehrholz et al. (2013, 2017). However, their recommendations 
are more cautious: “mechanically assisted walking may be considered in patients 
who are non-ambulatory or have low ambulatory ability early after stroke” (AHA/
ASA Guideline 2016); “Electromechanical (robotic) assisted gait training devices 
could be considered for patients who would not otherwise practice walking. They 
should not be used in place of conventional gait therapy.” (Canadian Guideline 2019).
Three of the guidelines (ReMoS; KNGF; and AHA/ASA) advocate to consider the 
use of these mechanical devices mainly in the early subacute phase (up to 3 months) 
after stroke. The guideline of the American physiotherapists (APTA Guideline 2020) 
does not address the ability to walk directly. However, with regard to walking speed 
und duration it states explicitly that “clinicians should not perform walking interven-
tions with exoskeletal robotics on a treadmill or elliptical devices to improve walking 
speed and distance in individuals greater than 6 months following acute-onset CNS 
injury as compared with alternative interventions (APTA Guideline 2020).”
4.2  Summary
For non-ambulatory patients after stroke, all the guidelines advocate intensive, pro-
gressive, and task-related mobility training, with direct and indirect evidence for 
intensive gait training especially during the (early) subacute phase after stroke. A 
Cochrane review (Mehrholz et al. 2017) showed that patients who received physio-
therapy in combination with electromechanical-assisted gait training after stroke 
were more likely to achieve independent walking than people who receive gait train-
ing without these devices. However, the strength of recommendations for the use of 
these devices in the first months after stroke varies between guidelines.
5  Improvement of Gait in Patients Who Walk 
Independently or With Little Help
The high number of steps is again the key to improvement in this patient group. 
However, support by devices such as an exoskeleton or an end-effector device does 
not improve patient’s performance further (Dias et  al. 2007). In rehabilitative 
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practice, intensive training of walking on the ground and/or walking on treadmills 
are often used (e.g., Duncan et al. 2011). Regardless of the exact mode of training 
(with or without a treadmill), intensity of therapy should be progressive, e.g., with 
an increase of speed, difficulties or complexity over time (Pohl et al. 2002). Such 
training can also be performed as “circuit training.”
Progressive high-intensity training is especially effective in the subacute phase 
after stroke (B—recommendations, Table  2). In chronic stroke, it also led to an 
improvement of gait in these patients, although with a lower quality of evidence for 
this patient group (0—recommendation, Table 2).
The effect of botulinum toxin injections was evaluated in chronic patients with a 
spastic equinovarus deformity. A reduction of the use of supportive devices was 
achieved. There was however no improvement of the abovementioned clinical out-
come parameters (Pittock et  al. 2003) (B—recommendation for chronic patients 
with spastic equinovarus deformity).
Task-specific training combined with motor imagery, usage of walking devices 
(e.g., crane, stick), the use of functional electrical stimulation, and additional elec-
troacupuncture all had lower levels of evidence and may be used during training 
(0—recommendations for the subacute phase, Table  2). The same was true for 
intensive and progressive training in the chronic phase after stroke (0—recommen-
dation for the chronic phase, Table 2).
In patients who can walk independently with or without an aid or 
with little help an intensive and progressive gait training should be per-
formed in the subacute stage after stroke (moderate quality of evidence; 
B–recommendation, see also Table 2) and can be performed (intermit-
tently) in the chronic phase after stroke (low quality of evidence, 
0–recommendation).
Table 2 Restoration of gait in patients who can walk independently with or without an aid or with 
little help (modified from the original German version of the ReMoS guideline)
Subacute phase after stroke Chronic phase after stroke
A (ought to)
B (should) •  Intensive and progressive gait 
training: Conventional or using 
a treadmill
•  For patients with spastic Equinovarus- 
deformity: Injections of Botulinum 
toxin to reduce the need of supportive 
devices
0 (can) •  Task-specific training combined 
with motor imagery
•  Functional electrical stimulation
•  Additional electroacupuncture
•  Usage of walking devices (e.g., 
crane, stick)
•  Intensive and progressive task-specific 
training
•  Intensive and progressive training in the 
chronic phase after stroke combined 
with VR
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5.1  Discussion: Improving Walking Ability in Ambulatory 
and Nearly Ambulatory Patients
The AHA/ASA guidelines (2016) recommend an intensive, repetitive, and task- 
related training also for this group of patients—similar to the recommendation 
above. The KGNF and the Canadian guidelines support this recommendation: e.g., 
“task and goal-oriented training that is repetitive and progressively adapted should 
be used to improve performance of selected lower-extremity tasks such as sit to 
stand, walking distance and walking speed” (Canadian Guideline 2019). There are 
however open questions: Where should such training be performed: on the ground 
or on a treadmill? What is the advantage of circle training, which is advocated by 
several of the guidelines? And do the level of evidence and the class of recommen-
dation differ between the guidelines, especially for some of “our” low-level 
recommendations?
Training on the ground is the most natural place and does not need any additional 
technical equipment. And at least for chronic stroke patients, it has been demon-
strated that “overground gait training by stroke patients who are able to walk with-
out physical support is more effective in increasing walking distance and reducing 
anxiety than walking on a treadmill” (KGNF Guideline 2014).
“Group therapy with circuit training is a reasonable approach to improve walk-
ing.” (AHA/ASA guideline) “It has been demonstrated that circuit class training 
(CCT) for walking and other mobility-related functions and activities improves 
walking distance/speed, sitting and standing balance and walking ability, and 
reduces inactivity in patients with a stroke” (KNGF Guideline 2014; evidence for 
patients in the subacute and chronic phases after stroke). Circuit class training 
allows therapists to combine advantages of group and individual treatments: if a 
reasonable ratio between patients and therapists is guaranteed (e.g., 2:1), therapists 
can use the positive aspects of group dynamics and also concentrate during indi-
vidual time slots on those aspects of gait, which are especially important for indi-
vidual patients. Thus, circle training tries to combine the advantages of the traditional 
one therapist–one patient relationship with the economically more effective 
therapist- patient ratio in group settings.
Overground walking exercises can be combined with treadmill training with or 
without body support to improve walking ability (AHA/ASA guideline). Treadmill- 
based training “should be used … as an adjunct to over-ground training or when 
over-ground training is not available or appropriate” (Canadian guideline, evidence 
for subacute and chronic stroke patients). Treadmill training can be especially use-
ful for patients, which are more severely affected and may profit from body weight 
support to train more effectively. It has even been demonstrated “that overground 
gait training for patients with a stroke who are unable to walk independently at the 
start of therapy has an adverse effect on their aerobic endurance compared to body- 
weight supported walking exercises” (KNGF Guideline 2014).
Treadmill-based gait training (with or without body weight support) can also 
been used to enhance specific aspects of gait: walking speed and distance walked 
(see paragraphs 7 and 8). Thus, treadmill-based training can be used twofold: either 
for specifically defined patient groups (e.g., with body weight support) or for the 
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training and optimization of specific tasks (e.g., maximal speed training (see 7) or 
training of endurance (see 8)). And sometimes it will just provide an alternative to a 
training session within a cold and rainy or snowy environment outside the building!
When we prepared the ReMoS guideline, we saw cognitive training (e.g., motor 
imagery in the subacute phase), external stimulation instead of usage of walking 
aids (e.g., FES in the subacute phase after stroke), and virtual reality in the chronic 
phase after stroke as treatment options, which might rapidly develop and become 
standard treatment methods (see Table 2).
According to the Canadian guidelines (2019), “mental practice should be consid-
ered as an adjunct to lower extremity motor retraining.” The role of cognitive train-
ing in daily routine seems to increase slowly over time. Mental imagery, movement 
observation, and dual-task paradigms become more and more popular (see also 
Table 4, paragraph 7). Cognitive training allows patients to concentrate on specific 
details of the tasks (motor imagery, motor observation) during a learning phase 
before trying to automatize the task, e.g., with the help of dual-task paradigms. It is 
important that the learning phase does always include not only imagined or observed 
but also “real practice.” Physiologically this may correspond to changing functional 
connections between different sensorimotor areas (e.g., Stephan et  al. 1995; 
Hardwick et al. 2018). Only then will cognitive training develop its full potential 
during the learning process.
In patients with remedial foot paresis (foot drop) ankle foot orthoses (AFO) 
remain the standard (e.g. AHA/ASA Guideline 2016). Similarly, the Canadian 
Guidelines (2019) advise that “ankle-foot orthoses should be used on selected 
patients with foot drop following proper assessment and with follow-up to verify its 
effectiveness” (evidence for the subacute and chronic stages after stroke). 
Neuromuscular electrical stimulation remains a valid alternative to an AFO (AHA/
ASA Guideline 2016).
Functional electrical stimulation (FES) is often used to improve strength and 
function (gait). According to the Canadian guideline, “FES should be used in 
selected patients, but the effects may not be sustained” (Canadian Guideline 2019, 
evidence for subacute and chronic stages after stroke). There was no substantial 
change of the quality of evidence in the last years.
Finally, VR combined with progressive training may be used in the chronic phase 
after stroke (Table 2). The Dutch guideline (2014) is uncertain about the advantages 
of VR in combination with conventional therapy. The North American guidelines 
consider VR as possibly beneficial (AHA/ASA Guideline 2016) or as a possible 
adjunct (Canadian Guideline 2019). The APTA Guideline (2020) is the only guide-
line which gives a strong recommendation for the use of VR in conjunction with gait 
training in chronic patients.
These diverging classes of recommendations even in the two guidelines which 
were published within the last 2 months (Canadian Guideline Dec. 2019 and APTA 
Guideline Jan. 2020) indicate that for the lower extremities there is still uncertainty 
about the exact role of VR in routine clinical therapy. Thus, a strong recommenda-
tion cannot (yet) be given.
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5.2  Summary
In ambulatory patients and patients who need a little help to walk after stroke all 
guidelines advocate intensive, progressive, and task-related gait training in order to 
further improve walking ability. Recommendations are given for overground walk-
ing and additional treadmill-based therapy. Treadmill-based therapies have differ-
ent advantages: a) they may be especially useful for more severely affected patients 
and b) they support the training of specific aspects of walking, walking speed, and 
distance walked (paragraphs 7 and 8).
Cognitive training, external stimulation, and virtual reality are specific methods 
of training, which have become more popular over the last years. However, until 
now, the quality of evidence is not yet very high and therefore recommendations for 
their therapeutic use are not yet very strong.
6  Improvement of Balance, Reduction of Falls
Isolated balance training does not lead to an improvement of balance during walk-
ing or to a reduction of falls in stroke patients. An integration of balance training 
into the context of standing and walking seems to be the key aspect for clinical 
meaningful improvements. (Duncan et al. 2003). It is therefore not surprising that a 
“motor relearning program” with a focus on activities of daily living shows a clear 
improvement of functionally relevant balance parameters (Chan et al. 2006). This 
evidence exists mainly for the subacute phase (moderate quality of evidence, B—
recommendations for the subacute phase, Table 3) and with a lower quality of evi-
dence also for the chronic phase (0—recommendation). Such an integration of 
balance exercises into gait-related training may also lead to a reduction of the num-
ber of falls (Duncan 2011).
There is low quality of evidence that an increase in gait speed without accompa-
nying balance training may lead to a higher number of falls (Duncan et al. 2011). 
Therefore, context dependent balance training should be part of any mobility train-
ing after stroke.
Conventional gait training combined with training using mechanical devices 
(treadmill, end-effector device, or exoskeleton), and strength and endurance 
In order to improve balance in the subacute stage after stroke and 
reduce the number of falls in patients who can walk independently with 
or without an aid or with little help dynamic balance training should be 
performed as an integral part of an intensive gait training (moderate 
quality of evidence, B—recommendation, see also Table 3). An intensive 
supervised home training program with progression and a motor relearn-
ing program have the same quality of evidence for the subacute stage 
after stroke (moderate quality of evidence, B—recommendations).
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training may also improve balance, especially in the subacute and chronic stages 
after stroke (low quality of evidence, 0—recommendation, Table  3). If balance 
training is performed as a specific training session, training with an unstable support 
base (Saeys et al. 2012) or with a systematic reduction of the size of the support base 
(McClellan and Ada 2004) is recommended. Ai Chi (Tai Chi in the water) seems 
also be beneficial (Noh et al. 2008) (low quality of evidence and 0—recommenda-
tions for those interventions in the subacute and/or chronic phases after stroke; see 
Table 3).
6.1  Discussion: Improvement of Balance, Reduction of Falls
Balance training programs are encouraged for those stroke patients who fall or who 
have fear of falling (e.g., AHA/ASA Guidelines 2016). The Dutch KNGF Guideline 
(2014) and the ReMoS guideline also encourage the use of such programs (see 
Table 3).
At first sight, however, the other recommendations of the different guidelines 
vary widely regarding the best therapies to improve balance: e.g., training on a force 
platform is advocated (Canadian guideline and to a lesser extent KNGF guideline) 
or dismissed (ReMoS Guideline, APTA guideline); similarly treadmill training may 
Table 3 Improvement of balance (static, dynamic, reduction of falls) (modified from the original 
German version of the ReMoS guideline)
Subacute phase after stroke Chronic phase after stroke
A (ought to)
B (should) •  Intensive gait training including balance 
training without treadmill or
•  Intensive gait training including balance 
training with the use of a treadmill or
•  Intensive supervised home training program 
(strength, endurance and balance training) 
with progression
•  Motor relearning program
0 (can) •  Conventional gait training including balance 
training combined with training using an 
exoskeleton (e.g., Lokomat) or an end-
effector–based device
•  Strength–endurance training
•  Training to stand on an unstable support 
base
•  Acoustic feedback during walking
•  Orthopedic shoe when indicated
•  Conventional gait training 
including balance training 
combined with training of a 
treadmill or other 
mechanical training devices
•  Exercises on an unstable 
support base
•  Exercises on a 
progressively smaller 
support base
•  Progressive increase of 
perturbations of the support 
base
•  Additional VR-based 
training
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lead to an improvement of balance (Canadian guideline) or may increase the num-
ber of falls (Duncan 2011; ReMoS Guideline, paragraph 7).
A second look however reveals that the goals of the different recommendations 
differ; taking these different goals into account, the full picture becomes more uni-
fied again.
 (A) Exercising postural control with visual feedback while standing on a force plat-
form improves the postural sway in stance (KNGF Guideline 2014), such exer-
cises are also advocated by the Canadian guidelines (2019) to train standing. 
These exercises do, however, not improve dynamic balance e.g., while walking 
(ReMoS guideline) and are therefore discouraged, if patients want to improve 
their balance during walking (see also (APTA guideline for the chronic 
phase, 2020)).
 (B) Balance training on an unstable support base and balance boards (ReMoS 
guideline, subacute, and chronic phase (Table 3); Canadian Guideline 2019, 
chronic phase), and balance training with virtual reality while standing in the 
chronic phase (ReMoS guideline (Table 3) and Canadian Guideline 2019), but 
not in the subacute phase after stroke (Canadian Guideline 2019) may improve 
dynamic balance and especially balance while walking.
 (C) Treadmill training with partial body weight support in the subacute phase 
(Canadian Guideline 2019) and training with other mechanical devices (see 
Table 3, especially in severely affected patients) may improve dynamic bal-
ance. However, intensive gait training on a treadmill to improve gait speed may 
also lead to a higher number of falls compared to intensive home-based train-
ing (Duncan 2011; for discussion see also Nave et  al. 2019). Duncan et  al. 
(2011) argue that presumably the intensity of balance training was too low 
compared to the intensity of gait speed training on the treadmill. Thus, it may 
depend on the context whether treadmill training is facilitating or inhibiting the 
rehabilitation of dynamic balance during walking.
 (D) Exercising balance may not only improve walking abilities. It has also been 
demonstrated that exercising balance during various activities results in 
improved performance of basic activities of daily living in the subacute and 
chronic phases after stroke (KNGF guideline).
 (E) Balance may also be stabilized using assistive devices or an orthosis if appro-
priate (AHA/ASA Guideline 2016;).
Thus, balance training while performing functional relevant tasks will lead to an 
improvement of balance within the context of these tasks. As far as we know, there 
is not much carryover of “balance abilities” from one functional task to another. In 
clinical practice, patients may show different degrees of balance control between 
slow and fast walking, between walking in an open space, and while navigating 
obstacles between walking with and without carrying objects in their hands. It is 
important to identify those differences and address them during the rehabilitative 
process if necessary.
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6.2  Summary
In stroke patients, environmentally adapted balance training improves those aspects 
of balance which are specifically trained: (a) exercising postural control on a force 
platform improves postural sway in stance, (b) training of walking abilities by over-
ground gait training, circle training, or with the help of walking devices (e.g., tread-
mill, end-effector devices, exoskeletons) improves standing balance, walking ability, 
and walking distance and speed, and (c) exercising balance during various basic 
activities results in improved performance of those basic activities in daily living. 
According to the clinical data, there seems to be very limited carryover between 
different aspects of balance control. Therefore, balance should be trained within the 
context of walking, and while performing, ADL tasks in order to reduce the risk of 
falls and resulting injuries.
7  Improvement of Walking Speed
Once walking ability including basic balance control has been achieved, other out-
come variables become important such as walking speed or walking distance. To 
improve walking speed, a progressive increase of training requirements is the domi-
nant therapeutic principle. Progressive circuit training (Outermans et al. 2010) and 
progressive treadmill training (Pohl et al. 2002; Eich et al. 2004) have the highest 
quality of evidence (A—recommendations for the subacute phase, Table  4). 
Treadmill training without monitoring of heart frequency or perceived exertion or 
an intensive home exercise programs also have a positive effect (Duncan et  al. 
2011), but at a lower quality of evidence (B—recommendations for the subacute 
phase, Table 4). Progressive anaerobic training without direct functional relevance, 
however, does not lead to a further improvement of maximal gait speed, even when 
compared to “relaxation” (Nave et al. 2019). In this study (PHYS-stroke), both sub-
acute patient groups showed a comparable increase in gait speed when the interven-
tions were added to a standard rehabilitation program. This result demonstrates the 
importance of task- and goal-directed training, when patients, who have already 
learned the basic walking skills, try to achieve maximal walking speed.
An increase of walking velocity can also be achieved by intensive training in the 
chronic phase after stroke (see, for example, (Duncan et al. 2011)), however, the 
overall quality of evidence is lower than for patients in the subacute phase (0—rec-
ommendation, Table 4).
Stimulation of flexor-reflex afferents synchronous to the steps (Spaich et  al. 
2014) leads to an increase of velocity in the subacute phase (moderate quality of 
evidence, B—recommendation). In patients with a leg paresis, gait training with an 
orthosis (Thijssen et al. 2007; Erel et al. 2011) may also increase gait velocity (mod-
erate quality of evidence, B—recommendation for the chronic phase, Table 4). Until 
today, there is however no evidence for a differential effectiveness of static or 
dynamic devices (de Seze et al. 2011).
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The effectiveness of the different intervention may be further improved by the 
combination of gait training with other techniques in the subacute and chronic 
stages. There are encouraging results for the combination of gait training with cog-
nitive training (e.g., movement observation, movement imagery (Verma et al. 2011), 
• In order to increase walking velocity in patients who can walk inde-
pendently with or without an aid or with little help, goal-directed pro-
gressive training of gait velocity ought to be performed (high quality of 
evidence, A—recommendation for the subacute phase after stroke, see 
also Table 4).
• If this is not possible, an intensive gait training with or without a use of 
a treadmill, an intensive supervised home training program or training 
with stimulation of flexor-reflex afferents should be performed in the 
subacute stage (moderate quality of evidence, B—recommendation).
• In the chronic stage, an orthosis with or without electrical stimulation 
should be applied in appropriate patients if available (moderate qual-
ity of evidence, B—recommendation).
• Intensive task specific gait, strength, endurance, and cognitive training 
can also be performed in the chronic stage (0—recommendation).
Table 4 Improvement of walking speed in patients who can walk independently, with supervision 
or with a little help (modified from the original German version of the ReMoS guideline)
Subacute phase after stroke Chronic phase after stroke
A (ought to) •  Intensive task-specific progressive 
gait training (using a treadmill or 
performing a task specific circuit 
training)
B (should) •  Intensive gait training without 
treadmill or
•  Intensive gait training with the use 
of a treadmill or
•  Intensive supervised home training 
program (strength, endurance, and 
balance training) with progression
•  Gait training with stimulation of 
flexor-reflex afferences
•  Orthosis with or without electrical 
stimulation (indirect effect)
0 (can) •  Task-specific strength–endurance 
training
•  Gait training with acoustic 
rhythmic stimulation
•  Task-specific training using 
additional cognitive elements e.g., 
motor imagery
•  Acoustic (e.g., musical) feedback, 
knowledge of results
•  Intensive, task-specific gait training
•  Task-specific endurance training 
(e.g., aerobic treadmill training 
combined with gait training on the 
floor)
•  Task-specific strength training
•  Task-specific cognitive training,  
e.g., motor observation, dual-task 
paradigms
•  Functional electrical stimulation
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training under dual-task conditions), with additional stimulations and/or feedback 
(electrical stimulation, acupuncture, rhythmic acoustic stimulation (Thaut et  al. 
1997), and acoustic feedback (Schauer and Mauritz 2003)) as well as with addi-
tional strength and endurance training (low quality of evidence and 0—recommen-
dations for all interventions; for some interventions only for the subacute or for the 
chronic phase, see also Table 4). An isolated use of these techniques out of a func-
tional context does, however, not lead to the desired improvements.
7.1  Discussion: Improvement of Walking Speed
Again repetitive, progressive, and task-related training forms, the basis for any 
training-related improvement of gait speed in the subacute phase (Table 4; AHA/
ASA Guideline 2016; Canadian Guideline 2019).
Training on the ground, possibly also in the form of circuit training and treadmill 
training are the two main modes of training which are often combined. Treadmill 
training with or without body weight support should (Canadian guideline) or could 
(Dutch guideline) be used to improve walking speed after stroke. Especially with 
regard to maximum walking speed, it has been demonstrated that treadmill training 
without body weight support is more effective than conventional gait training 
(Dutch guideline). Mehrholz et al. (2017) have shown that the quality of evidence 
for the use of treadmills is highest for ambulatory patients in the first 3 months. 
However, although the improvement of maximum walking speed was statistically 
significant at the end of treatment, even these patients had no persisting beneficial 
effects.
Thus, whenever possible, the achieved improvements in walking speed should be 
transferred into meaningful and relevant tasks of daily routine (see Table 4).
Strength and endurance training and balance training are further components of 
such an intensive training program. Strength and aerobic endurance training are 
advocated by all guidelines in this context (e.g., Canadian guideline (2019) and 
Dutch Guideline 2014). The role of aerobic endurance training in stroke rehabilita-
tion will be discussed in more detail in the next paragraph chapter (paragraph 8). 
The importance of balance training was already shown in the previous paragraph 
(paragraph 6).
Rhythmic acoustic stimulation (RAS) is a further technique to facilitate the 
speed of repetitive movements and furthermore to influence the gait dynamics. 
While the Dutch (2014), the ReMoS and the AHA/ASA guideline (2016) identi-
fied a low quality of evidence and gave weak recommendations (e.g., Table 4), 
the Canadian guideline (2019) advised that “rhythmic auditory stimulation 
should be considered for improving gait parameters in stroke patients, including 
gait velocity ….” Evidence for RAS in stroke is building up, although there is 
still a need for long-term evaluations and for a deeper understanding of its 
(patho-)physiology in healthy subjects (Stephan et al. 2002) and patients. As a 
reduced effect over time is known, it might be advisable to try to preserve the 
gain in walking speed by including such tasks in daily routine similar to the 
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strategy after treadmill training (see above). As RAS is much easier to adminis-
ter than treadmill training, shorter RAS sessions can easily be included in daily 
or weekly routines.
7.2  Summary
Task- and goal-oriented training that is repetitive and progressively adapted should 
be used to improve walking speed. Overground training and treadmill training are 
the most common forms of training.
In order to improve comfortable walking speed, strength and aerobic endurance 
training, balance training, rhythmic acoustic stimulation and mental observation, 
and motor imagery help to train further aspects of mobility. In order to improve 
specifically maximal walking speed, structured treadmill training may be most 
promising as it allows the patients to concentrate on this specific aspect of mobility. 
Thus, similar to training in sports, basic skills are the basis for advanced training 
with specific goals.
Unfortunately, the training at the rehabilitation center does not lead to a perma-
nent improvement of function on a stable level. Therefore, whenever possible, the 
achieved improvements in walking speed should be transferred into meaningful and 
relevant tasks of daily routine.
8  Improvement of Walking Distance
Walking longer distances (e.g., for 6 min as in the 6-min walking test) does not only 
require a sufficient quality of gait parameters but also cardiovascular fitness. The 
American Heart Association (AHA) has developed criteria for effective endurance 
training such as a minimal training duration, optimal heart frequency, and perceived 
levels of exertion (Gordon et al. 2004). In order to improve walking distance, the 
cardiovascular fitness training has to be embedded into a specific functional context, 
e.g., treadmill training (16) or task-specific circuit training (Outermans et al. 2010) 
(high quality of evidence and A—recommendations for the subacute phase; moder-
ate quality of evidence and B—recommendation for the chronic phase, Table 5). 
Isolated aerobic endurance training on a cycling ergometer does not improve walk-
ing distance (Katz-Leurer et al. 2003). This result stresses the importance of task- 
and goal-directed training also for the improvement of walking distance.
Other progressive forms of training without monitoring of heart frequency or 
perceived exertion such as supervised home training (Duncan et al. 2011) or pro-
gressive treadmill training (Pohl et al. 2002) have a lower quality of evidence (mod-
erate quality of evidence and B—recommendations for the subacute phase; low 
quality of evidence and 0—recommendations for the chronic phase, Table 5).
Improvement can be achieved both in the subacute and in the chronic phases 
after stroke, once basic walking ability has been achieved (e.g., (Duncan et  al. 
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2011)). However, the overall quality of evidence is higher for patients in the sub-
acute phase than for patients in the chronic phase leading to different levels of rec-
ommendation (see above).
In chronic stroke, patients with paresis may benefit from the use of assistive 
devices such as an orthosis. Continuous use of an orthosis with electrical stimula-
tion also leads to an improvement of walking distance (Kottink et al. 2007) (moder-
ate quality of evidence, B—recommendation).
Elements of cognitive training (motor imagery, motor observation), additional 
stimulation techniques (peroneal stimulation, functional electrical stimulation), and 
especially task-specific endurance and strength training with or without feedback 
can also enhance walking distance (low quality of evidence and 0—recommenda-
tions for all interventions in the subacute and/or chronic phases after stroke, Table 5).
• In the chronic stage, task-specific endurance training, e.g., progressive 
aerobic treadmill training should be performed or an orthosis with 
electrical peroneal stimulation should be applied if indicated and 
available (moderate quality of evidence, B—recommendation).
• In order to increase walking distance in patients who can walk inde-
pendently with or without an aid or with little help task- and goal-
specific endurance training ought to be performed, especially in the 
subacute phase after stroke (high quality of evidence, A—recommen-
dation, see also Table 5).
• If this is not possible, an intensive gait training with or without a use 
of a treadmill, an intensive supervised home training program should 
be performed in the subacute stage (moderate quality of evidence, 
B—recommendation).
Table 5 Improvement of walking distance in patients who can walk with supervision or little help 
(modified from the original German version of the ReMoS guideline)
Subacute phase after stroke Chronic phase after stroke
A (ought to) •  Task- and goal-specific endurance 
training
B (should) •  Intensive supervised home training 
program (strength, endurance, and 
balance training) with progression
•  Intensive gait training with the use of a 
treadmill, especially progressive 
aerobic treadmill training
•  Task-specific endurance 
training, e.g., progressive 
aerobic treadmill training
•  Orthosis with electrical 
peroneal stimulation (indirect 
effect)
0 (can) •  Strength and endurance with or without 
feedback
•  Cognitive training (motor imagery)
•  Functional electrical stimulation during 
gait training
•  Intensive progressive training
•  Treadmill training and variable 
training on the floor
•  Feedback, motor observation
Mobility After Stroke: Relearning to Walk
140
8.1  Discussion: Increasing Walking Distance
Strength and aerobic endurance training within a task- and goal-related training 
program is the key to build up walking capacity after stroke. Strength and endur-
ance training should be repetitive and progressively adapted (e.g., Canadian 
Guideline 2019).
Again, a combination of overground training with treadmill training seems to be 
most useful to combine the strength of both training forms (see the Dutch Guideline 
2014, for the advantages of overground training, the Canadian Guideline 2019 for 
the advantages of treadmill training).
Such a setting also allows to include strength training in a functional context. It 
has been shown to be less effective: for persons with mild-to-moderate impairment 
in lower extremity function when performed on its own (Canadian Guideline 2019). 
The Canadian Guideline (2019) suggests that “individually-tailored aerobic training 
involving large muscle groups should be incorporated into a comprehensive stroke 
rehabilitation program to enhance cardiovascular endurance and cognitive func-
tion.” Such training can be easily performed as part of a comprehensive training 
regime to further walking capacity.
The Canadian Guideline (2019) gives recommendations, which investigations 
should be performed and which precautions should be taken to avoid harm to the 
patients. They further recommend “patients should participate in aerobic exercise at 
least 3 times weekly for a minimum of 8 weeks, progressing as tolerated to 20 min-
utes or more per session, exclusive of warm-up and cooldown” and “heart rate and 
blood pressure should be monitored during training to ensure safety and attainment 
of target exercise intensity.” More detailed recommendations for patient safety are 
given by Marzolini et al. (2019).
Training walking distance provides implicitly some feedback about the dis-
tance walked to every patient. Different forms of structured feedback have been 
used to provide the patients with information about their progress and details of 
their performance: verbal feedback (Dutch Guideline 2014), biofeedback, in the 
form of visual and/or auditory signals to indicate unequal weight bearing and tim-
ing (Canadian Guideline 2019), and EMG feedback (AHA/ASA Guideline 2016; 
Dutch Guideline 2014). However, none of the technical feedback signals have led 
to a substantial enhancement of functional recovery and were strongly recom-
mended in the guidelines. Verbal feedback seems to be the most promising form 
of feedback, possibly associated with a caring and supportive attitude of the 
therapist.
Continuous training after discharge is a problem for most patients after stroke. 
For aerobic exercise, the Canadian Guideline (2019) suggest: “to ensure long-
term maintenance of health benefits, a planned transition from structured aerobic 
exercise to more self-directed physical activity at home or in the community 
should be implemented.” Furthermore, strategies to address specific barriers to 
physical activity related to patients, healthcare providers, family, and/or the 
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environment should be employed. These recommendations are important for the 
transition of most learned skills on discharge from the rehabilitation hospital 
or center.
8.2  Summary
Task- and goal-specific strength and aerobic endurance training should be the focus 
of training to enhance walking distance after stroke. It should incorporate both 
overground training and treadmill training, if available. Pre-participation screen-
ing and monitoring during aerobic training should be performed to ensure 
patient safety.
Treadmill training has the advantage that it allows easy monitoring during train-
ing and attainment of target exercise intensity. However, it is difficult to maintain 
such a structure outside a rehabilitative setting. Therefore, a planned transition 
from a structured therapy setting to more self-directed physical activity at home or 
in the community should be implemented.
9  General Discussion and Conclusions
Five different guidelines with recommendations for rehabilitative therapies were 
compared. All of them were published by scientific societies. Their description of 
the timeline of rehabilitation was similar: the acute stage or phase lasted for about 
a week after stroke, the subacute stage until the end of the sixth month with a 
subdivision between an early subacute phase (up to 3 months) and a late subacute 
phase (after 3  months up to 6  months). Thereafter began the chronic phase 
after stroke.
Most of the evidence for specific interventions and the recommendations based 
on the evidence were similar between the guidelines. This is not surprising, as more 
or less the same literature formed the basis for the guideline, and the process of writ-
ing a guideline is now standardized internationally.
Nevertheless, the classification of the literature and the critical appraisal 
process also led to some different recommendations in different regions of 
the world.
First, the critical appraisal of a study may lead to different results regarding the 
level and/or quality of evidence. Second, synthesis of the evidence of individual 
studies may lead to different categories of quality of evidence for specific interven-
tions. Furthermore, the quality of evidence for a specific intervention may change 
over time: there are up to 5 years difference between the years of publication of the 
different guidelines. And during this time, further studies have been published, 
which may change the overall quality of evidence or the estimate of therapeutic 
effect itself.
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More often, however, the writers of the guideline will disagree about the level of 
recommendation. The GRADE system does explicitly require the guideline writers 
to include not only the quality of evidence but also relevant context factors and the 
degree of certainty of the recommendation. Therefore, it is not surprising when two 
or more writers disagree about the class of recommendation, especially when they 
have a different methodological, cultural, economic, and/or geographic background. 
From this perspective, the more or less unified view on the process of rehabilitation 
of walking after stroke is more surprising than the discrepancies between the 
guidelines.
The evidence underlying the recommendations suggests elementary rules for 
recovery and rehabilitation of gait according to the different stages of recovery 
after stroke. These elementary rules are valid for patients regardless of the coun-
try or region they live in and form a basis to shape local and regional clinical 
pathways.
• In the acute phase, directly after stroke (first 24 h), very intensive training may 
impair the degree of recovery 3 months later.
• In patients who cannot walk, intensive task-specific training (e.g., a high num-
ber of repetitions of the full gait cycle) supports recovery of basic walking abili-
ties in patients who cannot walk in the subacute stage after stroke. There is no 
evidence that such an intensive training is still effective to regain basic walking 
abilities in the chronic stage after stroke in this patient group. Thus, the training 
of compensatory modes of mobility (e.g., wheelchair handling) may be a major 
therapeutic aim in these patients (see Flowchart 2).
• In patients who can walk independently or with some help, intensive task- 
specific training supports improvement or even restoration of gait. Often bal-
ance, walking speed, and walking distance are the main therapeutic goals in 
intensive and repetitive task- and goal-related mobility training
especially gait training compensatory training (?)
patients, who are not able to walk 
acute/subacute stage chronic stage
Flowchart 2 Main therapeutic goals and interventions in the different phases of recovery in 
patients who are not able to walk
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these patients (see Flowchart 3). There is higher quality of evidence for such 
training in the subacute than in the chronic stage after stroke.
• Clinically meaningful improvements of balance are best achieved when dynamic 
balance training is performed as an integral part of stance and gait training and/
or during relevant ADL sessions. Such training may also lead to a reduction of 
main aim: improvement of gait and mobility

















moderate to intensive 
training
integration into a 
specific functional 
context
integration into a 
specific functional 
context
integration into a 
specific functional 
context
re-integration into participatory domains 
e.g. self-care, living with the family, return to work
- training, preparation for and practical support -  
Flowchart 3 Main therapeutic goals and therapeutic principles depending on different rehabilita-
tive priorities in patients who are able to walk (with some help)
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the number of falls after stroke. Again, there is higher quality of evidence for 
training in the subacute than in the chronic stage after stroke.
• While basic walking abilities and balance seem to be basic elements of mobility 
which have to be relearned early after stroke, walking speed and walking dis-
tance can be improved both during the subacute and chronic phases after stroke. 
Their training is most effective if the demands are increased progressively. It is 
not yet known, whether walking speed in the chronic stage is influenced by train-
ing schedules in the early phase after stroke.
• In addition to the main interventions, a great number of possible interventions 
are available, which have also been shown to be effective. These may be chosen 
according to the specificity of the clinical deficits and the individual preferences 
of the patients.
• In contrast to other tasks and activities after stroke (e.g., hand motor control, 
speech), gait and balance training seems to be more effective when the relevant 
functions are trained task and goal-specific with regard to the relevant activity. 
There is not much carryover from one task to another. This is even true for the 
training of strength and endurance.
• In the same line, additional stimulation techniques in order to further plasticity 
(e.g., central and peripheral stimulation) seem to be only effective when per-
formed in combination with functionally relevant aspects of gait training.
In the last years, goal setting during neurological rehabilitation concentrated 
more and more on activities, which are often more meaningful to patients than basic 
functions, which were mainly trained earlier in the twentieth century. Not surpris-
ingly, the main outcome parameters of scientific studies are today mostly activities 
and participation including quality of life—but not functions any longer. Therefore, 
we learned a lot about how to help patients to regain predefined activities and 
skills—but less on how to change basic networks in the brain and train basic senso-
rimotor abilities outside the labs.
The aim of our work was not only to evaluate the different forms of rehabilita-
tive interventions but also to distill the principles of effective treatment for the 
different aspects of mobility. This is especially important as worldwide most 
strokes happen in low- and middle-income countries (Norrving and Kissela 
2013) and thus not in Western Europe, North America, or Australia, where most 
of the guideline development takes place. Local and regional culture and tradi-
tions in Africa, the Middle East, or South America may stress the importance of 
other aspects of mobility, e.g., “standing and walking without a visible aid” and 
of therapeutic settings, e.g., “therapeutic sessions with individual therapists 
instead of sessions in a group setting.” Regional and local traditions and the cul-
tural background will influence goal setting and the choice of therapeutic inter-
ventions. Regardless of regional and local traditions, the above described 
elementary rules should be part of these clinical pathways to further the recovery 
of walking ability after stroke.
K. M. Stephan and D. Pérennou
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1  Introduction
Post-stroke spasticity (PSS) is a complication that contributes to limitations in per-
formance of activities and community participation. It occurs in anywhere from 
19% (Sommerfeld et al. 2004) to 92% (Malhotra et al. 2011) of stroke survivors. Its 
prevalence may be as high as 38% in the first year following a stroke (Watkins et al. 
2002). Estimates of incidence and prevalence vary widely perhaps due differences 
in the definition and clinical measurement of spasticity in varying severity and chro-
nicity of stroke. As well, based on a prospective, observational study, Wissel et al. 
(2010) found a prevalence of spasticity in 24.5% at 6 days, 26.7% 6 weeks, and 
21.7% (18 of 83 survivors at 16 weeks). The same group also found that in 98% of 
150
subjects with PSS, velocity-dependent increase in muscle tone in one joint was 
evident at about 6 weeks post-stroke.
Beside identified early clinical signs that predict PSS (velocity-dependent 
increase in muscle tone in two or more joints, severe paresis and loss of function 
resulting in severe disability/loss of ADL), recent studies showed that brain lesions 
involving the basal ganglia, thalamus, insula, and white matter tracts especially the 
internal capsule, corona radiata, external capsule, and superior longitudinal fascicu-
lus are also predictive for PSS when lesion load is compromising the corticospinal 
tract (Wissel et al. 2015; Lee et al. 2019).
There is a heightened awareness of the need to manage spasticity because not 
only can it limit limb movement and overall mobility but also can predispose to 
other complications, such as joint contractures and pain, which further magnify 
motor weakness and functional limitations. In this chapter, current evidence will be 
assessed in the following key clinical areas:
 – Problem identification and clinical assessment.
 – Treatment goal setting.
 – Pharmacological and surgical treatment.
2  Methods Used for Evidence Synthesis 
and Practice Recommendations
A comprehensive literature search was performed on 30 July, 2017 on PubMed 
(MEDLINE database) for guidelines, systematic reviews and meta-analyses (SR), 
and randomized controlled studies (RCT) published in the last 5 years on the topic 
of spasticity treatment across etiologies. This was performed in conjunction with 
preparations for the German Neurology Society S2k (consensus) guideline on the 
“Treatment of spasticity” (Platz et al. 2019). Search terms for SR and RCT were: (1) 
(Search (meta analysis [Publication Type] OR meta analysis [Title/Abstract] OR 
meta analysis [MeSH Terms] OR review[Publication Type] OR search*[Title/
Abstract]) AND (spast*)); (2) (Search ((clinical[Title/Abstract] AND trial[Title/
Abstract]) OR clinical trials as topic[MeSH Terms] OR clinical trial[Publication 
Type] OR random*[Title/Abstract] OR random allocation[MeSH Terms] OR thera-
peutic use[MeSH Subheading]) AND (spast* OR ton*)) AND (“last 5 years”[PDat]). 
The search initially yielded 297 references, and after eliminating duplicates, 215 
references remained, of which 28 were directly relevant for the preparation of said 
guideline. The vast majority of the 28 manuscripts were systematic reviews.
Additionally, the S2e (evidence-based) German Society for Neurorehabilitation 
(DGNR) guideline on “Treatment of Spasticity after Stroke” (Winter and Wissel 2013) 
was referenced and all essential information included. For the DGNR guideline (Winter 
and Wissel 2013), 172 references (164 original papers, 8 reviews) were evaluated, of 
which 111 served as a basis for the guideline, which included non- experimental studies 
(e.g., case series and cohort studies). In addition, further studies and reviews that were 
known to the authors and relevant for the healthcare question addressed were included.
The recommendations given below are based on the evidence as presented below. 
We categorized the level of evidence used for recommendations according to the 
G. E. Francisco et al.
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Oxford Centre for Evidence-Based Medicine Levels of Evidence (CEBM 2009). 
Further, the quality of this evidence has been grouped into four categories according 
to “GRADE” (“Grades of Recommendation, Assessment, Development and 
Evaluation”) (Owens et al. 2010):
• High quality: further research is unlikely to affect our confidence in the estima-
tion of the (therapeutic) effect.
• Medium quality: further research is likely to affect our confidence in the estima-
tion of the (therapeutic) effect and may alter the estimate.
• Low quality: further research will most likely influence our confidence in the 
estimation of the (therapeutic) effect and will probably change the estimate.
• Very low quality: any estimation of the (therapy) effect or prognosis is very 
uncertain.
The grading of the recommendations according to GRADE (Schünemann et al. 
2013) corresponds to the categories “ought to” (A) (strong recommendation), 
“should” (B) (weak recommendation). As a third category had been introduced 
“can” (0) (option) (Platz 2017). Recommendation category A is granted for clini-
cally effective interventions with high-quality evidence support (and when manda-
tory, e.g., for ethical reasons); with medium-quality evidence category B, and with 
low- or very low-quality evidence category 0 can be appropriate. Reasons to upgrade 
or downgrade are given: A+ or B+ denote a strong or weak recommendation in favor 
on an intervention and A− or B− against its use.
3  Problem Identification and Clinical Assessment
When assessing clinical problems associate with post-stroke spasticity, it is very 
important to keep in mind that spasticity defined as muscle overactivity as a positive 
sign of the upper motor neuron syndrome (UMNS) is only one component. The 
problems may be caused by other motor impairments, such as weakness, and/or dis-
ordered motor control. For example, patients may complain of abnormal joint posi-
tions, or that a limb could not be moved, or the resultant functional limitations, such 
as the inability to release a grasped object or difficulty with walking due to an inverted 
foot. In the majority of post-stroke patients, these problems are a combination of the 
above motor impairments. Thus, it is important to obtain a thorough, yet focused, 
history to identify clinical problems, to guide the examination, and to formulate 
treatment goals and plans. A systematic approach to history-taking and clinical 
assessment of spasticity that can be modified to suit different clinical scenarios is 
proposed in Tables 1 and 2.
With respect to the distribution of the positive signs of the UMNS identified as 
involuntary muscle overactivity (velocity-depended increase in muscle tone, 
spasms, clonus, spastic dystonia, and co-contracting muscle activation) spasticity 
could be classified as focal (one joint/functional region, e.g., the wrist and fingers), 
multifocal (minimal two or more joints, e.g., wrist, fingers, and ankle), segmental 
(adjacent joints in one or more limbs, e.g., toes, ankle, knee, and hip in one or two 
limbs, paraspastic: both lower limbs), hemispastic (arm and leg on one body side), 
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Table 1 Some important historical points in spasticity assessment
Is the limb tight all the time or only at certain times?
Does a particular position or movement trigger tightness?
Is the tightness related to spasms?
Does the tightness cause pain?
Have there been episodes of skin compromise due to tightness or spasm?
Does the tightness result in difficulty with cleaning?
Does the tightness result in difficulty donning splints?
Does the tightness limit ability to move limbs, reach for objects, and use the hands?
Does the tightness of the lower limbs result in problems with transferring form one surface to 
another or with walking?
What treatments for muscle tightness have been tried previously and their outcome?
What are the current medications?
Was there a recent increase in tightness (that may warrant further diagnostic testing to rule out 
a new neurologic problem)?
Any recent medical problems?
From Francisco GE and Li S. Clinical assessment and management of spasticity and contractures 
in traumatic brain injury. Chapter 8 In Neurological Rehabilitation Spasticity and Contractures in 
clinical practice and research. Pandyan AD, Hermens H, Conway B (2018). https://doi.
org/10.1201.9781315374369
Table 2 Practical clinical examination sequence
Examination 
phase What to look for What can be gleaned
Observation Observe limb posture at rest and how 
they change with position
Abnormal posture at rest—




Activea How limbs move and how much active 
range is available
Gait characteristics and associated upper 
limb and trunk postural abnormalities
Functional strength, coordination, 
spastic co-contraction, contractures, 
presence of other movement 
disorders, synkinesis, or associated 
reactions
Pain and discomfort during 
voluntary movements
Passive Passive range of motion, strength, muscle 










Performance of specific tests and tasks 
(both formal tests, such as Frenchay and 
improvised tasks such as demonstrating 
ability to pick up a bottle of water and 
pour its contents to a cup)
Impact of multiple impairments 
(e.g., spasticity, weakness) on 
performance
aActive movements, such as sit to stand, transfer, and ambulation, could be part of functional tests
G. E. Francisco et al.
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or generalized (more than two limbs involved, e.g., both legs and additional focal or 
segmental distribution of spasticity in arms, jaw, and trunk (Wissel et al. 2009)).
Spasticity assessment typically consists of a combination of quantitative and 
qualitative measures. Clinically, the Ashworth scale (AS), the modified Ashworth 
scale (MAS), and the Tardieu scale (TS) are most commonly used (Tables 3 and 4). 
Standardization of performance and scoring and summary scores across muscles 
groups were developed for the AS and resulted in high internal consistency, inter- 
rater, and test–retest reliability of a summary rating scale (REsistance to PASsive 
movement scale, REPAS) (Platz et al. 2008). A recent meta-analysis study reports 
satisfactory scores of inter- and intra-rater reliability in MAS, particularly when 
used for the upper extremity (Meseguer-Henarejos et al. 2018). The TS has advan-
tages over the MAS because not only it quantifies the muscles’ reaction to passive 
stretch but also it controls for the velocity of the stretch and measures the angle at 
which the catch, or clonus activity, occurs (Haugh et al. 2006); here, however, issues 
of reliability still have to be solved for the clinical user (Ansari et al. 2013; Li et al. 
2014; Banky et al. 2019). In patients with severe brain injury, the MTS was shown 
to provide higher test– retest and inter-rater reliability compared to MAS (Mehrholz 
et al. 2005). This is supported by other investigations (Paulis et al. 2011; Singh et al. 
Table 3 Ashworth scale and modified Ashworth scale
Ashworth scale
0 No increase in tone
1 Slight increase in tone giving a catch when the limb was moved in flexion or extension
2 More marked increase in tone but limb easily moved
3 Considerable increase in tone, passive movement difficult
4 Limb rigid in flexion or extension
Modified Ashworth scale
0 No increase in muscle tone
1 Slightly increase in tone, manifested by a catch and release at the end of ROM
1+ Slightly increase in tone, manifested by a catch, followed by minimal resistance 
throughout the remainder (less than half) of the ROM (catch in the first half of ROM)
2 Marked increase in tone through most of the ROM, still easily moved
3 Considerable increase in tone, passive movement difficult
4 Affected part(s) rigid in flexion or extension
Table 4 Tardieu scale Quality of muscle reaction
  0. No resistance
  1. Slight resistance
  2. Catch followed by a release
  3. Fatigable clonus (<10 s)
  4. Infatigable clonus (>10 s)
Angle of muscle reaction at different velocities of stretch
  V1. As slow as possible
  V2. Speed of limb galling under gravity
  V3. As fast as possible
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2011). Caution regarding reliability, however, was raised in at least two investiga-
tions (Ansari et al. 2008, 2013; Li et al. 2014).
To assess pain associated with arm spasticity following stroke a valid and reli-
able instrument, the Spasticity-Associated Arm Pain Scale (SAAPS), for adults with 
post-stroke upper limb spasticity was developed (see Table  5; (Fheodoroff et  al. 
2017)). Most studies published on spasticity-related pain have used nonspecific 
pain-assessment scales, e.g., the 11-point box scale (NRS) or visual analog scale 
(VAS). However, such scales have not been validated in patients with spasticity- 
related arm pain and may lack the sensitivity to detect change and may also be 
unsuitable for use in patients in nursing care homes, many of whom have severe 
cognitive impairment or late-stage dementia (Lichtner et al. 2014; Tyson and Brown 
2014). To address these shortcomings when documenting or managing pain in 
patients with arm spasticity following stroke, the SAAPS was developed and evalu-
ated and showed its sensitivity for detecting and documenting pain and its reduction 
following BoNT-A treatment in pain associated with arm spasticity following stroke 
(Fheodoroff et al. 2017).
While it is true that quantitative measures are desirable because of their inherent 
objectivity and reliability, they may not be practical and may discourage clinicians 
from assessing and managing spasticity. Quantitative assessment includes biome-
chanical and electrophysiological assessments. Biomechanical assessment utilizes 
the concept of velocity-dependent increase in resistance and has advantages of the 
ability to differentiate neural and nonneural component of spastic hypertonia, thus 
spasticity vs. contracture (Sinkjaer and Magnussen 1994; Kamper et al. 2003; Li 
et al. 2006). The measurement of electromyographic activity is able to determine 
the threshold of stretch reflex, i.e., a physiological evidence of the onset of spasticity 
(Levin and Feldman 1994; Calota et al. 2008). Advances in quantitative ultrasound 
Table 5 The Spasticity- 
Associated Arm Pain Scale 
(SAAPS) for adults with 
post-stroke upper limb 
spasticity: passive range of 
motion items and ratings
Item Description
1 Paretic shoulder abduction with elbow flexed to 90°







1 Pain on repeated movement (maximum of five 
repetitions)
2 Pain on end-range movement
3 Immediate pain on movement
Verbal and/or physiological responses (pain responses) are rated 
on a four-point Likert-type scale as 0 (“no pain”), 1 (“pain on 
repeated movement” (maximum of five repetitions)), 2 (“pain on 
end-range movement”), or 3 (“immediate pain on movement”). 
The SAAPS sum score ranges from 0 to 15 points, whereas 0 is 
the lowest and 15 is the highest pain intensity during passive 
range of motion in moderate speed of movement
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imaging have shown some promising pilot data to quantitatively assess spastic mus-
cles (Wu et al. 2017; Gao et al. 2018). Ideal spasticity assessment should include 
biomechanical and electrophysiological tests, but many of the devices are not avail-
able to a typical clinician, and the time needed to perform them properly may 
impose excessive demands in a busy practice.
Recommendations: It is important to keep in mind that spasticity could be one 
component of motor impairments and clinical problems following stroke and may 
contribute to reduction in activities of daily living and quality of life in about 
10–12% of chronic stroke survivors. Spasticity should be classified according to the 
topical distribution as focal, multifocal, segmental, hemispastic, paraspastic, or as 
generalized spasticity. It should primarily be assessed and documented by standard-
ized validated clinical assessment scales such as the AS or MAS (level of evidence 
2a, quality of evidence moderate, B+) or TS (level of evidence 2b, quality of evi-
dence low, 0).
4  Treatment Goal Setting
4.1  Goal Setting
The mere presence of spasticity is not always a reason to initiate treatment. Varying 
in its severity, spasticity is usually addressed when it presents with marked limita-
tion in range of motion due to abnormally increased muscle tone. Consideration, 
however, should be given to managing less-than-severe spasticity if it has profound 
impact on comfort and functioning. An example is a person with pes equinovarus 
deformity whose ankle plantar flexors and invertors merit only a modified Ashworth 
Scale score of 1+ at rest, but causes discomfort during walking. Spasticity interven-
tion ought to be considered not only based on severity but also on functional signifi-
cance and impact on well-being. Thus, the first important step in managing spasticity, 
and right after problem identification, is laying out the rationale for treatment by 
identifying goals. Goals, especially patient-centered ones, are a basis for collabora-
tion by patients and clinicians. Together (patient/care giver and clinician), they 
agree on the desired treatment outcome, which will be based on the extent to which 
goals were achieved. To assist in developing goals, a useful matrix, SMARTER, can 
be used (Francisco and Li 2015). This mnemonic stands for goals that are:
• S: Specific (well-defined and targets a specific problem to be addressed).
• M: Measurable (either quantitatively, as for technical goals, or qualitatively as 
for symptom-directed goals); Meaningful (achievement of goal should be benefi-
cial to the patient or caregiver).
• A: Agreed upon (the patient or caregiver and clinician work toward a com-
mon end).
• R: Realistic (will the patient’s potential for improvement and available resources 
support achievement of treatment goal?)




• E: Evaluated (at pre-determined points in time, goal achievement and progress in 
doing so should be performed to determine effectiveness of intervention).
• R: Revised (based on evaluation of goal achievement, new treatment goals may 
be identified or prior ones revised).
A recent national, multicenter study (Ashford et al. 2016) suggested that goals 
can be classified into two domains, namely, symptoms and impairment, and activi-
ties/function. The former includes pain/discomfort, involuntary movements, and 
range of movement/contracture prevention. Within the second domain are passive 
function (e.g., ease of caring for affected limb), active function (using affected 
limbs to perform tasks), and mobility.
4.2  Goal Attainment Scaling
The most commonly used measure to document treatment goals is goal attainment 
scaling (GAS), which was originally used in other healthcare settings (Kiresuk and 
Sherman 1968; Rockwood et al. 1997). GAS tracks the extent to which pre- identified 
patient-specific treatment goals are achieved using an ordinal scale during the 
course of treatment. The scoring method is standardized to promote consistent 
repeatability as the patient and clinician review the progress of goal achievement. In 
addition, early studies comparing GAS with more traditional outcome measures 
suggest that GAS is more sensitive. Active patient engagement through GAS may 
have beneficial impact on achievement of outcomes. Emerging evidence demon-
strate that when patients are involved in goal setting, they are more likely to achieve 
their goals (Turner-Stokes et  al. 2015). GAS also shows promise as a means of 
conveying caregiver burden as it is sensitive in highlighting priority outcomes by 
patients and caregivers (Turner-Stokes et al. 2010).
Recommendation: An important component of assessment and management 
decision-making is arriving at treatment goals. Identifying goals that are mutually 
agreed upon by the patient, caregiver, and clinician a priori should be an important 
step in spasticity treatment decision-making (level of evidence 2b, quality of evi-
dence moderate, B+). In this context, GAS is a useful tool in negotiating goals, 
highlighting priority outcomes by patients and caregivers, and tracking their 
achievement. GAS also encourages patient engagement in goal setting, which has 
been shown to have a positive relation to achieving the said goals.
5  Pharmacological and Surgical Treatment
5.1  Systemic Medications
Various oral medications with different mechanisms of action have been used to 
treat spasticity. The most commonly used medications include baclofen, tizanidine, 
dantrolene and benzodiazepines. Overall, these medications have marginal effect on 
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focal spasticity (Simpson et al. 2009) and marginal to moderate effects on reducing 
segmental and generalized spasticity (Montane et al. 2004). In a systematic review 
on contemporary pharmacologic treatments for spasticity of the upper limb after 
stroke. Olvey et al. (2010) only found one study with a systemic drug (tizanidine) 
that reported significant reductions in upper limb spasticity after 16 weeks of treat-
ment compared to placebo.
In a Cochrane review on pharmacological interventions other than botulinum 
toxin for spasticity after stroke, Lindsay et al. (2016) found seven RCTs with a total 
of 403 participants. Only two of them assessed a systemic drug versus placebo and 
only one with tizanidine showed significant results. Those two studies included 160 
patients and in the meta-analysis of those the antispastic effect of the oral drugs on 
spasticity showed no significant effects (MAS, Odds Ratio for Response 1.66, 95% 
KI 0.21–13.07; n.s.). On the other hand, the authors identified a significant risk of 
adverse events per participant occurring in the treatment group versus placebo 
group (risk ratio (RR) 1.65, 95% CI 1.12 to 2.42; 160 participants; I2 = 0%).
The common adverse effects of oral drugs include dose-dependent adverse 
effects, such as drowsiness and tiredness. Therapeutic efficacy of these medications 
is only supported by a few placebo-controlled trials with inadequate sample size and 
lack of functional outcome measurements (Francisco and McGuire 2012; Winstein 
et al. 2016). Furthermore, likely attributed to these adverse effects or a reflection of 
limited efficacy, oral medications have poor adherence (Halpern et  al. 2013). In 
general, it is recommended to limit the use of these oral medications for spasticity 
management (Francisco and McGuire 2012; Winstein et  al. 2016). On the other 
hand, these oral medications as single drug or combination may be a cost-effective 
treatment option for those who can achieve adequate spasticity management with-
out intolerable adverse effects.
Baclofen, a gamma amino butyric acid (GABA)-B agonist, is a potent inhibitory 
neurotransmitter. Baclofen has been shown dose-dependent reduction of spasticity 
and spasms, but has side effects of drowsiness and weakness. Abrupt discontinua-
tion of baclofen may result in a withdrawal syndrome, characterized by rebound 
spasticity, hallucinations, and seizures (Medaer et al. 1991; Meythaler et al. 2004). 
Similar to baclofen, benzodiazepines modulate GABAergic transmission by bind-
ing GABA-A receptors. Similarly, abrupt discontinuation of benzodiazepines may 
result in a withdrawal syndrome. Concerns for its side effects, mainly drowsiness, 
sedation, reduced attention and memory impairment, and the potential for physio-
logical dependence have limited the use of benzodiazepines as first-line treatment 
for spasticity. The use in post-stroke spasticity management is discouraged and 
might be reserved to situations when spasticity is accompanied by other conditions 
that are also amenable to benzodiazepine therapy, such as seizures, anxiety, insom-
nia, spasms, and other movement disorders (Medaer et  al. 1991; Meythaler 
et al. 2004).
Tizanidine, a central alpha2-adrenergic receptor agonist, reduces spasticity and 
clonus via inhibiting the facilitatory ceruleospinal tracts and the release of excit-
atory neurotransmitters from spinal interneurons (Stevenson and Jarrett 2006). In 
addition to the typical side effects of oral spasmolytics, hepatotoxicity may also 
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occur. Thus, monitoring liver function is important, especially in those patients who 
concomitantly take hepatically cleared drugs.
Unlike baclofen and tizanidine, dantrolene works directly on skeletal muscle by 
inhibiting the release of calcium from the sarcoplasmic reticulum during excitation–
contraction coupling (Krause et al. 2004). Although it is peripherally acting, dan-
trolene has also been associated with side effects that appear to be centrally 
mediated, such as drowsiness, dizziness, fatigue, and weakness, perhaps through 
alteration of neuronal calcium homeostasis (Flewellen et  al. 1983; Katrak et  al. 
1992). Due to its potential for hepatotoxicity, regular monitoring of liver function is 
recommended.
Beside baclofen, tizanidine, and dantrolene, other agents have reported to have 
some effects, including tolperison (Stamenova et al. 2005), gabapentin, clonidine, 
nabilone (Wissel et al. 2006), and cannabinoids (Whiting et al. 2015).
Summing up the results from studies on oral drugs in PSS, the evidence pub-
lished from RCTs showed significant risk of side effects and no sufficient data to 
confirm that systemic antispastic drugs are effective in treating PSS.
Recommendations: Oral systemic medications can be used for segmental and gen-
eralized spasticity, but may be associated with dose-dependent adverse effects (level 
of evidence 2b, quality of evidence low, 0). Selection of type of oral medication 
depends on individual circumstances and may include combinations. These medica-
tions should be titrated slowly, and both clinical benefits and unwanted effects need to 
be monitored (level of evidence 1a, quality of evidence low, B+ [clinical reasoning]).
5.2  Botulinum Toxin Treatment
Botulinum toxin Type A (BoNT-A) is widely regarded as the treatment of choice for 
the medical management of focal and multi-focal signs and symptoms of the UMNS 
including but not limited to hypertonia, spastic dystonia, clonus, and spasms. 
Systematic studies have also demonstrated improvement in so-called passive func-
tion like reducing spasticity-associated pain, hygiene and passive movement of 
involved limbs, and reduction of mal-positioning of limbs (Brashear et al. 2002a, b) 
(level of evidence 1b). Demonstration of active functional gains in terms of enhance-
ment of active limb movements in the upper limbs (e.g., reaching or grip and relieve 
movements with the hand) and increased mobility (e.g., gait speed and gait endur-
ance) has proven to be difficult. But systematic reviews of the outcome of BoNT 
treatment in spastic upper limbs (Foley et al. 2013; Dong et al. 2017) (level of evi-
dence 1a) and a randomized, controlled, trial in subjects with chronic PSS and trau-
matic brain injury–related spastic upper limb (Gracies et al. 2015) (level of evidence 
1b) reported statistically significant functional improvements in active function of 
the upper limb.
Controlled studies in the post-acute phase of stroke rehabilitation (less than 
3 months following stroke) showed that BoNT-A injected before spasticity became 
moderate or severe result in improvements in impairment and passive function and 
reduced occurrence of muscle and/or tendon shortening in long finger flexors (Hesse 
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et al. 2012). The therapeutic outcomes also appeared to be more pronounced and 
longer lasting (Rosales et al. 2012; Fietzek et al. 2014) (level of evidence 1b). Thus, 
early BoNT-A intervention seems to have the potential to modify the natural evolu-
tion of PSS while a resent systematic review did not indicate higher functional gains 
or effects on disability (Rosales et al. 2016).
5.2.1  Treatment Outcomes: Upper Limbs
Numerous controlled studies and multiple meta-analyses show a dose-dependent 
effective reduction of spastic muscle tone, improvement in passive range of motion 
(PROM) and passive function (measured with the Disability Assessment Scale, 
DAS) as well as a reduction in carer burden while handling affected limbs, both by 
single and repeated intramuscular injections of BoNT-A (abobotulinumtoxinA, 
incobotulinumtoxinA, and onabotulinumtoxinA) in upper limb with increased spas-
tic hypertonia in the chronic stage after stroke and other etiologies ((van Kuijk et al. 
2002; Turkel et al. 2006), level of evidence 1a; (Simpson et al. 2008, 2016), level of 
evidence 1a; (Gracies et al. 2015), level of evidence 1b; (Dong et al. 2017), level of 
evidence 1a)). In severely affected arms, BoNT-A application supports self-care 
activities and integration of the spastic arm in everyday life by improving passive 
function (Baker and Pereira 2015) (level of evidence 1a). Evidence quality for the 
11 studies for arm spasticity in a meta-analysis was moderate (GRADE). Significant 
results of BoNT-A therapy were observed for 4 to 12 weeks post-injection (SMD 
0.80, 95% CI 0.55 to 1.06, P < 0.0001) and continued for up to 6 months (SMD 
0.48, 95% CI 0.34 to 0.62, P < 0.0001). Randomized trials included in the system-
atic review showed a reduced incidence of shortening of finger muscles with 
improved hand hygiene (Hesse et  al. 2012; Rosales et  al. 2012) (level of evi-
dence 1b).
In the subacute phase (<3 months) after stroke following BoNT-A use, forearm 
and leg spasticity significant reductions in velocity-dependent tone increase over 
more than 3 months could be documented in a systematic review with meta-analysis 
(3 studies), whereas no greater functional gains and no increase in side effects were 
shown (Rosales et al. 2016) (level of evidence 1a).
BoNT-A injections may improve active function in some of the patients with arm 
spasticity (Foley et al. 2013; Gracies et al. 2015; Baker and Pereira 2016, level of 
evidence 1a). Evidence quality for the six studies for effects on arm activities in a 
meta-analysis was low to very low (according to GRADE). A small significant 
result of BoNT-A therapy was documented 4 to 12 weeks post-injection (SMD 0.32, 
95% CI 0.01 to 0.62, P = 0.04) and only for the Action Research Arm Test (ARAT)—
persisted for up to 6 months (MD 1.87, 95% CI 0.53 to 3.21, P = 0.006). In a single 
randomized controlled trial of abobotulinumtoxinA, an increase in active finger and 
wrist extension with BoNT-A injections into the finger flexors was found and sup-
ported the prior statement (Gracies et al. 2015), (level of evidence 1b). For treatment 
of focal spasticity after stroke, BoNT-A is superior to oral antispastic medication 
(tizanidine) in terms of both efficacy, measured as reduction in muscle tone with the 




Recommendations: BoNT-A therapy should be considered for clinically rele-
vant upper limb PSS that does not sufficiently respond to nonpharmacological treat-
ment. In these cases, it should be entertained when the therapeutic goal is to support 
passive functions (prevention of contractures; hygiene, washing, dressing) (level of 
evidence 1a, quality of evidence moderate, B+) and can be used in selected cases to 
support active function (level of evidence 1a, quality of evidence low, 0).
5.2.2  Treatment Outcomes: Lower Limbs
In chronic ankle flexion spasticity with spastic pes equines and equinovarus gait 
pattern, significant reduction of muscle tone in the ankle following treatment with 
abobotulinumtoxinA and onabotulinumtoxinA by intramuscular injections into the 
calf muscle could be demonstrated after stroke (Pittock et al. 2003; Kaji et al. 2010; 
Wein et al. 2018) (level of evidence 1b) and after stroke and TBI (Gracies et al. 
2017) (level of evidence 1b). Additionally a reduced use of gait tools (orthosis) and 
an improvement of the Clinical Global Impression Scale in gait were shown 
((Pittock et al. 2003; Gracies et al. 2017; Wein et al. 2018), level of evidence 1b). 
However, no significant improvements in longitudinal gait parameters (e.g., gait 
speed and gait endurance) of the patients treated with BoNT-A could be achieved in 
that trials.
One systematic review (mainly by observational studies and case series, 14 stud-
ies, 181 patients) also shows a reduction of clonus activity in patients with chronic 
ankle flexion spasticity as an improvement in a different positive sign of the UMNS 
that velocity-dependent increase in muscle tone from BoNT treatment 
(Thanikachalam et al. 2017) (level of evidence 3a).
With respect to the treatment of hip and knee spasticity using BoNT-A injections 
(abobotulinumtoxinA, onabotulinumtoxinA, and incobotulinumtoxinA), clinical 
studies were able to show reduction of spastic movement disorders in hip and knee 
in the chronic stage of spasticity of different etiologies (stroke, traumatic brain 
injury, multiple sclerosis, and others), and it was also possible to conclude that inter-
ventions with BoNT-A showed improving mobility ((Hyman et al. 2000; Rosales 
and Chua-Yap 2008; Wissel et al. 2017), level of evidence 1b).
In an open dose-escalation study with incobotulinumtoxinA, dose escala-
tion from 400 units to 600 units and 800 units showed increasing numbers of 
treated upper and lower limb muscles or spastic patterns (combinations of 
typical spastic muscle activation, e.g., spastic pes equines, pes varus, flexed 
elbow or wrist, and spastic fist) per escalation level and led to almost double 
the number of patients, who were able to walk independently without increas-
ing the incidence of side effects at higher dose levels (Wissel et  al. 2017) 
(level of evidence 2b).
Recommendations: BoNT-A therapy can be considered for clinically relevant 
lower limb PSS (ankle, knee, or hip) that does not sufficiently respond to nonphar-
macological treatment (level of evidence 1b, quality of evidence moderate, 0 (func-
tional benefit uncertain)). It is also an option to treat functionally relevant sustained 
clonus (level of evidence 3a, quality of evidence low, 0).
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5.2.3  Treatment Outcomes: Spasticity- or Spasm-Associated Pain
Neuropathic (e.g., spontaneous burning pain in plegic limbs), nociceptive (e.g., 
knee joint pain when starting walking), spasm-related, and spasticity-associated 
(stretch- or exercise-induced muscle pain) pain following stroke are all part of the 
decision-making process with respect to selection of symptomatic treatment and 
treatments should be tailored accordingly (Finnerup 2017). Reduction of spasm-
related and stretch- or exercise-induced spasticity-associated pain in spastic limb 
segments after injections of upper and lower extremity onabotulinumtoxinA in 
chronic spasticity was observed in a cohort study with 60 patients with mixed eti-
ologies of spasticity in an open-label observational study and a randomized, 
placebo- controlled study in 273 patients following stroke and TBI ((Wissel et al. 
2000, 2016), level of evidence 2b and 1b). Spasticity-associated stretch- or exercise- 
induced arm (Fheodoroff et al. 2017) or shoulder pain (Yelnik et al. 2007; Lim et al. 
2008) also showed favorable influence by injections of abobotulinumtoxinA, inco-
botulinumtoxinA, and onabotulinumtoxinA (Fheodoroff et al. 2017, level of evi-
dence 2b; Yelnik et al. 2007; Lim et al. 2008, level of evidence 1b).
Recommendations: BoNT-A therapy can be considered to treat spasm-related 
and stretch- or exercise-induced spasticity-associated pain in spastic limb segments, 
both in the upper or lower extremity (level of evidence 1b, quality of evidence low 
[partially indirect], 0).
5.2.4  Botulinum Toxin A Injection Guidance
It is believed that in order to improve the accuracy of BoNT injection, instrumented 
guidance using ultrasonography (US), electrical stimulation (ES), and electromyog-
raphy (EMG) may be superior to a non-guided (e.g., pure anatomic localization) 
technique. Both ES and US appear to yield superior results over non-guided injec-
tion technique when BoNT is injected in wrist and finger flexors (Picelli et al. 2014; 
Santamato et al. 2014). ES (Chin et al. 2005; Picelli et al. 2012) and US (Picelli 
et al. 2012) have also been shown to be superior to anatomical guidance and EMG 
when injecting the triceps surae. A systematic review indicated that instrumented 
injection guidance is more effective than manual needle placement and showed 
similar effectiveness of US and ES for upper and lower limb spasticity in stroke 
(Grigoriu et al. 2015). A more recent investigation did not find a significant differ-
ence in clinical results among the various injection techniques when analyzing 
results of BoNT injections in a setting of an outpatient clinic (Zeuner et al. 2017). 
Thus, there is still no clear evidence that one injection technique is superior over 
another, but current literature suggests that for certain muscles instrument-guided 
injection is superior to pure anatomic localization (deep neck, forearm, and deep 
calf muscles).
Recommendation: Both US, ES, and EMG guidance can be used and are espe-
cially relevant when smaller or deeper muscles are injected (level of evidence 2a, 
quality of evidence low, 0). For the injection of larger superficial muscles, nonin-
strumented manual needle placement can be adequate (level of evidence 2a, quality 
of evidence low, 0).
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5.2.5  BoNT-A Products
BoNT-A drugs available are different and not interchangeable. (BoNT-B is also 
commercially available, but will not be included in this review considering its lim-
ited clinical use and scarcity of studies in spasticity. While BoNT-C and BoNT-F 
have been tried in human studies are up to now exclusive to dystonia.) The currently 
available BoNT-A drugs in Europe and North America are: abobotulinumtoxinA 
(Dysport®; Ipsen Ltd., Slough, Berks, UK), incobotulinumtoxinA (Xeomin®; Merz 
Pharmaceuticals, Frankfurt/M, Germany), and onabotulinumtoxinA (Botox®; 
Allergan Inc., Irvine, CA, USA). A recent entry in the market, daxibotulinumtoxinA 
(Revance, USA) is currently being investigated in both dystonia and spasticity. 
Additional BoNT-A drugs used in other countries (South America, India, and Asia) 
to manage spastic hypertonia and movement disorders include the Chinese BoNT-A 
Hengli® (Lanzhou Institute of Biological Products, Lanzhou, Gansu Province, 
China) and marketed as Prosigne® elsewhere (e.g., Brazil). Neuronox® (Medy-Tox, 
Ochang, South Korea) is another BoNT-A available in some Asian countries. It is 
important to note that there has been no published systematic head-to-head com-
parison of the clinical properties, safety, and efficacy of commercially available 
formulations of BoNT-A. Hence, clinicians choose a BoNT-A formulation to treat 
PSS based on availability and experience with particular formulations, and no rec-
ommendation can be made regarding choice of a BoNT-A formulation in PSS.
5.2.6  BoNT-A Dosing
Appropriate dosing of BoNT-A is crucial in optimizing treatment outcomes and 
mitigating dose-related adverse events. Unfortunately, there is scarcity of dose- 
ranging studies (Simpson et al. 1996; Hyman et al. 2000; Gracies et al. 2015, 2017; 
Wissel et al. 2017) to allow evidence-based clinical decision-making with regard to 
dose selection for specific muscles. Hence, clinicians choose doses based on drug- 
specific summaries of product characteristic in package inserts, clinical experience, 
availability of toxins, and expert consensus recommendations ((Wissel et al. 2009; 
Esquenazi et al. 2013; Schramm et al. 2014), level of evidence 3).
Physician surveys suggest that many believe that greater flexibility in dosing 
might benefit some patients (Bensmail et al. 2014; Wissel 2018). Recently, a pro-
spective, open-label, single-arm, multicenter, dose-titration study using high doses 
of incobotulinumtoxinA (up to 800 U) did not yield new safety signals (Wissel et al. 
2017) (level of evidence 2b). In this particular trial, it was shown that high doses of 
incobotulinumtoxinA enabled simultaneous treatment of upper and lower limb and 
was associated with higher treatment goal attainment and no increase in side 
effect rate.
5.2.7  Adjuvant Therapies to BoNT-A
In a systematic review (without meta-analysis) of nine randomized trials (7 with 
neuromuscular electrostimulation, 2 with functional electrostimulation, 182 partici-
pants), it was shown that adjuvant electrostimulation therapy enhances the effect of 
BoNT-A injections on spasticity (Intiso et al. 2017) (level of evidence 1a). In two of 
these studies (both RCTs), spasticity was more responsive to additional 
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electrostimulation after BoNT-A treatment than to additional stretching, but showed 
comparable effects as taping and lower effects than additional shock wave therapy. 
Neuromuscular electrostimulation was mostly performed in the studies for 30 min, 
1 to 6 times a day for 3 to 5 days after the injection. In another systematic review, 
17 studies were included; it was shown that the effect of BoNT-A injections could 
be improved by various adjuvant therapies (Mills et al. 2016). Thus, an added ben-
efit in the sense of a stronger tonus reduction (MAS ≥1) was demonstrated to be 
proven for concomitant physiotherapy, modified constraint-induced movement 
therapy (mCIMT), electrostimulation, casting and dynamic splint treatment com-
pared to BoNT-A alone, but not for taping, segmental muscle vibration, cyclic func-
tional electrostimulation, or motorized arm ergometer (Mills et al. 2016) (level of 
evidence 1a).
Individual examples from selected studies are: After BoNT-A treatment of spas-
tic calf muscles, a 1-week casting and to a lesser extent a 1-week taping showed 
better results with regard to spasticity reduction, increase of passive range of motion, 
and increased walking distance per time (6 min walking test) for 3 months after 
inclusion compared to a 1-week manual stretching by a physiotherapist following 
injection of BoNT-A (Carda et al. 2011) (level of evidence 1b). In another random-
ized controlled study for spastic pes equinus, no relevant additional effect of taping 
could be demonstrated (Karadag-Saygi et al. 2010) (level of evidence 1b).
In a Cochrane review, limited evidence could be provided as to whether and how 
multi-professional rehabilitation after BoNT-A treatment could improve spasticity 
in patients following stroke (3 RCS with 91 participants after stroke; (Demetrios 
et al. 2013), level of evidence 1a). With low-quality studies (GRADE) for mCIMT 
treatment following BoNT-A treatment, an improvement in active motor function 
and spasticity reduction could be shown. With very low-quality studies (GRADE) 
for occupational therapy following BoNT-A treatment improved in elbow mobility 
using a dynamic elbow extension splint compared to ergotherapy alone could 
be shown.
Recommendations: Neuromuscular electrostimulation applied for 3 to 5 days 
after BoNT-A therapy can be considered to enhance treatment effects in treated 
muscle groups (level of evidence 1a, quality of evidence low (risk of bias), 0). 
Safety aspects for the medical products used need to be taken into account. Other 
adjuvant therapies such as casting taping, mCIMT, and dynamic splint treatment 
can be used as individually indicated (level of evidence 1a, quality of evidence very 
low (risk of bias, inconsistency), 0). Active motor training and robotic training 
should be tailored to individual goals (refer to chapters on arm rehabilitation and 
mobility).
5.3  Neurolysis
Nerve blocks with neurolytic agents (phenol and alcohol) are effective in managing 
focal spasticity (Petrillo and Knoploch 1988; Chua and Kong 2000; Karri et  al. 
2017). For neurolysis, concentration of phenol usually ranges for 5% to 7%, while 
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concentration of alcohol varies from 50% to 100%. These agents denature proteins 
in axons and membranes nonselectively in both afferent and efferent nerve fibers, 
leading to denervation and degeneration of spindles (Bodine-Fowler et al. 1996). 
Therefore, it requires precise localization and injection of these agents to the nerve 
fibers at the trunk, branch, or motor points of the target nerves. Precision localiza-
tion is usually achieved with guidance of ultrasound imaging and/or electrical stim-
ulation (Karri et al. 2017). Neurolysis usually produce immediate anesthesic effects 
and a later neurolytic effect on spasticity reduction. The duration depends on the 
dose, accuracy of injection, and repeated injections, ranging from 3 to 9 months. 
Unlike BoNT-A injections, nerve blocks can be repeated as early as several days. 
Common adverse effects include post-injection dysesthesia, localized swelling, and 
excessive weakness. In a recent retrospective chart review of 293 procedures, phe-
nol neurolysis has a relatively favorable safety profile, including pain (4.0%), swell-
ing and inflammation (2.7%), dysesthesia (0.7%), and hypotension (0.7%) (Karri 
et al. 2017). Although nerve blocks are widely used to manage spasticity, there is 
paucity of evidence of efficacy and safety based on randomized controlled studies. 
In a randomized, double-blind trial which compared phenol neurolysis and BoNT-A 
injection in the treatment of ankle and foot spasticity after stroke (Kirazli et  al. 
1998), the authors reported that both interventions were effective in plantar flexor 
spasticity reduction. The benefits were more significant in the BoNT-A group at 
weeks 2 and 4 post-injection, while there was no significant difference between two 
interventions at weeks 8 and 12.
Recommendations: Phenol and alcohol neurolysis can be considered for clini-
cally relevant PSS that does not sufficiently respond to nonpharmacological treat-
ment (and oral medication), especially when BoNT-A treatment is not feasible 
(level of evidence 2b, quality of evidence low, 0). The possibility of long-term 
unwanted side effects, especially neuropathic pain following mixed nerve injec-
tions, need to be taken into account.
5.4  Intrathecal Baclofen (ITB)
Intrathecal baclofen therapy (ITB) is effective in managing post-stoke spastic 
hypertonia (Meythaler et al. 2001; Ivanhoe et al. 2006). It is licensed in the European 
Union to manage severe chronic spasticity in children between ages 4 and 18 years 
that is recalcitrant to oral spasmolytics and for managing severe spasticity of both 
cerebral and spinal etiology. In the United States (US), ITB is approved by the US 
Food and Drug Administration (US FDA) for managing severe spasticity of both 
cerebral and spinal etiology. Although few randomized, controlled trials of safety 
and efficacy exist, ITB has high levels of satisfaction among users of 10–24 years’ 
duration (Mathur et al. 2014).
The US FDA recommends initiation of ITB therapy 1-year after disease onset, 
but a consensus panel of ITB experts suggested that ITB can be considered as early 
as 3–6 months post-stroke when spasticity is not controlled by other modalities or a 
patient is unable to tolerate side effects of other treatments (Francisco et al. 2006). 
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A more recent consensus panel of experts (Saulino et al. 2016) recommended early 
consideration of ITB to avoid or delay various complications of spasticity and miti-
gate subsequent functional impairments. The same group commented that ITB 
should be considered only if other treatments have failed.
Meythaler et al. (2001) demonstrated superiority of ITB over placebo in a small 
cohort of stroke patients. Twenty-one stroke survivors with severe spasticity received 
either baclofen or placebo intrathecally. At 6  h post-bolus infusion, the average 
(mean ± SD) paretic lower limb Ashworth scores of the group that received baclofen 
decreased significantly from 3.3 ± 1.2 to 1.4 ± 0.7 (P < 0.0001), spasm score from 
1.2 ± 1.2 to 0.1 ± 0.3 (P = 0.0224), and reflex score from 2.1 ± 1.2 to 0.1 ± 0.5 
(P < 0.0001), compared to the group that received placebo. Seventeen subjects then 
received an intrathecal pump for continuous baclofen infusion. At 12 months fol-
lowing implantation and with an average daily dose of 268 micrograms per day, the 
average lower limb Ashworth score of the paretic side decreased from 3.7 ± 1.0 to 
1.8  ±  1.1 (P  <  0.0001), the spasm score decreased from 1.2  ±  1.3 to 0.6  ±  1.0 
(P = 0.4282), and the reflex score decreased from 2.4 ± 1.3 to 1.0 ± 1.3 (P < 0.0001).
The effect of ITB on ambulant stroke survivors is controversial. Small reports 
(Francisco and Boake 2003; Remy-Neris et al. 2003) showed improvement in gait 
speed following ITB therapy, but others demonstrated otherwise (Kofler et al. 2009).
A recent randomized, controlled, open-label, multicenter trial also demonstrated 
superiority of ITB therapy over conventional medical management (cMM) with oral 
spasmolytics in terms of efficacy (mean Ashworth scale score reduction, −0.99 
(ITB) vs. −0.43 (cMM); Hodges-Lehmann estimate −0.667 (95.1% CI −1.0000 to 
−0.1667); p  =  0.0140) and pain control (numbers). While more subjects who 
received ITB reported adverse events (24/25 patients, 96%; 149 events) compared 
to those who received cMM (22/35, 63%; 77 events), no new safety signals were 
discovered (Creamer et al. 2018a, b).
Recommendations: ITB can be considered for clinically relevant severe seg-
mental or generalized PSS that does not sufficiently respond to other interventions 
(level of evidence 1b, quality of evidence moderate, 0 (benefit risk for harm assess-
ment)). ITB treatment ought to be tested, initiated, adjusted, and monitored with 
long-term support (including emergency work-up when indicated) by physicians 
experienced with the treatment (level of evidence 1b, quality of evidence moderate, 
A+ (benefit risk for harm assessment)).
5.5  Surgical Management
Surgical procedures at the spinal cord level, such as interventions in the posterior 
root entry zone or dorsal rhizotomy, may be introduced in severe cases of spasticity 
after stroke, which are otherwise untreatable and represent a possibility of avoiding 
abnormal positions due to a severe spasticity and its complications in care, hygiene, 
pain, and contractures (review by (Chambers 1997), level of evidence 3a). One posi-
tive case report with persistent effects for the partial posterior rhizotomy is available 
in the literature ((Fukuhara and Kamata 2004), level of evidence 4). Controlled 
Post-Stroke Spasticity
166
studies on these procedures in children with cerebral palsy are published, and stud-
ies in adults following stroke are not available. One major criticism with this surgi-
cal procedure is that it may only bring temporal improvements.
Partial neurotomy of the motor branches of the tibial nerve to the triceps surae 
muscle is an established neurosurgical procedure and leads to reduced spastic mus-
cle tone in pes equinus or equinovarus deformity, and therefore can improve posi-
tioning of the foot and can reduce associated pain during walking ((Sindou and 
Mertens 2000), level of evidence 2b).
Following reports of successful orthopedic surgery with fasciotomy, transfer 
of muscle attachments, tendon transfer, and even bony surgery to increase upper 
and lower limb function in persons with low functioning spastic upper and lower 
limbs following spinal cord injury (Fox et al. 2018) (level of evidence 3) in the 
last 10 years also in chronic stroke patients with limited upper and lower limb 
function, those procedures became more available, but no large cohort studies 
are published. Fascia, tendon and muscle lengthening (e.g., Achilles tendon 
lengthening, soleus muscle fasciotomy, or lengthening), and tendon transfer sur-
gery (e.g., transfer of the tendon of the flexor carpi ulnaris muscle to the dorsal 
aspect of the wrist or tibialis posterior split transfer and transpositioning of a 
part of the tendon to the dorsal aspect of the foot) may help correcting spastic 
hand or foot posture and help to improve active wrist and foot extension to 
improve residual function as well as preventing complications due to spastic 
posturing and development of contracture ((Duquette and Adkinson 2018), level 
of evidence 4; (Sturbois-Nachef et al. 2019), level of evidence 3). Despite the 
recognized effectiveness of orthopedic surgery for neuro-orthopedic disorders 
like chronic stroke patients with spastic contractures, few studies have formally 
evaluated them. Hence, there is a need for research to provide evidence to sup-
port orthopedic surgery for treating such neuro-orthopedic disorders (Genet 
et al. 2018).
Thumb-in-palm deformity is a well-known cause of disability in the chronic 
stroke population with upper limb spasticity but no reports on surgical treatments 
are published. On the other hand, surgical correction of spastic flexion of the thumb 
due to in juvenile cerebral palsy is established and it was evaluated in a Cochrane 
review. The authors describe a positive effect noted by patients (patient-related out-
come) and the surgeons. The authors of the review critiqued that no standardized 
surgical procedure is defined, and different assessment methods in evaluation of the 
results following surgery were used. The authors concluded that based on the data 
available an evidence-based assessment of this treatment, procedure was not possi-
ble (Smeulders et al. 2005) (level of evidence 1a).
Recommendations: In individual cases, after careful examination in the multi- 
professional team and exhaustion of other reversible treatment options for spastic 
movement disorder, surgical procedures may be considered as treatment option in 
chronic spastic movement disorder following stroke (level of evidence 4, quality of 
evidence very low, 0).
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1  Introduction: The Clinical Problem
Speech, communication and language disorders are many and heterogeneous. The 
modalities of communication affected include spoken understanding and expres-
sion, reading, writing and gesture. The three predominant speech and language dis-
orders that can be acquired post-stroke are as follows:
1.1  Aphasia
Aphasia is a language disorder affecting understanding of spoken language; the 
ability to express thoughts verbally, including difficulties with word retrieval (ano-
mia), and sentence production; the ability to read and understand written words and 
sentences and the ability to write including spelling and structuring written sen-
tences. These difficulties result from damage to the left side of the brain in the 
majority of people. The extent of impairment to each of the four language domains 
varies from person to person depending on the locations and extent of neurological 




Dysarthria is a motor speech disorder resulting from impaired movement of the 
muscles used for the production of speech. The main parameters of speech are res-
piration, phonation, resonance, articulation and prosody. One or more of these 
parameters can be affected leading to reduced speech intelligibility and reduced 
communication effectiveness. These parameters can be impaired in different ways 
(for example muscles may be more or less paretic, become hypotonic or hyper-
tonic), and they may each be impaired to different extents. This results in different 
dysarthria profiles (e.g. Darley et  al. 1975). Flowers et  al. (2013) estimated the 
incidence of dysarthria post-stroke to be 42%.
1.3  Apraxia
Apraxia of speech (AOS), also known as verbal apraxia or dyspraxia, is also a motor 
speech disorder. AOS results from a reduction in the ability to co-ordinate the ges-
tures required for speech leading to difficulty producing the right sounds in the right 
order when speaking. It is characterised by multiple different attempts to articulate 
words accurately. AOS can occur in isolation, but frequently coincides with expres-
sive aphasia. AOS is acquired with lower frequency following stroke than aphasia or 
dysarthria.
Aphasia, dysarthria and apraxia are not mutually exclusive, and more than one 
speech and language disorder may need to be treated.
Communication impairments affect everyday activity, for example the ability 
to have conversations, make phone calls, listen to the radio, write letters, construct 
emails and text messages and read for pleasure, for information or for work. They 
may also affect the use of sign language for people in the deaf community. In turn, 
they restrict participation: the ability to carry out pre-stroke employment, loss of 
roles within the family and community and withdrawal from participating in usual 
activities both outside of and within the family. These changes affect the well-
being of both the person with a communication disability and their family/carer 
with increased frustration, misunderstandings and breakdown/strain on relation-
ships. For the carer, increased responsibilities, mending communication break-
downs and misunderstandings, loss of the person to talk to and dealing with 
frustration of both the person with the communication difficulty and their own 
have significant impact on their well-being. It is recognised that the impact of a 
communication impairment is not always proportional to its severity. For example 
people with relatively mild dysarthria may be intelligible, but sound different thus 
challenging their identity and self-confidence. Communication disorders also 
place a burden on society due to increased dependence, loss of employment of 
both the individual and the carer who may need to give up work to look after the 
person and reduced ability to perform previous caring roles, looking after other 
dependent family members for example.
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2  Recommendations for the Assessment and Treatment 
of Post-Stroke Communication Disorders
Recommendations have been based on evidence from Cochrane reviews in apha-
sia, dysarthria and AOS and supplemented with evidence from other systematic 
reviews and recent RCTs. The Cochrane library was searched for reviews of apha-
sia/dysphasia, dysarthria, apraxia of speech/verbal dyspraxia and motor speech. 
Twelve reviews were returned and five (those referring to stroke) were used to 
inform the recommendations. Additional systematic and narrative review evi-
dence is drawn upon in each section where useful in providing additional clinical 
direction. An information specialist performed searches for reviews in Medline 
published from 2010 to December 2017 including aphasia OR dysphasia AND 
speech and language therapy OR therapy OR treatment OR assessment AND 
stroke AND meta-analysis OR review. A second search was performed replacing 
aphasia/dysphasia with apraxia of speech OR dysarthria. Thirty-two results were 
returned for aphasia and 86 for apraxia or dysarthria. A third search was per-
formed for recent RCTs from 2015 to December 2017, replacing the terms meta-
analysis OR review with RCT returning 46 results. The first author reviewed the 
abstracts of all returned papers and excluded non stroke, non-systematic method, 
known Cochrane reviews, non- treatment or assessment studies, non SLT interven-
tions and non RCT design (for RCT search only). Eleven reviews for aphasia, two 
reviews for dysarthria and apraxia of speech and eight recent RCTs were identi-
fied. Information from selected reviews and RCTs was used if it added informa-
tion to that already identified in Cochrane reviews. An additional known review of 
dysarthria treatment was included, published in 2009. Evidence from adequately 
powered RCTs published between December 2017 and publication of this chapter 
have also been added.
Levels of evidence for recommendations are indicated using CEMB (levels 1a to 
5 according to the ‘Oxford Center for Evidence-Based Medicine—Levels of 
Evidence’, last version from March 2009, http://www.cebm.net/Oxford-centre- 
evidence-based-medicine).
The quality of evidence was rated with four categories according to ‘GRADE’ 
(‘Grades of Recommendation, Assessment, Development and Evaluation’) (Owens 
et al. 2010):
• High quality: further research is unlikely to affect our confidence in the estima-
tion of the (therapeutic) effect.
• Medium quality: further research is likely to affect our confidence in the estima-
tion of the (therapeutic) effect and may alter the estimate.
• Low quality: further research will most likely influence our confidence in the 
estimation of the (therapeutic) effect and will probably change the estimate.




The grading of the recommendations according to GRADE (Schünemann et al. 
2013) corresponds to the categories ‘ought to’ (A) (strong recommendation), 
‘should’ (B) (weak recommendation). As a third category had been introduced ‘can’ 
(0) (option) (Platz 2017). Recommendation category A is granted for clinically 
effective interventions with high-quality evidence support; with medium-quality 
evidence category B and with low- or very low- quality evidence category 0 can be 
appropriate; deviations might be indicated based on clinical judgement, individually 
applying reasons are denoted in [brackets]. A+ and B+ denote a strong or weak 
recommendation in favour on an intervention, A− and B− against its use.
2.1  Clinical Assessment of Communication Disorders
With increasing globalisation, the proportion of people who speak more than one 
language is rapidly expanding with each language potentially being differently 
affected (Lekoubou et al. 2015). The clinical profile of aphasia may differ to a 
variable extent, in the two or more languages used by an individual. Aphasia 
needs to be assessed in all languages spoken by an individual to assist therapeutic 
planning.
A systematic review by Hachioui et al. (2017) identified screening tests that have 
been validated for aphasia, with varying methodological quality and levels of bias. 
These include the Frenchay Aphasia Screening Test (FAST) (Enderby et al. 1987), 
Language Screening Test (LAST) (Flamand-Roze et al. 2011), Mississippi Aphasia 
Screening Test (MAST) (Nakase-Thompson et  al. 2005), the Mobile Aphasia 
Screening Test (also MAST) (Choi et al. 2015), ScreeLing (Doesborgh et al. 2003), 
Sheffield Screening Test for Acquired Language Disorders (SST) (Al-Khawaja 
et al. 1996), Semantic Verbal Fluency (SVF) (Kim et al. 2011) and Ullevaal Aphasia 
Screening Test (UAS) (Thommessen et al. 1999).
Recommendation: Screening tests should be used to identify the presence of 
aphasia (evidence level 2a, very low quality, B+ (clinical importance)).
No validated screening tools have been published for dysarthria or dyspraxia.
The World Health Organisation endorsed the International Classification of 
Functioning Disability and Health (ICF) in 2001, recommending assessment of a 
patient’s impairment, activity and participation. For communication, impairment 
refers to the speech or language disorder itself and the profile of this. Activity refers 
to having a conversation, reading and writing. Participation refers to carrying out 
daily activities that are usual for the individual and the degree to which these have 
been affected by the communication disorder. Additionally, the ICF encourages 
assessment of the environment (or context) in which the disability is experienced. 
The quality of life of both patients and their carers/family members is also an impor-
tant focus of assessment. Detailed assessment should therefore address all areas 
identified by the ICF.
Commonly used assessments of impairment that have been validated or shown to 
be reliable include the Western Aphasia Battery (WAB), Boston Diagnostic Aphasia 
R. Palmer and A. Pauranik
179
Examination (BDAE-2) and the Comprehensive Aphasia Test (CAT), Aachen 
Aphasia Test (AAT), Minnesota Aphasia Test (MAT), Porch Index of Communication 
Ability (PICA) and the Frenchay Dysarthria Assessment (FDA-2).
Recommendation: Published assessments of speech and language should be used 
to provide a profile of the speech or language disorder in patients with a positive 
screening result (evidence level 2b, very low quality, B+ (clinical importance)).
A systematic review by van Dijk et al. (2016) reviewed instruments available for 
assessing depressive symptoms in people with aphasia. The majority were not suf-
ficiently investigated and those that were generally had low methodological quality. 
However, the authors recommended the Stroke Aphasia Depression 
Questionnaire–10, the Stroke Aphasia Depression Questionnaire–H10 and the 
Signs of Depression Scale as most feasible for use in clinical practice.
Recommendation: Published assessments of depression in aphasia can be con-
sidered (level of evidence 2a, very low quality, 0).
Goal setting can help with therapy planning. This is usefully conducted with the 
person with communication difficulties and their families. Goals can be informed 
by a screening or detailed assessment in combination with what the patient and fam-
ily wish to achieve from rehabilitation.
There is a rich literature about imaging in aphasia, including predicting outcome 
and suggesting individual therapy (Faroqi Shah et  al. 2013). For the time being, 
however, imaging techniques still need to be considered research tools, and while 
they have the potential to eventually become relevant for clinical management, they 
are currently investigational.
2.2  Behavioural Therapy Interventions
Behavioural therapy interventions can focus on the ICF levels of impairment, activ-
ity and participation. Impairment-based interventions can be carried out in order to 
underpin improvements in activity and participation level goals.
2.2.1  Aphasia Therapy
Impairment Focus
The Cochrane review of speech and language therapy for aphasia post-stroke 
(Brady et al. 2016) included impairment-based interventions based on cognitive 
neuroscience/psycholinguistic models. For example semantic therapies focus-
sing on interpretation of meaning to improve semantic processing; phonological 
therapies aiming to improve the sound structure of language; sentence mapping 
matching meaning to sentence structure and narrative therapy to provide a mac-
rostructure for sentences and discourse. Many impairment-based therapies focus 
on improving specific domains of language such as reading, writing, comprehen-





Constraint-induced aphasia therapy (CIAT) (Pulvermuller et al. 2001), also known 
as intensive language action therapy (ILAT), is one example of therapy focusing on 
the activity of using language. The intervention employs constraint, encouraging 
patients to only use spoken language to communicate during activities such as mak-
ing requests from other group members.
Functional therapy specifically targets improvement in communication tasks 
considered to be useful in day-to-day functioning.
Brady et al. (2016) provide evidence from a meta-analysis of RCTs for the effect 
of speech and language therapy (SLT). Twenty-seven RCTs (1620 participants) 
assessed SLT versus no SLT. According to these meta-analyses, SLT resulted in 
clinically statistically significant weak-to-moderate benefit to patients’ functional 
communication (standardised mean difference (SMD) 0.28, 95% confidence inter-
val (CI) 0.06 to 0.49, 10 trials, 376 participants), reading (SMD: 0.29 (0.03 to 0.55); 
8 trials, 254 participants), writing (SMD: 0.41 (0.41 to0.67); 8 trials, 253 partici-
pants) and expressive language (SMD: 1.28 (0.38 to 2.19); 7 trials, 248 partici-
pants). However, there is currently no evidence for one type of therapy being 
superior to another or of long-term effects of therapy.
Recommendation: Speech and language therapy should be provided to people 
with aphasia as individually indicated to reduce communication difficulties and 
enhance functional communication (level of evidence 1a, very low-to-moderate 
quality, B+).
The activity-based ‘constraint-induced therapy’ has been the subject of several 
studies enabling meta-analysis of results for this therapy specifically. In the 
Cochrane review (Brady et al. 2016), five RCTs (160 participants) compared CIAT 
to other forms of therapy. The comparisons showed no evidence of greater improve-
ment with CIAT than with other types of therapy in functional outcomes (SMD: 
0.15 (−0.21 to 0.50); 3 trials, 126 participants) or aphasia severity (SMD: 0.11 
(−0.57 to 0.79); 2 trials, 34 participants), although the quality of evidence for these 
findings was low and very low, respectively. Zhang et al. performed a more recent 
systematic review of RCTs of CIAT in 2017. Eight RCTs were found but conclu-
sions were similar to the Cochrane review, in that CIAT may be useful for improv-
ing chronic post-stroke aphasia although there is no evidence of superiority to other 
techniques.
Recommendation: Constraint-induced aphasia therapy can be considered for the 
treatment of people with aphasia, especially when promotion of verbal communica-
tion activity is the aim (level of evidence 1a, very low to low quality, 0).
2.2.2  Dysarthria Therapy
In a Cochrane review of interventions for dysarthria due to stroke including five 
small RCTs with 234 participants (Mitchell et al. 2017), there was a statistically 
significant effect of therapy at the level of impairment immediately post-therapy 
when comparing treatment to another intervention, placebo or control (SMD: 0.47 
(0.02 to 0.92, 4 trials, 99 participants)) but no evidence of a persistent effect (SMD 
0.07, (−0.91 to 1.06); 2 trials, 56 participants). There was no evidence of effect of 
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therapy at the level of activity or participation immediately post-therapy (activity 
SMD: 0.29 (−0.07 to 0.66); 3 trials, 117 participants) (participation SMD: −0.24 
(−0.94 to 0.45); 1 trial, 32 participants) or of persistent effects (activity SMD: 0.18, 
(0.18 to 0.55); 3 trials, 116 participants) (participation SMD: −0.11 (−0.56 to 0.33); 
2 trials, 79 participants).
Recommendation: People with dysarthria should receive rehabilitation to try to 
improve their speech impairment. (level of evidence 1a, very low to low quality, B+ 
(clinical relevance)).
A narrative review of non-randomised studies outlines impairment-based tech-
niques that have demonstrated some qualitative benefit in improving the clarity of 
speech (Palmer and Enderby 2007). These include articulation exercises practising 
precision in the production of single sounds, words and sentences; modelling cor-
rect pronunciation of words and sentences and providing feedback ‘clear’ or 
‘unclear’ on repeated attempts; use of visual feedback to increase the use of pitch, 
loudness and intonation (prosody) and use of the Lee Silverman technique to 
increase loudness.
At the activity level, compensatory strategies to increase intelligibility through 
purposeful speech production such as over-articulation or slowing rate of speech 
can be used. Visual feedback and pacing techniques to slow rate (using a metronome 
or pointing to the first letter of each word on an alphabet chart) have been described 
(Palmer and Enderby 2007). Evidence is needed to understand the effectiveness of 
these therapy options.
Recommendation: Techniques to try and improve clarity of speech described in 
the literature can be considered (level of evidence 3–4, very low quality, 0).
2.2.3  Apraxia of Speech
The Cochrane review of treatments for apraxia of speech post-stroke found no 
trials had been conducted (West et al. 2005). In 2015, Ballard et al. conducted a 
systematic review of studies in AOS and included 26 within-participant experi-
mental designs. The review indicated potential benefit at the level of impairment 
of articulatory- kinematic and rate-rhythm approaches to treatment, although 
there is no evidence of effect of AOS interventions on activity and 
participation.
Kinematic approaches involve motoric practice (repetitive practice of phonemes 
building in complexity), modelling and repetition (watching listening and speaking 
with the therapist) and articulatory cuing (involving sound production treatment 
using minimal pair words and prompt for restructuring oral muscular phonemic 
targets, e.g. tactile cues for accurate articulation placement (PROMPT). Rate- 
rhythm approaches use prosodic patterns, e.g. melody, rhythm and stress to improve 
speech production. In addition, Varley et al. published a small RCT (50 participants) 
in 2016 and showed single word production benefited from a behavioural speech 
treatment involving hierarchical exercises from understanding word meanings to 
imagery of word production to repetition to autonomous word production in words 




Recommendation: Behavioural treatment approaches can be used to treat the 
impairment in AOS (level of evidence 2a, very low quality, 0).
2.3  Biological Therapies
2.3.1  Pharmacological Treatments
A number of drugs have been used to try and improve language recovery after 
stroke. A Cochrane review of pharmacological treatments (Greener et  al. 2001) 
found 10 RCTs evaluating the effect of six different drugs. There was weak evi-
dence that Piracetam may be effective in the treatment of aphasia (odds ratio: 0.46 
(0.3–0.7); 5 trials, 661 participants). Patients who were treated with Piracetam were 
no more likely (considering statistical significance) than those who took a placebo 
to experience unwanted effects, including death (odds ratio 1.29, 95% confidence 
interval for difference 0.9 to 1.7). However, despite not reaching statistical signifi-
cance, the difference in death rate between groups does give rise to some concerns 
that there may be an increased risk of death from taking Piracetam. A further review 
and meta-analysis of Piracetam was conducted by Zhang et al. (2016) showing no 
overall improvement in aphasia severity but pronounced improvement in written 
language (SMD: 0.35 (0.04 to 0.66); 7 trials, 261 participants).
Recommendation: On the whole, drugs cannot yet be recommended to augment 
the effects of behavioural therapy for aphasia. Piracetam can be considered to 
improve aphasia, notably written language but further investigation of long-term 
effects and safety are needed (level of evidence 1a, very low quality, 0). 
Pharmacological licensing issues need to be considered based on regional regula-
tory affairs.
2.3.2  Non-Invasive Brain Stimulation (NIBS)
Repetitive transcranial magnetic stimulation (rTMS) and transcranial direct current 
stimulation (tDCS) have been employed in chronic aphasia either to suppress the 
maladaptive and inhibitory right-hemisphere activity or to stimulate compensatory 
left-hemispheric peri-lesion areas. Elsner et al. (2015) conducted a Cochrane review 
and meta-analysis of trials that compared the effect of tDCS to control interventions 
on correct picture naming and found that tDCS did not enhance picture naming 
(SMD:0.37 (−0.18 to 0.92); 6 trials, 66 participants). Li et al. (2015) conducted a 
meta-analysis including four RCTs showing that low-frequency rTMS was benefi-
cial for post-stroke patients in terms of naming (SMD: 0.51 (0.16 to 0.86)) with no 
adverse effects. In 2016, Shak-Basak et  al. conducted a systematic review of 
between and within-subject studies of rTMS and tDCS and concluded that the mag-
nitude of effect on picture naming was similar: rTMS—SMD: 0.448 (8 trials, 143 
participants) and tDCS—SMD: 0.395 (8 studies, 140 participants). However, Al 
Harbi et al. (2017) identify a range of methodological issues with existing studies 
and consider evidence to be at the pre-efficacy level with emerging evidence at the 
efficacy level.
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Caution must be exercised as non-invasive brain stimulation (NIBS) may lower 
the threshold for epileptic seizures, and individual contraindications need to be 
taken into account (Lefaucheur et al. 2014).
No systematic reviews of non-invasive brain stimulation have been conducted 
specifically for dysarthria or AOS.
Recommendation: tDCS or rTMS to enhance verbal production in aphasia can be 
considered (level of evidence 1a, low quality, 0). Licensing of specific medical 
devices needs to be considered based on regional regulatory affairs and safety stan-
dards ought to be followed (level of evidence 1a, level of evidence high, A+).
2.4  Timing, Intensity, Dose and Duration of Therapy
2.4.1  Timing
In a pilot RCT (N = 59), people with moderate and severe aphasia were recruited 
from 3 days post-stroke. Those who received daily impairment-based therapy of 
45 min per day scored 15.1 more points (P = 0.010) on the aphasia quotient and 11.3 
more points (P = 0.004) on the functional communication profile than those receiv-
ing usual care therapy (which averaged 10.5 min a week) (Godecke et al. 2012).
Recommendation: Early intensive therapy should be considered for people with 
moderate-to-severe aphasia immediately post-stroke if the individual can tolerate it 
(level of evidence 2b, low quality, B (clinical relevance)).
Traditionally, it has been thought that recovery from language can reach a ‘pla-
teau’ which has led to intervention not being offered, if a patient is more than 
6 months or a year post-stroke in many places. However, there is evidence to sug-
gest people can improve their communication with therapy in the chronic phase. In 
a review of 21 RCTs, Allen et  al. (2012) found evidence to support the use of 
computer- based treatments, constraint-induced language therapy, group therapies 
and training of communication partners more than 6 months post-stroke. Further to 
this, in a computerised word finding therapy RCT (n = 278), Palmer et al. (2019) 
found that improvement in word finding was not affected by time post-stroke (up to 
36 years in this study).
Recommendation: Therapy should be provided to people with aphasia who still 
wish to have therapy in the chronic phase post-stroke to improve their communica-
tion (level of evidence 1a, very low-to-medium quality, B+ (clinical relevance)).
2.4.2  Intensity, Dose and Duration
In the Cochrane review for aphasia (Brady et al. 2016), functional communication 
was significantly better in people with aphasia that received therapy at a high inten-
sity, i.e. 4 to 15 h a week (MD: 11.75 (4.09 to 19.40); 2 trials, 84 participants), or 
over a long duration, i.e. 3 to 22 months (SMD: 0.81 (0.23 to 1.40); 2 trials, 50 
participants), compared to those who received therapy at a lower intensity, i.e. 1.5 
to 5 h a week, or over a shorter period of time, i.e. 2 weeks to 9 months. However, 
more people stopped attending these highly intensive treatments (of up to 15 h a 
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week) than those who had a less-intensive schedule. People were often more able to 
tolerate intensive therapy later post-stroke.
An example of intensive speech and language therapy in the chronic stage post- 
stroke (>6 months) from a high-quality RCT showed significant statistical and clini-
cal benefit of intensive speech and language therapy compared to waiting list 
controls in 19 rehabilitation centres in Germany (Breitenstein et  al. 2017). The 
intensive therapy was delivered in clinical settings for 10 h or more per week for at 
least 3 weeks (minimum dose 30 h) and combined one-to-one speech and language 
therapy, group therapy with an SLT and self-managed computer therapy or pencil 
and paper linguistic exercises prescribed by an SLT.
Recommendation: People with aphasia who want to improve their language and 
communication abilities should be offered intensive therapy of a long duration in 
both the acute and chronic stages post-stroke, if they can tolerate it (level of evi-
dence 1a, medium quality, B+ (clinical relevance)).
There is no Cochrane or systematic review level evidence for timing, intensity, 
dose or duration of therapy for motor speech disorders acquired after stroke, but 
neuroplasticity and motor learning principles would suggest that ‘more is better’ for 
motor speech as well as aphasia.
2.5  Methods of Therapy Delivery
Speech and language therapy is often delivered by a qualified speech and language 
therapist in a one-to-one, face-to-face therapy session. However, other methods of 
delivery exist that may make delivery of therapy more efficient:
2.5.1  Group Therapy
Groups of people with communication disorders can be an advantageous way of 
providing communication therapy, providing exposure to a range of communication 
partners. The Cochrane review for aphasia (Brady et al. 2016) concluded that there 
was no difference in functional outcome (SMD: 0.41 (−0.19 to 1.00); 3 trials, 46 
participants) or aphasia severity (SMD: 0.15 (−0.21 to 0.50); 4 trials, 122 partici-
pants) between therapy provided in a group or one to one.
2.5.2  Use of Volunteers
The Cochrane review for aphasia (Brady et al. 2016) found little indication of a 
difference in the effectiveness of therapy facilitated by trained volunteers than 
therapy delivered by an SLT. The volunteers were trained, had access to therapy 
materials and were delivering interventions designed and overseen by a qualified 
speech and language therapist. Volunteers could include family members. In addi-
tion, Teasell et al. (2016) found limited evidence that suggests CIAT delivered by 
trained volunteers may be as effective as delivery by experienced speech and lan-
guage therapists.
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2.5.3  Use of Computers/Telepractice
Computers, tablet computers and smartphones can be used to provide therapy mate-
rials for communication practice during a therapy session with either a speech and 
language therapist or a volunteer or can provide an option for independent or self- 
managed practice between sessions with a therapist to increase the amount of ther-
apy or to increase the duration of therapy where the amount available from a speech 
and language therapist is limited. Where internet connections are available, it is 
often possible for the therapist to monitor the progress of the patient remotely and 
update therapy exercises. In the Cochrane review of aphasia (Brady et al. 2016), 
there was no difference shown between therapy delivered on a computer and one-
to- one therapy from a speech and language therapist in functional communication 
(SMD: 0.44 (−0.10 to 0.98); 3 trials, 55 participants). In another systematic review 
of computerised aphasia therapy, Zheng et al. (2016) conclude that therapy deliv-
ered using a computer is more effective than no therapy, and potentially as effective 
as therapy delivered by a speech and language therapist, although they acknowledge 
the low quality of the evidence due to including only seven small studies. Marshall 
et al. (2016) also reported a small quasi-randomised study (n = 20) showing poten-
tial benefits of using a virtual reality environment for aphasia therapy.
Recommendation: Individual, one-to-one or group therapy from a qualified SLT, 
computer-mediated therapy and volunteer-supported therapy can all be considered 
for the provision of speech and language therapy (level of evidence 1a, very low to 
low quality, 0).
The recommendation for use of computerised aphasia therapy is augmented by 
an RCT (n = 278) of daily self-managed word finding practice on a computer at 
home, tailored by a speech and language therapist and supported by monthly volun-
teer/speech therapy assistant visits (Palmer et al. 2019). Word finding improvement 
was 16.2% (95% CI 12.7 to 19.6; p < 0.0001) higher in the computer therapy group 
than in the usual care group and was 14.4% (10.8 to 18.1) higher than in the atten-
tion control group. There were no significant differences between groups in conver-
sational ability however.
Recommendation: Use of self-managed computerised therapy for word finding 
practice should be considered as a method for delivering repetitive practice to 
improve word finding ability. However, combination with additional techniques to 
promote functional use of newly learned vocabulary in conversation need to be con-
sidered (level of evidence 1b, medium quality, B+).
2.6  Alternative and Augmentative Communication
Communication aids can be low tech, for example alphabet boards to spell out 
words, picture charts to point to pictures that indicate wishes or E-tran frames that 
enable a patient to use eye gaze to communicate. Many high-tech aids and apps are 
also available using advances in technology. Baxter et  al. (2012) reviewed the 
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evidence for high-tech communication aids and concluded that although benefit is 
reported, existing studies use designs that are at a high risk of bias and that the high 
level of individual variation in outcome requires a greater understanding of patients 
who may benefit from high-tech communication aid solutions.
Recommendation: Augmentative and alternative modes of communication can 
be considered (level of evidence 2a, very low quality, 0).
2.7  Communication Environment
2.7.1  Conversation/Communication Partner Training
Several different approaches to communication partner training exist and training 
has been provided to usual communication partners, volunteers providing opportu-
nities for conversation and healthcare staff. Systematic reviews (including all study 
designs) by Simmons-Mackie et al. (2016) conclude there is sufficient evidence that 
communication partner training can improve partner skill in using strategies to 
facilitate the communication of people with chronic aphasia, although higher qual-
ity randomised trials are needed to strengthen this recommendation.
Recommendation: Communication partner training should be considered to facilitate 
communication (level of evidence 2a, very low to low quality, B+ (clinical relevance)).
2.8  Psychosocial Interventions to Manage Mood Disorders 
Secondary to Aphasia
It is recognised that people with aphasia and their carers are at high risk of develop-
ing depression (Worrall et al. 2016). A systematic review of rehabilitation interven-
tions to prevent and treat depression in aphasia post-stroke from 45 studies (Baker 
et al. 2017) suggested that for people without depression, interventions such as goal 
setting and attainment, psychosocial support and communication partner training 
may be helpful in preventing depression. People with mild depression may benefit 
from behavioural therapy, psychosocial support and problem-solving. More research 
is needed in this area however to make strong recommendations.
Recommendation: A range of techniques to support people with mild symptoms 
of depression can be considered (level of evidence 2a, very low to low quality, 0). 
People with moderate-to-severe depression require specialist intervention from 
mental health services in collaboration with stroke specialists.
3  Top Ten Best Practice Recommendations for Aphasia 
and Forthcoming Information
In this chapter, the authors discuss the evidence base and recommendations for the 
assessment and treatment of aphasia, dysarthria and apraxia based on a synthesis of 
Cochrane reviews, other systematic and narrative reviews of randomised and 
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non- randomised studies, and of definitive RCTs conducted since the Cochrane 
reviews were published.
The Aphasia United Best Practices Working Group and Advisory Committee 
developed and published ten best practice recommendations for aphasia that are 
applicable across multiple countries (Simmons-Mackie et al. 2017). This entailed 
crafting a set of recommendations drawing from research evidence and stroke 
guidelines and using a Delphi procedure to obtain consensus on wording from 
healthcare experts from the United States, Canada, Australia, UK, Ireland, China, 
Germany, Finland, Sweden, Norway, Denmark, Korea, Greece, Turkey, Japan, 
Argentina, Israel, South Africa, Russia and India. This chapter would not be com-
plete without making reference to these rigorously developed, internationally appli-
cable recommendations that consider assessment and treatment in the broader 
context of aphasia management:
 1. All patients with brain damage or brain disease should be screened for com-
munication deficits.
 2. People with suspected communication deficits should be assessed by a quali-
fied professional (determined by country); Assessment should extend beyond 
the use of screening measures to determine the nature, severity and personal 
consequences of the suspected communication deficit.
 3. People with aphasia should receive information regarding aphasia, aetiologies 
of aphasia (e.g. Stroke) and options for treatment. This applies throughout all 
stages of healthcare from acute to chronic stages.
 4. No one with aphasia should be discharged from services without some means 
of communicating his or her needs and wishes (e.g. using AAC, supports, 
trained partners) or a documented plan of how and when this will be achieved.
 5. People with aphasia should be offered intensive and individualised aphasia 
therapy designed to have a meaningful impact on communication and life. This 
intervention should be designed and delivered under the supervision of a quali-
fied professional.
 6. Communication partner training should be provided to improve communica-
tion of people with aphasia.
 7. Families or caregivers of people with aphasia should be included in the reha-
bilitation process.
 8. Services for people with aphasia should be culturally appropriate and person-
ally relevant.
 9. All health and social care providers working with people with aphasia across 
the continuum of care (i.e. acute care to end of life) should be educated about 
aphasia and trained to support communication in aphasia.
 10. Information intended for use by people with aphasia should be available in 
aphasia-friendly/communicatively accessible formats.
Further insights into factors affecting success of treatments for aphasia are forth-
coming from the RELEASE collaboration meta-analysis of individual patient data 
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1  Neurovisual Disorders After Brain Damage
Neurovisual disorders are frequent function losses after brain damage and occur in 
about 20–50% of the patients with cerebrovascular disorders (Rowe et al. 2009). In 
stroke patients >65  years, the incidence rises to 40–60% (Suchoff et  al. 2008). 
Homonymous visual field defects (further abbreviated as VFDs) are present in 
20–50% of all neurological patients with stroke (Kerkhoff 1999; Rowe et al. 2009) 
and also occur frequently in patients with traumatic brain injury, TBI (Kerkhoff 
1999). Visual field sparing is <5° on the blind side in 70% of stroke cases with VFDs 
(Zihl 2011; Kerkhoff 1999). Spontaneous field recovery is present in the first 
2–3 months post-lesion in up to 40% of the patients with a stable aetiology such as 
stroke (Zhang et  al. 2006). After 6  months post-lesion, spontaneous recovery is 
extremely unlikely (Zhang et al. 2006; Zihl 2011).
Patients with VFDs present three types of associated deficits: visual exploration 
(or scanning) deficits, hemianopic alexia, and visuospatial deficits. With respect to 
the first point, patients show a time-consuming, inefficient visual search due to loss 
of overview and unsystematic search strategies. They make many, small amplitude 
staircase saccades in the blind hemifield and omit targets in the blind field (Kerkhoff 
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et al. 1992a, 1994; Pambakian et al. 2004; Machner et al. 2009). Second, the central 
visual field (±5° around the fovea) is crucial for reading because only here visual 
acuity and form recognition are sufficient for letter recognition (“perceptual reading 
window”). Hence, slow reading with errors is evident in VFD patients with a field 
sparing <5° on the blind side of the field, as there is a monotonic relationship between 
the degrees of visual field sparing on the blind side and reading speed (Kerkhoff 
1999). Third, the patient’s feeling of the subjective visual straight ahead in space or 
his/her subjective midline in bisecting horizontal lines and objects is shifted towards 
the blind field. This shift is horizontally in left/right VFDs, vertically in altitudinal 
upper/lower VFDs, and oblique in quadrantic VFDs and occurs in 90% of the patients 
(Kerkhoff 1993; Barton and Black 1998; Kuhn; for review see Kerkhoff and Schenk 
2011). This spatial shift is also evident in pointing (Hesse et al. 2012) and in daily life 
(walking through doorways, halving a bread).
Importantly, all three types of visual deficits in VFDs are relevant for daily life: 
the visual exploration disorder leads to problems in finding objects, persons, or vehi-
cles or colliding with them, especially on the blind side. The reading deficit impairs 
virtually all activities where reading of letters, numbers, or other symbols is required, 
and the spatial midline shift affects pointing, walking, halving objects, or drawing. 
The International Classification of Functioning (ICF) serves as a reference for holis-
tically understanding the different aspects of a pathology (WHO 2001). Figure 1 































Fig. 1 Neurovisual deficits in the ICF-Framework
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Apart from homonymous VFDs and the associated impairments in reading, 
visual exploration, and spatial midline perception, further low-level (impaired 
visual acuity and contrast sensitivity, stereopsis and binocular fusion, colour per-
ception, light–dark adaptation, motion perception) as well as high-level (visual 
object and face agnosia, spatial-perceptual disorders) neurovisual disorders are 
often found after brain damage (for review see Schaadt and Kerkhoff 2016). 
Consequently, routine screening of the various types of visual deficits is necessary 
both for diagnosis and rehabilitation planning.
1.1  Assessment of Neurovisual Disorders
Before starting any assessments, a systematic anamnesis of the most frequently 
encountered neurovisual deficits should be performed (Table 1) as it reduces the 
clinician’s risk to overlook relevant disorders. Patients with intact awareness can 
Table 1 Schema for the anamnesis of neurovisual disorders after acquired brain lesions
Question Purpose of question, underlying disorder, tests
1.  ... any changes in vision …? –  Awareness of deficits? Case history?
2.  ... diplopia …? transiently/permanently? –  Type of gaze palsy? If transient: fusional 
disorder? Impaired stereopsis?
3.  … reading problems …? … syllables/
words missing, change of line, reduced 
reading span …?
–  Hemianopic alexia due to VFD? Differential 
diagnosis of neglect dyslexia, aphasic alexia, 
pure alexia, or Balint-Holmes syndrome
4.  … problems in estimating depth on a 
staircase …? … reaching with your 
unimpaired hand for a cup, hand, door 
handle …?
–  Depth perception? Optic ataxia? Reduced 
acuity/contrast sensitivity?
5.  … bumping into obstacles …? … failure 
to notice persons …? at which side?
–  Visual exploration deficits due to VFD/
Neglect/Balint-Holmes syndrome?
6.  … blinding after exposure to bright 
light …?
–  Foveal photopic adaptation?
7.  … dark vision …? … that you need 
more light for reading …?
–  Foveal scotopic adaptation?
8.  … blurred vision …? transiently/
permanently?
–  Contrast sensitivity? Visual Acuity? Fusion?
9.  … that colours look darker, paler, less 
saturated …?
–  Colour hue discrimination? Impaired 
contrast sensitivity?
10.   … that faces look darker, paler, unfamiliar …? –  Face discrimination/recognition disorders?
11.   … problems in recognizing objects …? –  Object discrimination/recognition disorders?
12.   … problems in finding your way in 
familiar/unfamiliar environments …?
–  Topographic orientation deficits? Spatial 
memory?
13.   … visual hallucinations (stars, dots, 
lines, fog, faces, objects …) or illusions 
(distorted objects, faces …) …?
–  Simple or complex visual hallucinations, 
illusions? Awareness about illusory 
character?
Indent the questions in the table into the following phrase: “Did you experience ... since your brain 
lesion?” (Based on Neumann et al. 2016). On the right side, the purpose of each question is illustrated 
and the putative underlying disorder and tests to be performed. VFD: homonymous visual field defect
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easily and quickly (<10 min) be questioned with this simple questionnaire, responses 
to which prove clinically useful and reliable in 95% of cases (Neumann et al. 2016). 
Moreover, this anamnesis leads the clinician to appropriate diagnostic tests and sub-
sequent treatments.
Subsequently, quantitative tests should be performed. As VFDs are the most fre-
quent neurovisual deficits after brain damage, a quantitative perimetry (using a bowl 
perimeter) or at least campimetry (on a flat monitor or test plate) should be per-
formed in every case (for details see Biousse and Newman 2009). If time is too short 
for an apparative perimetry/campimetry, finger perimetry should be performed, by 
using a coloured pen as a target for identification along the different meridians. This 
quick (3 min) procedure increases the sensitivity of detecting scotomas by some 
20% when compared with using only the examiners fingers (Kerr et al. 2010). After 
the visual field test, reading should be tested with a standardized reading test (i.e. 
Radner test), visual scanning, or search with a standardized test, and finally, hori-
zontal and vertical line bisection should be performed to detect a subjective visual 
midline shift (see Lezak, Howieson, Bigler and Tranel 2004 for appropriate tests). 
Further, neurovisual tests may be necessary depending on the type of deficit and the 
patient’s subjective complaints. These may include tests of visual object and face 
recognition, as well as naming tests, in order to disentangle visual object recogni-
tion from deficits in object naming (see Schaadt and Kerkhoff 2016, for overview). 
For these purposes, the VOSP (Visual Object and Space Perception Battery) is suit-
able to test visual object recognition, the Facial Recognition Test for face percep-
tion, and several naming tests including the Boston Naming Test to evaluate naming 
performance (see Lezak, Howieson, Bigler and Tranel 2004 for further details to 
these tests and references).
1.2  Therapy of Neurovisual Disorders
The recommendations for treatments given below are based on results from indi-
vidual trials as stated below, a Cochrane review (Pollock et al. 2012), and two fur-
ther reviews of that topic (Trauzettel-Klosinski 2011; De Haan et al. 2014).
As spontaneous visual field recovery is very limited during or absent after the 
first 3–6 months post-stroke (Zhang et al. 2006), the vast majority of VFD patients 
will suffer from a permanent and stable VFD.
The Cochrane meta-analysis demonstrated that scanning training is more effec-
tive than control or placebo at improving reading ability (3 studies, 129 participants; 
standardized mean difference (SMD) 0.79, 95% confidence interval (CI) 0.29–1.29) 
and visual scanning (3 studies, 129 participants; SMD 1.14, 95% CI 0.29–2.00) but 
that scanning may not improve visual field outcomes (2 studies, 110 participants; 
MD −0.73, 95% CI −3.18 to 1.72). The review reached the following conclusions: 
“There is limited evidence that supports the use of compensatory scanning training 
for patients with visual field defects (and possibly coexisting visual neglect) to 
improve visual field, scanning, and reading outcomes. There is insufficient evidence 
to reach a conclusion about the impact of compensatory scanning training on 
G. Kerkhoff et al.
195
functional activities of daily living. There is insufficient evidence to reach general-
ized conclusions about the benefits of restitutive or substitutive interventions for 
patients with visual field defects after stroke”. For clarity, we will deal with these 
treatments in separate sections below in more detail.
1.2.1  Saccadic Compensation (or Scanning) Training
Saccadic compensation training (SCT or scanning) aims at improving the quick 
and safe visual overview over a visual scene, despite the fact that the field cut will 
persist in the vast majority of patients with VFDs. This is reached by enlarging 
saccade amplitude and reducing saccadic reaction time when looking to the blind 
portion of the visual field (Kerkhoff et al. 1992a, b, 1994). Several observational 
and smaller randomized controlled trials (RCTs) (Kerkhoff et al. 1992a, b, 1994; 
Roth et  al. 2009; Lane et  al. 2010; Mödden et  al. 2012; De Haan et  al. 2015; 
Aimola et  al. 2014) indicated that these procedures improve visual scanning in 
VFDs; the effects might, however, at least partially be related to attention training 
effects (e.g. Lane et al. 2010), which in itself might also be an effective treatment 
strategy. Moreover, it can be assumed that visual scanning training almost always 
includes attentive elements, otherwise the training cannot be performed. Moreover, 
improvements in ADLs were inconsistently shown, e.g. on mobility (De Haan 
et al. 2015). A cross- modal (visual-auditory) variant of this training is also effec-
tive in improving scanning and reading in hemianopia (Keller and Lefin-Rank 
2010). Here, visual and auditory targets are presented time- locked in identical 
locations of the visual field, and the patient has to look to them. This training 
induces similar improvements as conventional visual scanning training but requires 
additional technical facilities.
1.2.2  Hemianopic Reading Training
Hemianopic reading training entails the oculomotor compensation of the reading 
deficit that arises from the loss of parafoveal visual field regions that have a suffi-
ciently good visual acuity in order to identify letters and syllables. Most effective 
strategies of reading training for hemianopic alexia have used an “optokinetic” 
approach. Here, letters, syllables, words, and numbers are presented in a single text 
line which float from the right to the left side on a computer screen, while the patient 
is instructed to read the words in the middle of the screen. The moving character of 
the words induces pursuit eye movements to the side of motion and an optokinetic 
nystagmus to the opposite side (Kerkhoff et al. 1992a, b). At least four more or less 
well-controlled treatment studies have shown that this kind of treatment signifi-
cantly improves reading speed, reduces reading errors, and reduces the number of 
eye fixations during reading (Kerkhoff et al. 1992a, b; Zihl 1995; Spitzyna et al. 
2007; Schuett et al. 2008; see review in Schuett 2009). The mean improvement of 
reading speed when expressed in words per minutes (WPM) read was 38.4 WPM 
after this type of reading training (see Kerkhoff 2010, page 85). In cultures reading 
from left to right the motion should be from right to left, in those reading from right 
to left the motion should be left to right, and in those reading from top to bottom the 
motion should move upwards.
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1.2.3  Compensatory or Restorative Visual Field Training?
In recent years, restorative visual field training has been revived after publica-
tion of apparently advantageous results following new training procedures 
(Kasten et  al. 1998). However, numerous subsequent replication studies have 
failed to find significant visual field enlargements (Nelles et al. 2001; Pambakian 
et  al. 2004; Schreiber et  al. 2006; Roth et  al. 2009), or found only minimal 
visual field increases (1°, cf. Mödden et al. 2012). In our view, restorative field 
training is only promising when lesions are incomplete, and a high degree of 
residual visual capacities (light, motion, form, or colour perception) is pre-
served in specific regions of the scotoma (Kerkhoff 2000; Bouwmeester et al. 
2007). This residual vision is only present in some 5% of VFD patients and is 
lacking in the majority of patients. Moreover, restorative visual field training 
induces only very small or no visual field increases (~1°) and improves visual 
search or reading only minimally, or not at all (Mödden et al. 2012). Formally 
assessed, the overall evidence is unclear and thus restorative visual field training 
cannot generally be recommended for that purpose.
Further, when compared with hemianopic reading training (see above), the effect 
of restorative visual field training on reading speed is 7 WPM after therapy, com-
pared to 38.4 WPM improvement after reading training (see above, Kerkhoff 2010). 
Hence, direct reading training is 5 times more effective and less time-consuming 
than restorative visual field training when we consider reading speed, which is the 
main handicap of reading in VFDs.
Moreover, compensatory field training (SCT and reading training) leads to a 
much quicker reduction of visual impairments and needs fewer treatment sessions. 
Recently, home-based treatments of visual search and reading have been success-
fully tested in VFDs (Pambakian et al. 2004; Lane et al. 2010; Aimola et al. 2014). 
These approaches are cost-effective, but require regular advice by the therapist (i.e. 
by telephone or visit).
In conclusion, SCT and hemianopic reading training improve visual scanning 
and “visual” activities of daily living in VFD, and they increase functional inde-
pendence of the patient reliably (Kerkhoff 1999, 2000; Bouwmeester et  al. 
2007; Spitzyna et al. 2007; Zihl 2011). Therefore, these two types of treatments 
are based on a consistent body of study evidence of low-to-moderate quality 
(observational studies and smaller RCTs with one meta-analysis) showing their 
effectiveness on visual scanning and transfer of treatment gains to some func-
tional domains of ADL such as reading and mobility as reviewed above. Two 
recent RCTs underlined these findings: Ivanov et  al. (2019) treated children 
with homonymous VFDs and revealed significant improvements after scanning 
training in visual search behaviour, reported quality of life and ADLs that 
remained stable for at least 6  weeks after training at follow-up. Rowe et  al. 
(2016) showed that visual search training was more effective than prism glasses 
and standard care (no training) in improving vision-related quality of life in 
patients with VFDs. As a consequence, they should be used for treatment of 
VFD patients (CEBM classification: level 2b to 1a, Grade quality: low to mod-
erate, recommendation: B+) (see Fig. 2).
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1.2.4  Ineffective or Disadvantageous Therapies in VFDs
Most hemianopic patients get confused when using prisms to substitute the visual 
field loss. However, small prisms fitted to a spectacle can be useful in some cases. 
Compensatory head shifts towards the scotoma (either spontaneously adopted by 
the patient or to instruction) are of no use in the rehabilitation of VFDs because they 
lead to visual exploration deficits in the ipsilesional visual field, strain of the neck 
muscles, and delay treatment progress in visual scanning training (Kerkhoff et al. 
1992a). Training of “blindsight” (the ability of rare cases of cortical blindness who 
respond to stimuli in their visual field, e.g. by pointing to them, even if they are not 
able to consciously perceive them) is probably not useful for the majority of the 
patients because it does not lead to improved functioning in daily life.
1.2.5  Convergence/Fusion and Stereoscopic Deficits
Apart from VFDs, other neurovisual deficits occur. Impairments in convergent hori-
zontal fusion represent the most frequent oculomotor deficit after brain damage 
(Kapoor and Ciuffreda 2002). Importantly, they are often associated with visual 
perceptual deficits such as loss of stereopsis, reduced reading duration, blurred 
vision, and asthenopic eye symptoms. This is especially relevant for all visual activ-
ities in near- space (reading, writing, smartphone and computer use, typing, knitting, 
and all visuo-motor activities in near-space). Moreover, it has been shown that right-
hemispheric vascular lesions cause deficits in stereopsis (Rizzo 1989; Rizzo and 
Barton 2008). Three recent treatment studies (two controlled group studies, one 
controlled case series, but none of them randomized controlled) showed that a repet-
itive binocular fusion treatment using three sorts of dichoptic devices reinstated 
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Fig. 2 Clinical pathways for neurovisual rehabilitation
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binocular depth perception, stereopsis, and improved reading duration and reduced 
asthenopic symptoms in chronic brain damage of cerebrovascular, traumatic, or 
hypoxic aetiology (Schaadt et al. 2013, 2014). As the available observational studies 
consistently showed a significant treatment effect in about 90% of treated patients 
these treatments can be used (CEBM classification: level 2b, Grade quality: low, 
recommendation: 0) (see Fig. 2).
1.2.6  Visual Light Adaptation Deficits
Some 20–30% of patients with acquired brain damage suffer from feelings of 
“blinding” and “dark vision” after brain damage (Zihl and Kerkhoff 1990; Jackowski 
et al. 1996; Kapoor and Ciuffreda 2002; Neumann et al. 2016). The reason for this 
is an acquired deficit of light and/or dark adaptation of the visual system (not the 
eye!). Tinted glasses may reduce the feelings of blinding (Jackowski et al. 1996; 
Kapoor and Ciuffreda 2002), while additional light sources and the use of light dim-
mers are helpful to cope with dark vision. These treatments do not “heal” the origi-
nal underlying disorder or light–dark adaptation, but they alleviate the behavioural 
consequences for the patients and can be used (CEBM classification: level 4, Grade 
quality: very low, recommendation: 0).
Figure 2 summarizes the clinical procedures described herein as a clinical path-
way diagram.
1.2.7  Conclusions
We have reviewed here the available treatments for the most frequent neurovisual 
disorders after stroke. However, as pointed out in a recent systematic review on 221 
publications about homonymous VFDs, most of the available research has so far 
focused on body functions, less on activities, and almost never on participation (De 
Haan et al. 2014). One exception to this may be the treatment of reading because it 
is an integral part of daily life. So, improvement of reading by reading therapy in 
hemianopic alexia can be viewed as regaining an important daily activity that 
enables participation in reading books, newspapers, handwritten notices, short 
notices on a smartphone, or managing internet banking at home, hence 
participation.
Moreover, very few studies have analyzed how many patients returned to work 
after neurovisual rehabilitation. This is an important part of participation and this 
aspect should be included more often in future treatment studies.
2  Spatial Neglect, Extinction, and Anosognosia
Spatial neglect is defined as the inability to respond to sensory stimuli in the contral-
esional hemispace or body of a neurological patient (Kerkhoff 2001; Husain 2008). 
In addition to visual, auditory, or tactile neglect, motor neglect often co-occurs as a 
reduced use of contralesional extremities, i.e. during reaching, standing, or walking. 
Moreover, neglect patients show a lack of insight into their left-sided sensory and 
motor deficits termed anosognosia or unawareness. Anosognosia in patients with 
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neglect delays recovery (Gialanella et al. 2005) and both are a major source of long- 
term disability and associated with an adverse rehabilitation outcome (Jehkonen 
et al. 2006a, b) and longer hospital stays (Kalra et al. 1997). Return to work seems 
almost impossible in chronic neglect, even after treatment.
Spontaneous recovery from neglect occurs mostly in the first 3  months after 
stroke (Nijboer et  al. 2013). Some 30–40% of those patients presenting initially 
with neglect show chronic neglect at 1  year post-lesion (Karnath et  al. 2011; 
Rengachary et al. 2011). The presence of an additional visual field defect reflects 
larger lesions and predicts chronic neglect as well as severe neglect dyslexia (Ptak 
et al. 2012). Spatial neglect is most often multimodal (visual, auditory, haptic, olfac-
tory, Kerkhoff 2001). Behavioural recovery is task- and side-specific: while the con-
spicuous conjugate gaze deviation may be up to 30–40° ipsilesionally in the first 
weeks, this recovers continuously within 3 months, paralleled by a more symmetri-
cal, wider visual exploration field of the patient (Aimola et  al. 2014). Similarly, 
visual scanning and cancellation tests improve first on the ipsilesional side, later on 
the contralesional side (Nijboer et al. 2013). Directional hypokinesia (which desig-
nates the phenomenon that neglect patients do not reach far enough to their contral-
esional side with their intact, nonparetic limb/s) shows better spontaneous recovery 
than visuospatial inattention (Rengachary et al. 2011).
Moreover, left hemineglect is frequently associated with left hemianopia, which 
is often difficult to disentangle (pseudo-hemianopia). Left hemianopia worsens the 
severity of visual neglect. Furthermore, hemiparesis/-plegia and hemi-anaesthesia 
or hypaesthesia are also often present in patients with left neglect. All these associ-
ated deficiencies worsen neglect and reduce the functional effects of rehabilitation.
2.1  Assessment of Neglect and Associated Disorders
Assessments should include a visual scanning or exploration task (i.e. crossing out 
numbers or lines or bells), a standardized text reading task, horizontal and vertical 
line bisection to detect shifts in the subjective visual midline, and an assessment of 
anosognosia. The Behavioural Inattention Test (BIT) is a useful test battery to 
screen for visual neglect in basic and functional tasks (Wilson et al. 1987). Another 
useful assessment tool for the acute and early post-acute phase is the Catherine 
Bergego Scale (CBS; Azouvi et al. 2002, 2003, 2006) which assesses visual and 
body neglect in daily life on a rating scale basis and also anosognosia. Ideally, 
assessments should also include additional tests of visual, tactile, and auditory 
extinction—especially in the post-acute phase or when only residual neglect is pres-
ent. This is important as extinction is often chronic and specific extinction tests are 
most sensitive to detect such residual neglect symptoms and extinction (for assess-
ment see Lezak et al. 2004).
While most neglect tests assess egocentric neglect phenomena, stimulus-centred 
or word-centred neglect phenomena may also occur, particularly during reading and 
visual scanning (Caramazza and Hillis 1990; Hillis et  al. 1998) and should be 
assessed as well. Word-centred neglect phenomena can be detected with a reading 
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test (as in hemianopia, see above) or having the patient read compound words. The 
apples test is useful to disentangle object-centred and egocentred neglect deficits 
during a visual search task, where different types of apples have to be cancelled out 
(Bickerton et al. 2011).
2.2  Rehabilitation of Neglect in the ICF Framework
2.2.1  Effects of Neglect Therapy on Disability to Prove
The latest Cochrane review by Bowen et al. (2013) including 23 randomized clini-
cal trials (628 participants) showed that most studies evaluate the effect of rehabili-
tation on standardized assessment tests; 15 studies assessed the impact on activities 
of daily living immediately after rehabilitation and only 6 studies measured these 
effects at a longer follow-up test after the end of therapy. The currently available 
results show a significant effect in favour of cognitive rehabilitation, but only on the 
standardized assessment tests of hemineglect. The effectiveness on the activities of 
daily life is therefore not rigorously demonstrated.
A limitation in the interpretation of studies is related to the measure of functional 
impact of cognitive neglect rehabilitation. Indeed, hemineglect is a rarely isolated 
deficiency, most often associated with multiple sensorimotor and cognitive deficits 
consecutive to the extent of the brain injury (cf. Kerkhoff 2001). The vast majority 
of the patients selected in the Cochrane review (last from 2013) had hemineglect 
due to a stroke of the middle cerebral artery, which was also responsible for left- 
sided sensory-motor hemiplegia, left-sided hemianopia, and other cognitive deficits 
such as constructional apraxia, non-lateralized attention deficits, or others. The 
functional consequences therefore result from all these deficits and not only from 
hemineglect. Although an improvement of hemineglect is observed after cognitive 
rehabilitation, it remains in most cases insufficient to decisively reduce the overall 
measured disability (see Fig. 3).
In addition, the measurement of therapeutic effects on disability is generally car-
ried out by generic assessment scales such as the Barthel Index, the Functional 
Independence Measure (FIM), or the Activity of Daily Living Scale. A more tar-
geted measurement of the functional consequences of hemineglect can be made by 
specific scales such as the Catherine Bergego Scale (CBS), provided however that 
the measured gain is significant in view of the associated deficits and their conse-
quences on the autonomy (Azouvi et al. 2006).
2.2.2  Cognitive Rehabilitation of Hemineglect Based 
on the International Classification of Functioning (ICF)
The International Classification of Functioning (ICF) not only is a reference for 
holistically understanding the different aspects of a pathology (WHO 2001) but also 
is a model adapted to the development of neurological rehabilitation strategies 
(Lexell and Brogårdh 2015). Indeed, the four dimensions described by the classifi-
cation can be considered as targets for neurorehabilitation (Alford et al. 2015) and 
cognitive rehabilitation of hemineglect. The first dimension, called “body structure/
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lesion”, corresponds to brain anatomical structures that are likely to be activated by 
re-education via brain plasticity mechanisms. The second dimension, “body func-
tion/impairment”, refers to the recovery of hemineglect (or clinical subtypes) by 
selective cognitive rehabilitation techniques (bottom-up and top-down strategies, 
explicit or implicit learning). The third dimension, “activity/limitation”, refers to 
the reduction of disability and the possible functional generalization of therapeutic 
effects as well as the improvement of activity through compensation methods. 
Finally, the fourth dimension, “participation/restriction”, refers to the reduction of 
participation restrictions, notably through improved body function, compensation 
methods, social interventions, and a better recognition of the deficit and its personal 
and social consequences (see Table 2).
The ICF model can therefore provide a methodological basis for the develop-
ment of hemineglect cognitive rehabilitation (Rode et al. 2017). For the specialist in 
neurorehabilitation and the neuropsychologist, an important question will be to 
determine what is the best judgment criterion for showing the impact of the inter-
ventions. This choice should also take into account the recommendations of 
Evidence-Based Medicine applied to non-drug therapies (Bowen et al. 2013; Yang 
et al. 2013).
Therapy of Neglect
A Cochrane analysis (Bowen et al. 2013) analyzed randomized controlled treatment 
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Fig. 3 Spatial neglect and associated deficiencies in the ICF-Framework
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23 included RCTs compared cognitive rehabilitation with any control intervention 
(Placebo, attention or no treatment). Meta-analyses demonstrated no statistically 
significant effect of cognitive rehabilitation, compared with control, for persisting 
effects on either ADL (5 studies, 143 participants) or standardised neglect f(8 stud-
ies, 172 participants), or for immediate effects on ADL (10 studies, 343 partici-
pants). In contrast, we found a statistically significant effect in favour of cognitive 
rehabilitation compared with control, for immediate effects on standardised neglect 
assessments (16 studies, 437 participants), standardised mean difference (SMD) 
0.35, 95 % confidence interval (CI) 0.09–0.62. However sensitivity analyses includ-
ing only studies with high methodological quality removed evidence of a significant 
effect of cognitive rehabilitation”. As a consequence, the authors gave no clear rec-
ommendations for therapy. In the meanwhile, several well- controlled randomized 
treatment studies have been published that allow some recommendations. Several 
reviews have described the available treatments in detail (Kerkhoff and Schenk 
2012; Bowen et al. 2013). Therefore, only a condensed survey of these treatments is 
given here (see the text below and Table 3), focussing on the currently documented 
therapeutic effects on visual neglect (which is the most often targeted domain in 
treatment studies), and also on nonvisual (tactile, auditory) neglect, sensory extinc-
tion, anosognosia, activities of daily living (ADLs), and motor/postural functions, if 
such effects have been published (for review see Kerkhoff and Schenk 2012). The 
references, therapeutic approaches, documented effects, the level of evidence 
Table 2 The International Classification of Functioning (ICF), a model adapted to strategies of 




Lesion Plasticity (structural, functional)—vicariousness






  Visual scanning training (VST)
  Attentional Cueing
  Mental practice or imagery
Bottom-up approaches
  Sensory stimulation (optokinetic, vestibular, 
proprioceptive, neck vibration)
  Prism adaptation
  Half-field eye patching
  Spatio-motor cueing
  Arm-activation intervention




Compensation by equipment (technical help, connects object)
Compensation by caregivers or environment
Participation Participation 
restriction
Compensation by family, people, society (legal, economic, 
politic dimensions); Recognition, inclusion
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(CEBM), the quality of evidence, and strength of recommendation (GRADE) are 
presented in Table 3 (see also Platz 2017).
2.3  Description of Treatments for Neglect
While with exception of the Optokinetic/smooth pursuit therapy (SPT), the quality 
of evidence available is too low to give a weak or strong recommendation, there is 
nevertheless a variety of therapeutic options that are supported by clinical experi-
ence. The résumés presented below are therefore expert opinion.
In visual scanning training (VST or exploration training), patients typically look 
at a visual display (on a table, a computer screen, or a large projection wall) on 
which different classes of visual stimuli (i.e. stars, circles, numbers, photos from 
real objects) are shown, and the patient is required to look for a specific class of 
stimuli (“Search for all stars and point to them”, with a stick or laser pointer or on a 
touch screen). Patients are verbally instructed to look to the neglected side (“cueing 
of attention”), search systematically row by row as in reading in order to acquire a 
systematic search strategy. By this, the number of omissions and search time is 
reduced.
Résumé: VST is the most widely used treatment for neglect and improves selec-
tively visual neglect in scanning and related tasks, but has no effect on non-visual 
neglect. It can easily be realized but requires many sessions to be effective (>40). It 
is difficult to implement in the early phase (first 2 months after stroke) because it 
requires some awareness and cooperation on the patient’s side.
Optokinetic/smooth pursuit therapy (OKS, SPT): Patients are instructed to make 
following (pursuit) eye movements to visual stimuli that move slowly towards the 
neglected field. The stimuli are usually presented on a computer screen or via 
beamer to a large projection wall via specific software. When the patient has reached 
with his eyes the neglected side of space, he is instructed to remain there with his 
eyes for some seconds, before the task is repeated. OKS/SPT can be performed 
early after stroke at the bedside, or later. Twenty or more sessions (á 30-min) are 
recommended.
Résumé: OKS/SPT is more effective than scanning therapy and can be imple-
mented earlier. Improvements transfer to a wide variety of visual and non-visual 
neglect domains and reduce anosognosia.
Neck-muscle vibration (NMV): During NMV therapy, the patient’s contralesional 
neck muscles (hence left neck in left neglect) are vibrated with a conventional vibra-
tor (either battery-driven or not; with a small vibration head, <2 cm diameter, and a 
vibration frequency >60–80 Hz). This induces activation of muscle spindles and 
leads to a relocation of gaze (eye and head position) towards a more symmetrical, 
midline position. The vibrator is usually held by the therapist, which can be demand-
ing for the therapist as he/she will feel the vibration as well and has to do it for at 
least 20 sessions (á 30 min).
Résumé: NMV is easy to apply but is more demanding for the therapist holding 
the vibrator. On the other hand, a battery-driven vibrator makes therapy more 
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flexible and mobile, thus therapy can be performed at the bedside, in physio or occu-
pational therapy, or at home.
Prism adaptation (PA): This therapy requires a conventional spectacle on 
which two prism glasses are mounted inducing a gaze shift to the ipsilesional 
side (hence to the right in left neglect). This prism goggle is worn by the patient 
only for the period of the prism exposure (not during the day, especially not dur-
ing walking!). The prism exposure lasts typically for 20–30 min per session, and 
this should be repeated (several times per week). While the patient wears the 
prism goggles, he/she carries out visuo-motor tasks. These can be pointing to 
marked locations on a table, or reaching for objects in daily life (i.e. cups or 
glasses on a table or in a bookshelf). After this exposure period, the goggles are 
taken off and the therapeutic after-effect occurs (re-orienting of spatial attention 
to the neglected side). This can be used for other subsequent therapies (i.e. 
motor, postural, reading, cognitive …). Twenty or more sessions (á 20–30 min) 
are recommended.
Résumé: PA is a widely used tool for neglect therapy that works best with a 10° 
prism (not smaller prism angle!) and is also mobile and relatively easy to apply.
Visuo-motor feedback (VF): The patient has to lift wooden or metal rods with his 
ipsilesional hand (index finger and thumb), so that their left and right half are bal-
anced and the rod does not fall to one side. As the patient ignores initially the con-
tralesional side of the rod (due to his neglect), he will grasp it more to the right side 
and consequently the bar will fall to the left side. This “natural” feedback leads to a 
subsequent adaptation of the patient’s lifting behaviour, thus lifting the rods more 
accurately in the middle part during the course of the therapy. Twenty or more ses-
sions (á 20–30 min) recommended.
Résumé: VF is an easily applicable and low-cost treatment that can be imple-
mented in different settings, including the patient’s home. This makes it flexible 
and mobile.
Mirror therapy (MT): MT is a well-established treatment for therapy of motor 
impairments (of the hemiparetic arm or leg). It requires a vertically oriented mirror 
which is placed in front of the patient’s breast so that he can view his ipsilesional 
hand/arm/leg performing different motor tasks. This action observation facilitates 
motor recovery of the impaired extremity behind the mirror. MT has shown thera-
peutic effects in patients with left-sided hemiparesis and left-sided visual neglect. 
Twenty or more sessions (á 20–30 min) recommended.
Résumé: MT is an easily applicable, low-cost therapy which can be used as an 
add-on treatment (not as a primary neglect therapy) for neglect.
Attention training: Alertness and sustained attention can be trained by various 
ways: by computer-based training and specific software, by table-top exercises, and 
also by motor (for instance treadmill) training. Improvements in attention lead to 
better performance in neglect-specific tasks, especially dual-tasks (i.e. looking and 
recollecting numbers heard, or looking and walking simultaneously).
Résumé: Attention training can be an element of neglect therapy. However, ther-
apy should not rely solely on computerized training as such improvements are often 
not stable in the long term.
Treating Neurovisual Deficits and Spatial Neglect
208
Hemifield Fresnel Prisms: Press-on (Fresnel) prism foils are attached on the con-
tralesional side of the two glasses of a conventional spectacle sparing the central 
(macular) visual field region. This induces a gaze shift towards the neglected side 
(hence opposite to that in prism adaptation, see above).
Résumé: Easy-to-use technique, which should be used only during sitting and 
when the patient is not involved in transfers or other potentially dangerous activi-
ties, as the prism distorts the visual field. The central 10° of each glass should be 
free from foil to enable unimpaired central vision. Fresnel prisms reduce visual 
acuity by some 10–20%.
Repetitive transcranial magnetic stimulation (rTMS): During rTMS, a magnetic 
coil attached to a magnetic stimulator is hold by a medical doctor over the non- 
lesioned parietal cortex (hence the intact) hemisphere, to re-balance the attentional 
systems of both hemispheres. Left parietal attentional systems are typically hyper-
active in patients with left neglect thus preventing the lesioned right-sided atten-
tional systems from functional recovery. rTMS temporarily dampens the leftward 
hyperactive systems, thus improving functional recovery. This works without the 
patient being attentive, but care must be taken not to induce fits. Twenty or more 
sessions (á 20 min) are recommended.
Résumé: rTMS (or theta burst stimulation) is the most costliest neglect therapy to 
date and requires medical staff. It can be used earlier than other treatments as the 
mechanism of action does not require awareness or active cooperation from the 
patient. An optional add-on treatment when safety criteria are followed.
Transcranial direct current stimulation (tDCS): Similar principle of action as in 
rTMS, but instead of magnetic pulses, weak electrical currents are delivered via two 
electrodes over the two parietal lobes. Twenty or more sessions (of 20  min) are 
recommended.
Résumé: Less costly than rTMS, but often the technique cannot be applied due to 
exclusion criteria for safety reasons (fits, open scull) or is difficult to apply because 
of hairy skin thus preventing the flow of electric currents.
Transcutaneous electrical nerve stimulation (TENS): Application of weak elec-
trical currents to the contralesional neck/upper back. Portable, low-cost technique, 
easily applicable, and no safety problems. Twenty or more sessions (á 20  min) 
recommended.
Résumé: Suitable as an add-on treatment, probably less suited as a primary and 
sole neglect therapy. It has good effects also on postural imbalance and non- 
lateralized attention.
Arm/hand activation with/without peripheral electrical stimulation: The method 
entails volitional movement of the contralesional limbs (i.e. opening and closing the 
hand). This can be facilitated by the additional application of electrodes to the 
neglected limb.
Résumé: Limb activation is often not applicable in the early phase of neglect 
because of severe hemiparesis or plegia. Later, with concurrent electrical stimula-
tion, it is a useful, low-cost technique that particularly addresses neglect of the 
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neglected extremities which is not targeted by the majority of other neglect treat-
ments (except GVS, see below).
Galvanic vestibular stimulation (GVS): Application of weak electrical current 
via two electrodes attached behind both ears (over the mastoid bones) activates the 
vestibular system via the vestibular nerves. This has good therapeutic effects on 
body-related neglect (tactile extinction, sense of arm position for the neglected limb 
and visual neglect). Same limitations for safety reasons as in rTMS and tDCS (no 
fits). Twenty or more sessions (of 20 min) recommended.
Résumé: A suitable add-on treatment, especially for the body-related phenomena 
of neglect. The same electrical stimulators as used for tDCS can be used.
Drugs: The administration of attention-enhancing drugs is intended to improve 
non-lateralized attention (alertness), thereby reducing neglect. Moreover, antide-
pressant drugs can improve attention.
Résumé: Potentially, drugs may be helpful as an add-on treatment (not as a pri-
mary neglect therapy). Unfortunately, the therapeutic effects are inconsistent and 
many potential interactions with other drugs the patient must take have to be consid-
ered. Antidepressants given because of post-stroke depression may have an addi-
tional positive effect on neglect but should not be the primary reason for their 
prescription.
2.4  Clinical Decision-Making: Which Therapy, When, Which 
Dose, and Which Combinations?
While some treatments may be classified as “bottom-up” treatments because they 
manipulate a specific sensory input channel (i.e. vestibular), others (“top-down”) 
intend to change cognitive strategies (i.e. sustained attention, visual scanning) in 
order to compensate for neglect. While the knowledge about the exact action profile 
of these different treatments is still incomplete, some treatment-relevant conclu-
sions can be drawn. First, only a few treatments induce multimodal effects in the 
visual and nonvisual modalities, while others improve neglect only in one modality 
(mostly the visual). Second, not all treatments show transfer effects to ADL and to 
motor/postural capacities, both of which are very important for gaining functional 
independence for the patient. Finally, no treatment is currently available that affects 
all components and modalities of neglect and associated disorders. It is—in our 
personal opinion—therefore more likely to achieve a better treatment outcome by 
using several different treatments in combination—either simultaneously or sequen-
tially—than expecting that neglect can be cured by using one specific treat-
ment alone.
According to a recent Cochrane analysis, evaluating the effects of drugs therapy 
on neglect (Luvizutto et al. 2015), the quality of the evidence from available RCTs 
was very low. The effectiveness and safety of pharmacological interventions for 
neglect after stroke are therefore uncertain. Hence, drug therapy cannot be recom-
mended for the treatment of spatial neglect or associated disorders.
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For the clinician, the question arises: which of these different treatments should 
be used, when, how long, and how often? Although many of these questions are 
currently unanswered by scientific research, some practical recommendations based 
on the literature and own clinical experience may be given:
• Early phase after stroke (first 2 months): Use methods that need less cognitive 
control, awareness, and cooperation from the patient: rTMS, TENS, OKS/SPT, 
neck muscle vibration. If feasible, start therapy already at the bedside.
• Post-acute phase after stroke (after month 2 post-onset): Add methods that 
require more active cooperation and participation from the patient during ther-
apy: visual scanning therapy, attention training, mirror therapy, visuo-motor 
feedback, and arm activation with concurrent electrical stimulation.
• Late phase after stroke (>6 months post-onset): Introduce more dual- tasks into 
therapy because in daily life the patient is often faced with such demands (i.e. 
looking and talking or walking and looking). This can be done by adding a cogni-
tive task to the primary therapeutic task (i.e. count backwards while scanning for 
objects on a table-top) or scanning visual scenes on a computer screen. Try ther-
apy with the patient standing instead of sitting. Mobility is of utmost importance 
for most neglect patients (see the chapter by Pèrennou et al., this volume) and the 
neglect impairs mobility and postural safety. Thus, neglect therapy can be per-
formed during stance looking at stimuli projected (via beamer) on a white wall 
or while the patient is standing or walking on a treadmill.
• Seeing straight: In the first months after stroke, it is important that the patient 
sees “more straight” instead of ignoring one side and looking always to the 
ipsilesional side.
• Systematic scanning strategy: Later, when the patient can look better to the 
neglected side, it is important that he can select certain stimuli while ignoring 
other things. This can be achieved by a systematic scanning strategy taught to the 
patient (i.e.): “Start looking always on the top left side row by row, scan horizon-
tally row by row. Don’t forget the left lower corner, as it is the most often 
neglected part of the scene (also in daily life)”.
• Multidisciplinary treatments: Try to implement treatments that span different 
vocational specialties in your rehab-team: for instance, try to combine physio-
therapy with i.e. neck muscle vibration or TENS or attention training in addition 
with motor therapy for hand function.
• Motor and Postural Functions: Left-sided motor functions are often more 
impaired in patients with neglect than those without neglect (both with hemipa-
resis or plegia). Specific neglect therapy augments the effects of physiotherapy. 
Try to combine postural training (i.e. standing during neglect therapy, or with an 
additional balance pad or on a treadmill with stabilization) with neglect therapy 
(i.e. visual scanning training, OKS/SPT, attention training).
• Visuospatial disorders: Neglect is not a unitary disorder, but rather a multicom-
ponent complex disease with—due to larger lesions—more associated deficits. 
Often, visuospatial perception (line orientation, subjective visual, or haptic verti-
cal) and visuo-construction are impaired due to parietal lesions. The prior can be 
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treated for instance with GVS, the latter with specific visuo-constructive therapy. 
This improves visuo-motor performance in daily life.
• Exploit after-effects: Use the known after-effects of several of these treatments 
(i.e. prism adaptation, OKS/SPT, NMV, rTMS, TENS) for the next therapy after-
wards; they facilitate the subsequent therapy.
• Start early: Use the morning instead of the afternoon for therapy, patients are 
more alert. In the early rehab phase, 20–30 min continuous neglect therapy is 
often the limit and preferable to 1-h sessions.
• Dose: More therapy induces more improvements although this remains to be 
proven scientifically. This can be reached by implementing different neglect 
therapies into the treatments delivered by different therapists (i.e. nurse, physio-
therapist, occupational therapist, neuropsychologist, social worker, recreation 
therapist, relative at home).
• Awareness/Anosognosia: Improved awareness comes gradually (a) by certain 
treatments (i.e. OKS/SPT or neck muscle vibration, or awareness training) and 
(b) by improving the patient’s and relatives’ knowledge about the impairments 
and treatment progress. This is a joint task of the whole rehab team.
• As a note of caution, it needs to be added that technical devices may not be 
licensed for the specific use mentioned; if that was the case, any application 
would be “off label” and related medico-legal aspects need to be considered.
• Late course of the disease: Moreover, most “therapy knowledge” comes from the 
first year after stroke. Almost nothing is known about the very late outcome from 
neglect several years after a stroke. There could be later functional recovery, a 
change of neglect type and/or some adaptation to the deficit. Such aspects should 
be evaluated in future treatment research.
2.5  Therapy of Sensory Extinction
Sensory extinction may be associated with spatial neglect or dissociate from it 
(Kerkhoff 2001). In the acute stage, both are often difficult to disentangle. In the 
chronic stage, extinction is often present although overt neglect signs have van-
ished. Extinction may persist for years after a stroke and impairs functional inde-
pendence (i.e. tactile extinction impairs ADLs, visual extinction impairs driving!). 
Only one treatment has so far shown lasting and significant treatment effects on 
extinction; Galvanic vestibular stimulation reduced tactile extinction permanently 
(Schmidt et al. 2013b).
2.6  Therapy of Anosognosia in Neglect
Improving awareness (or reducing anosognosia) is crucial when aiming at a better 
outcome for patients with neglect and anosognosia. Few studies have shown treat-
ment effects on unawareness after specific therapy. After repetitive neck muscle 
vibration, ADL functions and unawareness (as assessed from a rating scale) 
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improved significantly (Schindler et  al. 2002). Moreover, repetitive optokinetic 
therapy (SPT) reduced unawareness significantly (again rated from staff), while 
visual scanning therapy had no effect on unawareness (Kerkhoff et  al. 2014). 
Jenkinson et al. (2011) summarized helpful treatment strategies in anosognosia for 
hemiplegia, which is often but not always present in the early phase of neglect. 
These strategies require systematic evaluation in further controlled treatment 
studies.
2.7  Conclusions
The last two decades have seen a dramatic increase in the number of techniques 
available for the treatment of unilateral neglect and associated disorders (reviewed 
in Kerkhoff and Schenk 2012). Many of these techniques were developed from 
experimental interventions designed to influence the rightward orientation bias of 
neglect patients. These sensory stimulation techniques have some obvious advan-
tages. They are easy to apply, their effects tend to generalize, and they only require 
minimal patient compliance—a huge benefit in the case of a disorder that is fre-
quently associated with anosognosia. The induced improvements can last for sev-
eral weeks when multiple treatment sessions are applied. However, the initial hope 
for a quick cure for neglect after only one or few treatment sessions has turned out 
to be unrealistic. Instead, a higher number of treatment sessions are probably neces-
sary to reach functional improvements that last for a sufficiently long time and not 
only for 1 or 2 weeks. The challenge today is to select the best tool for a given 
patient and to combine this with other effective treatments to maximize outcome. 
We have formulated several practical recommendations which can be implemented 
into neurorehab teams in order to facilitate the transfer of novel knowledge, tech-
niques, and treatments into clinical practice. Finally, we should keep in mind that 
neglect is not a unitary disorder but rather a complex, multicomponential disease. 
This requires—like other complex diseases—multiple, coordinated single treat-
ments as we have tried to outline in this chapter.
References
Aimola L, Lane AL, Smith DT, Kerkhoff G, Ford G, Schenk T (2014) Efficacy and feasibility 
of a home-based computer training for individuals with homonymous visual field defects. 
Neurorehabil Neural Repair 28:207–218
Alford VM, Ewen S, Webb GR, McGinley J, Brookes A, Remedios LJ (2015) The use of the 
International Classification of Functioning, Disability and Health to understand the health and 
functioning experiences of people with chronic conditions from the person perspective: a sys-
tematic review. Disabil Rehabil 37:655–666
Azouvi P, Samuel C, Louis-Dreyfus A, Bernati T, Bartolomeo P, Beis J-M, Chokron S, Leclercq 
M, Marchal F, Martin Y, De Montety G, Olivier S, Perennou D, Pradat-Diehl P, Prairial C, 
Rode G, Siéroff E, Wiart L, Rousseaux M, French Collaborative Study Group on Assessment 
of Unilateral Neglect (GEREN/GRECO) (2002) Sensitivity of clinical and behavioural tests 
of spatial neglect after right hemisphere stroke. J Neurol Neurosurg Psychiatry 73:160–166
G. Kerkhoff et al.
213
Azouvi P, Olivier S, De Montety G, Samuel C, Louis-Dreyfus A, Tesio L (2003) Behavioural 
assessment of unilateral neglect: study of the psychometric properties of the Catherine Bergego 
Scale. Arch Phys Med Rehabil 84:51–57
Azouvi P, Bartolomeo P, Beis JM, Perennou D, Pradat-Diehl P, Rousseaux M (2006) A battery of 
tests for the quantitative assessment of unilateral neglect. Restor Neurol Neurosci 24:273–285
Barton JJS, Black S (1998) Line bisection in hemianopia. J Neurol Neurochir Psychiatr 
64(5):660–662
Bickerton W-L, Samson D, Williamson J, Humphreys GW (2011) Separating forms of neglect 
using the Apples Test: validation and functional prediction in chronic and acute stroke. 
Neuropsychology 25:567–580
Biousse V, Newman NJ (2009) Neuro-opthalmology illustrated. Thieme, New York
Bouwmeester L, Heutink J, Lucas C (2007) The effect of visual training for patients with visual 
field defects due to brain damage: a systematic review. J Neurol Neurosurg Psychiatry 
78(6):555–564
Bowen A, Hazelton C, Pollock A, Lincoln NB (2013) Cognitive rehabilitation for spatial neglect 
following stroke. Cochrane Database Syst Rev 2013(7):CD003586
Caramazza A, Hillis AE (1990) Levels of representation, co-ordinate frames, and unilateral 
neglect. Cogn Neuropsychol 7(5–6):391–445
Cazzoli D, Muri RM, Schumacher R et al (2012) Theta burst stimulation reduces disability during 
the activities of daily living in spatial neglect. Brain 135:3426–3429
De Haan G, Heutink J, Melis-Dankers BJM, Tucha O, Brouwer W (2014) Spontaneous recovery 
and treatment effecs in patients with homonymous visual field defects: a meta-analysis of exist-
ing literature in terms of the ICF framework. Surv Ophthalmol 59:77–96
De Haan G, Melis-Dankers BJ, Brouwer WH, Bredewoud RA, Tucha O, Heutink J (2015) The 
effects of compensatory scanning training on mobility in patients with homonymous visual 
field defects: a randomized controlled trial. PLoS One 10(8):e134459
Gialanella B, Monguzzi V, Santoro R, Rocchi S (2005) Functional recovery after hemiplegia in 
patients with neglect: the rehabilitative role of anosognosia. Stroke 36:2687–2690
Gossmann A, Kastrup A, Kerkhoff G, Herrero CL, Hildebrandt H (2013) Prism adaptation 
improves ego-centered but not allocentric neglect in early rehabilitation patients. Neurorehabil 
Neural Repair 27:534–541
Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schünemann JJ (2008) 
GRADE: an emerging consensus on rating quality of evidence and strength of recommenda-
tion. BMJ 336:924–926
Harvey M, Hood B, North A, Robertson IH (2003) The effects of visuomotor feedback training on 
the recovery of hemispatial neglect symptoms: assessment of a 2-week and follow-up interven-
tion. Neuropsychologia 41:886–893
Hesse C, Lane AR, Aimola L, Schenk T (2012) Pathways involved in human conscious vision 
contribute to obstacle-avoidance behaviour. Eur J Neurosci 36:2383–2390
Hillis AE, Rapp B, Benzing L, Caramazza A (1998) Dissociable coordinate frames of unilateral 
spatial neglect: “viewer-centered” neglect. Brain Cogn 37(3):491–526
Husain M (2008) Hemispatial neglect. In: Goldenberg G, Miller BV (eds) Handbook of clinical 
neurology. Elsevier B.V., Amsterdam, pp 359–372
Ivanov IV, Kuester S, MacKeben M, Krumm A, Haaga M, Staudt M, Cordey A, Gehrlich C, Martus 
P, Trauzettel-Klosinski S (2019) Effects of visual search training in children with hemianopia. 
PLoS One 13(7):e0197285
Jackowski MM, Sturr JF, Taub HA, Turk MA (1996) Photophobia in patients with traumatic 
brain injury—uses of light-filtering lenses to enhance contrast sensitivity and reading rate. 
NeuroRehabilitation 6:193–201
Jehkonen M, Laihosalo M, Kettunen J (2006a) Anosognosia after stroke: assessment, occurrence, 
subtypes and impact on functional outcome reviewed. Acta Neurol Scand 114:293–306
Jehkonen M, Laihosalo M, Kettunen JE (2006b) Impact of neglect on functional outcome after 
stroke: a review of methodological issues and recent research findings. Restor Neurol Neurosci 
24:209–215
Treating Neurovisual Deficits and Spatial Neglect
214
Jenkinson PM, Preston C, Ellis SJ (2011) Unawareness after stroke: a review and practical guide to 
understanding, assessing, and managing anosognosia for hemiplegia. J Clin Exp Neuropsychol 
33:1079–1093
Kalra L, Perez I, Gupta S, Wittink M (1997) The influence of visual neglect on stroke rehabilita-
tion. Stroke 28:1386–1391
Kapoor N, Ciuffreda KJ (2002) Vision disturbances following traumatic brain injury. Curr Treat 
Options Neurol 4:271–280
Karnath HO, Rennig J, Johannsen L, Rorden C (2011) The anatomy underlying acute versus 
chronic spatial neglect: a longitudinal study. Brain 134:903–912
Kasten E, Wüst S, Behrens-Baumann W, Sabel BA (1998) Computer-based training for the treat-
ment of partial blindness. Nat Med 4:1083–1087
Keller I, Lefin-Rank (2010) Improvement of visual search after audiovisual exploration training in 
hemianopic patients. Neurorehabil and Neural Repair 24:666–673
Kerkhoff G (1993) Displacement of the egocentric visual midline in altitudinal postchiasmatic 
scotomata. Neuropsychologia 31:261–265
Kerkhoff G, Münßinger U, Meier EK (1994) Neurovisual rehabilitation in cerebral blindness. Arch 
Neurol 51:474–481
Kerkhoff G (1999) Restorative and compensatory therapy approaches in cerebral blindness—a 
review. Restor Neurol Neurosci 15(2–3):255–271
Kerkhoff G (2000) Neurovisual rehabilitation: recent developments and future directions. J Neurol 
Neurosurg Psychiatry 68:691–706
Kerkhoff G (2001) Hemispatial neglect in man. Prog Neurobiol 63:1–27
Kerkhoff G (2010) Evidenczbasierte Verfahren in der neurovisuellen Rehabiliation. Neurol 
Rehabil 16:82–90
Kerkhoff G, Schenk T (2011) Line bisection in homonymous visual field defects—recent findings 
and future directions. Cortex 47(1):53–58
Kerkhoff G, Schenk T (2012) Rehabilitation of neglect: an update. Neuropsychologia 6:1072–1079
Kerkhoff G, Munssinger U, Haaf E, Eberle-Strauss G, Stogerer E (1992a) Rehabilitation of hom-
onymous scotomata in patients with postgeniculate damage of the visual system: saccadic com-
pensation training. Restor Neurol Neurosci 4(4):245–254
Kerkhoff G, Münßinger U, Eberle-Strauss G, Stögerer E (1992b) Rehabilitation of hemianopic 
alexia in patients with postgeniculate visual field disorders. Neuropsychol Rehabil 2(1):21–42
Kerkhoff G, Reinhart S, Ziegler W, Artinger F, Marquardt C, Keller I (2013) Smooth pursuit eye 
movement training promotes recovery from auditory and visual neglect: a randomized con-
trolled study. Neurorehabil Neural Repair 27:789–798
Kerkhoff G, Bucher L, Brasse M et al (2014) Smooth pursuit “bedside” training reduces disability 
and unawareness during the activities of daily living in neglect. A randomized controlled trial. 
Neurorehabil Neural Repair 28:554–563
Kerr NM, Chew SS, Eady EK, Gamble GD, Danesh-Meyer HV (2010) Diagnostic accuracy of 
confrontation visual field tests. Neurology 74(15):1184–1190
Koch G, Bonnì S, Giacobbe V, Bucchi G, Basile B, Lupo F, Versace V, Bozzali M, Caltagirone 
C (2012) Theta-burst stimulation of the left hemisphere accelerates recovery of hemispatial 
neglect. Neurology 78:24–30
Lane A, Smith DT, Elison A, Schenk T (2010) Visual exploration training is no better than atten-
tion training for treating hemianopia. Brain 133(6):1717–1728
Lexell J, Brogårdh C (2015) The use of ICF in the neurorehabilitation process. 
NeuroRehabilitation 36:5–9
Lezak MD, Howieson E, Bigler E, Tranel D (2004) Neuropsychological assessment. Oxford 
University Press, New York
Luvizutto GJ, Bazan R, Braga GP, Resende LA, Bazan SG, El Dib R (2015) Pharmacological 
interventions for unilateral spatial neglect after stroke. Cochrane Database Syst Rev 
2015(11):CD010882
Machner B, Sprenger A, Sander T, Heide W, Kimmig H, Helmchen C et al (2009) Visual search 
disorders in acute and chronic homonymous hemianopia: lesion effects and adaptive strategies. 
Ann N Y Acad Sci 1164:419–426
G. Kerkhoff et al.
215
Mödden C, Behrens M, Damke I, Eilers N, Kastrup A, Hildebrandt H (2012) A randomized con-
trolled trial comparing 2 interventions for visual field loss with standard occupational therapy 
during inpatient stroke rehabilitation. Neurorehabil Neural Repair 26(5):463–469
Nelles G, Esser J, Eckstein A, Tiede A, Gerhard H, Diener HC (2001) Compensatory visual field 
training for patients with hemianopia after stroke. Neurosci Lett 306:189–192
Neumann G, Schaadt AK, Reinhart S, Kerkhoff G (2016) Clinical and psychometric evalua-
tions of the cerebral vision screening questionnaire in 461 nonaphasic individuals poststroke. 
Neurorehabil Neural Repair 30:187–198
Nijboer TC, Kollen BJ, Kwakkel G (2013) Time course of visuospatial neglect early after stroke: 
a longitudinal cohort study. Cortex 49:2021–2027
Pambakian AL, Mannan SK, Hodgson TL, Kennard C (2004) Saccadic visual search train-
ing: a treatment for patients with homonymous hemianopia. J Neurol Neurosurg Psychiatry 
75(10):1443–1448
Paolucci S, Antonucci G, Guariglia C, Magnotti L, Pizzamiglio L, Zoccolotti P (1996) Facilitatory 
effect of neglect rehabilitation on the recovery of left hemiplegic stroke patients—a cross-over 
study. J Neurol 243:308–314
Pizzamiglio L, Antonucci G, Judica A, Montenero P, Razzano C, Zoccolotti P (1992) Cognitive 
rehabilitation of the hemineglect disorder in chronic patients with unilateral right brain dam-
age. J Clin Exp Neuropsychol 14:901–923
Pizzamiglio L, Vallar G, Magnotti L (1996) Transcutaeneous electrical stimulation of the neck 
muscles and hemineglect rehabilitation. Rest Neur Neurosi 10:197–203
Platz T (2017) Practice guidelines in neurorehabilitation. Neurology International Open 
1:E148–E152
Polanowska K, Seniow J, Paprot E, Lesniak M, Czlonkowska A (2009) Left-hand somatosensory 
stimulation combined with visual scanning training in rehabilitation for post-stroke hemine-
glect: a randomised, double-blind study. Neuropsychol Rehabil 19:364–382
Pollock A, Zazelton C, Henderson CA, Angilley J, Dhillon B, Lanthorne P, Livingstone K, Munro 
FA, Heather O, Row F, Shahani U (2012) Interventions for visual field defects in patients with 
stroke. Stroke 43:e37–e38
Ptak R, Di PM, Schnider A (2012) The neural correlates of object-centered processing in reading: 
a lesion study of neglect dyslexia. Neuropsychologia 50:1142–1150
Rengachary J, He BJ, Shulman GL, Corbetta M (2011) A behavioral analysis of spatial neglect and 
its recovery after stroke. Front Hum Neurosci 5:29
Rizzo M (1989) Astereopsis. In: Boller F, Grafman J (eds) Handbook of neuropsychology. Elsevier, 
Amsterdam, pp 415–427
Rizzo M, Barton JJS (2008) Central disorders of visual function. In: Miller NR, Newman NJ, 
Biousse V, Kerrison JB (eds) Walsh and Hoyt’a clinical neuro-opthalmology: the essentials. 
Lippincott Williams & Wilkins, Philadelphia, pp 263–284
Robertson IH, Tegnér R, Tham K, Lo A, Nimmo-Smith I (1995) Sustained attention training 
for unilateral neglect: theoretical and rehabilitation implications. J Clin Exp Neuropsychol 
17:416–430
Rode G, Lacour S, Jacquin-Courtois S, Pisella L, Michel C, Revol P, Alahyane N, Luauté J, 
Gallagher S, Halligan P, Pélisson D, Rossetti Y (2015) Long-term sensorimotor and therapeuti-
cal effects of a mild regime of prism adaptation in spatial neglect. A double-blind RCT essay. 
Ann Phys Rehabil Med 58:40–53
Rode G, Pisella L, Petitet P, O’Shea J, Huchon L, Jacquin-Courtois S, Rossetti Y (2017) Quelles 
stratégies de rééducation dans la négligence spatiale unilatérale ? In: Roussel M, Godefroy O, 
de Boissezon X (eds) Troubles neurocognitifs vasculaires et post-AVC. De l’évaluation à la 
prise en charge. De Boeck Supérieur, Paris, pp 97–110
Rossi PW, Kheyfets S, Reding MJ (1990) Fresnel prisms improve visual perception in stroke 
patients with homonymous hemianopia or unilateral visual neglect. Neurology 40:1597–1599
Rossit S, Benwell CSY, Szymanek L, Learmonth G, McKernan-Ward L, Corrigan E, Muir K, 
Reeves I, Duncan G, Birschel P, Roberts M, Livingstone K, Jackson H, Castle P, Harvey M 
Treating Neurovisual Deficits and Spatial Neglect
216
(2017) Efficacy of home-based visuomotor feedback training in stroke patients with chronic 
hemispatial neglect. Neuropsychol Rehabil 23:1–20
Roth T, Sokolov AN, Mesias A, Roth P, Weller M, Trauettel-Klosinski S (2009) Comparing explor-
ative saccade and flicker training in hemianopia: a randomized controlled study. Neurology 
72:324–331
Rowe F, Brand D, Jackson CA, Price A, Walker L, Harrison S et al (2009) Visual impairment fol-
lowing stroke: do stroke patients require vision assessment? Age Ageing 38(2):188–193
Rowe FJ, Conroy EJ, Bedson E, Cwiklinski E, Drummond A, Garcia-Finana M, Howard C, 
Pollock A, Shipman T, Dodridge C, MacIntosh C, Johnson S, Noonan C, Barton G, Sackley 
C (2016) A pilot randomized controlled trial comparing effectiveness of prism glasses, visual 
search training and standard care in hemianopia. Acta Neurol Scand 2017(136):310–321
Schaadt AK, Kerkhoff G (2016) Vision and visual processing deficits. In: Husain M, Schott J 
(eds) Oxford textbook of cognitive neurology & dementia. Oxford University Press, Oxford, 
pp 147–160
Schaadt AK, Schmidt L, Reinhart S, Adams M, Garbacenkaite R, Leonhardt E, Kuhn C, Kerkhoff 
G (2013) Perceptual relearning of binocular fusion and stereoacuity after brain injury. 
Neurorehabil Neural Repair 28(5):462–471
Schaadt AK, Schmidt L, Kuhn C, Summ M, Adams M, Garbacenkaite R, Leonhardt E, Reinhart S, 
Kerkhoff G (2014) Perceptual relearning of binocular fusion after hypoxic brain damage: four 
controlled single-case treatment studies. Neuropsychology 28(3):382–387
Schindler I, Kerkhoff G, Karnath H-O, Keller I, Goldenberg G (2002) Neck muscle vibration 
induces lasting recovery in spatial neglect. J Neurol Neurosurg Psychiatry 73:412–419
Schmidt L, Keller I, Artinger F, Stumpf O, Kerkhoff G (2013a) Galvanic vestibular stimula-
tion improves arm position sense in spatial neglect: a sham-stimulation-controlled study. 
Neurorehabil Neural Repair 27:497–506
Schmidt L, Utz KS, Depper L et al (2013b) Now you feel both: galvanic vestibular stimulation 
induces lasting improvements in the rehabilitation of chronic tactile extinction. Front Hum 
Neurosci 7:90
Schreiber A, Vonthein R, Reinhard J, Trauzettel-Klosinski S, Connert C, Schiefer U (2006) Effect 
of visual restitution training on absolute homonymous scotomas. Neurology 67:143–145
Schröder A, Wist ER, Hömberg V (2008) TENS and optokinetic stimulation in neglect therapy 
after cerebrovascular accident: a randomized controlled study. Eur J Neurol 15:922–927
Schuett S (2009) The rehabilitation of hemianopic dyslexia. Nat Rev Neurol 5:427–437
Schuett S, Heywood C, Kentridge W, Zihl J (2008) Rehabilitation of hemianopic alexia: are words 
necessary for relearning oculomotor control? Brain 131:3156–3168
Smit M, Schutter DJLG, Nijboer TCW, Visser-Meily JMA, Kappelle LJ, Kant N, Penninx J, 
Dijkerman HC (2015) Transcranial direct current stimulation to the parietal cortex in hemispa-
tial neglect: a feasibility study. Neuropsychologia 74:152–161
Spitzyna GA, Wise RJ, McDonald SA, Plant GT, Kidd D, Crewes H et  al (2007) Optokinetic 
therapy improves text reading in patients with hemianopic alexia: a controlled trial. Neurology 
68(22):1922–1930
Suchoff IB, Kapoor N, Ciuffreda KJ, Rutner D, Han E, Craig S (2008) The frequency of occur-
rence, types, and characteristics of visual field defects in acquired brain injury: a retrospective 
analysis. Optometry 79(5):259–265
Thieme H, Mehrholz J, Pohl M, Behrens J, Dohle C (2013) Mirror therapy for improving motor 
function after stroke. Stroke 44:e1–e2
Trauzettel-Klosinski S (2011) Current methods of visual rehabilitation. Deutsches Ärzteblatt 
International (English) 108:871–878
Turgut N, Miranda M, Kastrup A, Eling P, Hildebrandt H (2018) tDCS combined with optoki-
netic drift reduces egocentric neglect in severely impaired post-acute patients. Neuropsychol 
Rehabil 28(4):515–526
Van Wyk A, Eksteen CA, Rheeder P (2014) The effect of visual scanning exercises integrated into 
physiotherapy in patients with unilateral spatial neglect poststroke: a matched-pair randomized 
control trial. Neurorehabil Neural Repair 28:856–873
G. Kerkhoff et al.
217
WHO (2001) International classification of functioning, disability and health. World Health 
Organization, Geneva.
Wilkinson D, Zubko O, Sakel M, Coulton S, Higgins T, Pullicino P (2014) Galvanic vestibular 
stimulation in hemi-spatial neglect. Front Integr Neurosci 8:4
Wilson B, Cockburn J, Halligan P (1987) Development of a behavioral test of visuospatial neglect. 
Arch Phys Med Rehabil 68:98–102
Yang NYH, Zhou D, Chnung RCK, Li-Tsang CWP, Fong KNK (2013) Rehabilitation interven-
tions for unilateral neglect after stroke: a systematic review from 1997 through 2012. Front 
Hum Neurosci 7:1–11
Zhang X, Kedar S, Lynn JJ, Newman NJ, Viousse V (2006) Natural history of homonymous hemi-
anopia. Neurology 66:901–905
Zihl J (1995) Eye movement patterns in hemianopic dyslexia. Brain 118:891–912
Zihl J (2011) Rehabilitation of visual disorders after brain injury, 2nd edn. Psychology Press, 
New York
Zihl J, Kerkhoff G (1990) Foveal photopic and scotopic adaptation in patients with brain damage. 
Clin Vis Sci 2:185–195
Open Access This chapter is licensed under the terms of the Creative Commons Attribution- 
NonCommercial- NoDerivatives 4.0 International License (http://creativecommons.org/
licenses/by-nc-nd/4.0/), which permits any noncommercial use, sharing, distribution and 
reproduction in any medium or format, as long as you give appropriate credit to the original 
author(s) and the source, provide a link to the Creative Commons license and indicate if you 
modified the licensed material. You do not have permission under this license to share 
adapted material derived from this chapter or parts of it.
The images or other third party material in this chapter are included in the chapter's Creative 
Commons license, unless indicated otherwise in a credit line to the material. If material is not 
included in the chapter's Creative Commons license and your intended use is not permitted by 
statutory regulation or exceeds the permitted use, you will need to obtain permission directly from 
the copyright holder.
Treating Neurovisual Deficits and Spatial Neglect
219© The Author(s) 2021
T. Platz (ed.), Clinical Pathways in Stroke Rehabilitation, 
https://doi.org/10.1007/978-3-030-58505-1_12
C. M. van Heugten (*) 
Brain Injury Center Limburg, Maastricht, The Netherlands 
Department of Neuropsychology & Psychopharmacology, Faculty of Psychology  
& Neuroscience, Maastricht University, Maastricht, The Netherlands 
School for Mental Health and Neuroscience, Faculty of Health, Medicine and Life Sciences, 
Maastricht University Medical Center, Maastricht, The Netherlands
e-mail: caroline.vanheugten@maastrichtuniversity.nl 
B. A. Wilson 
The Oliver Zangwill Centre, Ely, UK




Stroke can have physical as well as cognitive, emotional and social consequences. 
Depending on the time of measurement, cognitive impairments are present in 
50–70% of stroke survivors (e.g. Rasquin et al. 2002, 2004; Nys et al. 2005; Barker- 
Collo and Feigin 2006). In the first 2 weeks almost every stroke patient (92%) is 
impaired in at least one cognitive domain (Linden et al. 2005). Memory, executive 
functions, speed of information processing, language and visuo-spatial abilities are 
the most affected domains. The latter two have been discussed in chapters 
“Rehabilitation of Communication Disorders” and “Treating Neurovisual Deficits 
and Spatial Neglect”, respectively.
Cognitive deficits have a negative impact on long-term outcomes such as inde-
pendent functioning, community integration and quality of life (Nys et al. 2005; 
Duits et al. 2008; Van der Zwaluw et al. 2011; Barker-Collo et al. 2010; Wagle et al. 
2011). Early identification of cognitive deficits is therefore necessary (van Dijk and 
de Leeuw 2012) and treatment should be offered accordingly (Langhorne et  al. 
2011; Albert and Kesselring 2012).
The same is true for emotional consequences after stroke. Depressive symptoms 
also have a profound influence on outcome and occur frequently. These symptoms 
range from 5 to 54% in the acute phase and remain present in 23–25% after 6 
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months, when anxiety is present in 19–23% (Whyte and Mulsant 2002; Aben et al. 
2002; De Wit et al. 2008; Kouwenhoven et al. 2011). Prevalence rates decrease over 
time but after 2 years major depression is seen in 20% of the stroke patients (Van 
Mierlo et  al. 2015). In research and clinical practice, more attention is paid to 
depression but anxiety is almost as common and the two symptoms often occur 
together. Irritability, agitation, eating disturbances and apathy are also commonly 
found post-stroke (Angelelli et al. 2004).
Another common and debilitating but also less visible problem after stroke is 
fatigue. A recent meta-analysis showed that prevalence estimates vary from 25 to 
85% on the basis of the Fatigue Severity Scale with a pooled prevalence estimate of 
50% (Cumming et al. 2016). Post-stroke fatigue is an independent predictor of dis-
ability and burden of care and should therefore be taken into account when formu-
lating post-stroke rehabilitation treatment goals (Mandliya et al. 2016).
Patients usually receive further rehabilitation treatment after suffering a major 
stroke (Winstein et al. 2016), while full recovery is assumed in a transient ischemic 
attack (TIA), and minor stroke patients are discharged home without further reha-
bilitation or follow-up treatment (Edwards et al. 2006). However, previous studies 
in TIA and minor stroke patients found high prevalence of dysfunction across all 
domains of health, of which cognitive and emotional problems and fatigue were 
most notable (Arts et al. 2008; Muus et al. 2010; Radman et al. 2012; Moran et al. 
2014)—and mostly specific to stroke (van der Kemp et al. 2017; De Graaf et al. 
2018; Fens et  al. 2013). These symptoms may be overlooked with conventional 
clinical measures such as the neurological examination or the Barthel Index, despite 
the fact that they can be a major contributor to an impaired performance in activities 
of daily living including decreased participation and a diminished quality of life 
(QOL) (Edwards et al. 2006; Duncan et al. 1997; Suenkeler et al. 2002; Verbraak 
et al. 2012).
2  Best Evidence Synthesis
Best evidence synthesis relevant to clinical decision-making (with reference to 
Cochrane reviews, meta-analyses and RCTs as well as selected guidelines) includ-
ing (when applicable).
The evidence on therapy presented in this chapter is gathered by a systematic 
search in December 2017 using the following steps. First, the Cochrane database of 
systematic reviews was consulted to select the most recent reviews on cognition, 
emotion and fatigue post-stroke. In addition, the search terms from these reviews 
were used to find additional, more recent studies. In case no recent Cochrane review 
was available, PubMed was searched using the filter ‘review’ and a combination of 
the search terms ‘stroke’ and the topic of interest. Furthermore, studies were added 
on the basis of the authors’ own knowledge of relevant studies in this field. The 
evidence on assessment is mostly based on the authors’ own knowledge because 
Cochrane reviews are not available in this field.
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2.1  Assessment: Brief Overview, Key Instruments
2.1.1  Screening for Cognitive Problems
Given the high prevalence of cognitive and emotional consequences including 
fatigue after stroke and the negative impact on daily life functioning and social par-
ticipation, it is important to screen every stroke patient for problems in these areas. 
Early screening can support the discharge destination and can help to plan the most 
adequate rehabilitation treatment and inform the patient and his or her caregivers 
about the possible consequences of these impairments in daily life and future 
functioning.
Cognitive screening early after stroke is recommended in many stroke guidelines 
and has even been determined as a key quality indicator of stroke services (Hachinski 
et  al. 2006). Extensive neuropsychological assessment is recommended at later 
stages, but in the first days after stroke this is not feasible because patients may not 
be medically stable, can be fatigued easily and arousal levels may fluctuate. 
Screening for cognitive consequences should be conducted using a sensitive instru-
ment specifically for stroke. From three systematic reviews in recent years (Stolwyk 
et  al. 2014; Van Heugten et  al. 2015; Burton and Tyson 2015), the Montreal 
Cognitive Assessment (MoCA) was identified as the most reliable, sensitive and 
feasible instrument for cognitive screening after stroke. A cutoff score of 26 is com-
monly used in stroke patients. In a recent study, it was shown that even in a mild 
stroke population (n = 324) 66.4% of the patients was cognitively impaired on the 
basis of the MoCA at 2 months post-stroke, with a significant improvement leaving 
51.9% impaired at 6 months (Nijsse et al. 2017b). All reviews on cognitive screen-
ing instruments state that the widely used Mini Mental State Examination (MMSE) 
should no longer be used for this purpose because it was originally designed for 
screening of dementia and is therefore not sufficiently sensitive for consequences of 
stroke. Also for TIA and mild stroke patient, the MoCA can be used (Sivakumar 
et al. 2014).
Cognitive impairment may arise due to damage to strategic areas of the brain, 
even in patients who do not have motor or communication deficits. Especially in the 
group of so-called ‘walking and talking’ patients (i.e. good outcome in terms of 
motor and communication functioning), cognitive problems may be missed (van 
Dijk and de Leeuw 2012; Mark 2012). A routine follow-up visit, which is often 
dedicated to secondary prevention, should therefore also include cognitive screening.
Additionally, people may experience subjective cognitive complaints which are 
not necessarily related to objective cognitive functioning. Subjective cognitive com-
plaints are very common after stroke, may increase over time and have a negative 
impact on outcome (van Rijsbergen et al. 2014). The use of stroke-specific instru-
ments that measure subjective cognitive complaints, such as the Checklist for 
Cognition and Emotion (CLCE-24; van Heugten et  al. 2007), are preferred (van 
Rijsbergen et al. 2015). Patients and their informal caregivers may disagree about 
the presence, nature and severity of these problems (van Rijsbergen et al. 2014), 
which is why it is advisable to also ask the primary caregiver about potential 
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problems in these areas. The CLCE-24 can also be used to assess the experience of 
cognitive changes by the patient’s caregiver.
A 5-min cognitive screening such as the MoCA should be the absolute mini-
mum, and cognitive assessment should only be restricted to this global form of ini-
tial assessment in the acute phase post-stroke and in later phases when no other 
means or capacity of neuropsychologists is available. The National Institute of 
Neurological Disorders and Stroke—Canadian Stroke Network Vascular Cognitive 
Impairment already proposed a 30-min and 60-min protocol for neuropsychological 
assessment as part of their harmonization standards (Hachinski et al. 2006). There 
may be cultural differences and therapist preferences for the use of specific instru-
ments, but more extensive neuropsychological assessment in addition to a 5-min 
cognitive screening should be common practice after stroke. The choice for suitable 
neuropsychological instruments can be made by trained neuropsychologists; instru-
ments specifically validated for stroke patients are preferred.
2.1.2  Screening for Emotional Problems and Fatigue
Screening for mood disorders should involve both depression and anxiety screen-
ing, and the Hospital Anxiety and Depression Scale (HADS) has been found to be 
the only available tool to accurately screen for both (Burton and Tyson 2015). A 
cutoff value of 7 for both subscales on depression (HADS-D) and anxiety (HADS-A) 
is commonly used. The Stroke Aphasic Depression Questionnaire—Hospital ver-
sion (SADQ-H) has good psychometric properties and can also be used for stroke 
patients with aphasia (Burton and Tyson 2015; van Dijk et al. 2016).
The most widely used measure to screen for post-stroke fatigue is the Fatigue 
Severity Scale (FSS; Cumming et al. 2016). A cutoff value of 3 or 4 is commonly 
used. The FAS is also used after stroke. A cutoff of 24 provides the best sensitivity/
specificity values for the FAS (Cumming and Mead 2017).
2.1.3  Further Neuropsychological Assessment
Further neuropsychological assessment on cognitive, emotional, behavioural and 
social consequences should follow, especially when the screening has identified 
impaired functioning and also when there is a discrepancy between objective cogni-
tive test results and subjective cognitive experiences by patients and caregivers. 
Neuropsychological rehabilitation or vocational rehabilitation should start with a 
thorough analysis of mental functions to assess both impaired and intact cognitive 
functions to identify strengths and weaknesses. Additionally, the impact of cogni-
tive impairments on daily life functioning should be determined. Ideally, all levels 
of the framework of the International Classification of Functioning (ICF, WHO) are 
considered in a full neuropsychological assessment. In addition to assessment on 
the level of functions, activities and participation, the personal and external factors 
should be taken into account as well. In several studies, in the past few years, it has 
been shown that personal factors, especially psychological factors such as coping 
styles and personality traits influence the outcome after stroke (van Mierlo et al. 
2014). In a large longitudinal cohort study on stroke patients we showed that more 
neuroticism, pessimism, passive coping and helplessness, and less extraversion, 
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optimism, self-efficacy, acceptance, perceived benefits and proactive coping were 
associated with the presence of depressive symptoms at 2 months post-stroke (Van 
Mierlo et al. 2015). In the subsequent multivariate analyses, we showed that more 
helplessness and passive coping, and less acceptance and perceived benefits were 
independently significantly associated with the presence of depressive symptoms. 
Neuroticism at 2 months post-stroke appeared to be an independent predictor for 
both depression and anxiety at 1-year post-stroke in the same cohort (Kootker et al. 
2016). Similarly, more proactive coping was related to less cognitive complaints at 
2 months post-stroke (Nijsse et al. 2017a).
A treatment plan should be formulated at the start of rehabilitation allowing not 
only the planning of treatment but also the execution and evaluation. A stepwise 
approach is suggested by Wilson et al. (2003), which can be recommended to guide 
the treatment planning process. For an overview of all elements of a comprehensive 
neuropsychological assessment, we would like to refer to the chapter by Malec 
(2017) in the international handbook on neuropsychological rehabilitation (Wilson 
et al. 2017).
2.2  Therapy (Training, Technology, Medication):  
This Is the Major Focus
2.2.1  Cognitive Rehabilitation
After a stroke, spontaneous recovery can result in changes in structure and func-
tion of the brain, which is one form of neuroplasticity, but changes can also occur 
as a result of development, learning and environmental stimulation. Restoration 
of impaired cognitive functions will occur automatically to a certain extent but 
treatment is needed to further stimulate behavioural and brain changes. 
Restorative treatments are directed at the level of functions and have mostly 
short-term and only limited effects while long-lasting improvements in daily life 
functioning and societal participation should be the main goals of (neuro)
rehabilitation.
Restorative approaches to cognitive rehabilitation are being investigated both in 
pre-clinical and clinical studies. In pre-clinical studies, cognitive enhancement 
approaches are tested in animal models such as enriched environment, early-onset 
multimodal stimulation, neuro-stimulating, pharmacotherapy or neuro-modulation 
(i.e. nervus vagus stimulation) but effects are small, mechanisms are not fully 
understood and generalization to humans is very difficult (e.g. Wogensen et  al. 
2015; Neren et al. 2016; Kochanek et al. 2015; Mala and Rasmussen 2017). One 
approach that raised renewed attention is the stimulation of cognitive functioning 
through physical exercise (i.e. multimodal stimulation). A recent meta-analysis 
showed that physical activity has small but significant positive effects on post-stroke 
cognition, even in the chronic phase (Oberlin et al. 2017). A total of 14 studies rep-
resenting 736 participants showed an overall positive effect of physical activity on 
cognitive performance (Hedges’ g (95% confidence interval) = 0.30 (0.14–0.47)). 
Combined aerobic and strength training programs generated the largest effects. 
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Improving the functionality of the whole brain in order to enhance the experience- 
dependent brain changes is the most probable explanation for these findings.
Clinical studies aimed at cognitive recovery focus on pharmacotherapy, 
computer- based cognitive retraining (CBCR) and non-invasive brain stimulation 
(NIBS). Pharmacotherapy studies aimed at cognition functions in stroke patients 
are scarce, and a recent meta-analysis showed that there is insufficient evidence to 
evoke effects of central nervous system drugs on enhancing global cognition (Yeo 
et al. 2017). CBCR has become very popular in the last 10–15 years, both in clinical 
practice and among the public. The idea that cognitive functioning can be improved 
or decline can be prevented or even reversed by regularly playing computer games 
is attractive, but effects are limited to the trained tasks while near- and far-transfer 
effects to untrained tasks and daily life functioning are small or lacking (van 
Heugten et al. 2016; van Heugten 2017). The number of studies on NIBS is growing 
rapidly, and new techniques are being developed. A recent Cochrane review on tran-
scranial direct current stimulation (tDCS) for improving activities of daily living 
(ADL), and physical and cognitive functioning, in people after stroke showed that 
there are many ongoing studies (Elsner et al. 2016). A moderate effect of tDCS for 
improving ADL was found at the end of the intervention period (9 studies, 396 par-
ticipants; standardized mean difference (SMD) 0.24, 95% confidence interval (CI) 
0.03–0.44) and at follow up (6 studies, 269 participants; SMD 0.31, 95% CI 
0.01–0.62), but not on cognitive functioning. In stroke patients, NIBS studies focus 
mainly on neglect, aphasia and (working) memory deficits. However, most studies 
are conducted within experimental settings to show the proof of principle without 
evaluating long-term effects or improvements in daily life functioning (van Heugten 
2017). Recently, it has been suggested that NIBS can be applied as an adjuvant 
approach to rehabilitation (Wessel et  al. 2015). The idea is that it augments the 
effects of behavioural training by increasing cortical excitability, neuronal plasticity 
and that it interacts with learning and memory.
Compensatory approaches to cognitive rehabilitation are shown to be the most 
effective to improve cognitive functioning after stroke and are most often applied in 
clinical practice (Wilson et  al. 2017). In these circumstances, recovery is not 
achieved by restoring or substituting impaired cognitive functions but by offering 
patients’ strategies to compensate for their impairments at task level. However, most 
evidence comes from studies on patients with acquired brain injury in which stroke 
patients are included as one of the major patient groups besides traumatic brain 
injury (Cicerone et al. 2000, 2005, 2011; Van Heugten et al. 2012). A meta-analysis 
in which only randomized controlled trials with stroke patients were included con-
cluded that there was insufficient evidence or only evidence of insufficient quality 
to support recommendations for clinical practice (Gillespie et  al. 2015). The 
Cochrane reviews on cognitive rehabilitation for post-stroke apraxia (West et  al. 
2008), executive dysfunctioning following stroke (Chung et al. 2013), prevention 
and treatment of post-stroke fatigue (Wu et al. 2015) and occupational therapy for 
cognitive impairments post-stroke (Hoffmann et al. 2010) came to the same conclu-
sion about the lack of high-quality RCTs or positive outcomes. Recent Cochrane 
reviews have added to this evidence.
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In the Cochrane review on cognitive rehabilitation for memory deficits following 
stroke, 13 RCTs including 514 participants were selected (das Nair et al. 2016). The 
authors conclude that memory rehabilitation has beneficial effects on subjective 
measures of memory in the short term (7 RCTs, n  =  215; SMD 0.36, 95% CI 
0.08–0.64, P = 0.01, moderate quality of evidence), but long-term effects could not 
be substantiated statistically beyond trend level (3 RCTs, n = 149; SMD 0.31, 95% 
CI −0.02 to 0.64, P = 0.06, low quality of evidence). The results do not show any 
significant effect of memory rehabilitation on objective memory tests, mood, func-
tional abilities or quality of life. The authors conclude that more robust, well- 
designed high-quality trials are necessary.
A similar conclusion was drawn by Loetscher and Lincoln (2013) in their 
Cochrane review on attention deficits following stroke including 6 RCTs with 223 
patients in total. A statistically significant effect was found in favour of cognitive 
rehabilitation when compared with control for immediate effects on measures of 
divided attention (SMD 0.67, 95% CI 0.35–0.98; P value <0.0001; 4 trials, 165 
participants) but no significant effects on global attention (2 studies, 53 partici-
pants; P value = 0.06), or other attentional domains (6 studies, 223 participants; P 
value ≥0.16) or functional outcomes (3 studies, 109 participants; P value ≥0.21). 
Meta- analyses demonstrated no statistically significant effect of cognitive reha-
bilitation for persisting effects on global measures of attention (2 studies, 99 par-
ticipants; standardized mean difference (SMD) 0.16, 95% confidence interval 
(CI) −0.23 to 0.56; P value = 0.41), standardized attention assessments (2 studies, 
99 participants; P value ≥0.08) or functional outcomes (2 studies, 99 participants; 
P value ≥0.15).
Taking only Cochrane reviews on stroke patients into account, however, has 
the danger of throwing away the baby with the bathwater. Many evidence-based 
cognitive rehabilitation programs are available and used in clinical practice all 
over the world (Wilson et  al. 2017). Evidence is often based on samples of 
mixed aetiologies including stroke patients among other patient groups (mostly 
traumatic brain injury). In a series of systematic reviews on evidence-based 
cognitive rehabilitation by Cicerone et  al. (2000, 2005, 2011), practice stan-
dards, guidelines and options are formulated on the basis of studies in patients 
with acquired brain injury. Compensatory strategy training and the use of exter-
nal aids have been shown to be effective for memory deficits, reduced speed of 
information processing (Time Pressure Management), executive dysfunctioning 
(Goal Management Training in combination with problem solving therapy) and 
apraxia.
Moreover, cognitive impairments hardly ever occur in isolation, which is why 
in clinical practice many multidomain cognitive rehabilitation programs are 
offered. Limited evidence shows that these programs are effective in attaining 
individual goals related to daily life functioning which remained in the long term 
(Brands et al. 2013; Rasquin et al. 2010). Typically, these programs are low-inten-
sive and consist of a combination of psycho-education and compensatory strategy 
training. Often, these programs are offered in groups to strengthen the effects of 
peer support.
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2.2.2  Pharmacological and Psychological Interventions 
for Depression and Anxiety After Stroke
Both pharmacological and psychological treatments to prevent depression after 
stroke (Hackett et  al. 2008a, b) have been investigated. Fourteen trials involving 
1515 participants were included in a Cochrane review of which 10 trials involved 
pharmacological agents and did not show significant effects on preventing depres-
sion. The psychological interventions showed small but significant positive effects 
on mood including problem-solving therapy and motivational interviewing.
The Cochrane review on treatment of depression after stroke (Hackett et  al. 
2008a, b) included 16 trials in which 13 pharmacological agents were investigated 
and four trials in which the effect of psychological treatment was examined. In most 
trials, selective serotonin reuptake inhibitors (SSRIs) were applied and also tricyclic 
antidepressants (TCAs) were investigated. Moderate significant effects were found 
on remission of depression (pooled OR 0.47; 95% CI 0.22–0.98) and also small 
improvements of scores on depression questionnaires (pooled OR 0.22; 95% CI 
0.09–0.52). There was, however, also a significant increase of neurological and 
gastro-intestinal side effects. There was no significant improvement in cognitive 
and ADL functioning nor a reduction of disabilities. Mead et al. (2012) investigated 
the effect of SSRIs on stroke recovery. In the meta-analysis, 52 trials randomizing 
4059 patients to SSRI or control were included, and a positive effect was found on 
neurological deficits (SMD −1.00, 95% CI −1.26 to −0.75; 29 trials, 2011 partici-
pants), ADL dependence, level of disabilities (SMD 0.91, 95% CI 0.60–1.22; 22 
trials, 1343 participants), anxiety (SMD −0.77, 95% CI, −1.52 to −0.02; 8 trials, 
n = 413) and depression (SMD was −1.91 (95% CI, −2.34 to −1.48; 39 trials, 2728 
participants)), however, with considerable variability across trials and substantial 
risks for bias. For disability, neurological deficits and depression, the effects had 
been larger when depression was present among participants. The results of this 
review tentatively support the use of SSRIs in stroke survivors with depression and 
provide evidence for clinically relevant positive treatment effects not only in the 
emotional domain.
The psychological interventions in the review of Hackett et  al. (2008a, b) 
involved problem-solving therapy in combination with counselling, cognitive 
behavioural therapy, motivational interviewing and a combination of support and 
education, but no significant effects were found. Later studies on behavioural inter-
ventions for post-stroke depression show more positive results. The CALM 
(Communication and Low Mood) intervention for stroke patients with aphasia was 
effective in improving mood (Thomas et  al. 2013) and was cost-effective over a 
period of 6 months in comparison to care as usual (Humphreys et al. 2015). In a 
study by Mitchell et  al. (2009) patients (n  =  101) received a short psychosocial 
intervention in addition to antidepressants which led to lower depression scores and 
better remission both in the short and the long term. Home-based supportive care 
also has a positive effect on mood in home-dwelling stroke patients (Huang et al. 
2017). Recently, a scientific statement on post-stroke depression was published 
(Towfighi et al. 2017), summarizing seven studies on brief psychosocial interven-
tions for reducing depression showing a positive effect. Neuro-modulation, stroke 
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liaison workers and self-management programs did not have a positive effect. A 
meta-analysis on the effect of physical exercise on depression in neurological disor-
ders showed a positive effect of physical exercise, preferably those meeting physical 
activity guidelines, on the reduction of depressive symptoms (26 trials, 1324 partici-
pants; effect size 0.28 95% confidence interval 0.15–0.41) (Adamson et al. 2015). A 
higher effect size (0.38) was found for studies that met physical activity guidelines 
versus those that did not (0.19). It has to be noted though that only 2 of the 26 trials 
included stroke patients.
Only three trials have been conducted in which treatment of anxiety post-stroke 
was investigated according to the most recent Cochrane review (Knapp et al. 2017). 
Due to small sample sizes, methodological concerns and adverse effects, recom-
mendations for clinical practice cannot be given. In case of emotionalism after 
stroke (i.e. unwanted laughing or crying), a Cochrane review including seven trails 
showed that antidepressants can reduce the frequency and severity of crying or 
laughing episodes (7 studies, 239 participants). On the basis of five trials (213 par-
ticipants), a large effect was found in a 50% reduction of emotionalism but with a 
wide confidence interval showing a small positive effect and in one study even a 
negative effect (Hackett et  al. 2010). There is not one specific pharmacologi-
cal agent.
2.2.3  Managing Post-stroke Fatigue
The effects of treatment of post-stroke fatigue are still limited. In the most recent 
Cochrane review, 12 trials with 703 participants were selected, but only 6 trails 
could be used for the meta-analysis (Wu et al. 2015). Five pharmacological inter-
ventions and two non-pharmacological interventions (fatigue education and 
mindfulness- based stress reduction) were investigated, but effects were small and 
the studies were not without risk of bias. Since post-stroke fatigue is multifactorial 
in nature with physical, cognitive, mental components and individual differences in 
the way people cope with fatigue, there is not one treatment that will fit all patients’ 
needs (Visser-Keizer et al. 2015; Malley 2017). Psychosocial treatment and physi-
cal activity seem promising for the management of post-stroke fatigue but high- 
quality effect studies are necessary (Kutlubaev et al. 2015).
2.2.4  Comprehensive Neuropsychological Rehabilitation
The direct consequences of a stroke may also lead to secondary psychosocial prob-
lems, which hinder independent functioning and participation in society. The com-
plexity of these problems requires comprehensive rehabilitation programs. 
Comprehensive neuropsychological (holistic) rehabilitation is aimed at cognitive, 
emotional, behavioural and social consequences after stroke, taking into account the 
personal and environmental factors as well. The evidence is still limited but findings 
suggest that such programs can improve community integration, functional inde-
pendency and productivity, even many years after the injury (Cicerone et al. 2011). 
These programs can be divided into neurobehavioural interventions, residential 
community reintegration and day treatment programs (Geurtsen et al. 2010). Day 
treatment programs have the highest level of evidence leading to a reduction in 
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psychosocial problems, a higher level of community integration and an increase in 
employment. These programs are typically group-based and offer a combination of 
individual and group therapy. One of the essential components of such programs is 
psycho-education about the brain injury and its consequences both for patients and 
caregivers. Every stroke patient and their primary caregivers should receive infor-
mation about the potential consequences of stroke.
A Cochrane review on information provision after stroke included 21 trials 
involving 2289 patients and 1290 carers (Forster et al. 2012). This review shows that 
information improves patients’ (SMD 0.29, 95% CI 0.12–0.46) and more so care-
givers’ knowledge (SMD 0.74, 95% CI 0.06–1.43) and aspects of satisfaction (odds 
ratio (OR) 2.07, 95% CI 1.33–3.23, P  =  0.001) and reduces patient depression 
(mean difference (MD) −0.52, 95% CI −0.93 to −0.10). The best way to provide 
information is not clear yet, but active involvement of patients and carers has a 
higher effect on patient mood.
The Holistic Approach to Rehabilitation
Kurt Goldstein can probably be regarded as the grandparent of holistic rehabilita-
tion arguing that we should look at the whole aspects of a situation and not one 
isolated part such as word finding difficulties (Goldstein 1919, 1942; Boake 1996). 
Both Goldstein and later Ben-Yishay (1996) recognized that it is futile to separate 
the cognitive, social, emotional and functional aspects of brain injury given that 
how we feel affects how we think, remember, communicate, solve problems and 
behave. This is the core of the holistic approach. As Ben-Yishay and Prigatano said 
in 1990, holistic rehabilitation “…consists of well integrated interventions that 
exceed in scope, as well as in kind, those highly specific and circumscribed inter-
ventions which are usually subsumed under the term ‘cognitive remediation’” (Ben- 
Yishay and Prigatano 1990, p. 40).
Diller (1976), Ben-Yishay (1978) and Prigatano (1986) pioneered the holistic 
approach which is now seen as one of the most effective ways of providing cogni-
tive rehabilitation to survivors of brain injury. This approach is now much in evi-
dence (Wilson et  al. 2009). Holistic programs are concerned with increasing a 
client’s awareness, alleviating cognitive deficits, developing compensatory skills 
and providing vocational counselling. All such programs provide a mixture of indi-
vidual and group therapy. They differ from the combined approach primarily in 
their recognition of the importance of treating emotional problems at the same time 
as treating the cognitive and social difficulties. Thus, inherent in the holistic 
approach are theories and models of emotion, which are becoming increasingly 
important in cognitive rehabilitation, as evidenced, for example by a special issue of 
the journal Neuropsychological rehabilitation focussing entirely on biopsychoso-
cial approaches in neuropsychological rehabilitation (Williams and Evans 2003).
Ben-Yishay and Prigatano (1990) provide a model of hierarchical stages in the 
holistic approach through which the patient must work in rehabilitation. These are, 
in order, engagement, awareness, mastery, control, acceptance and identity. Holistic 
programs, explicitly or implicitly, tend to work through Ben-Yishay’s hierarchical 
stages and are concerned with (1) increasing the individual’s awareness of what has 
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happened to him or to her, (2) increasing acceptance and understanding of what has 
happened, (3) providing strategies or exercises to reduce cognitive problems, (4) 
developing compensatory skills and (5) providing vocational counselling. All holis-
tic programs include both group and individual therapy.
For a further overview of all aspects of neuropsychological rehabilitation after 
stroke and other forms of brain injuries, we would like to refer to the International 
Handbook of Neuropsychological Rehabilitation (Wilson et al. 2017).
2.2.5  Technical Aids
The use of assistive technology (AT) to compensate for cognitive impairments has 
become a common element of neuropsychological rehabilitation (Gillespie et  al. 
2012). In the area of attention, AT can be used to direct attention and support to sustain 
attention, for instance by tonal cues or automated text messages. Such mobile phone 
reminders and alarms/timers can also be used as reminders to support episodic mem-
ory (Jamieson et al. 2017). Additionally, time and planning management functions are 
common forms of AT which are nowadays available on any smartphone. In a meta-
analysis including seven group studies, the authors concluded that there is strong evi-
dence for the efficacy of prospective prompting memory devices (d = 1.27, p < 0.01; 
147 participants) (Jamieson et al. 2015). AT can also be used to assist organization and 
provide step-by-step support during task performance.
3  Clinical Pathway/Evidence-Based Recommendations 
(What, When, Why?)
Since our recommendations for screening and neuropsychological assessment of 
post-stroke cognitive impairment and emotional disorders are not systematically 
based on evidence, they are not presented with ratings of quality of evidence and 
strength of recommendations, but rather reflect expert opinion.
The evidence, quality ratings and conclusions are summarized in Table 1.
The therapeutic recommendations given below are based on the evidence that 
had systematically been searched and presented above. The quality of this evidence 
has been grouped into four categories according to “GRADE” (“Grades of 
Recommendation, Assessment, Development and Evaluation”) (Owens et al. 2010):
• High quality: further research is unlikely to affect our confidence in the estima-
tion of the (therapeutic) effect.
• Medium quality: further research is likely to affect our confidence in the estima-
tion of the (therapeutic) effect and may alter the estimate.
• Low quality: further research will most likely influence our confidence in the 
estimation of the (therapeutic) effect and will probably change the estimate.
• Very low quality: any estimation of the (therapy) effect or prognosis is very 
uncertain.
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The grading of the recommendations according to GRADE (Schünemann et al. 
2013) corresponds to the categories “ought to” (A) (strong recommendation), 
“should” (B) (weak recommendation). As a third category had been introduced 
“can” (0) (option) (Platz 2017). Recommendation category A is granted for clini-
cally effective interventions with high-quality evidence support; with medium-qual-
ity evidence category B and with low- or very low-quality evidence category 0 can 
be appropriate. A+ and B+ denote a strong or weak recommendation in favour on an 
intervention, A− and B− against its use.
The recommendations following from the evidence are summarized in Table 2.
3.1  Cognitive Screening in Hospital
Every stroke patient should be screened for cognitive and emotional consequences 
following stroke. Objective cognitive screening should be conducted before the 
patient is discharged from the hospital to support the decision on the discharge 
destination and further rehabilitation treatment. Cognitive screening can best be 
Table 2 Recommendations for the management of cognition, emotion and fatigue post-stroke
Management Phase Recommendation
Screening and Assessment
Cognitive screening Acute Every stroke patient should be screened for 
cognitive and emotional consequences 
following stroke before hospital discharge to 
support the decision on the discharge 
destination and further rehabilitation 
treatment
Cognitive assessment Post-acute If cognitive deficits are not present upon early 
global cognitive screening or not checked at 
all, cognitive functioning should be assessed 
again at a later stage. If communication 
disorders exist, the method of information 
extraction must be modified accordingly for 
valid conclusions to be made
Cognitive assessment First year Both objective and subjective cognitive and 
emotional screening should always be 






At the start of rehabilitation, and also when 
support is needed for community 
reintegration, an extensive 
neuropsychological assessment should be 
conducted
Treatment and Management
Information provision All phases All patients and caregivers should receive 
information about the (potential) cognitive 
and emotional consequences, including 
fatigue, following stroke (level of evidence 
1a, low quality, recommendation B+)
(continued)
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performed using the Montreal Cognitive Assessment (MoCA) because this is the 
most sensitive instrument for this purpose. A cutoff value of 24 is recommended. 
The Mini Mental State Examination (MMSE) should not be used because it was not 
designed for this purpose and is therefore not sufficiently sensitive. If cognitive defi-
cits are found, referral for neuropsychological rehabilitation should follow. If cogni-
tive deficits are not present upon early global cognitive screening or not checked at 
Table 2 (continued)
Management Phase Recommendation
Referral to specialist 
services for cognitive, 




Patients and caregivers should be referred to 
relevant follow-up care and 
neuropsychological rehabilitation within their 
stroke service (level of evidence 5, very low 
quality, recommendation B+)
There is no time limit to these programs 
which means that patients may also be 
supported many years after the injury (level 
of evidence 5, very low quality, 
recommendation B+)
General practitioners should be informed 
about the regional healthcare options for 
these problems
Cognitive rehabilitation From post-acute 
onwards
Compensatory strategy training and the use 
of external and technical aids should be 
offered to help stroke patients to deal with 
cognitive impairments (level of evidence 1b, 
low quality, recommendation B+).
Neuropsychological 
rehabilitation aimed at 
cognitive, emotional, 




Neuropsychological rehabilitation can be 
offered by experienced clinical or 
neuropsychologists working within a 
multidisciplinary team (level of evidence 5, 
very low quality, recommendation 0). Both 
low-intensity and high-intensity (holistic) 
group programs can be considered
Antidepressants Chronic phase SSRIs should be considered when depressive 
complaints or emotionalism are long lasting 
and become chronic while adverse effects 
should be monitored continuously (level of 
evidence 1a, moderate quality, 
recommendation B+)
Psychotherapy All phases Problem-solving therapy and motivational 
interviewing can be considered to prevent 
depressive symptoms post-stroke (level of 
evidence 2b, low quality, recommendation 0)
Classification of evidence level (1a to 5 according to the “Oxford Center for Evidence-Based 
Medicine  – Levels of Evidence”, last version from March 2009, http://www.cebm.net/Oxford-
centre-evidence-based-medicine). Rating of quality of evidence (very low to high) and categories 
of recommendations (0, B+, A+) according to GRADE (“Grades of Recommendation, Assessment, 
Development and Evaluation”); for explanation see text
These ratings are only given for evidence-based recommendation for interventions (not for screen-
ing and assessment: expert opinion)
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all, cognitive functioning should be assessed again at a later stage because cognitive 
deficits are easily missed during hospital admission when the patient has good func-
tional outcome in terms of motor and language functioning (i.e. the walking and 
talking patient).
3.2  Cognitive and Emotional Screening at Routine Follow-Up
Most stroke patients are invited to visit a neurological outpatient clinic for a 
neurological follow-up and secondary prevention purposes. We recommend that 
both objective and subjective cognitive and emotional screening are always per-
formed during these visits, which can be completed by a specialized stroke nurse. 
Cognitive deficits are easily missed during hospital admission. Cognitive func-
tioning may not have been assessed before. Additionally, global cognitive screen-
ing may not be enough to pick up cognitive problems which arise from the more 
complex daily life challenges and return to prior activities such as work. For this 
reason, subjective cognitive complaints should be surveyed as well. Patients and 
their informal caregivers may differ in their experiences of cognitive conse-
quences, which is why problems in cognitive functioning experienced by the 
primary caregiver should also be taken into account in the assessment. The 
stroke-specific Checklist for Cognition and Emotion (CLCE-24) can be used for 
this purpose.
Screening for emotional problems can be done with the Hospital Anxiety and 
Depression Scale (HADS), which is the only sensitive tool that also incorporates 
anxiety. The recommended cutoff value for each subscale (i.e. depression and anxi-
ety) is seven. Post-stroke fatigue can best be screened with the Fatigue Severity 
Scale (FSS) using four as the cutoff point.
Most of these screening instruments can be used by specialized stroke nurses 
who have been trained in using and interpreting these instruments. Screening for the 
less-visible neuropsychological consequences of stroke should be done on a regular 
basis. If patients and caregivers do not report problems spontaneously, this does not 
necessarily mean that they are not present. If cognitive and emotional problems are 
experienced which interfere with daily life functioning, referral for neuropsycho-
logical rehabilitation should follow. At the start of rehabilitation, and also when 
support is needed for community reintegration, an extensive neuropsychological 
assessment should be conducted.
3.3  Neuropsychological Rehabilitation
All patients and caregivers should receive information about the potential cogni-
tive and emotional consequences, including fatigue, following stroke because it 
improves patients’ and caregivers’ knowledge and reduces the level of depres-
sion in patients (level of evidence 1a, low quality, recommendation B+). Active 
and personalized information provision is preferred. Information can be given by 
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any experienced member of the treatment team and should be repeated as often 
as necessary and possible.
Cognitive problems may arise at a later stage when the patient is discharged 
home and environmental demands are increasing. Resuming to prior activities, 
especially returning to work, may lead to problems which were not detected earlier. 
Patients and caregivers should be referred to relevant follow-up care and neuropsy-
chological rehabilitation within their stroke service (level of evidence 5, very low 
quality, recommendation B+). General practitioners should be informed about the 
regional healthcare options for these problems.
Compensatory strategy training and the use of external and technical aids 
should be offered to help stroke patients with cognitive impairments to improve 
their daily life functioning (level of evidence 1b, low quality, recommendation 
B+). Psycho- education and strategy training can easily be combined in low-
intensity group-based programs aimed at individualized patient-centred goals. 
Regional low-frequency or national high-intensity (holistic) outpatient neuro-
psychological rehabilitation programs may be indicated because of the complex 
interplay between cognitive, emotional and social consequences. There is no 
time limit to these programs which means that patients may also be supported 
many years after the injury (level of evidence 5, very low quality, recommenda-
tion B+). New problems may occur in the chronic phase after stroke when envi-
ronmental demands are changing or increasing. Chronicity does not necessarily 
imply stability. Neuropsychological rehabilitation can be offered by experienced 
clinical or neuropsychologists working within a multidisciplinary team in which 
occupational therapists will address the link to the patient’s daily life functioning 
and societal participation (level of evidence 5, very low quality, recommen-
dation 0).
Clinicians should be aware of the influence of post-stroke fatigue on daily life 
functioning and societal participation. Although evidence is limited, psychosocial 
treatment and physical activity seem promising for the management of post-stroke 
fatigue (level of evidence 5, very low quality, recommendation 0).
In the first months, post-stroke antidepressant pharmacotherapy is only rec-
ommended if the process of rehabilitation is hindered by emotional problems. 
Increasing motivation for and participation in rehabilitation is the target for 
treatment. SSRIs should be considered when depressive complaints or emo-
tionalism are long lasting and become chronic while adverse effects should be 
monitored continuously (level of evidence 1a, moderate quality, recommenda-
tion B+). Problem- solving therapy and motivational interviewing can be con-
sidered to prevent depressive symptoms post-stroke (level of evidence 2b, low 
quality, recommendation 0). Psycho-education should always be offered to 
both prevent and reduce anxiety, stress and depressive complaints in both 
patients and caregivers (level of evidence 1a, moderate quality, recommenda-
tion B+).
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3.4  New Developments
There is no effective treatment for deficits in social cognition or emotion regulation 
yet, but professionals should be aware of problems in these areas, especially in rela-
tion to caregiver burden.
Restorative approaches such as pharmacotherapy, CBCR and NIBS can be 
offered to improve cognitive functioning but effects are limited to cognitive func-
tions in testing situations (level of evidence 2b to 1a, low quality, recommendation 
0). These forms of rehabilitation are primarily focused on alleviating cognitive 
impairment while neuropsychological rehabilitation is aimed at a broader spectrum 
of human functioning, also taking into account emotional, behavioural and social 
functioning, with the ultimate goal to optimize the participation and quality of life 
of both patients and caregivers. Although promising, restorative approaches in reha-
bilitation should always be offered only in combination with comprehensive neuro-
psychological rehabilitation programs aimed at improving daily life functioning 
and societal participation.
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1  Introduction
From childhood to older ages, there remains a constant, societal fascination with 
driving. At each stage of life, the autonomy of a motor vehicle provides for indepen-
dence, freedom and is even in many ways a symbol of success and vitality. 
Throughout the world, motor vehicles have been entrenched in our lifestyle, our 
communities, and even our entertainment. In 2013, across 180 countries, there were 
947 million registered passenger cars and numbers continue to grow (World Health 
Organisation 2016). It is from this perspective that persons who have sustained a 
stroke often find that their inability to return to driving is a major barrier or disap-
pointment along the road to recovery.
From the patient and family perspective, driving allows for independence in the 
community and the ability to leave the home. Driving is essentially a daily skill 
taken for granted where 87% of Americans over the age of 16 have a driver’s license 
(Federal Highway Administration 2011). In the United Kingdom, there are 45.5 
million licensed drivers representing 74% of the adult population (Driver and 
Vehicle Licensing Agency 2015). Contrarily, only 25% of the adult Chinese 
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population have driver’s licenses; however, this represents over 303 million drivers 
(National Bureau of Statistics 2016). From a clinical perspective, patients who have 
recovered from the effects of stroke will often ask about driving, or not recognize 
that driving ability could be affected. Inability to return to driving can have a nega-
tive impact on overall health in relation to isolation from community and resources 
(Waller 1991).
The role of jurisdictions is to keep roadways safe for all drivers. From an admin-
istrative perspective, there is an emphasis on public safety versus a focus on having 
individuals return to driving post-stroke. The evidence for increased crash risk post- 
stroke is inconclusive (Charlton et al. 2010; Devos et al. 2011). However, there is 
little doubt that ability to drive for many persons following stroke is clearly affected 
due to severe impairments that affect patients at an even more basic level of ability 
to provide self-care. Many countries have policies in relation to need for physician 
reporting and subsequent assessment prior to return to driving (Charlton et al. 2010). 
Administrative and financial barriers of paying for assessments are factors that may 
make it challenging for a patient post-stroke to return to driving.
From the perspective of the healthcare providers, there is often a balance 
between patient safety and autonomy that must be considered. While patients may 
want to return to driving post-stroke, there are clear impairments that can affect 
driving ability. Stroke impairments can be myriad, affecting everything from 
vision such as diplopia or visual field defects to motor impairments such as hemi-
paresis or ataxia as common examples. The less well-recognized impairments of 
visual neglect, cognition impairments, and even behavioral changes post-stroke 
can also have significant impact on driving ability. In this context, depending on 
the healthcare provider’s jurisdiction, some states, provinces, and countries have 
reporting laws requiring physicians and other healthcare providers to identify per-
sons who may be at risk to drive due to health reasons. This need to report can 
often have negative effects on the physician–patient relationship (Jang et al. 2007; 
Marshall and Gilbert 1999).
The impact of impairments from stroke on an individual can have significant 
implications for return to driving. This scenario is often counter to the more com-
mon scenario for physicians who may need to determine when health impacts for 
older drivers are at a point where driving cessation needs to be considered. Following 
stroke in most instances, patients are immediately unable to drive. Through recov-
ery, they may reach a point where their abilities, while not fully recovered, may be 
at a stage where they are able to resume driving safely. Visual, physical, cognitive, 
and behavioral impairments post-stroke may all impact the ability to return to driv-
ing. It is often the healthcare provider who must make decisions if the patient has 
recovered enough to resume driving or be further assessed for their potential to 
return to driving.
While these health factors can affect the ability to drive, it is not only health that 
plays a role in the ability to return to driving. Using Michon’s hierarchical model of 
driving (Fig. 1), driving can be broken down into stages each with inherent risks 
(Michon 1985). At the strategic level, drivers make general plans about their driving 
about destination, routes, identifying driving conditions such as weather and then 
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formulating a plan. At this stage, the driver is accepting the risks associated with the 
driving task. The next level is the tactical level where the driver maneuvers in rela-
tion to the driving task and is essentially taking risk. For example, a driver exceeds 
the speed limit in inclement weather or performs maneuvers such as tailgating or 
aggressive passing. These actions may put the driver or others at increased risk of 
collision. In the final operational level of Michon’s model, the driver is dealing with 
acute danger or risk and must take action to avoid a collision. The ability to avoid 
collision in this instance relies on factors such as reaction time, agility, and past 
experience of how to successfully control the vehicle in relation to actions such as 
steering and braking.
Often patients who have had a stroke have significant past driving experience; 
however, driving experience and ability are highly variable, and confidence may 
be high since driving is almost an overlearned and automatic task with most ele-
ments considered routine. For example, professional drivers or persons who have 
specialized driving training such as police or ambulance drivers would most 
likely have a higher skill set for driving compared to individuals who primarily 
use driving on a leisure or commuting basis. Many people are confident in their 
driving ability; however, as collision rates for young drivers demonstrate, experi-
ence and risk taking do play a role in driving risk (National Research Council 
US 2007).
Ultimately, return to driving post-stroke is seen by patient and family as both an 
indicator of recovery and an even more needed ability to compensate for newly 
reduced mobility. Clinicians typically are expected to advocate for return to driving 
but must do so responsibly for both the safety of the patient and the society. Many 
patients will be able to return to driving post-stroke, and the decisions faced by cli-
nicians will be to determine when the patient has reached the ability to be consid-
ered for return to driving and what evaluations or rehabilitation interventions can be 
reliably used. The aim for both patient and healthcare provider is to have a safe 
return to driving, if possible, in the most expedient manner. The determination of 




















Fig. 1 Michon’s hierarchical model of driving (Michon 1985). (Reproduced with permission)
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2  Evidence-Based Practice in Driving Screening, 
Assessment, and Interventions
A PubMed database search conducted on November 27, 2018 using the medical 
subject headings (MeSH) key terms “automobile driving” and “stroke” revealed 
105 studies on driving after stroke. Research on this topic has seen an exponential 
increase in the last decade, with more than half (58) of the research articles being 
published since 2010. This growing body of evidence may assist healthcare profes-
sionals in the evidence-based practice (EBP) of assessing fitness-to-drive after 
stroke. EBP is a clinical decision-making process within a specific healthcare set-
ting that integrates the best available scientific evidence with the best available clini-
cal expertise from a multidisciplinary team of healthcare providers (Sackett et al. 
1996). EBP considers internal and external influences on practice and encourages 
critical thinking in the judicious application of such evidence to the care of indi-
vidual patients, a patient population, or a system (Newhouse et al. 2005).
In this section, we will provide an evidence-based overview of three critical 
issues related to driving after stroke: (1) screening; (2) assessment; and (3) interven-
tions. Later, we will show how the evidence drives clinical decision-making for 
fitness- to-drive after stroke using an actual case scenario.
2.1  Screening for Fitness-to-Drive
The goal of a clinical screening tool is to identify individuals who meet the legal 
criteria for driving, but exhibit functional deficits that may adversely affect their 
fitness-to-drive. A fail performance on the screening battery warrants a more 
detailed assessment at a specialized driving clinic. The clinical utility of these 
screening tools depends on their efficacy in predicting on-road driving outcomes, 
the administration time, the ease of use, and the costs to purchase the tools. 
Although most screening tools lack face validity, some batteries have been devel-
oped particularly for fitness-to-drive screening after stroke. The Stroke Drivers 
Screening Assessment (SDSA) is one of such screening tools that was originally 
developed in the United Kingdom (Nouri and Lincoln 1993), but has successfully 
been adopted for use in other European countries (Selander et al. 2010; Lundberg 
et  al. 2003), Australia (George and Crotty 2010), Israel (Lincoln et  al. 2016), 
Korea (Park et  al. 2013), and the United States (Akinwuntan et  al. 2013). The 
SDSA consists of four subtests: (1) Dot Cancellation, (2) Directions, (3) Compass, 
and (4) Road Sign Recognition. A prediction equation algorithm that includes the 
results of each of the subtests shows the likelihood of passing or failing an on-
road driving assessment (Selander et al. 2010; Lundberg et al. 2003; Nouri and 
Lincoln 1993; Akinwuntan et al. 2013; Park et al. 2013). However, these predic-
tion equations suffer from methodological limitations such as subject and cultural 
bias and have rarely been validated in independent cohorts. No information is 
available on the prediction rates of the SDSA and other screening tools in devel-
oping countries.
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One way to bypass these limitations is to pool all evidence on screening tools 
for fitness-to-drive after stroke. In our PubMed search, we identified four system-
atic reviews listing the most accurate screening tools for fitness-to-drive after 
stroke (Hird et al. 2014; Murie-fernandez et al. 2014; Devos et al. 2011; Marshall 
et al. 2007). None of the proposed screening tools are perfect in predicting on-road 
driving performance. Yet, four tests emerged from the systematic reviews to best 
predict the likelihood of failing an on-road driving assessment: (1) the Compass 
and (2) Road Sign Recognition tests of the SDSA; (3) the Trail Making Test (TMT) 
B; and (4) the Rey-Osterrieth Complex Figure (ROCF). Table 1 shows the psycho-
metric properties, cutoff values, approximate administration time, training required, 
and approximate cost of these four tests. We also assigned the Oxford Centre for 
Evidence-Based Medicine–Levels of Evidence (OCEBM Levels of Evidence 
Working Group 2011) and Grades of Recommendation (Schünemann et al. 2013; 
Platz 2017) for each of the four tests. The description of the levels and quality of 
evidence and grades of recommendations is detailed in chapter “Clinical Pathways 
in Stroke Rehabilitation: Background, Scope, and Methods” (Chap. 2). The 
Compass, Road Sign Recognition, and Trail Making Test B showed acceptable 
sensitivity at the expense of specificity.
2.2  Assessment of Fitness-to-Drive
Compared to the screening process, an assessment of fitness-to-drive is a more for-
mal, elaborate procedure that typically involves clinical (off-road) assessments of 
motor, cognitive, and visual abilities prior to a practical on-road driving test. The 
procedure for assessment of fitness-to-drive varies across countries depending on 
the legal framework, the licensing systems, and the resources available. Fitness-to- 
drive assessments take many shapes depending on location and include: medical 
tests, purpose-built driving assessment centers, clinical off-road and practical on- 
road comprehensive tests performed by driving assessors, healthcare workers, and/
or driving licensing agencies. The driving-related functions commonly tested after 
stroke include: memory, attention, visuospatial perception, spatial neglect, sensory 
and motor functions, and vision (e.g., hemianopia). These assessments are usually 
conducted by physicians, psychologists, occupational therapists, or physical thera-
pists with specialized training in fitness-to-drive assessments. Both the clinical off-
road and on-road assessment protocols reported in the literature differ between 
studies, usually due to the country in which the study was conducted (Devos et al. 
2011). Although there is still no commonly accepted standardized and validated 
battery to determine the fitness-to-drive of stroke survivors, many studies have iden-
tified some common cognitive, visual, and motor skills that predict performance on 
an on-road driving test (Ranchet et al. 2016; Devos et al. 2014; Aslaksen et al. 2013; 
Ponsford et al. 2008).
Apart from being the assessment used officially in countries around the world for 
licensing novice drivers, the on-road test is the only assessment that bears similarity 
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the criterion for assessing driving performance in most studies reported on driving 
after stroke (Nouri and Lincoln 1993; Lundqvist et  al. 2000; Akinwuntan et  al. 
2006). Yet, the use of the on-road assessment as the best indicator of fitness-to-drive 
of stroke survivors remains controversial. Some of the concerns include lack of 
repeatability of traffic events, reduced access to dual operated vehicle, the inability 
to assess driving ability during hazardous traffic situations or inclement weather 
conditions, the large variation in traffic demands and routes, different scoring sys-
tems, and low inter-rater reliability due to inconsistencies in judging the on-road 
driving performance by experts. These concerns prompted researchers to investigate 
the usefulness of novel assessment methods, including driving simulation technol-
ogy, as indicators of the true driving capabilities of stroke survivors (Blane et al. 
2017; Hird et al. 2015; Kobayashi et al. 2016; Park 2015). Many recent studies have 
reported on the use of driving simulators in the assessment of fitness-to-drive of 
stroke survivors (Akinwuntan and Devos 2017).
2.3  Interventions for Fitness-to-Drive
The body of literature on interventions to improve driving after stroke is sparse 
(George et al. 2014). The authors of this Cochrane review concluded that based on 
four randomized controlled trials and 245 participants, there was insufficient evi-
dence that a driving rehabilitation program was effective in improving driving skills 
after stroke.
It is nevertheless reasonable to assume that any training is better than no training 
at all. Different methods of training can be categorized as (1) non-contextual train-
ing using paper and pencil, computerized-video or specialized equipment or (2) 
contextual training in a simulator or on the road. Hence, the related evidence will be 
summarized next.
2.3.1  Non-contextual Training
Non-contextual training is a remedial form of training that targets the visual, motor, 
and cognitive deficits underlying impaired on-road driving performance in stroke 
survivors. Although the benefits from the training program are purported to general-
ize to improvements in on-road driving performance, there is little evidence to sup-
port the claim.
Cognitive training using specialized equipment such as the Useful Field of 
View® (UFOV) or Dynavision® generally show benefits of training on on-road 
driving skills after stroke in non-randomized or pilot randomized controlled 
trials (RCTs) (Klavora and Warren 1998; Mazer et al. 2001). However, in the 
only RCT comparing the effect of 18 sessions of Dynavision® training (n = 13) 
with a non-active control group (n = 13), no differences in pass rates on the 
on-road test (77% vs. 46%; p  =  0.23) were found after training (Crotty and 
George 2009). Although the study was likely underpowered due to the small 
sample size, a difference in pass percentages of 31% in favor of the Dynavision® 
training group appears clinically relevant. Likewise, Mazer et  al. (2003) 
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compared 20 sessions of visual attention training using the UFOV training 
(n  =  47) with traditional computerized visuoperceptual training (n  =  50). 
Although no differences on on-road driving were found between the UFOV 
(39%) and control intervention (33%; p = 0.53), stroke survivors with right-
sided lesions (52%) were almost twice more likely to pass the road test after 
UFOV training compared to those with left-sided lesions (29%) (Mazer 
et al. 2003).
In addition, cognitive skills that were specifically targeted in the intervention 
program show greater improvement compared to a control intervention. Crotty and 
George (2009) demonstrated a significant improvement in the Dynavision® group 
compared to the control group on visual neglect task (p = 0.007) and a response time 
task (p = 0.03; no measures of central tendency reported). Mazer et al. (2003) could 
not corroborate a differential effect of UFOV® training with other visuoperceptual 
training on any of the cognitive outcomes.
2.3.2  Contextual Training
With the advent of more realistic graphic images, higher fidelity of the driving simu-
lator steering wheel and pedals, and the improving flexibility of interactive pro-
gramming language, the use of driving simulators has sparked great interest in the 
scientific and clinical community to retrain driving-related skills after stroke. One 
RCT found that 15  h of training in a driving simulator was superior to a non- 
contextual training program that included paper-and-pencil route finding activities 
and board games in 73 stroke survivors. Participants who received simulator train-
ing were more likely to succeed on a formal on-road driving test at 3 months after 
training compared to those who received non-contextual training (73% versus 42%; 
p = 0.03) (Akinwuntan et al. 2005). The encouraging benefits of simulator training 
were confirmed in a more recent trial that compared 16 h of training in the driving 
simulator (n = 23) with no training (n = 22) (Mazer et al. 2015). Following comple-
tion of training, 6 out of 7 (86%) participants with moderate stroke-related deficits 
who were trained in the driving simulator passed an on-road test whereas only 1 out 
of 6 (17%) in the control group passed the same on-road test (p  =  0.03, effect 
size = 0.63). However, there were no differences for those with severe impairments 
(Mazer et al. 2015).
It is logical to assume that training of driving skills on a real road, in a real car, 
in real traffic, will result in most generalization of benefits from training to driving 
performance in real traffic. In a small study that included 15 participants with 
stroke who initially failed an on-road test, 13 eventually passed the test after 
6–12 h of on- road driving training. However, authors doubt if the on-road training 
program led to improvement in driving skills since there were no associated 
improvements in any visuo-cognitive functions. The authors surmised that the 
natural recovery of stroke, awareness of driving difficulties, or familiarization 
with the test process led to passing the driving test after the intervention program 
(Soderstrom et al. 2006).
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3  Adaptive Driver Assistance Systems 
and Car Modifications
There is emerging research on the impact of Advanced Driver Assistive Systems 
(ADAS) for older adults with and without medical conditions (Shaheen and 
Niemeier 2001; Davidse 2006; Davidse et al. 2009). These studies show that some 
ADAS systems, including but not limited to—lane departure warnings, lane keep-
ing support, automated cruise control, collision avoidance systems, pedestrian 
crash avoidance mitigation, night vision systems, driver fatigue warning systems, 
turning assist, surround view, and traffic sign recognition—could extend the older 
drivers’ mobility and have the capacity to improve road safety. In a driving simula-
tor study, Dotzauer et  al. (2013) studied the effects of an intersection ADAS on 
driving in healthy older adults. Equipped with ADAS, drivers allocated more atten-
tion to the center of the road and crossed intersections in shorter time, but also 
engaged in higher speeds and accepted more risk in taking left turns against oncom-
ing vehicles. To our knowledge, no studies have evaluated the use of ADAS to 
improve driving safety in drivers with stroke.
The other areas of technological aids for driving are disability vehicle adapta-
tions that are used to maintain or improve the functional capabilities of an individual 
with disabilities. Common examples of this are a spinner steering driving knob 
which enables one-handed steering and a left-side accelerator that can assist some-
one with hemiparesis to resume driving of an automatic transmission vehicle.
4  Clinical Pathway
Rules for fitness-to-drive vary between countries, states, and provinces. It is impor-
tant for healthcare providers to familiarize themselves with the specific licensing 
requirements and clinical guidelines for driving after stroke in their own locality. 
Figure 2 below offers a framework for driving assessment and intervention after 
mild stroke which is based on best evidence and practice.
Our review of evidence examined screening, assessment, and interventions. 
Based on this evidence, Fig. 3, along with the following broad-based recommenda-
tions, presents a clinical algorithm for fitness-to-drive to aid decision-making. The 
description of the levels and quality of evidence and grades of recommendations is 
detailed in chapter “Clinical Pathways in Stroke Rehabilitation: Background, Scope, 
and Methods” (Chap. 2).
 1. Determine that the patient meets the jurisdiction’s minimum requirement for 
driving (if any) (level of evidence/quality of evidence: not applicable (regula-
tory), A+).
 2. If there are specific requirements for driving after stroke in the jurisdiction, 
refer to it and ensure the patient meets the requirements (level of  evidence/ 
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quality of evidence: not applicable (regulatory), A+). Clinical guidelines for 
stroke and driving in several countries stipulate a preclusion period of 4 weeks 
post event (Austroads 2016; Canadian Medical Association 2017; Driver and 
Vehicle Licensing Agency 2018), although some countries mandate a driving 
ban up to 6 months after stroke (Devos et al. 2012).
State Licensing Requirements
Visual Acuity/Visual Field/Specific Medical Advisory Board Requirements
Does not meet all state licensing
requirements
Meets all state licensing
requirements
Consultation with physician













Fig. 2 Framework for driving assessment and intervention after stroke based on best evidence and 










Fit to drive without
restrictions























Impairment in ≥ 1 domain?
Remediable?
Fig. 3 Clinical decision rule for fitness-to-drive after stroke. (Permission to use from De Baets 
et al. (2018). Complex Case Management. Physical Management for Neurological Conditions)
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 3. If the patient does not meet one or more of the jurisdiction’s prescribed require-
ments, the patient ought to be advised to allow more time for better recovery 
and/or discuss alternative transportation methods (level of evidence 5, quality 
of evidence very low, A+).
 4. Red flags ought first to be assessed, i.e. risk of recurring stroke, risk of epileptic 
seizures or severe neglect, and others listed below (level of evidence 5, quality 
of evidence very low, A+). Red flags are usually exclusion criteria that preclude 
patients from driving legally. These vary between countries and jurisdictions. It 
should be noted that this is a non-exhaustive list and healthcare providers 
should consult medical guidelines for fitness-to-drive which apply locally.
 (a) Uncontrolled medical status.
 (b) Uncontrolled epilepsy.
 (c) Severe neglect.
 (d) Hemianopia that patients cannot compensate for.
 (e) Marked cognitive or behavior impairment such as impulsivity, aggression, 
anosognosia and severe dementia.
 5. Then, screening tools such as the ones presented in Table 1 should be used to 
determine patients whose functional deficit(s) is(are) reason(s) for concerns 
(level of evidence 1a, quality of evidence moderate, B+).
 6. If the outcome of the screening shows concerns, the patient should be referred 
for a comprehensive fitness-to-drive assessment with a driving rehabilitation 
specialist, if available (level of evidence 1a, quality of evidence moder-
ate, B+).
 7. The off-road part of the fitness-to-drive assessment (e.g., Table  2) ought to 
include tests of monocular and binocular visual acuities and visual field; cogni-
tive testing to ascertain general cognitive status also needs to be done; finally, 
basic motor testing of strength, coordination, and range of motion should be 
assessed. However, there is no consensus on the selection of tests to include in 
the assessment (level of evidence 5, quality of evidence very low, A+).
 8. If the outcome of the off-road assessment shows some, but no serious concern, 
the patient should be referred for a practical on-road test (if available) to con-
firm the suitability to resume driving with or without restrictions (level of evi-
dence 5, quality of evidence very low, B+). The driving assessment expert will 
determine if the patient has enough compensatory skill to be declared fit-to- 
drive with or without restrictions or fit-to-drive with vehicle aids or will benefit 
from driving-specific rehabilitation or unfit-to-drive. Not all countries use con-
ditional licensing, and in these cases, driving may only resume if the patient is 
fit to drive.
 9. If driving-specific rehabilitation is warranted, contextual training in a driving 
simulator is preferred for maximum generalization of benefit, although non- 
contextual training has also shown moderate benefit (level of evidence 1a, qual-
ity of evidence low (imprecision, inconsistency), B+). Retraining can also be 
offered in the form of lessons with a driving instructor in a dual controlled 
vehicle (level of evidence 4, quality of evidence very low, 0).
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 10. If the patient is found unfit to drive, alternative transportation methods should 
be discussed with the patient (level of evidence 5, quality of evidence very 
low, A+).
Table 2 Results of Mr. Smith’s Driving Assessment (areas of concern are italicized in table)
Physical/sensory
Range of motion of the neck/
torso
Reduced bilaterally, neck and torso
Range of motion of the major 
joints of upper and lower limbs
110-degree shoulder level (left torn rotator cuff), 100-degree/
slightly reduced hip flexion bilaterally, reduced left ankle 
flexion.
Within functional range for driving
Strength in limbs 4/5 left, 5/5 right
Cylindrical and pincer grip Within functional range for driving
Balance with static sitting/
dynamic sitting, and static 
standing/dynamic standing
Romberg negative: balance within functional range for 
driving
Barthel Index Score 95/100
Rapid Pace Walk test 7.1 s
(>7.5 s = 2.5 × risk, >9 s = 3 × risk) (Mielenz et al. 2017)
Brake reaction test
(using driving simulator)
3.57 s, inside of the corresponding age-based average 
normal value on the same task (Akinwuntan et al. 2009)
Other; coordination, vehicle 
transfers, proprioception, 
sensation, tremor, response 
speed, tone, pain
All normal
Visual assessment using a visual screening apparatus, no visual aids used with test.
aFar acuity, contrast sensitivity, 
glare recovery, aperipheral 
horizontal visual field
Satisfactory







Prediction of pass or fail
–
Time 721 s, 12 errors, 1 false positive
28/32
22/32 (cut off score is 25, Devos et al. 2011)
9/12 (cut of score is 8.5, Devos et al. 2011)
Difference Value: + 0.951 pass (Akinwuntan et al. 2013)
Trail Making Test A 51 s
(age-based norm value = 42 ± 15 s) (Tombaugh 2004)
bTrail Making Test B 150 s




(age-based norm value = 31 ± 4) (Fastenau et al. 2010)
MoCA 25/30, lost 1 point for recall, 2 for attention, and 2 for 
visuospatial/executive
(≤26 = possible impairment) (Nasreddine et al. 2005)
Maze test Time seconds 38, risk category: safe risk (<60 s) (Barco 
et al. 2014)
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5  Case Example: Mr. Smith’s Driving Assessment
A 75-year-old male sustained a right-hemispheric stroke lesion. Pre-stroke comorbidi-
ties included history of smoking, mild osteoarthritis of the spine, and hypertension. As 
per the hospital medical guidelines, Mr. Smith was advised not to drive for 1 month 
post event. In a follow-up visit with his neurologist, Mr. Smith was asked if he could 
resume driving; however, in that same visit, Mr. Smith’s wife expressed concerns about 
this. The neurologist conducted a clinical assessment that included physical, visual, 
and cognitive tests. His visual acuity was tested as within the visual driving standards 
of 6/12 (20/40) in both eyes, and a confrontation visual field test did not suggest any 
peripheral difficulties. Mr. Smith scored 25/30 on the Montreal Cognitive Assessment 
(MoCA) indicating impairment (≤26 cutoff) (Nasreddine et al. 2005). The neurologist 
determined that Mr. Smith has ongoing mild left-sided hemiparesis and executive and 
visuospatial issues. He was uncertain about Mr. Smith’s functional ability to drive, so 
referred him to a driving assessor for a fitness- to- drive determination.
Three weeks later, Mr. Smith underwent an off-road, clinical assessment and an 
on-road, practical assessment. The off-road clinical evaluation examines physical, 
visual, sensory, and cognitive abilities specific to driving and identifies any problem 
Table 2 (continued)
Physical/sensory






14.8 ms suggestive of normal processing speed
258 ms suggesting some difficulty with divided attention
500 ms suggesting severe difficulty with selective attention
Risk category: moderate risk, 3 (Visual Awareness Research 
Group 2009)
Other; Insight, communication, 
endurance, praxis
Reduced insight into driving limitations
On-road Practical Test
Competencies Demonstrated following competencies: pedal/steering 
control, follow distance, gap selection, lane position, mirror/
indicator use, stop signs, signage, intersections, and road 
rule knowledge
Performance Slow cautious driving performance, demonstrating 
problem-solving, and anticipatory responses. Overtook 
vehicles and blocked road obstacle in appropriate manner. 
Too slow at times and demonstrated some difficulties with 
parking
Non-critical errors 2× driving too slow, driving 45 km/h in 60 km/h zone.
Parking: Unable to turn adequately to check if clear for 
reversing of car, however used mirrors satisfactory
Disoriented when trying to find exit point from carpark
Critical errors Nil observed
The tests used here are a select few of a multitude available





skill areas for the on-road test to focus on. Prior to both assessments, Mr. Smith’s 
demographic data, driving particulars, relevant medical history was obtained, and he 
reviewed and signed the informed consent and release of information form. His driv-
er’s license was valid and standard, he drove a medium-sized automatic transmission 
car, avoided busy traffic times, and had been driving about 16,000 km annually prior 
to stroke event. He reported no history of traffic violations or motor vehicle crashes in 
the past 5 years. His falls history was documented as falls in older adults is associated 
with significantly increased risk of subsequent crash risk (Scott et al. 2017).
A battery of off-road tests was administered and some of these results are out-
lined in Table 2.
The on-road practical test took place on a separate day with the same occupa-
tional therapist driving assessor in a dual operated car. The test took 50  min to 
complete and included a standardized route with a residential area, strip mall with 
pedestrian crossings, traffic light intersections, stop sign intersections, roundabout, 
change of lanes, left and right-hand turns, and a forward single space car park 
between two parked cars. A competency and error checklist were used to record Mr. 
Smith’s performance and covered: gap selection, follow distance, lane position, 
brake reaction, indicator/mirror use, speed observance, parking, intersections, road 
rule knowledge, driver interventions, and critical and non-critical errors.
5.1  Interpretation of Results
Physically, client is generally within functional standards for driving task. Range of 
motion issues was detected related to neck and torso turns which affect ability to 
safely perform over shoulder checks and looking behind vehicle for reversing.
Client meets visual standards in terms of visual acuity. Mildly impaired depth 
perception apparent.
Satisfactory cognitive results in relation to, Trail Making Test A, Rey Osterrieth 
Complex Figure, Road Sign Recognition, overall pass value of the SDSA, and 
Snellgrove Maze test. The results of Trail Making Test B, MoCA, Compass, and 
UFOV (divided and selective attention) demonstrated mild-to-moderate impair-
ments in areas of visuospatial, memory, planning, attention, problem-solving, task 
switching, and mental flexibility.
Mr. Smith performed well on the on-road practical car test, demonstrating safe 
skills. He experienced difficulties with parking and was unable to turn and safely check 
rearview when reversing car, however, demonstrated satisfactory use of his mirrors. 
Could not remember the entry/exit point of carpark. Client has an older vehicle with no 
reverse sensor or camera technology and already has a disability parking card.
Recommendations:
 1. Due to issues with range of movement in neck and torso, depth perception, plan-
ning, problem-solving, memory, and reduced attentional ability, the following is 
recommended: local area restriction, automatic transmission, blind spot mirrors, 
and reverse sensors or reverse camera technology installed. Mr. Smith was pro-
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vided with contact details for purchase of equipment and a mechanic to install 
the recommended equipment.
 2. Mr. Smith is to be provided with 3–4 rehabilitation training sessions to educate 
him on driving with specialized mirrors and reversing technology and practice 
parking.
 3. Contingent on successful completion of rehabilitation training sessions, the fol-
lowing driving recommendations are provided to Mr. Smith: automatic transmis-
sion only, 10-km radius restriction from place of residence, and installation of 
blind spot mirrors and reverse technology.1
 4. Reevaluation in 1 year or sooner if Mr. Smith’s medical condition deteriorates or 
he experiences a secondary stroke.
Copies of the assessment report were sent to: Mr. Smith, Neurologist, and driv-
ing licensing agency (if appropriate).
6  Summary
The decision-making process of fitness-to-drive after stroke is multidisciplinary and 
complex. We recommend the use of evidence-based screening tools such as the 
Compass test, Road Sign Recognition Test, Trail Making Test B, and the Rey- 
Osterrieth Complex Figure to determine who should undergo a formal driving eval-
uation. A final decision on fitness-to-drive should be made after an on-road driving 
test, preferably complemented with a detailed battery of visual, motor, cognitive, 
and behavioral tests. If training is required, contextual training in a driving simula-
tor may be more beneficial than non-contextual cognitive training.
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1  Introduction
Stroke care has changed from being largely supportive to interventional with 
emphasis on reduction of both mortality and resultant disability (Schwamm et al. 
2005; Powers et al. 2018). The development that started with integrated stroke units 
has evolved into hyperacute stroke care with emphasis on early diagnosis and revas-
cularization, by either dissolving the clot or mechanically removing it (Marler et al. 
2000; Rha and Saver 2007; Higashida et al. 2013; Powers et al. 2018). Alongside the 
early administration of recombinant tissue plasminogen activator and thrombec-
tomy, one other intervention showing some promise in limiting the long-term dis-
abling impact of stroke is early rehabilitation (Langhorne 2013; Momosaki et al. 
2016; Coleman et al. 2017; Yagi et al. 2017). Furthermore, there is now an under-
standing that establishing a continuum of stroke rehabilitation provides for best 
possible outcome for stroke patients (NICE 2013). Therefore, it is important to 
define the service structure for rehabilitation, one that follows the patient through 
the course of stroke care continuum. This chapter deals with recommendations in 
this context.
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Stroke rehabilitation is a continuous process that starts at the time the patient first 
presents with impairments and may need to be provided throughout the rest of his 
or her living years (Teasell et al. 2018). In order to do so, it is imperative that reha-
bilitation encounters are appropriately defined in terms of timing, service structures 
and resource requirements. Furthermore, effective interventions at each level of care 
must also be identified. Based on current evidence, we recommend the following 
settings as components of the stroke rehabilitation continuum:
 1. Early rehabilitation (hyperacute phase and acute phase).
 2. Subacute rehabilitation.
 3. Outpatient rehabilitation.
 4. Home-based rehabilitation.
 5. Community-based rehabilitation.
 6. Long-term and sustained rehabilitation.
2  Methodological Considerations
We present the current best evidence and evidence-based recommendations for spe-
cific interventions addressing each target domain of rehabilitation in stroke patients. 
As outlined in chapter “Clinical Pathways in Stroke Rehabilitation: Background, 
Scope, and Methods”, the focus is on best evidence and the corresponding recom-
mendations, but not on explicit health system design prescriptions. Clinical path-
ways for health system designs depend largely on regional circumstances and have 
to be developed locally taking both the evidence-based recommendations and the 
local context and needs into consideration (Platz 2019).
Nevertheless, there is still a need for guidance on health system design for stroke 
rehabilitation. Whilst we acknowledge the need for regional adaptation of specific 
practice recommendations and hence have been reluctant to make very explicit rec-
ommendations on system design in other chapters, in this chapter, the global author 
group provides some more general guidance on how to build healthcare settings for 
stroke rehabilitation.
This chapter makes primarily recommendations on how (best) to organize 
health care for stroke rehabilitation on a continuum from stroke onset to the long-
term situation of living with stroke sequelae. Since we know that such a continuum 
of care cannot be implemented in many regional settings, this chapter concludes 
with reflections on how to deal with the contextual limitations that exists in many 
low- income countries or rural settings. These limitations often include a severe 
shortage of trained staff and even most basic rehabilitative interventions often rely 
on the dedication of family members or other volunteers (see Sect. 3.7 for 
discussion).
In contrast to specific interventions, there is paucity of evidence addressing ben-
efit, harm and cost-effectiveness of healthcare settings. Therefore, this chapter is 
largely based on clinical reasoning and experience from clinical practice in diverse 
settings ranging from low-income to high-income countries. Many 
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recommendations made are expert opinions. When evidence is available, this is ref-
erenced and the level of evidence is then categorized according to the Oxford Centre 
for Evidence-Based Medicine—Levels of Evidence and rated with four categories 
according to “GRADE” (“Grades of Recommendation, Assessment, Development 
and Evaluation”) (Owens et al. 2010):
• High quality: further research is unlikely to affect our confidence in the estima-
tion of the (therapeutic) effect.
• Medium quality: further research is likely to affect our confidence in the estima-
tion of the (therapeutic) effect and may alter the estimate.
• Low quality: further research will most likely influence our confidence in the 
estimation of the (therapeutic) effect and will probably change the estimate.
• Very low quality: any estimation of the (therapy) effect or prognosis is very 
uncertain.
Whenever possible, recommendations of existing guidelines and/or evidence- 
based reviews have been included.
3  Stroke Rehabilitation Continuum
3.1  Early Rehabilitation After Stoke
With reduction in stroke mortality (Seminog et al. 2019) and more patients surviv-
ing the acute phase, attention is now focused on reduction of morbidity and dis-
ability due to stroke. Revascularization with tPA or mechanical thrombectomy as 
well as protection of neural tissue by effective management of complications, such 
as haemorrhagic transformation of infarct or brain oedema, is directed at limiting 
the extent of brain damage and thereby the disabling effect of impairments. To sup-
port this effort, emphasis on recovery of function and prevention of secondary 
complications should be considered as the main goal of early rehabilitation 
(Winstein et al. 2016). When rehabilitation is provided in an intensive care setting 
immediately after stroke, it is best referred to as hyperacute, whilst ward-based or 
step-down unit level rehabilitation should be termed as acute rehabilitation. Early 
rehabilitation refers to both of these levels of care. It is advisable, however, to use 
the individual terms as these reflect the exact level of rehabilitation setting more 
distinctly. The provision for early rehabilitation is recommended in the American 
Heart Association Guidelines, with evidence for this recommendation graded at 
1A (Winstein et al. 2016) corresponding to a strong recommendation (A) building 
on high-quality evidence.
In hyperacute setting, the stroke care team ought to include at least a physician 
with expertise in stroke rehabilitation, speech and language pathologist/therapist 
with expertise in swallow and early communication techniques, physical therapist, 
occupational therapist and stroke care–trained nurse specialists (Boulanger et  al. 
2018). In this setting, the main goal of rehabilitation should be to prevent early 
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complications and assess safety and feasibility of early mobilization (Coleman et al. 
2017). In this context the key domains of care are:
 1. Complete assessment of patient with focus on the following:
 (a) Impact of stroke with particular focus on presenting impairments and their 
severity (impairment mapping).
 (b) Co-morbidities and their premorbid impact on function.
 (c) Pre-existing musculoskeletal conditions and/or deformities.
 (d) Pre-existing disability(ies).
 (e) Family setup and support.
 (f) Work and social status.
 2. Protection of the airway and swallow assessment and management.
 (a) Early swallow assessment by speech and language therapist, who is ade-
quately trained in dysphagia management or by another professional (nurse 
or doctor), is recommended (Palli et al. 2017). Although, as yet, evidence is 
not conclusive regarding efficacy of this practice in reducing the aspiration 
episodes (Smith et  al. 2018), it is strongly recommended that screening 
should be carried out (Wolfe and Rudd 2011; Lakshminarayan et al. 2010) 
and in our judgement it should be adopted as part of acute stroke care.
 (b) The patient should not be fed orally or given medications unless cleared by 
swallow screening (Duncan et al. 2005).
 (c) The period within which this is to be conducted is difficult to specify as 
evidence in this respect does not support a standardized practice. However, 
currently, there is a consensus agreement that in patients who have signs of 
dysphagia, the assessment should be carried out within 24  h (Ellis and 
Adams 2016).
 (d) At present, there is no consensus on the instrument or instruments for the 
assessment, and we recommend that this should be agreed upon locally 
depending on resources, needs, availability, expertise and training (Donovan 
et al. 2013).
 (e) Enteral feeding should be initiated early in patients with dysphagia to avoid 
malnourishment. Whilst this should be considered as early as it is clinically 
established that patient is not able to swallow, the delay in introducing the 
enteral feeding should not exceed 3  days (Yamada 2015; Ojo and 
Brooke 2016).
 (f) Evidence indicate that early insertion of per-endoscopic gastrostomy tube 
should be avoided (George et al. 2017).
 (g) In patients requiring enteral feeding, nasogastric tube feeding is recom-
mended for as long as 3  weeks, beyond which insertion of PEG may be 
considered (George et al. 2017). Please note that nasogastric tube feeding 
can be associated with regurgitation and aspiration if the patient lies down 
immediately after a meal. Therefore, the patient should remain seated for 
over 2 h (gastric emptying time) after each meal to avoid regurgitation and 
aspiration.
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 3. Very early or early mobilization (VEM/EM):
 (a) Currently, there is no evidence to support VEM (defined as out of bed activ-
ity within 24–48 h). Indeed, AVERT III showed negative impact on mortality 
at 3 months (Langhorne et al. 2018; Bernhardt et al. 2019).
• In the light of lack of evidence for beneficial effect and evidence for nega-
tive impact at 3 months, we recommend that mobilization within 24 h 
after stroke cannot be recommended (Langhorne et al. 2018).
• Mobilization within 48 h may be considered acceptable in patients who 
meet key safety parameters. However, there is still no convincing evi-
dence for efficacy of this practice (Xu et al. 2017).
 (b) Early mobilization is recommended.
• Currently there is no agreement on the definition of “EARLY”. 
Mobilization within 72  h may be considered as such (Bernhardt 
et al. 2015).
• On the basis of current evidence, mobilization after 24 h, unless other-
wise contraindicated, is recommended. There are no studies to indicate 
that this practice is likely to harm patient and indeed, there is some evi-
dence that it may be of some benefit (Li et al. 2018).
• Dose, including intensity, frequency and duration should be commensu-
rate to patient’s clinical status. Dose should be incrementally increased in 
line with patient’s tolerance and response (Yagi et al. 2017).
• Specific motor rehabilitation focuses are head and trunk control, arm 
function, stance, gait and balance and should be addressed as individually 
indicated early after stroke.
• Change, progress and outcome should be analytically recorded daily.
 4. Communication and speech.
 (a) Early assessment of communication by a speech therapist is recommended.
 (b) Strategies for establishing communication early with stroke patients are rec-
ommended (National Institute for Health and Care Excellence (NICE) 2013).
 (c) The evidence for active speech and language therapy in early period after 
stroke, before 48 h, is not available (Nouwens et al. 2013).
 (d) There is some evidence that speech and language therapy when commenced 
from 2  days onwards has a beneficial effect on outcome (Mattioli et  al. 
2014). It is therefore, good practice to commence active speech and lan-
guage therapy from 48 h onwards for dysphasic/aphasic patients.
 5. Sensory and perceptual deficits.
 (a) Early detection of sensory and perceptual deficits is recommended.
 (b) There is evidence for introducing rehabilitation strategies for sensory deficit 
in early stroke rehabilitation (Pandian et al. 2014).
 (c) Given the current evidence, it is recommended that patients who are able to 
comprehend presence of deficits such as somatosensory deficits, visual field 
deficits, hemi-neglect or visual inattention should be made aware of these 
and rehabilitation strategies should be introduced early.
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3.1.1  Prevention of Secondary Complications
An important role of rehabilitation team in early rehabilitation is prevention of com-
plications. This has now been highlighted as key responsibility of rehabilitation 
teams in hyperacute and acute rehabilitation settings (Winstein et al. 2016).
The rehabilitation team must take steps to prevent, rapidly detect and treat
• Malnutrition and dehydration.
• Pressure sores.
• Aspiration-related chest infections.
• Over dependence on ancillary devices such as urinary catheter, tracheostomy 
tube and feeding tube.
• Contractures.
• Excessive muscle wasting.
• Shoulder pain and positional malalignment.
• Agitation and restlessness.
• Mood disorder/depression and social isolation.
• Urinary tract infection.
3.2  Subacute Stroke Rehabilitation
Subacute stroke rehabilitation is the next level of care for stroke patients. As shown 
for many of the target domains in this book and in national guidelines, in the sub-
acute stage of stroke, interventions should be intensive, challenging and tailored 
towards the individual needs of the patients.
When a patient is deemed fit to be discharged or transferred from acute care, 
a decision has to be made by the treating team whether a safe discharge home is 
possible or the patient should be transferred to a specialized facility to continue 
structured multidisciplinary stroke rehabilitation. Subacute stroke rehabilitation 
units are either stand-alone services or may be part of larger acute care hospi-
tals. There is some evidence in favour of this level of care of stroke patients 
(Rønning and Guldvog 1998). Several factors influence this decision: These 
include:
• Availability of required subacute stroke rehabilitation facilities (currently only 
developed healthcare systems consistently provide this level of care).
• Affordability of subacute rehabilitation.
 – State funded (most are eligible, but waiting lists and duration may be barriers).
 – Medical insurance (restrictive/selective).
 – Self-funding (expensive).
 – Charity funding (limited).
• Geographical location and accessibility to patient and his or her family.
• Medical capability of a facility, as this determines at what stage patient may be 
transferred. For example, if the patient has a tracheostomy tube and subacute 
rehabilitation facility that he or she can be transferred to does not have a clinical 
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set up to cater for tracheostomized patients then a safe transfer is not possible. 
This results in longer stay in acute care with limited access to subacute level of 
rehabilitation.
3.2.1  Transfer Criteria to Subacute Rehabilitation Facility
Whilst transfer criteria will differ from place to place and will depend on the ser-
vices available at the subacute rehabilitation facility, some guiding criteria for trans-
fer from acute to subacute level of rehabilitation may be applied:
 1. All investigations required for determining the nature and cause of stroke have 
been completed.
 2. All required interventions for secondary preventions have been optimized.
 3. Medical stability has been achieved with satisfactory control of blood pressure 
and diabetes mellitus.
 4. Patient continues to need close physician supervision.
 5. Patient continues to need specialized nursing care.
 6. Patient is cognitively able to engage meaningfully in therapies.
 7. Patient is able to tolerate higher intensity of therapies.
 8. Patient requires more than one therapy input daily.
 9. Patient and family have been suitably counselled to accept lesser level of medi-
cal surveillance and higher intensity of rehabilitation.
 10. Patient and family have agreed to the transfer and fully understand its need.
3.2.2  Subacute Rehabilitation Facility
The subacute rehabilitation facility for stroke patients should have integrated multi-
disciplinary set up for provision of this level of rehabilitation. The patient should be 
offered intensive therapies. We recommend that for optimal functioning a facility 
should at least meet the following standards:
• The physical space and environment should be optimal and conducive to ade-
quately accommodate the number of patients a given facility is likely to serve.
• The multidisciplinary team should include the following categories of staff:
 – Physician(s) with expertise in neurorehabilitation.
 – Rehabilitation-trained nurses.
 – Neurological physical therapists.
 – Neurological occupational therapists.
 – Neurological speech and language therapist with expertise in dysphagia man-
agement and communication rehabilitation.
 – Dietician(s).
 – Social worker(s)/case manager(s).
• When available, the provision of neuropsychological and orthoptic services is 
recommended.
The facility should have links with or access to orthotic, neurological, urological, 
psychiatry, ophthalmology and general medical services.
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• The facility should have all essential therapy equipment and aids.
• The facility should have dedicated therapy areas, e.g. for physiotherapy, occupa-
tional therapy and speech and language therapy.
• Social networking spaces and provision for community re-integration (shopping, 
leisure trips, etc.) are desirable.
The ideal staff to patient ratios have not been optimally evaluated and differ in 
various settings. We recommend that the following ratios be considered for plan-
ning such facilities:
• One physician (with expertise in neurorehabilitation) should not be expected to 
supervise the care of more than 20–25 inpatients.
• Nurse to patient ratio: No more than 5 patients to one nurse.
• Physiotherapist to patient ratio: No more than 10 patients to one 
physiotherapist.
• Occupational therapist to patient ratio: No more than 10 patients to one occupa-
tional therapist.
• Speech and language therapist to patient ratio: No more than 20 patients to one 
speech and language therapist.
• For each 40 patients one neuropsychologist is recommended.
3.2.3  The Transfer Process
The representative of the subacute rehabilitation facility should meet with patient 
and his or her family ahead of transfer and fully brief them about the nature of ser-
vices offered and the level of care they should expect. The transfer process should 
also be clearly explained.
The transfer process should be well coordinated and adjusted to the patient’s 
needs. The following standards should be adhered to:
• All required documentation including discharge summaries from each discipline 
involved in the care of the patient in the referring facility should be provided to 
the subacute rehabilitation facility.
• The discharge medications complete with doses and schedules should be 
clearly listed.
• Detailed nursing handover should be provided.
• All required equipment and devices (e.g. orthosis, splints, wheelchair) necessary 
for continued care of the patient should be provided.
3.2.4  Subacute Rehabilitation Programmes
After admission, the patient should have structured care provided to him or her. The 
facility should have standardized policies for all sessions and domains of care. 
These include:
• Mobility training including gait training and where necessary training for full or 
semi-independence from wheelchair.
• Management of cognitive impairment and cognitive rehabilitation.
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• Management of perceptual deficits.
• Management of dysphagia with the aim of retraining for oral feeding where this 
is possible to do safely.
• Participation in activities of daily living.
• Neuropathic pain management.
• Spasticity management.
• Management of mood disorder.
• Adjustment and “beginning to live with disability” training.
• Readiness for discharge to home or modified living.
The policies should highlight minimum standard of care for each domain of care. 
There should be agreed timeline for initial assessments and care planning and goals 
set thereafter should be measurable and achievable in realistic time frame. The fol-
lowing are some guiding parameters in this context:
• Patient(s) should undergo full multidisciplinary team (MDT) assessment within 
24–72 h of admission.
• The MDT should develop a goal-directed care plan with specified timelines.
• The patient and family should be fully briefed about the care plan and their sug-
gestions and concerns taken into consideration and the care plan adjusted 
accordingly.
• The progress of the patient should be reviewed by the MDT at least every week 
and goals and care plan modified to adjust for change.
• Discharge planning should start early, preferably within 1 week of admission.
• Periodic patient and family meetings should be held to brief them about the 
progress.
• Discharge planning meeting must always be convened.
The aim of subacute rehabilitation is to achieve clinical stability and functional 
readiness for discharge to community, home or modified living facility. This entails 
gaining modified partial to full independence and predictability of care needs. The 
discharge should be appropriately planned and the patient should be transferred to 
either outpatient or home-based rehabilitation services.
The specific recommendations given above have been formulated on the basis of 
good practice and in line with those detailed in several existing guidelines (Winstein 
et al. 2016; Gittler and Davis 2018).
The overall evidence for the effectiveness of this level of rehabilitation is not 
robust for the whole group of stroke patients (García-Rudolph et al. 2019). Teasell 
and co-workers differentiated their analysis according to the severity of stroke 
(Teasell et al. 2018; evidence-based review of stroke rehabilitation):
• In mildly affected patients, the site of rehabilitation does not influence func-
tional outcome (level of evidence 1A; high-quality evidence),
• For the subgroup of patients with moderately severe stroke, specialized 
rehabilitation in a subacute rehabilitation unit does improve functional out-
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come compared to conventional care on a general ward (level of evidence 1A; 
high-quality evidence),
• Patients with severe or moderately severe stroke who receive treatment on a 
stroke rehabilitation unit have a lower risk of being dependent or dead/dependent 
compared with patients who receive little or no rehabilitation (level of evidence 
1B; medium-quality evidence).
Not all patients will need treatment within a special subacute rehabilitation facil-
ity. Especially patients with mild or moderate functional deficits may prefer to 
attend specific rehabilitation modules on an outpatient basis or even at home using 
tele-therapeutic devices (see also Sect. 3.6).
3.3  Outpatient Stroke Rehabilitation Services
Patients may be discharged from acute care and subacute facilities with arrange-
ment to receive ongoing rehabilitation as outpatients. Indeed, there is evidence that 
early supported discharge directly from acute care to community-based rehabilita-
tion as well as integrated outpatient rehabilitation delivers good outcome for stroke 
survivors (Rice et al. 2016; Langhorne et al. 2017). Teasell et al. (2018) found level 
1A evidence that stroke patients with mild-to-moderate disability, discharged early 
from an acute hospital unit, can be rehabilitated in the community by an interdisci-
plinary stroke rehabilitation team and attain similar or superior functional outcomes 
when compared to patients receiving inpatient rehabilitation (high-quality evidence).
The patient could be referred to an outpatient stroke rehabilitation service if:
• He/she is clinically stable and is able to tolerate transportation to and from out-
patient rehabilitation facility.
• He/she has sufficient effort tolerance level and does not fatigue so much that 
precludes effective participation in therapy sessions.
• He/she is able to engage cognitively in therapy sessions, re-engage in subsequent 
sessions with demonstrable carry over.
The outpatient stroke rehabilitation facility should be designed to offer multidis-
ciplinary team rehabilitation. Patients should have access to all required therapies 
and interventions. The available services should include:
• Access to physician(s) with expertise in neurorehabilitation for continued man-
agement of residual effects of stroke including spasticity and pain.
• Physiotherapy service with adequately designed treatment areas with availability 
of most required equipment.
• Occupational therapy service with capacity to attend to issues such as extended 
activities of daily living and vocational rehabilitation.
• Speech and language therapy services with capacity to work on issues related to 
dysphagia and communication.
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• Neuropsychological therapy for the treatment of cognitive, behavioural and 
emotional post-stroke disorders is recommended when available.
• Optional or ancillary services include dietetics, orthotics and specialized nursing 
service particularly, continence management. These services may also be 
accessed through a referral arrangement.
If the patient is able to travel to and from the clinic and logistically it is possible 
to do so with the least level of disruption to family life, then outpatient rehabilitation 
is preferable to home-based rehabilitation. In less developed healthcare systems, 
cost and availability may limit access and this may be combined/supplemented with 
home-based rehabilitation.
3.4  Home-Based (Family-Based) Stroke Rehabilitation
Once patients with stroke have been discharged home, it is important to continue 
with rehabilitation. Home-based rehabilitation in the present context is defined as a 
form of rehabilitation, where the training is provided by members of the family. It 
may be beneficial as it realizes the actual need-based training true to the patient’s 
living environment. Task shifting is an attractive solution for healthcare sustainabil-
ity. The patient’s family can be trained to provide task-based training, and members 
of the rehabilitation team can visit the patient at home as needed to provide required 
therapies. In low- and middle-income healthcare systems, this may be an effective 
way of providing ongoing rehabilitation. (Lindley et al. 2017), and the outcomes 
may be comparable to long-term rehabilitation in non-domiciliary facilities (Mayo 
2016). However, home-based (family-based) rehabilitation is under stress where the 
joint families are disintegrating into nuclear families thereby shrinking the pool of 
family members who can attend to the rehabilitation of patient after stroke. 
Therefore, task shifting to family members may increase caregiving burden and 
stress. Nevertheless, family participation at home reduces the need for travelling for 
outpatient appointments in centres, especially when distant from patients’ homes. 
Furthermore, the financial burden is lessened if therapists are not required to admin-
ister therapy at home and day-to-day life is not severely disrupted. This may con-
tribute to reduction in patient’s and caregiver’s anxiety and improve quality of life 
of affected family. Conversely, though it can be argued that in patients with limited 
functional improvement, over long period of time, the situation may become bur-
densome and result in caregiver’s fatigue (Sarı 2017).
Furthermore, the results of the ATTEND trial did not demonstrate any benefit of 
family-led domiciliary care (ATTEND Collaborative Group 2017). This is also con-
sistent with the absence of benefit seen in a systematic review of trials of caregiver- 
mediated exercises to improve activities of daily living after stroke (Vloothuis et al. 
2016). Overall, these findings do not support investment in new stroke rehabilitation 
services that shift tasks to family caregivers, unless new evidence emerges. (Level 
2B evidence, moderate evidence against the establishment of new family-led thera-
peutic interventions without concomitant research.)
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The absence of benefit of the family-rehabilitation intervention has important 
implications for stroke recovery research, behavioural change, and task shifting in 
general. A future avenue of research should be to investigate the effects of task shift-
ing to healthcare assistants or team-based community care to offer care after dis-
charge (ATTEND Collaborative Group 2017). Another option may be to combine 
family-led rehabilitation with outpatient care. This may help reduce the frequency 
of outpatient care required thus promoting affordability.
3.5  Community-Based Stroke Rehabilitation (CBR)
Over the last couple of decades, CBR has acquired a lot of interest. CBR pro-
grammes improve, facilitate, stimulate and/or provide services to people with dis-
abilities (PWDs), such as stroke survivors, their families and caregivers within the 
locations of their families and communities through locally employed full or part 
time, paid or volunteer community rehabilitation workers, who are trained, fol-
lowed up and managed within a certain organizational set up, that has rehabilitation 
philosophy as its core operational principle (Ru et al. 2017). Only few studies are 
available on CBR and its advantages and disadvantages have not been critically 
studied (Stephenson and Wiles 2000). However, it is possible to list some advan-
tages on the basis of experience and current practice.
Advantages of CBR, compared to the institutional approach include:
• In time, and in theory, all the people living with disabilities in a community can 
be reached and their basic needs be met.
• “Tailor-made” rehabilitation programmes can be established, based on the indi-
vidual’s capacities and needs, and focused directly on integration into the family/
community. “Disability” is not a stable situation. CBR can evolve and adapt to 
changing needs of patients.
• Family members can witness and participate in the progress of a relative living 
with disability, thus enhancing their faith in that person’s abilities and potential 
and challenging their own prejudices.
• CBR services, apart from carrying out their core work in rehabilitation, can also 
contribute towards the prevention of secondary complications related to impair-
ments and disabilities, through activities such as primary healthcare, vaccina-
tions, nutrition and hygiene.
• CBR programmes can trace many people living with disabilities who would 
never have been found by institutions and, through referral, can make the work 
of other existing specialized services more effective.
• CBR can be more effective in tackling issues such as return to work and com-
munity access, including leisure activities and extended activities of daily living.
• CBR could be cost-effective (if well managed!).
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Problems of CBR, compared to the institutional-based approach,
• The poor living conditions of most people with disabilities are also poor condi-
tions for rehabilitation. The objectives of individual CBR programmes therefore 
have to be very realistic and must focus on essential needs.
• Community- and home-based services by community rehabilitation workers can 
sometimes be rather routine and boring, for the worker, client and family alike; 
this may be less challenging than training or education in a centre.
• Poor families’ priorities may be at the level of survival rather than solving prob-
lems of a member with disability. Furthermore, the disability of one family mem-
ber is not always problematic for other family members; therefore, it is sometimes 
very hard to enlist their active collaboration.
• The organization and management of CBR are complex and difficult due to orga-
nizational and political reasons and local priorities for funding.
• The educational level of the community rehabilitation workers (CRWs) may be 
low. Better-educated individuals are often difficult to engage in CBR work. 
Front-line CBR is a low-profile job, which does not offer notable social status to 
people with higher education.
These factors influence the type, level and quality of the services which can be 
provided at the community level through a CBR programme. Although, these fac-
tors have been determined through critical appraisal of the existing services, there 
are limited number of studies and it is difficult to provide firm structural basis for 
community rehabilitation.
In Europe (defined geographically), such structures are already implemented in 
some countries, e.g. in the UK and in France. As part of the NHS (e.g. in Milton 
Keynes), Stroke Clinical Specialists are available “to provide in-depth knowledge 
and expertise; consistent education, support and advice in accessing information 
and a full range of services from the NHS, social care and others. This service is 
available to people who have had a stroke/TIA, their relatives and carers, members 
of the general public, professionals and voluntary organisations” (NHS homepage 
Milton Keynes, accessed 28.12.2019).
In Germany, pilot studies are run to employ community rehabilitation workers 
(e.g. “Schlaganfall-Lotsen”) by regional stroke associations (e.g. “Schlaganfall 
Allianz Sachsen-Anhalt”) or by charities (e.g. “Stiftung Deutsche Schlaganfall- 
Hilfe”). Their main aims are to provide advice to patients and their relatives, to help 
to implement elements of effective secondary prevention and help to organize the 
continuum of stroke care and therapy after discharge from the primary hospital. 
Similar services are also available or in preparation in other European countries, in 
some American, Asian and African countries and well established in some areas of 
Canada and Australia.
The aim of these coordinators is always to guide and to augment the existing 
structures in the community, they cannot—and should not—substitute the existing 
medical and therapeutic resources.
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In many countries, stroke support groups and stroke survivor organizations (e.g. 
the Stroke Alliance for Europe (SAFE), a non-profit–making organisation with 
members from 24 countries) support education and stroke research; they campaign 
to support the acute treatment and prevention of stroke and help to improve the qual-
ity of life of stroke survivors, their families and caretakers.
It is our recommendation that at this time, local realities and resources should 
determine the structure and extent of services that are possible to provide under this 
umbrella taking into account the specificities of government run, insurance gov-
erned and privately financed systems. In this way, rehabilitation centres can also be 
included into the structure as local and/or regional centres of excellence especially 
for more severely affected patients. Such an approach is likely to be useful in low-, 
middle- and high-income countries. If implemented its effect should be scientifi-
cally evaluated whenever possible.
3.6  Long-Term and Sustained Rehabilitation
A significant number of stroke patients survive with established disability and with 
age as well as ongoing comorbidities. The burden of disability often increases and 
results in significant loss of function and independence (Meyer et al. 2015). If left 
unattended, the burden of care may progressively escalate (Van De Port et al. 2006). 
This can result in loss of employment, social restriction, care providers fatigue as 
well as ever-increasing financial burden. To date, there is no consensus as to how to 
support or provide care for stroke survivors in the long term (Aziz et al. 2016). It is, 
however, important to establish a suitable network of surveillance in order to pre-
vent decline in stroke survivor’s functional status and level of participation over time.
It is recommended that there should be a long-term care support and sustained 
rehabilitation program for patients with stroke. We recommend that consideration 
be given to providing this via primary care centres in the community or delivered by 
a specialist nurse practitioner. In developing and less-developed healthcare systems, 
a model of care can be developed whereby trained community workers can maintain 
regular contact with patients and their families and advise them to request help 
when they deem this is necessary. Modern technology can also be utilized for this 
purpose and contact can be maintained with patients and their families via mobile 
phones or specially developed apps. Telemedicine is also being utilized for surveil-
lance (Sarfo et  al. 2018) and it is anticipated that this model of care is likely to 
become widely used for provision of long-term support and sustained rehabilitation 
for stroke survivors in future.
3.7  Adapting Clinical Pathways to Diverse Regional 
Healthcare System Contexts
More than 80% of the world’s population live in over 100 developing countries. 
Delivery of neurologic care in developing countries varies depending on the needs 
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and resources of the country and the availability of medical and paramedical per-
sonnel (WHO 2014). Medical insurance and government support are usually mini-
mal or totally lacking. The financial burden is heavy and includes direct costs of 
inpatient care, outpatient care and therapy sessions, investigations, medications and 
transport (patients from rural areas often have to travel long distances to urban 
healthcare centres). The indirect cost includes the loss of earnings due to unemploy-
ment during illness and convalescence. In the large majority of these countries, 
there may be no access to financial support such as disability benefits (Disability 
and Development Report 2018; Singh 2013).
The availability of neurorehabilitation services is inconsistent and may range 
from highly sophisticated in developed countries to totally inadequate or lacking in 
developing and underdeveloped countries. Over 60% of the developing countries 
have no neurorehabilitation services. There is severe paucity of trained profession-
als. The task of managing patients with neurological impairments is often devolved 
to generic therapists and inadequately trained nursing and medical staff. The overall 
effect is that treatments are being provided by less than adequate professionals, pos-
sibly delivering outcomes for patients that fall short of their potential. Even in those 
developing countries, where some neurorehabilitation service is provided, the qual-
ity is rarely good enough due to a lack of a well-structured neurorehabilitation sys-
tem which can provide comprehensive rehabilitation services. More often than not 
treatment is not provided (WFNR 2015).
As stated before, hospital-based interdisciplinary neurorehabilitation care should 
be provided as a first line service to facilitate rapid recovery after neurological 
injury. The home-based or community-based services are appropriate for settlement 
at home and community re-integration in the recovery phase. Community-based 
rehabilitation services are the most appropriate way forward in enhancing outcomes 
particularly in developing countries, with tailored and culturally sensitive education 
for the family, to help them participate in the rehabilitation of the patient (Pandian 
et al. 2015). There have been repeated concerns about the adequacy of the evidence- 
base regarding the efficacy, effectiveness and efficiency of CBR predominantly 
using local resource in the local community (Surya 2010, 2015). However, on bal-
ance, in developing countries, CBR may be one of the most effective ways of pro-
viding rehabilitation after the acute/subacute phase, especially when there is an 
intimate social system and family structure that helps to provide the necessary phys-
ical, emotional and spiritual support. Strong family bond helps to overcome the 
negative impact of the disability and large extended family system ensures that the 
physical, social and financial burden of disease is shared.
The role as therapy giver can be switched depending on the availability of family 
members. Even though, the ATTEND trial ( 2017) and the Cochrane review by 
Vloothuis et al. (2016) have not shown a clear-cut beneficial effect of (additional) 
therapy provided by family members, these family members are often the only peo-
ple available to the patients. They provide valuable social, emotional and psycho-
logical support. In order to strengthen and improve their role in delivering 
rehabilitation, different models for training can be tried to ensure best possible out-
comes. As many family members as possible can be trained by the therapist or 
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through web-based teaching application. Use of mobile phone to record the exer-
cises and progress and sharing with the patient/caregiver is useful as patients/care-
givers can review them regularly at home to be implemented at home. Mobile phone 
records of exercises at home also make it possible for therapists to check whether 
family members are correctly following the programmes at home. The recorded 
exercise pattern on phone can be reviewed during outpatient visits and any modifi-
cation or adjustment to the programme can be made. This application is most useful 
tool in family-based rehabilitation (Zhou et al. 2018).
Family-based and community-based rehabilitation settings are likely to become 
important models in future for delivery of rehabilitation after the acute/subacute 
phase of stroke not only in low- and middle-income countries but also in high- 
income countries. As telemedicine and technologies become more sophisticated, 
this form of rehabilitation will play a pivotal role in patient’s recovery and improv-
ing outcomes.
4  Conclusions
Stroke care has advanced in the past two decades and more patients are surviving 
the acute stage. The mortality rates are reducing both in developed and developing 
countries, thereby resulting in increased disability burden (Feigin et al. 2019). In 
stroke care model, rehabilitation is now considered an integral component of all 
levels of stroke care (Fig. 1). Whereas, there may be a reduction in the individual 
level of disability in sophisticated healthcare systems due to timely interventions 
and reduction of the impact of disabling impairment because of appropriate level of 
rehabilitative care (Lees et al. 2016; Emberson et al. 2014; Campbell et al. 2015); in 
developing countries, prolonged survival is associated with heavier burden of dis-







Fig. 1 Essential levels of stroke rehabilitation
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(surveillance, prevention, acute care and rehabilitation), is lacking at many levels 
and contributes to poor outcome in the developing countries. It is imperative that 
despite the limitations of resources, appropriate efforts are made to improve ser-
vices for stroke survivors and foundations are laid upon which an effective contin-
uum of care can be developed. Some low-cost and simple measures can be put 
in place.
For developed countries, we recommend that the stroke care continuum should 
be reinforced with mechanisms in place for continual appraisal and improvement. A 
major challenge foreseen is the increasing demand for stroke rehabilitation that has 
to be met due to demographic changes with a higher proportion of elderly citizens 
who are at risk for cerebrovascular accidents.
For developing countries, we recommend that given the current evidence, early 
mobility, after 24 h, should be encouraged. Intensive care and acute care staff should 
be educated to pursue this objective. A simple measure of prescribing bed rest 
beyond 24 h only for those who require it and considering this as an exception may 
help to improve outcome. Deployment of physical therapists and other therapists in 
a multidisciplinary setting in hyperacute and acute care services must be considered 
vital. Training of all nursing staff in moving, handling and positioning of patients 
should be made mandatory. Furthermore, prevention of secondary complications 
must be diligently pursued (Scottish Intercollegiate Guidelines Network 2010). In 
fact, the healthcare cost savings through minimizing secondary complications 
should pay for any extra resource required to achieve this objective.
In the continuum of stroke care, subacute rehabilitation may be provided by spe-
cialized therapists on an outpatient or inpatient basis or in families in private homes, 
where most of the therapy will be provided by lay persons (Fig. 2). Although inten-
sive and at the same time specific professional therapy after stroke is highly recom-
mended in the subacute phase after stroke (see above), intermediate rehabilitation 
facilities may be difficult to provide in developing countries due to the cost of set-
ting up and maintaining such facilities. However, where available, such facilities 
may also support community-based and family-based care by proving oversight and 
outpatient/inpatient multidisciplinary care as may be needed (see above).
We recommend the development of services in the community with investment 
in CBR and home-based rehabilitation, utilizing low-cost resources and—building 
on positive and negative conceptual experience—engaging family members as part 
of rehabilitation team not only in the subacute stage after stroke but also for long- 
term and sustained rehabilitation. To incorporate therapy into daily routine and 
practice is however an unsolved problem—both in developed and developing 
countries.
We have deliberately avoided explicit recommendations for technical rehabilita-
tion interventions such as robotics, neuromodulation and other such expensive tech-
niques and equipment which due to lack of availability and cost are difficult to 
generally recommend as necessary for rehabilitation. Furthermore, with regard to 
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recovery of function, the principles of functional brain recovery apply to both tech-
nology- and mankind-supported restorative treatment and training. Both approaches 
or their combination can be recommended based on their regional availability. Both 
feasibility and cost-effectiveness of purely therapist-led and technology-based reha-
bilitation vary according to regional socioeconomic circumstances and thus any 
hitherto decisions have to rest on their regional assessment.
Finally, it is our opinion that all healthcare systems, globally, must make stroke 
a priority and consider investing in continuum of care for stroke as doing so will 





















Fig. 2 Recommended stroke rehabilitation model for developing countries
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